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Foreword
This report is very much the result of collaborative work within and outside
the Drug Misuse Research Division.  We in the Drug Misuse Research
Division, would like to thank very sincerely those people working in the
drugs area who gave generously of their time to inform us about recent
developments in their areas of work.  It is not possible to name all these
people but the agencies with which they are affiliated are acknowledged
as follows -
Many thanks to personnel from :
Department of Tourism, Sport and Recreation,
Department of Health and Children,
Department of Justice, Equality and Law Reform,
Department of Social Community and Family Affairs,
Department of Education and Science
Members of An Garda Siochana – Irish police force
Forensic Science Laboratory
Personnel from Health Boards and Drug Treatment Facilities
Mental Health Division of Health Research Board
Centre for Health Promotion Studies, National University of Ireland,
Galway
Members of the Judiciary,
Voluntary and Community Groups and
Academic Researchers.
New material for this year’s report is presented in italics except where
[almost] all the material is new i.e. Chapter 2 and Key Issues, Sections 13
and 14. As a complete report was requested, each chapter was started
anew and where relevant extracts were copied from last years report
[1999].
The authors would like to thank all those who provided comments on the
report, in particular personnel form Department of Tourism, Sport and
Recreation; Department of Health and Children; Department of Justice,
Equality and Law Reform and our colleagues at the Drug Misuse
Research Division, Tracy Kelleher and Paul Cahill.
Finally many thanks to Ms. Mary Dunne who put the final touches to the
document and managed its production.
Rosalyn Moran
Head of Division
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1SUMMARY
Main Trends and Developments : Rosalyn Moran
Some developments in policy and programmes of a general nature are
overviewed, followed by a review of developments in specific sectors as follows
-
 Treatment Policy and Programmes
 Prevention Policy and Programmes
 Criminal Justice / Law Enforcement and Supply Side
 
 Recent Developments – General
- A Review of the National Drugs Strategy is nearing completion. The
review had broad terms of reference and will address, inter alia, demand and
supply issues.
- The delivery of the National Drugs Strategy will take place within the
framework of the National Development Plan 2000-2006, which, inter alia,
will involve greater devolution of power to regional structures, with which
existing structures in the drugs area will co-operate. The intergrated inter-
agency approach and the involvement of local communities in the delivery of
policy will continue.
- A National Advisory Committee on Drugs has been established by the
Cabinet Committee on Social Inclusion in recognition of the importance of
having authoritative information and research findings available as a guide to
policy. The Group will have continuing responsibility for research and
information on drug misuse in Ireland and is implementing a prioritised three
year programme of research and evaluation on the extent, nature, causes
and effects of drug misuse in Ireland and identifying the contribution to be
made by all the relevant interests.
- The Integrated Services Process [described in last year’s report] has
been put in place in four areas on a pilot basis. Priority themes for each of
the four pilot areas are being implemented. The need for Departments and
Agencies to heighten their engagement to ensure that the ISP is integrated
into their budget planning, resource deployment and new programme
design has been highlighted. It is hoped these initiatives will form a model
of best practice that can be extended to other deprived urban areas.
- Addiction Research Centre – has been established in Trinity College,
Dublin. It is a joint initiative involving the Department of Social Studies and
the School of Pharmacy in TCD. The Centre will aim to provide a focus for
independent and critical academic research into the prevention and
management of alcohol and drug problems in Ireland.
- Private Sector Involvement in supporting initiatives, in the fight against
social inclusion, is growing. A number of schemes are underway e.g. The
Companies Caring for Children Initiative, Foundation for Investing in
Communities1and Irish Financial Service Centre Trust. The latter, for
example, provides financial support towards the development of a
                                                
1 Annual Report of the Inter-Departmental Committee, 1998/99. Social Inclusion Strategy.  Stationery
Office, Dublin. P.33.
2residential facility in Tullow, Co. Carlow where young drug offenders can
avail of training and be educated to prepare for employment; the Trust also
provides finance to St James’ Resource Centre which operates as a
rehabilitation centre for ex-prisoners and drug users.
- Cross border activity and co-operation in the drugs area is likely to
increase.
 Recent Developments in Treatment Policy and Programmes
 
- All health boards have continued to expand their prevention, treatment and
rehabilitation programmes. This is particularly so in the three area Health
Board in the East [ERHA], where the opiate problem is most acute.
- In 1999 & 2000 all Health Boards have been provided with additional funding
to continue to develop all aspects of their drug prevention and treatment
services.
- Increased resources have been allocated in 1999 by central Government to
all health boards to develop databases and information systems to help
characterise the drug problem in their areas.
- The Kilkenny Drugs Initiative, a cross community body which includes
representatives of the Garda and the South Eastern Health Board,
conducted a six-month study of substance misuse in Co. Kilkenny. It found
that cannabis is widely used in schools in Kilkenny and students are
dealing in many other drugs. It also found that the use and misuse of
substances was not confined to any age bracket, gender or socio-
economic background.
- The expansion of provision of drug treatment services by means of the
primary health care system continues for stabilised users.
- The Misuse of Drugs [Supervision of Prescription and Supply of Methadone]
Regulations 1998 came into force in July 1998, imposing strict control on the
prescribing and dispensing of methadone, which aimed inter alia, to reduce
the leakage of methadone onto the illicit market.
- In 1998 treatment cards were introduced for those receiving methadone.
- Five GP Co-ordinators have been recruited to facilitate GP involvement in
community based drug treatment in the three area health boards in the East
and to help lessen the waiting list. Liaison Persons have been appointed in
other health boards.
- By end of July 2000, there were 4,851 people receiving methadone in
Ireland [only 90 of these were from outside of the ERHA area]. In 1998 there
were 3,600 receiving methadone in ERHA area.
- In August 2000, there were 158 GPs prescribing methadone, 131 of these in
ERHA i.e. 27 in rest of country.  In addition, there are 207 pharmacists
dispensing methadone to clients who are either attending a GP-based
substitution programme or attending satellite clinics.  Of the 207 pharmacists
dispensing methadone, 154 are located in the ERHA area.
- There is much media coverage and political concern as there are still 406
opiate addicts on the waiting list for treatment in clinics around Dublin
[October, 2000].
- Public opposition to the opening of clinics in neighbourhoods continues. The
Health Boards are adopting a partnership approach with local communities.
3The ERHA Service Plan for the AIDS/Drugs Service included a commitment
to ‘Social Development’.
- Needle exchange has been available in the Dublin area since 1989. There
were 6,000 people attending needle exchange programmes in the EHB in
1999 and these are not included in the treatment returns2. The Drug Misuse
Research Division is exploring the possibility of reporting on these statistics
along with the regular drug treatment figures.
- Three liaison midwives are to be appointed in the ERHA to deal with
pregnant misusers, one has already been appointed.
- The funding available to the EHB/ERHA to develop drug programmes and
services has increased from IR£1million/Euro 1.27m in 1992 to IR£17
million/ in 1999 and IR£22m/Euro 27.95m in 2000.
- The EHB published an Inventory of Policies for the Board’s AIDS/Drug
Addiction Services in October 1998 which covers policy in all main areas
under the headings treatment, viral illnesses, general and administrative.
- The ERHA has been reconceptualising its service provision and affording a
greater role to prevention and rehabilitation along with the traditional focus
on treatment.
- The EHB in 1999, developed a Rehabilitation Blueprint which involves
realignment of treatment services to a rehabilitation focus. This new focus
will commence at assessment stage.
- A rehabilitation co-ordinator will be appointed in each of the three regions of
the ERHA.
- There is anecdotal evidence that benzodiazepines misuse has increased as
has prescribing of same by a small number of GPs. A committee to examine
the nature and extent of benzodiazepine prescribing in Ireland has been
established by the Department of Health and Children. The committee will
make recommendations on good prescribing practice in general and in
particular in relation to the management of drug misusers.
- Homelessness amongst drug misusers and ex misusers is recognised as an
increasing problem.
- Hepatitis C is becoming an increasing problem amongst injecting drug users.
- FAS has committed a significant number of Community Employment places
towards rehabilitation programmes for recovering drug misusers. These
programmes are being developed through the Local Drugs Task Forces.
- A review of the National AIDS Strategy has been carried out and AIDS Policy
2000 was published in June 2000.
- The Prison Service and the ERHA have put together a joint programme to
ensure greater cohesion and continuity of care in the treatment available to
drug misusers entering or leaving prison.
 
 
 
 Recent Developments in Prevention Policy and Programmes
- The Department of Health and Children has provided funding to all health
boards to collect information on drug prevention in their areas.
                                                
2 Figures for 2000 not available.
4- A number of initiatives in the prevention area are being funded through the
Local Drug Task Forces and Young People's Facilities and Services Fund.
- ‘Walk Tall’ is a substance misuse prevention programme for primary schools
piloted in 1998. This and a programme aimed at second level school pupils
‘On My Own Two Feet’ will continue to be implemented in schools during
2000.
- A National Youth Health Programme – a partnership between the
Department of Health and Children and the Department of Education and
Science and the National Youth Council of Ireland provided extensive
training on drug prevention and policy development in 1998. Training with
the pack ‘ Drug Questions Local Answers’ (developed by the Department of
Health and Children) continues to be used in several health board areas.
This is a resource pack, which enables communities to provide a multi-
disciplinary approach to the drugs issue.
- New information cards and other resource materials, designed to be user
friendly and accessible, were developed for European Drug Prevention
Week, 1998 and are still available free of charge to interested parties.
- The Irish element of the EDDRA database continues to be developed with
the addition of evaluated projects. The promotion of the database has
reinforced the need for evaluation in this context.
 Recent Development in Criminal Justice / Law Enforcement and Supply
Side
- Up to the mid 90s police activity focused mainly on supply reduction and law
enforcement. Since 1995 however, the area of demand reduction has
become a more important and prominent aspect of policing the drug
problem. The fostering of strong community links are seen as an important
aspect of effective policing.
- A Garda National Drugs Unit (GNDU) was established in September 1995,
replacing the former Dublin based Drugs Squad. The establishment of the
Unit was a marked departure in that it placed the responsibility for Drug Law
Enforcement on a national level within the GNDU. It also introduced the
concept of demand reduction.
- The new five year corporate strategy for the police force – ‘Policing In
Ireland’ was put in place on 1st January 2000. The enforcement of laws
relating to drugs was one of the major priorities identified. Operationally this
will involve each manager in each Garda Division/District and Station
drawing up specific plans/targets, reviewing progress and adjusting strategy
as needed [Sutton, 2000].
- Each of the 27 Garda divisions in the country have a specialised Drug Unit
with responsibility for enforcement of drugs legislation. In the cities of Dublin,
Limerick and Cork, districts have specific drug operational units dealing with
the drug problem at local level. For example, since January, 2000 there are
18 dedicated Drug Units in the Dublin Metropolitan Region who are in
constant liaison with each other and with the GNDU [Sutton 2000].
- The Commissioner is represented on the National Drug Strategy Team by
a Detective Superintendent from GNDU and each of the Local Drug Task
Forces has a Garda representative at Inspector level.
5- Interagency co-operation has increased and is seen as vital in combating
the international drug trade. Accordingly, there is growing co-operation
between the Police, Customs and Navy. A Memorandum of Understanding
and a working protocol has been drawn up between the police and the
Customs service. Both agencies engaged in joint training programmes and
exercises with the Naval Service. The interagency co-operation involved in
the operation of the CAB – the Criminal Assets Bureau [i.e. police, social
welfare, revenue] has been phenomenally successful in the freezing and
forfeiture of the proceeds of criminal activity including drug-related crime.
- A Coastal Watch Programme has been established where local people
assist in policing the 3,000 miles of coastal area in Ireland. Each coastal
division was assigned an Inspector with specific responsibility for liaison with
the local community so as to channel information and intelligence more
effectively.
- EU and International co-operation has also increased greatly since 1995.
Drug Liaison Officers have been established in The Hague, Europol and
Madrid. In June 1988 a Liaison Officer was posted to Interpol, Lyons on a
permanent basis.
- An EU funded initiative - the Oisin Programme was adopted by the Council
of Ministers in 1996. The aim is to improve channels of communication, to
identify international drug dealers, to share information and best practice in
relation to demand reduction, training and intelligence gathering and to
exchange insights in relation to the working methods of participating police
forces.  Police forces in Ireland, Finland, Northern Ireland, Portugal, Scotland
and Wales are collaborating in an initiative which will examine the extent and
effects of controlled drugs in rural areas, and to formulate programmes to
counteract the threat posed. A new Oisin programme was started in 2000
[details not available].
- Within the EU, an Garda Siochana is represented at a Senior
Management level in the following working groups – The Horizontal Drugs
Working Group, The Police Co-operation Working Group, The Multi-
disciplinary Group, The EU Working Party on Drug Trafficking and The
Mixed Committee on Drug Trafficking.
- Seizures – there has been an increase in heroin seizures in recent years.
Cannabis constitutes the highest proportion of seizures relatively.
- Ireland has the strongest legislation in Europe for countering drugs (e.g.
the 1996 Criminal Justice [Drug Trafficking] Act - allows for 7 days detention
of a suspect without charge, subject to judicial approval i.e. the suspect must
be brought before the courts within this period however; 1996 Proceeds of
Crime Act  - onus is on criminal to prove assets were obtained legitimately).
- Community Policing Forums have been set up to allow the Gardai to work
with local community groups and individuals in targeting drug pushers as
well as improving overall relations between the Gardai and local
communities. A number of these are being supported by Local Drug Task
Forces [Flood 1999]. A ‘policing forum’ is being piloted in the South Inner
City of Dublin.
- Complaints by communities, regarding open drug dealing on the streets led
to the set up of Operation Cleanstreet- an undercover operation to identify
small time drug dealers. Initially the Operation was focused on a few areas in
Dublin where open dealing had become a major problem [December 1997]
6but it is now a nation-wide initiative and has included operations in Kells,
Navan, Trim and Drogheda. Five Operation Cleanstreet programmes have
been put in place and over five hundred street dealers have been identified /
prosecuted.
- The Garda presence at large music events e.g. Homelands in Mosney and
Creamfields in Punchestown, has increased along with arrests of persons
found in possession of controlled drugs or possession for the purposes of
supply.
- Operation Nightcap – designed to target licensed premises who allow the
consumption, sale and supply of controlled drugs from their premises has
been implemented.
- Operation Rectify – designed to target individuals involved in the sale and
supply of controlled drugs and prescription drugs in the vicinity of
Treatment Centres is underway.
- Operation Tap – designed to target individuals in the sale and supply of
controlled drugs to the homeless and prostitutes, particularly in Central
Dublin has also been introduced.
- Operation Dochas – designed to make substantial inroads into the drug
problem in Dublin through the identification of the critical areas requiring
action and the deployment of Gardai solely to this operation in these
communites.
- Garda sources estimate that drug users are responsible for 66% of all
detected crime in the Dublin Metropolitan Area during 1996.
- Drug Courts are to be introduced on a pilot basis in Dublin in late 2000.
Commentators stress however, that development of the necessary
supportive infrastructure, is a prerequisite to the success of the initiative.
An independent evaluation of the pilot is planned.
- The Department of Justice, Equality and Law Reform is involved in a
number of diversion type initiatives at the moment. Intensive Probation
Supervision is provided through a number of projects. These projects
divert serious offenders from prison at the court stage and place them in a
community-based programme with the ultimate aim of reintegrating them
into employment. The EU INTEGRA programme funds the CONNECT
project which is aimed at the reintegration of certain prisoners [in Mountjoy
jail], some of whom may have had drug addiction problems, into society
and the workforce. A further phase of the project was implemented in
November 2000.
- Garda Youth Diversion Projects - The Garda Community Relations
Section has established a number of crime prevention and intervention
programmes throughout the country. These programmes are funded by
the Department of Justice, Equality and Law Reform and are generally
managed by either Foróige and/or the City of Dublin Youth Service Board.
At present there are 39 projects throughout the country, ten of which were
established as part of the first phase of the expansion of the Garda Youth
Diversion Programme under the National Development Plan earlier this
year. An additional IR£16 million has been provided over the life of the
Plan to facilitate a significant expansion of this particular Programme.
Provision for further phases of this expansion are well advanced.
- The Department of Justice, Equality and Law Reform’s Discussion Paper
‘Tackling Crime’ stated that the link between crime and disadvantage is
7real. In order to widen the debate on crime and its causes a Crime Forum
was established which reported in 1998. Following publication of the
Report of the National Crime Forum, the National Crime Council was
established by the Minister in 1999. The Council was established on an
initial two year non-statutory basis. The establishment of the Council will
facilitate broadly-based and well-informed discussions on crime on an
ongoing basis and will serve as an important aid to policy formulation. The
key roles envisaged for the council are :1) to focus on crime prevention,
with particular emphasis on the underlying causes of crime and the
development of partnerships and practical approaches which will be
effective at community level; 2) to focus directly on raising public
knowledge and awareness of crime; 3) to examine the ‘fear of crime’ and
to address the issues, including those relating to minorities, which arise as
a consequence of this fear; and 4) to identify research priorities which
could be commissioned by the Department of Justice, Equality and Law
Reform.
- A White Paper on Crime will be prepared in 2001. This paper will focus
on linkages between the various agencies within the system, and in the
wider sense between the causes of crime and the Government’s specific
measures to target social inclusion.
- Legislation is being prepared to establish the Prisons Service  as an
independent, statutory service. The first Director General was appointed
on 15 July, 1999 and given responsibility for day to day management of
the prison system. Amongst the Director General’s priorities is the
provision of medical care to prisoners on a par with public health care in
the community. To this end, two major initiatives have been taken. Firstly,
the Prisons Service in July 2000 published the First Report of the Steering
Group on Prison Based Drug Treatment Services which has identified the
resources required at individual prison level, to put in place a systematic
approach to treatment of prisoners with drug dependencies. The Report
indicated that the Eastern Regional Health Authority will have substantial
input in the delivery of drug treatment. On foot of this report, the
Government on 18/10/2000 approved the new approach to drug treatment
in prisons. It is estimated by the Director-General that full implementation
of the programme will take at least 2 years involving as it will, recruitment
and training of staff and key professionals, inter alia. Secondly, a Group
has been established to conduct a comprehensive review of the structure
and organisation of prison health care services. This Group’s report is due
for publication in the middle of 2001.
8PART 1
NATIONAL STRATEGIES:
INSTITUTIONAL & LEGAL FRAMEWORKS
1. Developments in Drug Policy and Responses
1.1 Political framework in the drug field : Rosalyn Moran
Introduction : Significant changes have occurred in Irish society over the last
years. Foremost amongst these are dynamic economic growth, improvement in
living standards, ending of large-scale emigration, improvement in employment
opportunities, growth in young educated population etc. Amidst these positive
developments however, there exists pockets of poverty, homelessness, drug
addiction and disaffection, particularly amongst young people in certain urban
areas [Annual Report of the Inter-Departmental Committee, 1998/99, p.56].
The Government recognising the inequitable distribution of societal resources
has made social inclusion a policy priority and has allocated on foot of wide
social partnership arrangements [e.g. National Development Plan - NDP,
Programme for Prosperity and Fairness - PPF, National Anit-Poverty Strategy -
NAPS etc.] much needed financial resources to combat poverty and exclusion.
The Government’s approach to the drugs problem is embedded in a broad
social inclusion framework [see Drug Misuse Research Division (1999), National
Report on Drug Issues : Ireland 1999]. The effects of social exclusion are seen
‘to contribute to the deep rooted and intractable problems of serious drug
misuse’ [Flood, 1999].  An integrated inter-agency approach to tackling these
problems has been put in place and local community participation in the
formulation and implementation of policy is being nurtured and resourced.
Devolution of power to local and regional authorities to tackle social exclusion
has begun and related structures are being developed.
National Drugs Strategy : Since 1996, the Government’s drugs
strategy has been underpinned by the findings, recommendations
and policies established by the two reports of the Ministerial Task
Force on Measures to Reduce the Demand for Drugs. This
strategy is being reviewed at the present time and it is anticipated
that the review will be completed before end of year 2000 [see
below].
The overall aim of the Irish Government’s Drug Strategy is to provide an
effective, integrated response to the problems posed by drug abuse and to
work in partnership with the communities most affected by the drugs problem
in tackling the issues raised.
9Arising from this, the key objectives of that policy are to :
· reduce the number of people turning to drugs in the first instance through
comprehensive education and prevention programmes
· provide appropriate treatment and aftercare for those who are dependent
on drugs
· have appropriate mechanisms at national and local level aimed at reducing
the supply of illicit drugs and
· ensure that an appropriate level of accurate and timely information is
available to inform the response to the problem.
In line with these overall aims and objectives, four basic principles underpin
the Government’s strategy –
- it is recognised that an effective strategy must encompass a range of
responses which not only addresses its consequences, but also attacks its
causes
- the response to the drug problem must take account of the different levels
of drug misuse, which are being experienced around the country.  While
illicit drug use is a nation-wide phenomenon, [particularly the use of drugs
such as cannabis and ecstasy], heroin abuse – in view of its public health
implications and close association with crime – is currently seen as the
most pressing aspect of the problem.  A more targeted response is
required, therefore, in the areas experiencing the highest levels of heroin
abuse
- the need for all agencies which have a role in responding to the drug
problem to work together so as to ensure that their individual contributions
form part of an overall coherent approach. There is a need to ensure that all
programmes and services which respond to the drug problem are
delivered in a coherent, integrated manner
- the need to tap the depth of experience and knowledge which community
groups and voluntary organisations can bring to a response to the drug
problem. It is recognised that there is considerable knowledge and
experience among communities in the areas experiencing the highest levels
of use. These communities, therefore, must have an opportunity to
participate in the design and delivery of the response to the problem in
their areas  [Flood, 1999].
An interesting aspect of the Irish Government’s drugs strategy is a resourcing of
the development of sporting and recreational activities for young people at risk
with a view to promoting more healthy and productive behaviour.
At the micro level, the objective of drug policy in Ireland is to maintain people in
and restore misusers to a drug free lifestyle.  In practice, it is acknowledged that
this is not an option for a number of citizens in the short-term.  Accordingly, a
pragmatic approach is taken and the importance of the minimisation of risk i.e.
harm reduction is stressed in treatment and in a number of education and
rehabilitation programmes. The emphasis on harm reduction has grown with the
concern relating to the public health implications of the growth in AIDS/HIV and
Hepatitis B and C infections.
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The Government’s strategy involves a range of responses, which addresses the
causes and consequences of drug misuse. The Government’s response can be
characterised as supporting general initiatives to tackle social exclusion and
specific initiatives within the social inclusion framework but more specifically
targeted at drug related problems. The general initiatives are targeted at issues
seen as contributing to the drugs problem [e.g. unemployment, social
deprivation] [see Drug Misuse Research Division,  National Report for EMCDDA
1999]. Such programmes provide scope for agencies and communities affected
by the drugs problem, to avail of financial and other resources to tackle the
broader problems associated with drug misuse in their communities.
The Government’s specific response to tackling the drugs problem is
focused around two major initiatives - the Local Drug Task Forces –
LDTF, and Young People's Facilities and Services Fund - YPFSF.
Both initiatives are largely focused on areas where the opiate problem
is most acute [see Part 4, 12.2].
In addition to these two major initiatives which are largely focused on urban
areas where the drug problem is most acute, Government strategy has begun
to address the drug problem on a nation-wide basis, in particular the use of
so-called ‘recreational drugs’, such as cannabis and ecstasy, particularly
among young people. Regional Drugs Co-ordinators have been appointed
to assist the Regional Health Boards in developing appropriate programmes
and services, mostly in relation to drugs awareness, education and
prevention. On the request of the Department of Health and Children all health
boards now have co-ordination structures in place which work with varying
degrees of success and involvement from other agencies and groups [DofHC
submission to National Drug Strategy Review, p.3, DofHC, internal document].
Thus, a number of the Health Boards have set up Regional Co-ordinating
Committees in their areas, which work in partnership with other relevant
agencies in developing a co-ordinated response to the drug problem, having
regard to the needs of their particular regions.
The Government’s strategy involves a number of major initiatives to tackle the
drug problem from the supply side [see 1.2 below]. Legislation has been
introduced over the past few years to significantly increase the powers of the
Gardai and other authorities to tackle organised crime and drug dealing. In a
complimentary manner, there is an increasing recognition by agencies working
on the supply side that demand reduction must accompany supply reduction
measures and thus demand reduction has become an increasingly important
aspect of the work of law enforcement agencies. Part 3 [9.3 and 9.6] describes
some projects on demand reduction which address interventions in the criminal
justice system.
The institutional mechanisms involved in ensuring the implementation of the
National Drug Strategy not surprisingly overlap with the mechanisms in place to
combat social exclusion in general. Foremost here is the Cabinet Committee
on Social Inclusion – which gives political direction to the Government’s
social inclusion policies. This Committee receives input from the Inter-
Departmental Group on the National Drugs Strategy and the National
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Drugs Strategy Team.  The relevant Government Departments and agencies
are represented in these groups. In addition, 2 representatives, one from each
of the community and voluntary sectors are represented on the National
Drugs Strategy Team which plays a central role in overseeing the
implementation of the Government’s Drug Strategy and at the operational
level the work of the Local Drugs Task Force, inter alia. The Team was
established on the principles outlined in the Strategic Management Initiative
for addressing issues which cut across the remit of a number of Government
Departments and Agencies. Finally the Local Drugs Task Forces – 12 in
Dublin, 1 in Cork and 1 in Bray - provide a strategic locally-based response by
the statutory, community and voluntary sectors to the drug problem in the
areas worst effected. The National Assessment Committee and
Development Groups established under the YPFSF are also involved at the
implementation level [see Part 4, 12.2].
Preliminary arrangements have been put in place to give expression to the
recent developments towards greater devolution to the regional level under
the National Development Plan, inter alia. Accordingly, the LDTFs and Area
Based Partnership Companies etc. are due to work with the Directors of
Community and Enterprise and the City/County Development Boards –CDBs,
when drawing up their integrated local action plans. Arrangements for co-
ordination of planning and delivery of services are to be agreed with the
CDBs.
International context : Ireland’s drug strategy is framed within the context of
various  international and EU agreements  e.g. Political Declaration on the
Guiding Principles of Drugs Demand Reduction - United Nations Special
Session on Drugs held in New York 1998 with its 2000-2008 targets;   UN
Conventions on Narcotic Drugs and Psychotropic Substances and EU Action
Plan on Drugs 2000-2004.
1.2 Policy implementation, legal framework and prosecution : Mary
O’Brien.
a) Law and regulations – drug-related issues
The body of legislation which forms the statutory framework for the control of
drugs in Ireland, is drawn up on an inter-sectoral basis by the relevant
Government Departments of Health & Children; Justice, Equality & Law
Reform; and Environment.  The law is implemented by the Garda Siochana
(police), the Revenue Commissioners, and the Customs Service.  A brief
description of the Acts and listing of Regulations - Misuse of Drugs Act 1977 &
1984, can be found at Appendix 1. These 1977 and 1984 Acts provide for a
wide range of controls over drugs, which are liable to be misused. They
include controls relating to cultivation, licensing, administration, supply, record
keeping, prescription writing, destruction and safe custody.  These laws also
include provisions designed to deal with the irresponsible prescribing of
controlled drugs by medical practitioners. The Misuse of Drugs Acts 1977 and
1984 are the two central pieces of legislation under which the majority of
prosecutions in relation to drug  misusers are made.
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In the past few years a number of changes have been made to the legislative
framework surrounding drug issues.   The Criminal Justice Act, 1999 makes
amendments to the Misuse of Drugs Act, 1977 to provide for a new drug
related offence.  The new section (15A) creates a new offence related to the
possession of drugs, with a value of IR£10,000/ Euro12,700 or more, for the
purpose of sale or supply.  A person found guilty of such an offence may be
imprisoned for up to life and be subject to an unlimited fine.  The Act also
provides for a mandatory minimum sentence of ten years in prison.  However,
where it is found that addiction was a substantial factor leading to the
commission of the offence, the sentence may be reviewed after half of the
mandatory period, at which time the court may suspend the remainder of the
sentence on any condition it sees fit.
The Housing (Traveller Accommodation) Act, 1998, which is the legislative
framework within which housing authorities provide for the accommodation
needs of Travellers, is a key element in the Government’s efforts to promote
social inclusion and equality and to counter discrimination.  This law applies
relevant sections of the Housing (Miscellaneous Provisions) Act, 1997 in respect
of the control of anti-social behaviour, such as drug dealing, to halting sites
provided by local authorities or by voluntary bodies.
New legislation in relation to mental health, which is currently being drawn up,
proposes that addiction will be excluded from the scope of the definition of
mental disorder in the legislation.  Although in practice it is not invoked, under
current legislation (Mental Treatment Act, 1945) addiction remains on the
statute books as a criterion for non-voluntary committal to a psychiatric
hospital.  It is now considered unacceptable to detain by law, people whose
primary problem is addiction.
New regulations introduced in 1999 (Misuse of Drugs (Amendment No. 1)
Regulations, 1999) gave authority to certain officials of the Department of
Agriculture to possess cannabis hemp, lawfully, in the course of their duties
for monitoring and sampling in the production of hemp fibre.
I In 2000 new regulations (Customs-free Airport (Extension of Laws
Regulations, 2000) were introduced to extend drug controls under the Misuse
of Drugs Acts, 1977 and 1984, and the Irish Medicines Board Act, 1995, to
include the Customs free area at Shannon airport.  This instrument covers a
loophole in the legislation and allows the Irish Medicines Board to inspect any
company within the customs free area at Shannon Airport.
An order has been drafted (Misuse of Drugs Act, 1977 (Controlled Drugs)
(Declaration) Order, 1999) to extend the list of substances controlled under
the Misuse of Drugs Acts.  The need to do this arose out of Ireland’s
obligations under the United Nations Conventions on Narcotic Drugs,
Psychotropic Substances and Precursor Chemicals, but also because of
concerns about the abuse of amphetamine-type substances, and the use of
certain drugs in sport.   The drugs to be controlled include substances
associated with ecstasy misuse  (4-MTA, ketamine, ephedrine and
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pseudoephedrine), as well as a number of substances which are on the
current International Olympics Committee list of prohibited substances in an
effort to prevent doping in sport.   This order will be brought into force shortly.
Social and health drug-related issues have arisen, particularly in relation to
the implementation of two pieces of legislation.  The first is a health issue in
relation to the Criminal Law (Sexual Offences) Act, 1993. A study carried out
by the Women’s Health Project in Dublin (O’Neill and O’Connor 1999) found
that the legislation dealing with prostitution is having a negative impact on the
lives of prostitutes.  The researchers comment that increasing complaints from
local residents and the requirements of the legislation, that anyone ‘loitering
for the purposes of prostitution’ be directed from the area, has resulted in sex
workers going underground and working in increasingly unsafe environments.
Consequently, it is becoming more difficult for health workers, with the aim of
providing healthcare and preventing HIV, to reach the women.  This has
serious implications for public health policy.  The authors of the study
recommend that a review of the current legislation be undertaken as soon as
possible.
The second is a social and health issue in relation to housing legislation
(Housing (Miscellaneous Provisions) Act, 1997) and its effect on drug users.
This law allows public housing authorities to initiate an excluding order
procedure against occupants of local authority housing who are ‘involved in
anti-social behaviour’.    A study of the impact of the legislation (Memery and
Kerrins 2000) found that it gave local authorities the political go-ahead to evict
tenants and to use indirect means, such as encouraging other family
members to exclude the individual, to remove those considered to be involved
in anti-social behaviour much of which was drug-related.  People excluded
from access to public housing can find themselves also discriminated against
in seeking hostel accommodation because of their drug use.  The exclusion of
the individual involved in anti-social behaviour from the home, results in the
loss of essential family supports, as well as removal from community based
drug services.  This report states that ‘street homelessness resulting from
exclusion leads to open drug taking and riskier drug taking practices’ (p 33).
Such behaviour will increase the risk of contracting infectious diseases.
Outreach workers from one local drug project are experiencing difficulty in
contacting intravenous drug users because they have gone ‘underground’ for
fear of local anti-drug activists (personal communications with drug project
workers).  A study of out-of-home drug users (Cox and Lawless 1999)
suggests that the housing legislation has contributed to the rise in homeless
among drug users.
Other aspects of drug legislation were criticised at the public National Forum
on Crime held in 1999.  One such issue, is the provision under the Criminal
Justice (Drug Trafficking) Act, 1996, which allows the police to detain a person
accused of drug trafficking for a period of seven days.  Some contributors to
the Forum considered that this provision could prove to be counterproductive,
resulting in more convictions of drug users and small-time dealers rather than
curbing the activities of large-scale drug traffickers.  Another was the then
proposal (now law - Criminal Justice Act, 1999) to provide for a new drug
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offence related to the possession of drugs, with a value of IR£10,000 or more,
for the purpose of sale or supply, and for a mandatory minimum sentence of
ten years in prison.  It was criticised ‘both on grounds of principle relating to
mandatory sentences generally and because of the difficulty of establishing
the actual value of a seizure’ (National Crime Forum Report 1998: 72).
Barry (2000) [Reference: Irish Medical News June 2000] in a discussion paper
writes that the supply of drugs and the legal framework in which drug policy is
formulated in Ireland require examination.  He poses the question as to what
the benefits and disadvantages of current drug laws are to the health of the
population.  He suggests that posing such questions usually meets a blanket
response of no softening of the laws on drugs. He also comments that there
does not seem to be an acknowledgement of the fact that there is not
necessarily a link between whether something is legal, and whether it is good
or not good for one.  He proposes that the time is right to have an honest
debate on the current legislative basis of drug policy in Ireland; and though
such a debate may not be welcomed, he posits that it is necessary.
b) Prosecution policy, priorities and objectives in relation to drug addicts,
occasional users, drug-related crime
All criminal prosecutions are taken under the authority of the Director of Public
Prosecutions (DPP).  It is a function of the Garda Siochana (police) not alone
to investigate crime but also to initiate prosecutions and in summary cases
(where an offence is a minor one chargeable by way of a summons, tried
before a judge)  to prosecute offenders to verdict.  Consequently most
prosecutions are taken by the police, usually the Garda who investigated the
matter, under the name of the DPP.
Sections 3 and 15 of the 1977 legislation are the sections most frequently
used in drug prosecutions.  Section 3 covers the possession of any controlled
drug, and Section 15 concerns trafficking of controlled substances. The use
per se of a drug, other than opium, is not a criminal offence.
In addition to custodial measures there is a range of non-custodial options
available to sentence those who plead or are found guilty.  The decision of the
court in relation to sentencing may be influenced by a Pre-Sanction Report.
This report is compiled by the Probation and Welfare Service and includes
information on factors that may have contributed to the individual’s offending,
such as addiction to drugs.  Non-custodial options include :
- Probation Order (Probation of Offenders Act, 1907) – this is to secure the
rehabilitation of the offender, to protect the public and to prevent the offender
from committing further offences.  It is used, inter alia, for drug users where
conditions may include attendance for treatment and the provision of urine for
analysis.  This is the preferred procedure in the District Court when dealing
with drug users.
- Order of Recognisance (Misuse of Drugs Act, 1977, Section 28 as amended
by the Misuse of Drugs Act, 1984) – This is an order requiring an offender to
undergo treatment for drug addiction in a residential centre or in the
community.  This is an important non-custodial option for drug users who
offend in Ireland. However, in practice this Order is not generally used by the
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courts since the provision of a statutory place of treatment has always been
problematic, inter alia.
It has been recommended that the necessary Courts’ Rules and Regulations
be updated by the various Court Rules Committees (Final Report of the
Expert Group on the Probation and Welfare Services, 1999).
c) Any other important project of law or other initiative with political
relevance to drug related issues
While the legislative framework requiring an individual to undergo treatment
for drug addiction as a non-custodial option in sentencing exists, in practice it
is rarely used by the courts. The establishment of a Drug Courts system,
initially on a pilot basis in Dublin, under the jurisdiction of the District Court, is
being planned.  These courts are intended to be treatment oriented, where
people with a drug problem and who are charged with non-violent offences,
are diverted to treatment programmes rather than to prison.  This
development is likely to have major implications for treatment services and the
success of the initiative will depend on the formulation and implementation of
cohesive treatment and rehabilitation programmes.
The Medical Bureau of Road Safety at the Department of Forensic Medicine,
National University of Ireland, Dublin, in collaboration with the Garda
Siochana (police) has undertaken a study to examine the level and type of
drug use among drivers and its contribution to accidents.  All  samples
submitted between 1 July and 31 December 1999, which were under the legal
limit for alcohol, were tested.  Preliminary results from 338 samples showed
that cannabis was most frequently found (34%), followed by benzodiazepines
(25%).  Cocaine was the drug least commonly found at 4% of the sample
(Medicine Weekly) [Reference: Medicine Weekly, May 2000, Vol.4, No.19).
1.3 Developments in public attitudes and debates : Rosalyn Moran
The first national survey of  Drug-Related Knowledge, Attitudes and Beliefs in
Ireland was published by the Drug Misuse Research Division of the Health
Research Board in September 2000 [Bryan et al 2000]. The questionnaire on
which the research was based constituted a module of the 1998 Irish Social
Omnibus Survey.  A total of 1,000 adults 18 years and over, randomly
selected from the 1997 Register of Electors for Ireland, took part in the study.
Data was collected using face-to-face interviews between February and April
1998.
Key Findings and Recommendations
The Irish have a good general awareness of commonly used illegal
drugs. However, their perception of the general harmfulness of these
substances indicates a lack of accurate knowledge about the different
effects associated with different types of drugs.
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Recommendation: The provision of accurate information of a non-
sensationalist type to all age groups, on the relative known risks associated
with different types of drugs.
Societal attitudes towards drug users are mostly negative. Those with
personal experience of someone ‘with a drug problem’ tend to have less
negative attitudes, as do the younger adults surveyed and those with
higher levels of education.
Recommendation: The promotion of more positive attitudes towards those
who misuse drugs, particularly among older people and those with less
education. A positive attitudinal climate is important to the social integration of
problem drug users and to their willingness to avail of treatment.
The public generally perceives drug taking to be common among young
people, and there is a high level of concern about the current drug
situation in Ireland. Notwithstanding, alcohol abuse tends to be
perceived as a more serious problem in society than drug abuse.
Recommendation: The continuation of efforts to address the problem of legal
as well as illegal drugs.
While societal attitudes towards those who use drugs are negative,
respondents attach high priority to providing help to drug users. This
high level of support for drug treatment is likely to be related to the
widespread perception that the drug problem is a very serious issue in
Irish society.
Recommendation: The retention of the drugs issue high on the political and
social agenda.
More Detailed Results include :
- members of the general public were generally aware of the kinds of
illegal drugs most commonly used.  Ninety-four per cent reported that
they had heard of heroin, cocaine, ecstasy and cannabis, while 70 % had
heard of LSD and amphetamines
- self-reported cannabis use (as measured by lifetime prevalence) stood
at 12 % for the entire sample. The younger urban sector of society
tended to have greater personal experience of cannabis and to know
people who had taken cannabis or had ‘a drug problem’. Males reported
greater use of cannabis and knowledge of cannabis users than females
- the results indicated a high level of concern about the current drug
situation among the general public
- a substantial proportion of respondents believed that experimentation
with drugs was commonplace among young people .  Over half of
those who took part in the survey believed that it was ‘normal’ for young
people to try drugs at least once, and at least 40 per cent believed that
most young people experimented with cannabis and ecstasy
- respondents generally regarded illegal drug taking as a dangerous
pursuit.  Approximately three quarters (77%) believed all illegal drugs to
be equally harmful to health, while over 40 % believed that one could
become dependent on drugs after just one experience. Half the sample
(54%) believed regular use of cannabis was just as dangerous to health as
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regular use of heroin. This somewhat exaggerated sense of the effects
of illegal drugs was less common among the younger members of the
adult population surveyed
- social avoidance and fear of drug users and those addicted to drugs
were high among respondents.  Moreover, sympathy for drug addicted
individuals was relatively low. Younger respondents and respondents with
a higher level of education were less inclined to perceive drug addicts in a
negative light. Moreover, those with personal knowledge of someone ‘with
a drug problem’ typically held more positive attitudes towards those who
were addicted to drugs
- consistent with the widespread concern about the severity of the current
drug situation was an overwhelmingly high level of support for drug
prevention.  Over 90 % of respondents agreed that the allocation of
financial resources for drug prevention was worthwhile.  Almost 95 per
cent supported the notion of providing drug education to primary school
children
- current harm reduction initiatives, including the provision of heroin
substitutes such as methadone, and needle exchange facilities to
heroin dependent clients, received support from two thirds of
respondents (63% and 66% respectively).  Furthermore, while the
provision of drug treatment on the basis of need received almost
unanimous support, two thirds of respondents (65%) felt this should only
be provided to those who had abstinence as their ultimate goal
- regarding alternative policy options, 76 per cent of respondents agreed
that cannabis use should be against the law, while over 70 per cent
agreed that drug addicts convicted of petty offences should be given the
option of receiving treatment instead of having a jail sentence for their
crime.
The publication of this report based on empirical findings received some
media attention. In general issues surrounding the misuse of drugs continue
to receive a high level of attention in the media. Law enforcement issues
receiving attention include policing initiatives, drug seizures, drug-related
crime, criminal law cases and lifestyles of drug ‘barons’.  In addition, one of
the issues frequently reported on is the opposition of local communities to the
opening of drug treatment facilities in their neighbourhoods – the NIMBY
phenomenon (Not In My Back Yard). In response to such opposition, health
boards endeavour to involve local communities in the planning and
management of services. More recently, the outbreak of illness and deaths
among injecting drug users in Dublin received a lot of media coverage which,
inter alia, reiterated the risks taken by drug users.
The methodological work carried out by Dr. C. Comiskey on prevalence of
drug misuse in Dublin has been widely covered in the media. The fact that
these are estimates is rarely mentioned and rarer still is the presentation of
ranges and confidence intervals or a number of estimates, as recommended
by the EMCDDA. As a consequence, in general the coverage has not been
very balanced. An outcome of the EMCDDA- National Working Group on
Prevalence was the adoption of a set of recommendations aimed to improve
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standards in the conduct and reporting of prevalence data. These standards
were broadly circulated.
Two issues – prescription of heroin and decriminalisation of cannabis have
received some attention from the Irish parliament – Dail Eireann, on a motion
to note the Report of the Joint Committee on European Affairs on European
Aspects of Drug Issues, Thursday 18 May, 2000. In relation to cannabis, the
Minister of State at the Department of Tourism, Sport and Recreation, Mr.
Eoin Ryan T.D., referred to the sensitive issue of the decriminalisation of
cannabis and noted that the Joint Committee’s document did not come out
with any specific recommendations but drew attention to the ‘diversity of
approaches in the European context’ and recommended that ‘an objective
presentation of the facts relating to different strategies’  must be part of any
ongoing debate or policy formulation [Ryan 2000]. Thus, there is little
evidence of a desire to decriminalise cannabis, as the KAB survey  findings
reported above also, would indicate.
The issue of heroin prescription was referred to in this Minister’s speech also.
The Report of the European Affairs Committee referred to a “heroin
prescription” model which was being piloted in Switzerland.  Minister Ryan
observed ‘Obviously, such a radical approach has aroused much debate, and
indeed controversy, not only in Europe but also here in Ireland. I note that
while the European Affairs Committee recommends that the Irish health
authorities should consider the need for and be authorised to develop what it
describes as “innovative drug treatment measures”, the Committee stops
short of specifically recommending the introduction of the Swiss model here in
Ireland’ [Ryan 2000].
In the course of debates amongst professionals regarding the need for a
variety of treatment options, the desireability / feasibility of the provision of
injecting rooms is beginning to be discussed. A proposal was made in a
submission of the Merchants Quay project to the National Drug Strategy
Review, in this regard. Recent statements from Government representatives
have indicated that there are no plans to introduce heroin prescription projects
in this country [DofHC, personal communication].
In summary, it would appear that along with political initiatives including the
devolution of powers to more local and regional levels, the growing
involvement of the community & voluntary sectors and the inter-agency and
integrated approach to the drugs problem - that a more open climate for
debate is developing.
1.4 Budget and funding arrangements : Rosalyn Moran
 Given the positive state of the national finances and reflecting the priority the
Government has given to the drugs issue, it is not surprising that allocations to
address the drugs problem have increased greatly. Under the National
Development Plan 2000-2006 most spending in the drugs area is accounted for
under the broad Social Inclusion policy. Much of the money has been
channelled to support local action and community groups in their efforts to tackle
the drugs problem. To date the focus has been on areas where the drug
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problem is most acute – Dublin, Cork and Bray, with smaller allocations to other
regions. However, under the new NDP, a number of sub-programmes which
address the drugs problem directly or indirectly [operating under the broader
Social Inclusion Strategy] are more geographically dispersed.
 
Details of funding to support the Drugs Initiative and Social Inclusion measures
are outlined below.
Funding in the drugs area is most appropriately viewed in the broader context
of the Irish Government’s National Development Plan - NDP 2000-2006 and,
in particular, the Plan’s commitment to tackle social exclusion as a policy
priority. The Plan covers the seven year period 2000-2006 and will involve an
investment of £40.588 billion Irish pounds/ Euro 51.55 billion [at 1999 prices]
of public, European Union and private money. This Plan is one element of a
nexus of social partnership agreements [e.g. National Anti-Poverty Strategy -
NAPS, Programme for Prosperity and Fairness – the PPF] which embrace the
major sectors and interest groups of civic society and all of which address the
issue of social inclusion.
The Plan involves inter alia three National [or Inter-regional] Operational
Programmes
- economic and Social Infrastructue
- employment and Human Resources
- productive Sector
and 2 Regional Operational Programmes for the
- Border, Midlands and Western  - BMW Region and
- Southern & Eastern – S&E Region.
The following national objectives underpin the National Development Plan
(NDP);
· continuing sustainable national economic and employment growth
· consolidating and improving Ireland’s international competitiveness
· fostering Regional Development
· promoting Social Inclusion.
Spending on the Inter-Regional or National Operational Programmes will
include financing of projects relating to social inclusion, which of course have
important implications for all citizens including drug misusers, but at the more
macro level [e.g.. development of rural transportation will increase access to
resources including treatment]. This type of spending on social inclusion is
complemented by spending on the S&E and BMW  Regional Operational
Programmes which are designed to promote, inter alia, balanced regional
development.
The focus at these regional levels will be on Sub-Programmes such as
Regional Infrastructural Investment, Social Inclusion and Productive
Investment. Measures which will be taken under the Social Inclusion Sub-
Programme in both Regions fall under headings such as - Childcare, Equality,
Community Development/Family Support, Crime Prevention [many measures
here address drugs area], Youth Services and Services for the Unemployed.
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Table 1.1 shows expenditure on Social Inclusion in the NDP Operational
Programmes.
Table 1.1 : Expenditure on Social Inclusion, NDP 2000-2006
Operational
Programme
National
€ million
BMW Region
€ million
S&E Region
€ million
Economic and
Social Infrastructure
Employment and
Human Resources
Regional
Programmes
10,157.9
7,576.7
1,343.1
2,451.9
2,154.7
280.1
7,706.0
5,422.0
1,063.0
Total 19,077.7 4,886.7 14,191.0
Expenditure Per
Capita €
5,261 5,062 5,333
Source : Ireland, National Development Plan 2000-2006. p. 187. Stationery Office, Dublin.
Footnote to table : In addition to the Community Support Framework there will be four Community Initiative
programmes – Interreg, Equal, Leader and Urban – each supporting  some projects in the social inclusion
arena.
Under the Regional Programmes, the allocations to combat drug abuse
specifically, for this seven year period, will be IR£112 million/ Euro 142m for
the SE Region and IR£10 million / Euro 12.7m, for the BMW Region. This
totals IR£122 million/ Euro 155m [DofTSR, Internal Doc. 10]. These funds will
be allocated to the LDTF areas and will address the drug problem under the
themes education, prevention, treatment rehabilitation and supply reduction
[DofTSR, Internal doc 10].
Funding for the LDTFs [and most likely for YPFSF in 2002] will be channeled
through the new or adapted structures which are being or will be put in place
to deliver the NDP.  These structures will involve devolution of the
implementation of these initiatives to the regional level and will involve
continued integration of relevant agencies.
Thus the recently established County and City Development Boards – CDBs
whose primary function will be to draw up a comprehensive Strategy for
Economic, Social and Cultural Development [by Jan 2002] have a key role in
co-ordinating local delivery of social inclusion measures. The  CDBs will
operate on the partnership principle with the Regional Assemblies and under
the local government umbrella with membership drawn from local
development organisations, social partners, local representation of State
agencies and local government itself [NDP 2000 document]. A Director of
Community and Enterprise has been appointed by each CDB. All the relevant
programmes and projects, and their delivery mechanisms, covered by the
NDP will be expected to accord with this framework.
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Key underlining principles of the framework will be the use of common
delivery areas (e.g. county/city and, where appropriate, local electoral areas
for community development/social exclusion) and of a single agency
designated for delivery of specific components (e.g. micro-enterprise) of local
development in any one area so as to avoid overlap, confusion and
competition between agencies [NDP 2000].
Preliminary arrangements have been put in place to coordinate existing
structures for the implementation of actions in the drugs area [see
implementation mechanisms described in 1.1 above] with these new local
structures. Thus the LDTFs and Area Based Partnership Companies, ADM-
Community Groups are due to work with the Directors of Community and
Enterprise and the CDBs when drawing up their integrated local action plans.
Arrangements for co-ordination of planning and delivery of services are to be
agreed with CDBs by the mid-term review of the Regional Operational
Programmes – i.e. 2003 [DofTSR, Internal Doc. No. 10].
No detailed breakdowns of national expenditure relating to drugs in the
requested areas i.e. law enforcement; epidemiological, prevention and
treatment; evaluation, quality and training is available. The Drug Misuse
Research Division submission to the National Drug Strategy Review include a
recommendation to start work on costing expenditure on drugs  - this is in line
with recent  recommendations at EU level [see EU Action Plan].
As  noted above, geographical differences in the nature and extent of drug
use exist in Ireland. For example, problematic drug use, in particular the heroin
problem is concentrated in inner city areas of our larger cities. Consequently the
major policy programmes and financial resources are targeted at these areas of
need. However, there is a growing recognition that illegal drugs particularly
cannabis and ecstasy are readily accessible in towns and rural areas throughout
the country and along with alcohol are becoming an increasing aspect of
recreational activity amongst categories of youth in particular. Pockets of heroin
use in some larger rural towns have also been reported. Accordingly,
Government strategy has begun to address the drug problem on a nation-
wide basis, in particular the use of recreational drugs, such as cannabis and
ecstasy, particularly among young people. Regional Drugs Co-ordinators
have been appointed to assist the Regional Health Boards in developing
appropriate programmes and services, in relation to drugs awareness,
education, prevention and appropriate treatment and rehabilitation when
needed. These regional co-ordinators also have a role to co-ordinate the
response of agencies at a local level. Since 1992, these programmes and
services have been in receipt of a specific financial allocation from the
Department of Health and Children [DofTSR, Internal doc. No. 1]. This
allocation represented additional funding for the drugs area for the regional
health boards.
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APPENDIX 1
Legal Framework – Laws and Regulations
The following Acts and Regulations provide the statutory framework for the
control of drugs with potential for misuse.  The legislation is drawn up and
implemented on an inter-sectoral basis by the relevant government
departments of Health & Children, Justice, Equality & Law Reform and
Environment; the Garda Siochana, Revenue Commissioners and Customs
authorities.
The Poisons (Ireland) Act, 1870 applied control to the sale of scheduled
poisons including opium, morphine, cocaine, heroin and preparations
containing these drugs.
The Pharmacy Act (Ireland), 1875 confined the sale of scheduled
substances to authorised persons i.e. registered pharmaceutical chemists.
The Probation of Offenders Act, 1907.
The Dangerous Drugs Act, 1934 which was based on international law
controlled the import, export, distribution sale and possession of specified
drugs.
The Medical Preparations (Control of Sale) Regulations, 1966 regulated
the retail sale of amphetamines and their analogues, barbiturates and
tranquillisers and limited these to prescription only.
Under the Medical Preparations (Control of Amphetamines) Regulations,
1969 & 1970 the manufacture, sale and distribution of amphetamines and
preparations containing amphetamines or their derivatives were prohibited.   
The Misuse of Drugs Acts, 1977 and 1984 and the Regulations made
thereunder provide for a wide range of controls over drugs which are liable to
misuse. They include controls relating to cultivation, licensing, administration,
supply, record keeping, prescription writing, destruction and safe custody.
Included in the Acts are the provisions designed to deal with the irresponsible
prescribing of controlled drugs by medical practitioners.
Possession of any controlled drug, without due authorisation, is an offence
under Section 3 of the Principal Act (1977).   Section 15 of the same Act
concerns the possession of a controlled drug for the purpose of unlawful sale
or supply.   Section 16 details the prohibition of certain activities relating to
opium.   The use of prepared opium, the frequenting of premises used for the
use of opium and the possession of utensils used for smoking opium are all
offences under this section.
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The penalties on being found guilty of an offence under section 15 of the 1977
Act, range from a fine or imprisonment for a term not exceeding twelve
months or both on summary conviction, to an unlimited fine or imprisonment
for life or both on conviction on indictment.
The maximum penalty for possession of cannabis for personal use is
restricted to a fine for first or second offences tried on summary conviction.
For third and subsequent offences there is a fine or twelve months in prison,
or both. The penalty for a third offence on indictment is an open-ended fine or
three years in prison, or both.
The penalties for the possession of other controlled drugs are harsher and
depend on the type of court in which the case is tried.   On summary
conviction the penalty is a fine or twelve months in prison, or both.   On
conviction on indictment, the maximum fine for possession is left to the
discretion of the court, which may also impose a seven-year prison sentence,
or both a fine and a prison sentence.
Provision is made under the Acts for the judicial possibility in 'certain cases to
arrange for the medical or other treatment or for the care' of a person
dependent on drugs and convicted of an offence under the Acts.
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Statutory Instruments (S.I) and Regulations
The following are the Statutory Instruments (S.I) and Regulations relating
to the Misuse of Drugs Acts, 1977 and 1984 which set out the details of the
regulations regarding the misuse of drugs.
Misuse of Drugs Act, 1977 (No.12 of 1977)
(Commencement) Order, 1979 (S.I. No. 28 of 1979)
(Controlled Drugs) (Declaration) Order, 1987 (S.I. No. 251 of 1987)
(Controlled Drugs) (Declaration) Order, 1993 (S.I. No. 328 of 1993)
Misuse of Drugs (Licences Fees) Regulations 1979 (S.I. No 164 of 1979)
  (Amendment) Regulations 1988 (S.I. No. 11 of 1988)
Misuse of Drugs (Custodial Treatment Centre) Order 1980 (S.I. No. 30 of 1980)
Misuse of Drugs (Safe Custody) Regulations 1982, (S.I. No. 321 of 1982)
Misuse of Drugs Act, 1984 (No. 18 of 1984)
(Commencement) Order, 1984 (S.I. No. 205 of 1984)
Misuse of Drugs (Committee of Inquiry) Regulations 1984  (S.I. No. 264 of 1984)
Misuse of Drugs (Exemption) Order, 1988 (S.I. No. 326 of 1988)
 ( Amendment) Order 1993  (S.I. no. 339 of 1993)
Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988)
Misuse of Drugs (Scheduled Substances)- Regulations 1993  (S.I. No. 338 of 1993)
 (Scheduled Substances)- (Exemption) Order 1993 (S.I. 341 of 1993)
Misuse of Drugs Regulations (Designation) Order, 1998 (S.I. No. 69 of 1998)
Misuse of Drugs (Supervision of Prescription and Supply of Methadone) Regulations,
1998 (S.I. No. 225 of 1998)
Misuse of Drugs (Amendment No.1) Regulations, 1999  (S.I. No. 273 of 1999)
Customs-Free Airport (extension of laws) Regulations, 2000  (S.I. No. 169 of
2000)
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The Criminal Justice Act, 1984 provides for a widening of the scope of the
criminal law and procedures to deal more effectively with serious crime,
including serious offences under the Misuse of Drugs Acts.
Section 74 of the Child Care Act, 1991 states that where a shopkeeper sells
a substance, in particular glue, likely to be inhaled to cause intoxication to a
minor, he/she can, on conviction, be fined or imprisoned for up to twelve
months.   There is a provision for the retailer to put forward a defence that
reasonable steps were taken to ensure that this was not a deliberate offence.
The Criminal Justice Act, 1994 provides for the seizure and confiscation of
assets derived from the proceeds of drug trafficking and other offences.  It
contains provisions related to money laundering and allows for international
co-operation in respect of certain criminal law enforcement procedures, the
forfeiture of property used in the commission of crime and related matters.
The Criminal Justice (Drug Trafficking) Act, 1996 provides for the detention
of persons accused of drug trafficking offences for up to seven days.   It also
allows inferences to be drawn by a court from the failure of an accused person
to mention particular facts during questioning.
Under the Criminal Assets Bureau Act, 1996 the Criminal Assets Bureau
was established on a statutory footing with powers to focus on the illegally
acquired assets of criminals involved in serious crime.   The aims of the
Bureau are to identify the criminally acquired assets of persons and to take
the appropriate action to deny such people of these assets. This action is
taken particularly through the application of the Proceeds of Crime Act, 1996.   
The Licencing (Combating Drug Abuse) Act, 1997 introduced a number of
measures allowing for the suspension of intoxicating liquor licences and/or
disqualification for ever from obtaining an intoxicating liquor, a public dancing
or a public music and singing licence, following conviction for drug offences,
e.g. knowingly allowing consumption or sale of drugs on premises.
The Europol Act, 1997 provides for the establishment of a Europol National
Unit and enables the ratification, by the State, of the Europol Convention and
related protocols.   This Convention establishes a European Police Office
(Europol) to improve the effectiveness of and co-operation between Member
States in preventing and combating serious international crime involving two
or more Member States.   It provides for a progressive development of the
types of crimes in respect of which Europol will have competence and which
will include within Europol's initial remit unlawful drug trafficking offences.
Once the Convention enters into force Europol will effectively replace the
Europol Drugs Unit (EDU).
The Criminal Justice Act, 1999 makes amendments to the Misuse of Drugs
Act, 1977 to provide for a new drug related offence.  The new section (15A)
creates a new offence related to the possession of drugs, with a value of
IR£10,000/Euro 12,700 or more, for the purpose of sale or supply.  A person
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found guilty of such an offence may be imprisoned for up to life and be subject
to an unlimited fine.  The Act also provides for a mandatory minimum
sentence of ten years in prison.  However where it is found that addiction was
a substantial factor leading to the commission of the offence the sentence
may be reviewed after half of the mandatory period, at which time the court
may suspend the remainder of the sentence on any condition it sees fit.
The Criminal Justice (Theft and Fraud Offences) Bill, 2000 substitutes a
section of the 1994 Criminal Justice Act, which deals with money laundering.
The new section makes it an offence for a person to remove the proceeds of
criminal activity from the State, with the intention of concealing its true nature;
or to assist another person to avoid prosecution for criminal offences.  The
maximum penalty is an unlimited fine or up to 14 years in prison or both.  This
is a Bill as distinct from a Law and as such has not as yet been enacted.
Other relevant laws
The following are statutes indirectly related to the control of drugs.
The Customs Consolidation Act, 1876 was a consolidation of all Customs
legislation up to that time and concerns importation, seizures, detention of
goods and persons and arrests.
The Mental Treatment Act, 1945 provided for the compulsory hospitalisation
of 'addicts to drugs'.   Addiction remains on the statute books as one of the
criteria for non-voluntary committal to a psychiatric hospital, but in practice it is
not invoked and one of the recommendations of the White Paper on Mental
Health, 1995 was that it be abolished.
  
The Customs Act, 1956 'shall be construed as one with the Customs Acts'
which means all enactments relating to the Customs. It deals with the illegal
importation and exportation of goods.
The Customs and Excise (Miscellaneous Provisions) Act, 1988 amends
and extends the law relating to customs and duties of excise and to amend
the law relating to certain penalties for illicit distillation of spirits.   In
conjunction with other Customs and Excise Legislation, specifically 1876 and
1956, the Customs and Excise (Miscellaneous Provisions) Act, 1988 provides
the legal basis for customs controls.
The Data Protection Act, 1988 is designed to protect the privacy of
individuals with regard to automated 'personal data' (data relating to
individuals who can be identified from the data).   This covers relevant
information which is kept with regard to drug users.   The legislation gives
effect in Ireland to the Council of Europe Data Protection Convention.
The Criminal Law (Sexual Offences) Act, 1993, which mainly refers to the
decriminalisation of homosexuality, also includes a number of clauses
covering prostitution.  Under this legislation it is an offence to solicit another
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person for the purpose of prostitution.  The penalty on conviction is a fine or
three months in prison or both.
The Proceeds of Crime Act, 1996 provides for the freezing and forfeiture of
the proceeds of crime.   This legislation complements the confiscation
provisions of the Criminal Justice Act, 1994.
The Disclosure of Certain Information for Taxation and Other Purposes
Act, 1996 provides for more effective exchange of information between police
and revenue where there are reasonable grounds for suspecting that profits
have been gained from unlawful sources or activities.
The Children Bill, 1996 is primarily concerned with the introduction of
provisions which will allow for the creation and development of a new juvenile
justice system.   It proposes for example, that the Garda Juvenile Diversion
Programme, which gives the opportunity to divert juvenile offenders from
criminal activity and to provide an alternative to their being processed through
the formal criminal justice system, would operate on a statutory basis. It
currently operates on an administrative basis.
The Freedom of Information Act, 1997 enables members of the public to
obtain access to information in the possession of public bodies and to have
personal information relating to them corrected.
The Bail Act, 1997 was enacted to give effect to the amendment to the
Constitution and also to tighten up on other areas of the law in relation to the
granting of bail.   It allows the courts the discretion to refuse bail where they
are satisfied that there is a danger of the commission of serious offences by a
person while on bail.   The Act also includes a requirement that an accused
person and his/her surety lodge in court, in cash or cash equivalent, a
proportion of the amount set for bail.   It also strengthens the provisions of the
Criminal Justice Act, 1984 in relation to the imposition of consecutive
sentences for offences committed on bail.   The Act is to come into operation
by order to be made by the Minister for Justice, Equality and Law Reform.
The Non-Fatal Offences Against the Person Act, 1997, provides a range of
new offences to combat criminal conduct involving syringes.  The Act also
includes; possession of a syringe or container of blood, with intent to threaten
or injure; placing or abandoning a syringe in any place in a manner which
injures or is likely to injure any person; injuring a person with a syringe or
threatening to do so; and throwing or putting blood on another person or
threatening to do so.   The penalties range from five years to life
imprisonment.
The Housing (Miscellaneous Provisions) Act, 1997 introduced a number of
measures designed to assist housing authorities and approved voluntary
housing bodies in addressing problems arising on their estates from anti-
social behaviour, such as drug dealing.   The Act provides for a new excluding
order procedure against individual occupants of a local authority house
involved in anti-social behaviour, thereby avoiding the need for eviction of
entire households in certain circumstances.   It also includes provisions for the
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police, on notification by the housing authority to remove squatters who are
engaged in anti-social behaviour from local authority housing.   The Act also
assists housing authorities to discharge their housing estate management
function in a positive manner in conjunction with the various other initiatives
which have been taken to promote estate management particularly in the area
of partnership between the authority and tenants.   The Act allows health
boards to refuse supplementary welfare allowance, by way of payment to
supplement the person's income in respect of rent or mortgage interest, to
individuals who have been prosecuted under the Act.
The Criminal Justice (Miscellaneous Provisions) Act, 1997 provides for
the reduction of the amount of time spent by police on court-related duties,
thus helping to ensure a greater presence of uniformed police on the streets.
The Act also speeds up aspects of court procedure in criminal matters.   It
makes general provision, for the first time, for the issue of search warrants in
relation to the commission of serious offences such as murder or rape and
extends the application of certain other Garda powers.
The Housing (Traveller Accommodation) Act, 1998, which is the legislative
framework within which housing authorities provide for the accommodation
needs of Travellers, is a key element in the Government’s efforts to promote
social inclusion and equality and to counter discrimination.  This law applies
relevant sections of the Housing (Miscellaneous Provisions) Act, 1997 in respect
of the control of anti-social behaviour, such as drug dealing, to halting sites
provided by local authorities or by voluntary bodies.
Copies of the above may be purchased directly from Government Publications
Sales Office, Sun Alliance House, Molesworth Street, Dublin 2
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PART 2
EPIDEMIOLOGICAL SITUATION
2. Prevalence, Patterns and Developments in Drug Use
– Mary O’Brien
2.1 Main developments and emerging trends
a) Overview of most important characteristics and developments
The main developments are included in this section, see text below for
supporting data and references.
Ø Cannabis is the most commonly used illicit drug, followed to a lesser
extent by amphetamine and ecstasy use.
Ø Drug users in Ireland are young – this reflects the general demographic
situation where 47% of the population is under 30 years of age
Ø The lifetime experience of drug use in the general population of young
people in Ireland is significant but this does not necessarily mean that they
continue to use drugs after an initial experience, or go on to become
regular users.
Ø Drug use is more prevalent among young Dublin males.
Ø Heroin is the least used illicit drug and it is the most problematic.
Ø The profile of the typical problematic drug user is young, unemployed
male, leaving school at an early age and living in a socially and
economically disadvantaged area.
Ø The level of employment among problem drug users has increased
considerably.
Ø Problem heroin use is mainly confined to the Dublin area but there are
pockets of heroin use in other parts of the country.
Ø The sharp rise in the number of drug-related deaths can be substantially
attributed to more accurate recording procedures, though undoubtedly
there has also been a real increase in drug-related death.
Ø A significant proportion of prisoners, who have a history of drug use,
continue to engage in illicit drug use once incarcerated.
Ø There are indications of increasing homelessness among young drug
users.
b) Emerging trends
Ø There has been a decrease in high-risk behaviours – needle sharing
decreased, safe sex (use of condoms) practices increased among clients
attending a needle exchange programme over the eight-year period 1990-
1997.  This is probably due to increases in service provision and the freer
availability of clean needles and condoms.
Ø Women are more at risk than men, but while women tend to be involved in
more risky behaviours than male drug users, they do present earlier for
treatment.
Ø Patterns of drug use are changing.  Over a number of years, among those
presenting to treatment for the first time, there was a trend towards the
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smoking, rather than injecting, of heroin.  Smoking seems to have been
the preferred route for young people starting to use heroin, at least in the
initial year or so of their drug careers.  However, trends since 1997 show
that the route of administration for heroin is tending again towards
injecting.  The explanation is likely to be a complex one, involving many
factors such as the availability of heroin, fluctuations in the price of heroin,
but it may be that young people who originally preferred to smoke heroin
are now no longer reluctant to inject.
Ø Injecting drug use continues to be one of the main risk categories to which
new HIV positive cases are attributed each year.
Ø There is an upward trend in the number of HIV positive cases among Irish
drug users.
Ø The prevalence of Hepatitis C among injecting drug users over the past
decade has been consistently high.
c) Analysis of drug trends in wider social context
Several factors, including the media, can influence society’s perspective on
drug use and drug users, and research evidence can sometimes be at
variance with what is perceived in society at large.  When discussing drug
issues ‘It is important to look beyond the stereotypes or reliance on the media-
fed explanations of phenomena’ (NicGabhainn and Walsh 2000: 2).
The KAB study (Bryan et al. 2000:xv) on the knowledge, attitudes and beliefs
of the general public in Ireland found that:
Ø Irish people have a good general awareness of commonly used illegal
drugs.  However, their perception of the general harmfulness of these
drugs indicated a lack of accurate knowledge about the different effects of
different types of drugs.
Ø Societal attitudes to drugs were mostly negative.  Younger members of
society and those with personal experience of someone with a drug
problem tended to have less negative attitudes.
Ø The public generally perceived drug taking to be common among young
people, and there was a high level of concern about the current drug
situation in Ireland.
Not many qualitative studies have been carried out in the general population
of young people in Ireland.  Such studies to date have tended to concentrate
on problematic drug use.  It is important that there is a general awareness,
and in particular awareness among policy makers of the social context of
young people’s drug taking if suitable and appropriate prevention measures
are to be adopted.
The lifetime experience of drug use in the general population of young people
in Ireland is widespread but this does not necessarily mean they continue to
use drugs after an initial experience, or go on become regular users.  A
sizeable minority of young people have tried cannabis at some time in their
lives. Media reports tend to concentrate on such figures without any reference
to what is meant by lifetime prevalence.  Drug use in the past year or the past
month is more indicative of recent use but such distinctions tend to be ignored
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in media reports of drug use.  Recent use tends to be considerably less than
lifetime use and an increase in lifetime use does not necessarily mean that
there is also an increase in recent use (see Tables 2.2b, 2.2d, 2.2e, 2.2f
below).
The authors of the KAB study recommend that accurate information of a non-
sensationalist type on the relative known risks associated with different types
of drugs, should be made available to all age groups of people; and that more
positive attitudes towards those who misuse drugs should be promoted.  This
is important to the social integration of problem drug users and to their
willingness to avail of treatment.
2.2 Drug use in the population
a) Main results of surveys and studies
Historically there has been little information available in Ireland on drug use
among the general population.  The first nation-wide survey of drug use
among adults was carried out in 1998.  Information on drug use among school
pupils is more readily available  but most of the studies have been conducted
at regional level and use different methodologies, different sample sizes,
different questionnaire designs, different age groups, etc.. In addition,
differences in theoretical approaches (health behaviours, health promotion,
education/prevention, problem drug use behaviours) reflecting different
perspectives can preclude meaningful comparisons of survey results.
What is evident (SLÁN; HBSS; Rhatigan and Shelley 1999; Kiernan 1995; et
al. 1997) is that alcohol and tobacco are the most widely used drugs in Irish
society.  Cannabis is the most commonly used illicit drug, followed to a lesser
extent by amphetamine and ecstasy use, and their use is widespread (see
Sections 2.2c and 2.2b below).  Whether drug use is increasing is not clear
from general population survey data (see Table 2.2f).  Even among young
people of school-going age it is difficult to interpret trends from survey results
of the past two years.  The much quoted, relatively high lifetime prevalence of
cannabis use (37%) among 15-16 year old school pupils (Hibell et al. 1997),
has not been sustained in more recent school surveys (HBSS; Rhatigan and
Shelley 1999).
From the available general population survey data it is apparent that,
generally speaking, young men in urban areas are the most likely to have
misused drugs, mainly cannabis.  However, a distinction must be made
between the adult population and young people.  Among adults over 18 years
of age, after cannabis, amphetamines and ecstasy are the drugs most
commonly used, though to a much lesser extent.  On the other hand, among
young people there is some disparity between different age groups.  For
example, among young people in general (ages 9-18) after cannabis, solvents
are the most widely used substances.  However, adolescents between 11-14
years of age are more likely to use solvents (see Section 2.2c).  Anecdotal
evidence suggests that the recreational use of cocaine is on the increase.
Heroin, which is generally considered to be the drug that causes the most
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problems for individuals, communities and society, is the drug least used in
the general population (see Section 2.3).
b) General population
In 1998, a general population Survey of Lifestyle, Attitudes and Nutrition
(SLÁN) was undertaken for the Department of Health and Children by the
Department of Health Promotion, National University of Ireland, Galway
(results of module on drug use unpublished).  This is the largest study
undertaken in Ireland to date in which drug use prevalence was measured.
The sampling frame was the electoral register, the target population thus
being adults of 18 years and over.  A proportionate random sampling design
was used to select the survey sample.  The questionnaires were posted to
respondents and were self-administered. The sample size of drug the section
of the survey was 10,415.  The response rate was 62.2% (n=6,539) (S. Friel,
personal communication).
Cannabis was the most commonly used drug, followed by amphetamines and
ecstasy (see EMCDDA Standard Table 1a at Appendix 2 (Part 2); Tables 2.2a
and 2.2b below).  The use of amphetamines was slightly higher than ecstasy
use.  Heroin was found to be the drug least used in the general population.
Table 2.2a.  Ireland 1998. SLÁN Survey. Last 12 months prevalence.  Type of drug by
age groups.  Percentages
Age Groups
Type of Drug 18-64 18-34 18-24
Cannabis 9.4 17.7 26.0
Amphetamines 2.6 5.4 8.8
Ecstasy 2.4 4.9 8.1
LSD 1.4 2.9 5.1
Cocaine 1.3 2.6 3.4
Hypnotics and sedatives* 1.2 1.4 2.1
Solvents 0.3 0.8 1.4
Heroin 0.3 0.7 0.8
Source: SLÁN, Dept. Health Promotion, NUI, Galway
*includes benzodiazepines
The highest prevalence rate for cannabis use was found among 18-24 year
olds: 33.4% had used cannabis at some time in the past; 26.0% during the
last 12 months; and 15.3% in the last 30 days. The rates were lower in older
age groups.
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Table 2.2b.  Ireland 1998.  SLÁN Survey.  Lifetime, last 12 months, last 30 days
prevalence of cannabis use by age groups. Percentages
Age Groups
Prevalence 18-64 18-34 18-24
Lifetime 19.9 30.0 33.4
Last 12 months 9.4 17.7 26.0
Last 30 days 5.1 9.7 15.3
Source: SLÁN, Dept. Health Promotion, NUI, Galway
Young men under 25 were the most likely to have used drugs.  This was the
case for all drug types in the 18-24 age group (see EMCDDA Standard Table
1a). In the older age groups women were slightly more likely to have used
hypnotics and sedatives which include benzodiazepines.  Interestingly, there
were no gender differences in the 55-64 year olds for cannabis use during the
past year and the past month, although the rates were small at 0.5%.
Geographically, drug users were more likely to live in an urban location.
In the same year (1998) a general population survey (KAB survey), using a
much smaller sample (n=1,000), was undertaken by the Drug Misuse
Research Division, Health Research Board (Bryan et al. 2000).  The fieldwork
was carried out by an independent research organisation as part of a broader
social omnibus survey.  The aim of the survey was to investigate the attitudes
of the general public towards drug use and drug users, and to determine the
extent of cannabis use.  As in the SLÁN study, the sampling frame was the
register of electors, target population adults aged 18 years and over.  The
sampling procedure was a two-stage proportionate to size random sample.
The questionnaires were administered face-to-face in the respondents’
homes. The final sample size was 1,000 (response rate was 64.5%).
Prevalence information on lifetime use of cannabis only was collected.  The
findings of this survey (see EMCDDA Standard Table 1b at Appendix 2; and
Table 2.2c below) were quite similar to those found in SLÁN, particularly so in
the case of the 18-24 age group.  SLÁN found that lifetime prevalence of
cannabis use among 19-24 year olds was 33.4%, the KAB figure was 32.3%.
Interestingly, no significant gender difference was found among the KAB 18-
24 year olds; lifetime use of cannabis was 32.3% for both males and females.
The older age groups in the KAB survey showed somewhat lower prevalences
than those found in SLÁN.
Table 2.2c.  Ireland 1998.  KAB Survey. Lifetime prevalence of cannabis use by age
groups. Percentages
Age Groups
Prevalence 18-64 18-34 18-24
Lifetime 14.2 26.2 32.3
Source: Knowledge Attitudes & Beliefs Survey, Drug Misuse Research Division, Health Research Board
c) School and youth population
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There is more information available on drug use among school pupils, than
among adults in the general population in Ireland.  However, up to now most
of the work has been carried out at regional level.  The survey studies vary in
a number of ways; objectives, methodologies, focus of data collection,
questionnaire design, age groups studied etc..  Differences in theoretical
approaches, for example health behaviour, health promotion, education,
prevention, problem drug use behaviour, reflect different perspectives.  This
affects interpretations of survey results and can preclude meaningful
comparisons.  Therefore, comparisons below are tentative and must be
viewed with these variations borne in mind.
A survey of substance use among adolescents of school-going age (12-18
year olds) was conducted in the Western Health Board area (WHB) (Kiernan
1995).  A sample of early school-leavers was also included in this study.
Cannabis and solvents were the drugs most likely to have been used (see
Table 2.2f below).
In 1995 nation-wide school surveys of 15-16 year old (born in 1979) post-
primary pupils (ESPAD) were carried out in a number of European countries
Hibell et al. 1997: 12).  In Ireland the data collection period was March 10 –
April 20, 1995 (Hibell et al. 1997: 134).  The Irish lifetime prevalence rate for
cannabis use (ever having used) was found to be 37%.  This was among the
highest of the countries participating in the study – UK was higher at 40%.
However, this relatively high rate has not been found in subsequent surveys.
This may be due to methodological differences.
A survey was carried out in 1996 to examine lifestyles of second level
students in the Midland Health Board area (MHB).  The results were
presented in a short report entitled Report on school survey of second level
students in the Midland Health Board area (unpublished). Unfortunately, a
detailed description of the methodology was not provided. Twelve schools
were randomly selected and 1,654 pupils completed a questionnaire in the
classroom.  Cannabis was the most widely used drug, followed by solvents
(Table 2.2f below).
The latest national survey was conducted in 1998 (Irish Health Behaviours in
Schools Survey [HBSS], Department Health Promotion, NUI Galway,
unpublished) (EMCDDA Standard Table 2a at Appendix 2; Tables 2.2d and
2.2e below).  All types of schools were sampled – primary and post-primary
schools - from Department of Education & Science lists.  Pupils were selected
using two-stage random sampling within health board regions and
classrooms. The sample size was 8,497; the response rate was 73%.
Respondents ranged in age from 9-18 years old.  Lifetime prevalence of
cannabis use was found to be much less (21.7% for 15-16 year olds) than the
ESPAD finding of 37% in 1995 (see Table 2.2d).
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Table 2.2d.  Ireland 1998. Schools Survey - HBSS.  Prevalence of cannabis use by age
groups.  Percentages
Age Groups
Prevalence 11-12 13-14 15-16 17-18
Lifetime 3.0 8.0 21.7 28.5
Last 12 months 2.3 6.5 18.3 24.0
Last 30 days 1.3 4.3 10.5 11.0
Source: Irish Health Behaviours in Schools Survey (HBSS),  Department Health Promotion, NUI, Galway
The highest prevalence was among 17-18 year olds; 28.5% had used
cannabis at some time in the past (lifetime prevalence); 24% had done so in
the past twelve months and 11% had used cannabis recently (in past 30
days).  All drug types were more likely to be used by males.  However, in the
case of lifetime use of cannabis among this (17-18) age group there was very
little gender difference – male 28.7%, female 28.5% (EMCDDA Standard
Table 2a at Appendix 2).  Details on different types of drugs were not provided
for drug use experience in the past 12 months.
Among young people in general (ages 9-18) after cannabis, solvents are the
most commonly used substances (Table 2.2e below).
Table 2.2e.  Ireland 1998. Schools Survey - HBSS.  Last 30 days prevalence.  Type of drug
by age groups.  Percentages
Age Groups
Type of Drug 11-12 13-14 15-16 17-18 9-18
Cannabis 1.3 4.3 10.5 11.0 5.9
Amphetamines 0.7 0.9 2.4 4.9 1.6
Ecstasy 0.6 0.9 1.9 3.7 1.3
LSD 0.8 0.9 1.7 3.7 1.3
Hypnotics & sedatives* 0.8 1.4 1.9 2.1 1.4
Cocaine 1.9 1.6 1.5 1.8 1.7
Solvents 2.9 5.7 5.9 4.1 4.8
Heroin 0.8 0.8 1.0 2.0 0.9
Source: Irish Health Behaviours in Schools Survey (HBSS), Deptartment Health Promotion, NUI, Galway
*includes tranquilisers or sedatives without prescription (barbs, jellies, downers)
Among 17-18 year olds (Table 2.2e) prevalence of recent cannabis use
(11.0%) was followed by amphetamine use (4.9%).  Solvents (4.1%) were the
next most commonly used substances, and not ecstasy as might be expected.
The prevalence of LSD use was similar to that of ecstasy use at 3.7%.  The
picture which emerged among younger age groups was quite different.
Among 15-16 year olds the use of cannabis (10.5%) and solvents (5.9%) was
followed by amphetamine use (2.4%).  Solvents are the substances most
commonly used by 11-14 year olds; followed by cannabis in the case of 13-14
year olds.  Surprisingly, among 11-12 year olds, use of solvents (2.9%) was
followed by cocaine use (1.9%), even before cannabis use (1.3%).  Cocaine
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use was in fact highest among 11-12 year olds (1.9%).  Heroin use seems
higher than would be expected, especially among 17-18 year olds at 2%.
In 1998 also, a school survey was conducted in the eastern region (Eastern
Health Board (EHB), now Eastern Regional Health Authority, area) of the
country (Rhatigan and Shelley 1999) to study the health behaviours of school
pupils.  Again, as above, the sampling frame was the schools’ list of the
Department of Education & Science.  A random sample of schools stratified
by county and school type was selected.  The response rate was 78.2%.  The
sample size was 6,081 pupils aged between 10-18 years.  Cannabis was the
most commonly experienced at least once (lifetime) followed by solvents
(EMCDDA Standard Table 2b at Appendix 2; Table 2.2f below).  These data –
lifetime use of cannabis (21%), solvents (13%); and recent use of cannabis
(11%), solvents (7%) – are somewhat higher than results from HBSS (Health
Behaviours in Schools Survey).  This could be expected given that the sample
was drawn from the most urbanised eastern region, including Dublin.
Prevalence rates (both lifetime and recent) for cocaine use among the whole
group are the same, both in the HBSS and the EHB surveys, at 2%.
Tables 2.2f and 2.2g below illustrate the difficulties involved in making
comparisons between different studies.  Attempting to compare youth surveys
for different geographic locations where different methodologies are used
must be done with considerable caution.  Drug use prevalence among young
people also varies quite considerable according to the age groups examined.
As an example of the disparity in results - in the HBSS the prevalence of
cannabis use for the whole sample (9-18 year olds) was 12% whereas for the
15-16 year olds it was 22%, and for those aged 17-18 it was 29% (see Table
2.2d above).
Table 2.2f.  Ireland 1995-1998. Comparison of school/youth surveys of drug use.
Lifetime prevalence of drug use by type of drug.
Survey /
Year
ESPAD
1995
(National)
WHB
1994
(Local)
MHB
1996
(Local)
HBSS
1998
(National)
EHB
1998
(Local)
Sample size 1,849 2,762 1,654 8,497 6,081
Age group 15-16 13-18 16-18 9-18 10-18
Cannabis 37% 16% 26% 12% 21%
Amphetamine 3% 2% 5% 3% 5%
Ecstasy 9% 2% 7% 2% 3%
LSD or other hallucinogens 13% 9% 9% 4% 3%
Hypnotics & sedatives 7% 2% 4% 3% 3%
Cocaine 2%* 1% Na 2% 2%
Solvents 19% 14% 17% 10% 13%
Heroin 2% 1% Na 1% 1%
*  3% also claimed to have ever used crack
Na=not available
The results from the 1995 ESPAD survey show higher prevalence rates for
most drug types.  In fact the results of this survey give the highest prevalence
rates of all school surveys conducted in Ireland to date.  No explanation for
this is immediately evident but it may be, perhaps, due to methodological
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differences in the research.  However, the fact that 3% in this survey,
conducted in 1995, claimed to have used crack requires further exploration.
Table 2.2g.  Ireland 1995-1998. Comparison of school/youth surveys of drug use.
Recent prevalence (past 30 days) of drug use by type of drug.
Survey /
Year
ESPAD
1995
(National)
WHB
1994
(Local)
MHB
1996
(Local)
HBSS
1998
(National)
EHB
1998
(Local)
Sample size 1,849 2,762 1,654 8,497 6,081
Age group 16 13-18 16-18 9-18 10-18
Cannabis 19% 9% Na 6% 11%
Amphetamine Na 1% Na 2% 3%
Ecstasy Na 1% Na 1% 3%
LSD Na Na Na 1% 2%
Hypnotics & sedatives Na na Na 2% 2%
Cocaine Na 1% Na 2% 2%
Solvents Na Na Na 5% 7%
Heroin Na 0% Na 1% 1%
* Na=not available
What does emerge is that drug use is more prevalent among young Dublin
males.  What also emerges is the importance of carrying out prevalence
surveys using comparable methodologies, if meaningful comparisons are to
be made.  Also, information on recent use (past 30 days/past month) of drugs
is not always as readily available as lifetime use (ever used), even though it is
usually a better indication of the current situation.
d) Specific groups – Lucy Dillon
Prisoners : Research has found that a significant proportion of Ireland’s
prison population has a history of drug use, and that a number of prisoners
continue to use drugs while incarcerated. Two recent studies (Allwright et al.
1999; Long et al. 2000) concerned with the prevalence of HIV, hepatitis B and
hepatitis C among the Irish prison population, explored the related risk
behaviours and drug use engaged in by prisoners. Allwright et al. (1999)
found that of 1,205 respondents, 630 (52.3%) reported that they had used
heroin and 43.2% reported that they had ever injected drugs. Furthermore, the
authors concluded that “drug use within prison was common” (Allwright et al.
1999, p. 18). Forty-five percent of the 334 respondents who reported that they
had a history of drug use and had been in prison for longer than three months,
reported that they had injected drugs in the previous month. Thirty one
percent (n=103) reported that they had injected between 1 and 19 times in the
previous month, while 14% (n=48) said they had injected more than 20 times
in the previous month (Allwright et al. 1999). The subsequent study of a
sample (N=604) of committal3 prisoners found lower rates of prisoners
reporting drug use (Long et al. 2000). Thirty five and a half percent of the
                                                
3 Committal prisoners were defined as “prisoners who have been admitted to the prison within
the preceding 48 hours, accused or guilty of a new crime, excluding those on temporary
release or transferred from another prison. The committal population includes individuals
entering on remand, following sentence, committed as a result of a bench warrant, and non-
nationals without valid documentation” (Long et al 2000).
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sample reported that they had ever smoked heroin and/or injected drugs, 29%
reported that they had ever injected drugs. Both of these studies suggest that
there is a significant proportion of prisoners who have a history of drug use
and, furthermore, a significant proportion continues to engage in illicit drug
use once incarcerated.
Minorities :  Research has not been carried out in Ireland on drug use among
minority groups.  Recent years have seen a significant change in the
migration profile of Ireland.  Table 2.2 at Appendix 2 shows that net migration
in Ireland has gone from 8,000 in 1996 to an estimated 20,000 for the year
2000. Furthermore, there has been a large increase in the numbers of people
applying for asylum in Ireland. In 1992 there were only 39 applications made,
whereas for the first 11 months of 1999 the figure had increased to 6,507
(Table 2.2h below).
Table 2.2h.  Ireland 1992-1999 (30/11).   Total number of applications for asylum in Ireland.
1992 1993 1994 1995 1996 1997 1998 1999 (30/11)
39 91 362 424 1179 3883 4626 6507
Source: Department of Justice, Equality and Law Reform
Anecdotal evidence suggests that some of those coming to Ireland have been
engaged in illicit drug use in their countries of origin and that they have
continued their drug use since entering Ireland.  A change in the nationality
profile of people presenting for treatment is not evident from data recorded in
the National Drug Treatment Reporting System.  For example, in 1998 only 34
of the total number of first treatment contacts (N=1625) were non-nationals
(other than Irish).  Twenty-eight of these were from Great Britain (O’Brien et
al. 2000: 17).  While nothing is known about either the extent to which illicit
drug use occurs within minority groupings in Ireland or the nature of this use,
anecdotal evidence suggests that there is a need to explore drug use in this
context. It is important that the necessary information be available to facilitate
Irish services to address any specific needs that drug users from minority
groups may have and offer services in a way that will encourage these users
to access them.
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2.3 Problem drug use – Mary O’Brien
a) National and local estimates
Studies on national and local prevalence estimates of problem drug use are
quite limited in Ireland.  Two exploratory studies were carried out (Comiskey
1996; Comiskey 1999) to estimate the prevalence of problematic opiate use.
Using the capture re-capture methodology with three samples of data
(methadone treatment list, hospital inpatient data and police record data), the
result of the local (Dublin) study estimated that there were between 10,655
and 14,804 opiate users in Dublin in 1996.  The estimated national prevalence
of opiate misuse in Ireland was found to be between 4,694 and 7,884 with a
prevalence rate of between 16.8% and 23.3%.  There were difficulties with the
samples; for example in the ‘local’ study, 22% of the police sample contained
ambiguous data (7% were non-opiate users; 10% were included because they
were found to be in possession of an opiate; and 5% were identified by
unspecified means).  The data used for this sample was originally collected for
another purpose: to examine drug-related crime (Keogh 1997).  These studies
should be regarded as an exploratory exercise in the development of
methodologies, and the resultant estimates of opiate use should be viewed in
this light.
Another local area prevalence study was carried out in north-east inner city
Dublin, an area with higher than average levels of social and economic
disadvantage. This study (Coveney et al. 1999) collected data from four
sources: five treatment and support agencies; agency waiting lists; a
residents’ street survey and two general practitioners. Of the 1,657 individuals
identified, 477 were residents of the Dublin 1 postal district (north inner city). It
was estimated that the prevalence rate of heroin use was 2.0 percent of the
population of that area. This is somewhat surprising, given that it is
considered to be a high-risk area, but is probably a reflection of the
methodology used in the study.
More problematic drug use is represented by the treated population of drug
users.  This information is collected by the Drug Misuse Research Division,
Health Research Board for the National Drug Treatment Reporting System
(NDTRS) and refers to people who receive treatment for problem drug use.  In
recent years there has been an extensive increase in the services provided for
problem drug users. Compared to ten years ago services are now de-
centralised and have become more diversified and dispersed both locally and
nationally.  Data collected by the National Drug Treatment Reporting System
give a good profile of the characteristics of clients, patterns of use and trends
over time (see Section 3.1a). Problematic opiate use, mainly heroin, continues
to be concentrated in the Dublin area, in localities with high levels of social
and economic disadvantage.  Pockets of heroin use are being reported in
recent times in a number of areas throughout the country.
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b) Risk behaviours and trends
Risk behaviours are very important in the transmission of HIV infection;
injecting with shared equipment is the crucial transmission route among
injecting drug users; sexual contact is likely to be the most common
transmission route to the wider population.  A retrospective examination of
data from the Needle Exchange Programme (NEP) in the Eastern Health
Board area was carried out to identify the factors associated with high-risk
behaviours (Mullen and Barry 1999).  The NEP was set up in 1989. Drug
users who attended for the first time between 1990-1997 were included –
6025 in total. The number of first attenders increased from 350 in 1990 to
1039 in 1997. Four needles, on average, were distributed to first attenders; all
were offered condoms, 45% accepted.  First-time attenders were
predominantly male, but over the eight-year period the proportion of women
increased from 18% in 1990 to 24% in 1997 - this increase was particularly
noticeable in young women under 20 years of age.  The mean number of
years of injecting drug use of the study group was 4 years.  The overall
prevalence of needle sharing in the year prior to attendance was 39%, but
women (44%) were more likely to share than men (38%).  Women (51%) were
also more likely to engage in unsafe sex than men (44%).  Young injectors
under 20 years old, were just as likely as all attenders to share injecting
equipment (39%).  Those who did not share injecting equipment were more
likely to use condoms, than those who did share.  Young attenders under 20
years old, were less likely to be involved in unsafe sex than the overall group
(see Table 2.3 below).
Table 2.3a.  Eastern Health Board area. Characteristics and Risk Behaviours of Needle
Exchange Attenders 1990-1997.
Characteristics All attenders Young attenders
     <20 years
Total N 6025 1224
Gender ratio:
      Overall Male:Female 80:20 75:25
       1990   Male:Female 82:18 86:14
       1997   Male:Female 76:24 68:32
Mean age 25 18.6
Risk behaviour:
  Injecting-mean no. years 4 <1
  Sharing prevalence-past year:
       Total 39% 39%
        Male 38% Na
        Female 44% Na
   Unsafe sex:
         Male 44% 36%
         Female 51% 48%
Source: Mullen and Barry (1999)
*  Na=not available
Trends over the time period 1990-1997 showed a significant decrease in high-
risk behaviours – needle sharing practices fell and safe sex (use of condoms)
practices increased.  Women engage in more risky behaviours, and with the
proportion of women increasing over time this has serious health implications.
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Young injecting drug users are a particularly at-risk group. However, they do
seem to present quite early in their drug using careers to needle exchange
programmes. The authors state that ‘it is crucial that young people do not
encounter barriers to protecting themselves, such as parental permission,
mandatory treatment, and statutory notification’ (Mullen and Barry 1999: 29).
The authors argue that this would defeat the purpose of a low threshold
service, to which young people are more likely to present.  The profile of the
attenders at the NEP highlights the importance of providing prevention and
early intervention programmes particularly for young people.  The authors
recommend that more in-depth/qualitative research is needed to increase
understanding of injecting drug users – ‘the issues surrounding drug use, risk
management and sexual relationships’ (ibid.: 25) – in order to make
prevention strategies more effective.
Another study also highlights the fact that women, although in a minority, are
a very at-risk group among drug users (Geoghegan et al. 1999).  Taking a
somewhat different perspective and focusing on gender differences the
research study carried out at the Merchants’ Quay Project (a voluntary agency
providing a needle exchange service), explored patterns of drug use, risk
behaviour, health and well-being among 934 new attenders.  Data were
collected, between May 1997 and April 1998, from all new clients.   A sizeable
minority was female (25%) and notable gender differences were found.
Women were younger than men and were more likely to:
Ø have a sexual partner who was an injecting drug user
Ø be living with an injecting drug user
Ø share injecting equipment with their sexual partner
Ø report recent sharing of injecting paraphernalia
Ø report having problems finding an intravenous site
Ø report having abscesses and to be suffering from weight loss
Ø report depression, unable to cope, feeling isolated and having suicidal
tendencies
Ø have attended a GP in the previous 3 months
Ø have a medical card.
Heroin was the preferred drug of choice of all the study participants. A
majority (86%) of the overall group reported that they had smoked heroin prior
to injecting – no gender difference was found.  However, women had
significantly shorter smoking careers and were more likely to present sooner
in their injecting careers to treatment services, than men.  The authors
conclude that this research illustrates that it is important to recognise that
women drug users do exist and that they ‘are more likely than their male
counterparts to engage in risk behaviour which has a detrimental effect on
their mental and physical health’ (Geoghegan et al. 1999: 135).
 
Data from the National Drug Treatment Reporting System (NDTRS) were
used in a study (Smyth et al. 2000) to examine trends in treated opiate use
and to identify factors associated with the route of administration of heroin.
Dublin clients presenting for the first time for treatment of an opiate problem
over the six-year period 1991-1996 were included.  The study population was
3981.  Over the period there was a three-fold increase in the number of new
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clients and the proportion of females increased.  The mean age of first opiate
use declined and users began presenting for treatment earlier in their opiate-
using careers. There was an increase in the proportion who were using heroin
as distinct from other opiates, such as morphine sulphate tablets.  There was
a dramatic increase in heroin smoking after 1994 when it became the most
common route of heroin use.  Heroin was most likely to be smoked by young,
employed people who were using heroin for less than three years.
The reasons for the increase in chasing (heroin smoking) are not clear.  It is
suggested that while awareness of AIDS and the risks of injecting may be a
factor, it would be simplistic to assume that this alone accounts for the change
in the pattern of heroin use (Smyth et al. 2000).  In a later study of first time
attenders at a needle exchange programme between May 1997 and February
1998, a comparative analysis of the risk behaviour of younger and older
injectors, i.e. under 25 and over 25 years of age, was carried out.  It was
found that the younger group (under 25 years old) were significantly more
likely to have smoked illicit drugs prior to injecting and to report using heroin
as their primary drug (Cassin et al. 1998).  It may be that smoking is the
preferred route for young people starting to use heroin, particularly for those
reluctant to inject.  The more acceptable nature of chasing, it was suggested,
may attract increasing numbers to use heroin and concern was expressed
that ‘chasing may prove to be a dragon in sheep’s clothing’ (Smyth et al.
2000: 1223).
Data from the NDTRS for 1997-1999, suggest that these concerns were
warranted.  The data show (EMCDDA Standard Table 4 at Appendix 2) that
between 1990 and 1996 the proportion of all treated drug users who injected
their main drug decreased from 66.3% to 36.9%.  However, since then the
proportion who inject has increased a little, from 45.3% in 1997, to 48.7% in
1998 and 48.8% in 1999.  The explanation is likely to be a complex one,
involving many factors (sub-group norms, availability, price of drugs, etc.) but
it may be that the young people who preferred to smoke heroin initially are no
longer reluctant to inject.
In a qualitative study of a group of prisoners (n=29) it was found that moving
from smoking to injecting heroin was motivated by a more efficient use of a
scarce commodity.  Because of the limited quantity of heroin available in
prison, drug-using prisoners managed their drug use in order to ensure that
the maximum number of people were facilitated by the heroin which could be
accessed.  Since smoking was considered to be wasteful this meant that
injecting rather than smoking the heroin was more acceptable.  Furthermore,
injecting was perceived to give a better ‘buzz’ than smoking, once an
individual had become an habitual user (Dillon, forthcoming).
A study of 77 drug-using women (O’Neill and O’Connor 1999) involved in
prostitution found them to be a very at-risk group:
Ø 45 percent started working in prostitution between 13 and 19 years old,
mainly to earn money for drugs
Ø 83 percent had injected in the past month. A quarter of these (n=16) had
shared needles in the past month
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Ø less than one-third had been screened for sexually transmitted diseases.
Compared to similar research carried out in 1996 (in O’Neill and O’Connor
1999: 9) the women in the 1999 study:
Ø tended to be younger
Ø their children were more likely to be cared for by someone else
Ø they were more likely to be homeless.
The women in the latter study were found to be a particularly vulnerable and
marginalised group who engaged in high-risk behaviours.
The importance of more imaginative education initiatives in harm reduction
interventions was demonstrated by a study conducted in a specialised
treatment setting (Smyth et al. 1999b).  The level of knowledge of intravenous
drug users regarding hepatitis C (HCV) and the factors influencing this
knowledge were assessed using an instrument developed by the research
team.  The results showed that there were prominent misconceptions about
the cause of transmission and natural history of HCV infection.  Contact with
services did not lead to any significant gain in understanding.  The authors
concluded that current education approaches in specialist treatment centres
and by general practitioners are deficient.  They recommend a move away
from the ‘typical didactic model of fact provision’ (ibid.: 263) to a more
explorative approach where misconceptions are more likely to emerge,
thereby providing the opportunity to correct and educate.
In summary, problem drug use studies reviewed above show a number of
similar trends:
Ø drug users are young – this reflects the general demographic situation in
Ireland where 47% of the population is under 30 years of age
Ø lifetime experience of drug use in the general population of young people
in Ireland is widespread but may not be as persistent/lasting as is
generally perceived.  The high lifetime experience of cannabis use
(ESPAD, 37%) found five years ago has not been found in more recent
studies
Ø there has been a decrease in high-risk behaviours – needle sharing
decreased and safe sex (use of condoms) practices increased among
clients attending a needle exchange programme over an eight-year period.
This could be due to increase in service provision and the freer availability
of clean needles and condoms
Ø women are more at risk than men, but while women tend to be involved in
more risky behaviours than male drug users, they do present earlier for
treatment
Ø patterns of drug use are changing.  Over a number of years (1990-1996),
among those presenting to treatment for the first time, there was a trend
towards the smoking, rather than injecting, of heroin.  Smoking seems to
have been the preferred route for young people starting to use heroin, at
least in the initial year or so of their drug careers.  However, trends since
1997 show that the route of administration for heroin is tending again to
injecting.  The explanation is likely to be a complex one, involving many
factors such as the availability of heroin, fluctuations in the price of heroin,
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but it may be that young people who originally preferred to smoke heroin
are now no longer reluctant to inject.
3. Health Consequences – Mary O’Brien
3.1 Drug treatment demand
a) Characteristics of clients, patterns of use and trends
People encountering very serious problems with drug misuse will more than
likely eventually come into contact with treatment services.  The treated
population of drug users is well represented in the National Drug Treatment
Reporting System (NDTRS).  Analysis of the characteristics of clients
presenting to treatment for the first time, gives a good overview of trends over
time.
Drug use patterns in Ireland vary according to geographic location.  Problem
opiate use, mostly heroin, is mainly confined to the Dublin area. This is
beginning to change, with pockets of heroin use now becoming apparent in a
number of urbananised areas in regional locations. While the profile of the
typical problematic drug user – young, unemployed male, leaving school at an
early age and living in a socially and economically disadvantaged area – has
not varied much over the years, there has been a change in some trends over
the past five years.
Data on clients presenting for treatment for the first time are presented in
Table 3.1a below.  Gender distribution has not changed much over the five-
year period, and the mean age has remained fairly stable at around 22 years.
Over 70% of those presenting for treatment for the first time are under 25
years old.  This is younger than in other EU countries and is a reflection of the
demographic situation in Ireland where the median age of the Irish population
is much younger than the EU average.  Nearly half the population in Ireland
(47%) is under 30 years of age, whereas the median age in other EU
countries is between 35 and 40 years of age.
Table 3.1a.   Ireland 1995-1999.  New clients presenting for treatment.  Characteristics and
patterns of use. Percentages.
Characteristics 1995 1996 1997 1998 1999
Valid N 1870 2014 1465 1621 1636
Gender ratio   Male:Female 80:20 73:27 72:28 74:26 73:27
Mean age 21.1 21.3 22.0 22.1 22.7
Living status – with parental family 79.0 76.5 71.6 71.1 70.2
Early school-leavers (<16 years old) 51.8 50.2 45.8 45.2 43.2
Regular employment 15.2 13.9 19.5 24.8 31.2
Mean age first used any drug (excl alcohol) 15.6 15.4 16.0 15.5 15.7
Main drug - Heroin 54.6 63.2 58.4 55.7 53.5
Main drug - Route of administration- inject 23.8 24.3 29.3 28.8 30.6
Main drug - Route of administration- smoke 56.3 59.6 50.6 53.5 53.0
Source: National Drug Treatment Reporting System (NDTRS), Drug Misuse Research Division, Health Research
Board
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Between 1995 and 1999 there was a fall in the proportion of clients living in
the parental home (Table 3.1).  There was a decrease in those who left school
before the age of 16 years from 52% in 1995 to 43% in 1999. There was a
sizeable increase in the level of employment among problem drug users, from
a very low 15% in 1995 to 31% in 1999, again reflecting more general
changes in Irish society in relation to improvements in the economy, inter alia,
over the same period.  The mean age of initial drug use was between 15-16
years of age and did not change much over the five-year period.  Heroin was
the main drug of misuse for over half of those presenting for treatment for the
first time.  Over the five-year period there was an increase in the proportion
injecting their main drug of misuse and a decrease in smoking (c.f. discussion
on risk behaviours at Section 2.3).
There is great disparity in the pattern of drug use in different parts of the
country.  Problematic opiate/heroin use is mainly in the eastern region of the
country, around Dublin.  Seven out of ten Irish clients receiving drug treatment
are residents of the Eastern Health Board area (now the ERHA) (O’Brien et al.
2000).  Most of these clients (80%) are treated for heroin misuse (ibid.).  In
other health board areas throughout the country cannabis is the drug for
which the majority of people receive treatment (ibid.). Of course, the
characteristics of clients using different types of drugs varied accordingly.
Heroin users were must less likely to be still at school than cannabis users;
and they were much more likely to be involved in behaviours with detrimental
effects to their health, such as injecting, and sharing injecting equipment.
b) Comments on different client profiles in different types of treatment
The majority of people presenting for treatment for drug use problems in
Ireland are treated at non-residential treatment centres.  Data from the
NDTRS for 1999 show the following proportions presenting to different types
of treatment services: 57% non-residential; 34% residential; 6% low threshold;
3% medical doctors in general practice (National Drug Treatment Reporting
System, personal communication).  It should be stressed that in 1999 not all
GPs were reporting to the NDTRS and contacts in prisons were very poorly
represented.  Men were more likely to be receiving treatment at residential or
low threshold services, while women were more likely to present to non-
residential or GP services for treatment.  Clients living in the parental home
were least likely to be attending low threshold services.  Unemployed clients
were the most likely to be attending low threshold services; those in regular
employment were more likely to be receiving treatment from a GP.
Against a background of increasing encouragement of GPs to become more
involved in the treatment of drug users, a study was carried out in a
specialised drug treatment setting during August-September 1997, to assess
the utilisation of primary care services for general health purposes, by
injecting opiate users (n=77) (Smyth et al 1999a).  A structured questionnaire
was used to interview clients.  The sample size was 139 with a response rate
of 75 percent.  The sampling procedure was opportunistic.  Despite general
policy changes, such as more emphasis on harm minimisation, the findings
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were similar to those of a similar study in 1991.  In particular, the relative
frequency of GP and A&E (hospital accident and emergency department)
attendances were unchanged.  Concern was expressed by the authors
(Smyth et al. 1999a) at the high proportion who were being prescribed
benzodiazepines (39%) by GPs.  They state that this indicated that there is
‘clearly a wide gap’ between treatment approaches by psychiatrists
specialising in substance misuse at treatment centres, and GPs, in the
management of co-morbid disorders, such as anxiety and sleep disorders
among drug users.  The need for improved communication and co-operation
as well as explicit protocols relating to clarity, consistency and continuity in
treatment approaches, was stressed.
c) Comments on treatment demand for different drugs
Heroin :  A majority of people (around 6 out of 10 new cases each year)
presenting to the treatment services have problems with the misuse of heroin,
i.e it is the main drug of misuse (National Drug Treatment Reporting System).
This is mainly confined to the Dublin area but in recent years pockets of
heroin use in other parts of the country are being reported.  A sizeable
proportion (56% in 1999) of those presenting to treatment services with
problem heroin use for the first time are involved in intravenous drug using
practices with very serious health and social consequences.  This is the
highest level in the past five years (38% in 1995; 37% in 1996; 49% in 1997;
48% in 1998) (EMCDDA Table 4 at Appendix 2).  See discussion at Section
2.3b.
Cannabis : Since the NDTRS was set up in 1990, the proportion of people
presenting for treatment for cannabis use has not varied much: between 11%
and 16%.  After heroin it is the next drug, at a much lower level, for which
treatment is most commonly sought.  More than half (55%) started to use
cannabis between 15-19 years of age, 37% started before the age of 15 years
(Moran et al. 1997).
Cocaine: Treatment demand for problem cocaine use has always been very
low: between 1%-2%.  Apart from addiction counselling, there are no specific
treatments for problem cocaine users in Ireland right now.  Of all those
presenting for treatment for the first time in 1999 with multiple drug problems
(more than one drug) (64%), 7% were seeking treatment for problem cocaine
use.
Synthetic drugs : Demand for treatment for problem ecstasy use has
decreased somewhat in recent years (from 11% in 1995 to 8.8% in 1999).
The proportion of problem amphetamine users presenting for treatment for the
first time has increased from 0.4% in 1995 to 2.1% in 1999.  A worrying
development is that in 1999, 6% of these were injecting the drug.  The
proportion presenting with problem LSD use has been falling (from 1.6% in
1995 to 0.2% in 1999)
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3.2 Drug-related mortality
a) Drug-related deaths, direct and indirect, characteristics and trends
Official Irish statistics on drug-related deaths from the General Mortality
Register (GMR) are compiled routinely by the Central Statistics Office.  They
are recorded according to the International Classification of Diseases,
Version 9 (ICD-9), that is, the cause of death is designated as the underlying
cause of death.  This is defined as -
(a) the disease or injury which initiated the train of morbid events leading
directly to death, or (b) the circumstances of the accident or violence which
produced the fatal injury (WHO, 1977:700)
The underlying cause of death can be from natural or external causes.  The
definition of external cause of death is as follows:
…a supplementary classification that may be used, if desired, to code external factors
associated with morbid conditions classified to any part of the main classifications.
For single-cause tabulation of the underlying cause of death, however, the E Code
should be used as a primary code if, and only if, the morbid condition is classifiable to
Injury and Poisoning     (WHO, 1977:xxix)
For the purpose of this report a drug-related death is defined as one where
the underlying (natural or external) cause of death was due to drug
dependence (ICD-9 Code 304) or opiate poisoning (ICD-9 Code 965.0).
These are deaths directly related to problem drug use.
An examination of drug-related deaths recorded between 1990 and 1999
(Table 3.2 at Appendix 2) shows that the number of deaths over the ten-year
period increased considerably from 1995 onwards. The highest number was
recorded (N=99) in 1998.  It was in that year that an amendment was made to
the information recorded, in the case of a sudden death, by the Garda
Siochana (on Form 104): a question on drug/alcohol dependency was
included on Form 104. This was as a result of the work of the National Task
Force on Suicide (Department of Health & Children 1996; 1998).  The
increasing trend did not continue in 1999 when the number of deaths was 80
(Table 3.2 at Appendix 2).  In terms of geographic location the vast majority of
deaths were in Dublin.  The majority were males, between the ages of 15 and
49.  Most deaths were due to drug dependence.
Indirect as well as direct drug-related death was the subject of an ad hoc
retrospective study carried out in 1999 (Keating et al. 1999).  Dublin City and
County Coroners’ files were examined to study the number of drug-related
(direct and indirect) deaths in 1997.  The criteria for inclusion were that the
death had to have occurred in Dublin (city or county), between 1 January and
31 December 1997, and have positive toxicological evidence of the presence
of drugs, and where drugs were implicated in the cause of death - this is a
much broader definition that that used for the purpose of the GMR.
Toxicological screens included testing for alcohol, opiates, benzodiazepines,
tricyclics, barbiturates and cocaine.  One-hundred-and-twenty cases were
found to be toxicologically positive for drugs and 65 of these were known to be
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drug users.  The gender ratio was 3:1 (male:female) and more than half of the
deaths were in the 20-39 year age group.  The drug most commonly identified
was benzodiazepine (75 cases) mainly in combination with other drugs. The
most common combination of drugs was opiates and benzodiazepines.
Methadone was found in 47 cases; alcohol was found in 47 cases; cocaine in
7 cases; MDMA in 2 cases; and amphetamines in 2 cases.  A similar study of
coroners’ files in 1992 (in Keating et al. 1999) found no cocaine, MDMA nor
amphetamines in drug-related deaths.  The 1992 study found a similar
number of drug-related deaths recorded (in Dublin coroners’ files) to that
recorded in the GMR for that year.  However, the total number (120) found in
the 1997 study did not correspond with the number (49) recorded in the more
narrowly defined GMR for the same year.
In summary, the increase in the number of deaths, as recorded by the GMR,
is partly due to more awareness of the need for such information and
consequent improvement in the collection procedure of the GMR data; and
partly due to a real increase in the number of drug-related deaths.
b) Mortality and causes of death in drug users, trends
An outbreak of 24 cases of illness among injecting drug users in the Dublin
area in Summer 2000 resulted in 8 deaths.  This was similar to an outbreak of
the illness in Glasgow where the first cases were recognised.  While the
definitive cause of death for all cases has not yet been established, the likely
cause has been identified as a toxin-producing strain of Clostridium novyi, but
other bacteria may be involved.  The ‘significance of the presence of clostridial
species remains to be determined but it may suggest contamination of the
drugs or other materials’ used by the intravenous drug users (Andraghetti et
al. 2000).
Research on mortality among drug users is not yet available, therefore it is not
possible to discuss associated mortality trends.
3.3 Drug-related infectious diseases  - Lucy Dillon
a) HIV and AIDS
The majority of data collected on drug related infectious diseases are
related to HIV.  There are two main sources of data that will be
discussed below: first, the routine data on HIV positive tests that are
reported by the Department of Health and Children; and second, the
special studies which have estimated the prevalence of HIV among
drug users, mainly in treatment settings.
Routine data on HIV testing
In Ireland, the Department of Health and Children, in collaboration with the
Virus Reference Laboratory, produces statistics on HIV positive tests which
are published every six months. The figures relating to HIV tests are broken
down according to risk category. There are a number of risk categories
identified in relation to HIV infection including injecting drug use, homosexual
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sex and haemophiliac contact. Therefore, it is possible to get a breakdown of
the number of positive HIV cases attributable to injecting drug use in a given
year. However, there are a number of limitations to this data source that
should be noted:
Ø It is limited to the tested population. Nothing can be inferred for those drug
users who have not been tested.
Ø It is not possible to identify non-injecting drug users within the data set.
Ø No socio-demographic data is collected on those who are tested.
Ø There is only a limited geographical breakdown available.
Ø A gender breakdown has only been made available since 1997.
Ø Both risk behaviours (e.g. injecting drug use) and test locations (e.g.
prison) are used as categories. This makes the data somewhat unclear.
For example, it is not known through what risk activity those tested in the
prison setting became infected with HIV.
Despite these limitations, this data source provides the best information with
which to examine the epidemiological profile of HIV in Ireland over the past
decade and a half.
The cumulative figures for the positive cases of HIV from the start of data
collection in 1982 up until 1985, show that just over 60% (n=221) of all
positive cases (N=363) were attributed to injecting drug use (see table 3.3a).
Since 1985, injecting drug use has continued to be one of the main risk
categories, accounting for 41.6% of the cumulative number of positive cases
up until December 31st1999 (see Table 3.3a). Since data have been collected,
injecting drug use has continued to be one of the main risk categories for
infection. Two possible explanations have been given by O’Gorman (1999) for
the high proportion of intravenous drug users in the known HIV positive
population. She argues that the culture of injecting drug use that existed
among drug users in Ireland during the 1980s, at a time when both
information on safe injecting practices and access to clean injecting
equipment were limited4, resulted in the rapid transmission of HIV among the
injecting population. Secondly, she argues, the injecting drug using population
may be more likely to have been tested for HIV through their contact with drug
treatment services than those individuals who may be at risk of infection
through other routes e.g. heterosexual sex (O’Gorman 1999, p. 6).
The proportion of positive cases attributed to the intravenous drug user
category generally decreased from 1992 through to 1998. In 1994, for the first
time, intravenous drug use accounted for less new positive cases than the
‘homosexual sex’ or ‘heterosexual sex and/or risk unspecified’ categories (see
Table 3.3a). In fact, the proportion of positive HIV tests attributed to
intravenous drug use fell from 49.7% in 1989, to a low of 17.6% in 1997 (see
Table 3.3a). It is suggested that the reduction both proportionately and in
absolute numbers over this period may be attributed, at least in part, to the
expansion of services aimed at reducing the spread of HIV among injecting
drug users, i.e. substitution and needle exchange programmes. In an analysis
                                                
4 The first needle exchange programme in Dublin was established in 1989.
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of the trends up until 1998 the National AIDS Strategy Committee has
commented that:
 “Epidemiological surveillance of HIV would indicate that in recent years the
overall incidence of HIV among intravenous drug users is reducing. While we
must be wary of drawing major conclusions from short term changes in infection
patterns service providers are optimistic that this trend is as a result of the
intervention through a combination of substitution therapy with methadone and
needle exchange services.”
(National AIDS Strategy Committee 2000: 63)
Table 3.3a.  Ireland 1985-1999. HIV positive cases by risk category. Numbers
and percentages
Year IVDUs n
(%)
Homosexual
Sex
n (%)
Heterosexual
Sex/ Risk
unspecified
n (%)
Other
n (%)
Total
n (%)
1985* 221 (60.9) 39 (10.7) 0 103 (28.4) 363 (100.0)
1986 112 (66.3) 11 (6.5) 21 (12.5) 25 (14.8) 169 (100.0)
1987 72 (49.7) 21 (14.5) 26 (17.9) 26 (17.9) 145 (100.0)
1988 58 (50.4) 17 (14.8) 20 (17.4) 20 (17.4) 115 (100.0)
1989 57 (49.1) 33 (28.5) 0 26 (22.4) 116 (100.0)
1990 50 (45.1) 25 (22.5) 24 (21.6) 12 (10.8) 111 (100.0)
1991 34 (36.9) 27 (29.4) 25 (27.2) 6 (6.5) 92 (100.0)
1992 82 (40.8) 58 (28.9) 50 (24.9) 11 (5.5) 201 (100.1)
1993 52 (38.0) 48 (35.0) 21 (15.3) 16 (11.7) 137 (100.0)
1994 20 (23.5) 31(36.5) 22 (25.9) 12 (14.1) 85 (100.0)
1995 19 (20.9) 33 (36.3) 30 (33.0) 9 (9.9) 91 (100.1)
1996 20 (18.9) 41 (38.7) 27 (25.5) 18 (17.0) 106 (100.1)
1997 21 (17.7) 37 (31.1) 40 (33.6) 21 (17.7) 119 (100.1)
1998 26 (19.1) 37 (27.2) 47 (34.6) 26 (19.1) 136 (100.0)
1999 69 (33.0) 40 (19.1) 59 (28.2) 41 (19.6) 209 (99.9)
Total 913 (41.6) 498 (22.7) 412 (18.8) 372 (17.0) 2195 (100.1)
Source: Department of Health and Children
Despite the apparent reduction in the proportion of positive cases attributed to
injecting drug use and the actual number of positive tests, figures from 1999
show a substantial increase in the number of positive cases. Between 1998
and 1999 the total number of new cases of HIV increased from 136 to 209.
Furthermore, the number of new positive cases attributed to injecting drug use
increased from 26 of the total new cases (n=136) in 1998 to 69 of the new
cases (n=209) in 1999. Therefore, proportionately, injecting drug use as a risk
category increased from accounting for 19% of new HIV positive cases within
this data source in 1998, to 33% in 1999. This is the highest annual proportion
of new positive cases attributed to injecting drug use since 1993.
Anecdotal evidence suggests a couple of explanations for the increase in the
number of positive cases being attributed to injecting drug use during 1999.
Firstly, leading on from the Protocol for the Prescribing of Methadone issued
in 1993, guidelines were developed for GPs prescribing methadone within the
general practice setting and for pharmacists in their dispensing of methadone.
Following the completion and evaluation of a pilot programme, in January
1998 the Report of the Methadone Treatment Services Review Group made a
                                                
* Cumulative figures
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number of recommendations on tightening control on both the prescribing and
dispensing of methadone, in accordance with the 1993 protocol.
Consequently, the Misuse of Drugs (Supervision of Prescription and Supply of
Methadone) Regulations, 1998 were drawn up. The regulations aim to create
a more controlled environment for the prescribing and dispensing of
methadone. Within this context, all those who were receiving methadone in
Ireland were integrated into a structured programme. Furthermore, drug users
were integrated into a structured programme setting where there is an active
policy of carrying out virology in relation to HIV and hepatitis. It is suggested
therefore, that this may have resulted in an increase in the number of injecting
drug users being tested for HIV and, in turn, an increase in the number of
positive cases being attributed to injecting drug use during 1999. Secondly, it
has also been suggested anecdotally that perceptions may be beginning to
change among the drug using population in relation to HIV. It is argued that
the availability of new treatment (HAART) and the visibility of individuals in the
community for whom treatment has been effective, has encouraged people to
come forward for testing so that they can avail of treatment if necessary.
Prisoners :  As mentioned above, within the Department of Health and
Children’s reporting system on HIV positive tests, those who are tested in
prison are categorised according to the testing location, i.e. prison. While the
proportion of positive cases from the testing location category of prison which
are attributable to injecting drug use is not known, anecdotal evidence
suggests that most of those being tested have a history of injecting drug use.
Since 1989, a total of 39 new positive cases have been attributed to
‘prisoners’, 13 of whom tested positive in 1999. The use of both risk
categories and testing locations in the Department of Health and Children’s
reporting system does not allow for any conclusions to be drawn as to the
significance of these figures in relation to the injecting drug using population. It
is important that the risk category of these cases be clarified.
Gender :  While there are no socio-demographic data collected on those who
are tested for HIV from the Department of Health and Children’s Data source,
the gender of the individual being tested has been reported since 1997. An
examination of the figures by gender suggests a possible change in the
gender distribution of those who are testing positive for HIV in Ireland (see
table 3.3b). In 1997, females only accounted for 3 of the 21 new positive
cases attributed to injecting drug use. In 1998 this had increased to 10 of the
26 positive cases among injecting drug users, and in 1999 it had increased
further to account for 34 of the 69 positive cases. Speaking in percentage
terms, women have increased from representing 14.3% of the positive tests
among injecting drug users in 1997, to 38.5% in 1998 and finally 49.3% in
1999. Due to the lack of information on gender prior to 1997, it is not possible
to explore trends over a more extended period of time. Anecdotal evidence
suggests that these figures may reflect a real increase in the number of
women injecting drug users who are becoming infected with HIV. However, it
is also suggested that these women may be becoming infected through their
sexual behaviour rather than their injecting drug use. Once identified as an
injecting drug user however, their infection will tend to be attributed to their
injecting drug using behaviour. Anecdotal evidence also suggests that a
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growing number of women may be attending for testing in order to be able to
minimise the risk of infection to their baby were they to become pregnant.
Table 3.3b.  Ireland 1997-1999. HIV seropositive intravenous drug users by gender. Numbers
and percentages.
Year Male
n (%)
Female
n (%)
Total
n (%)
1997 18 (85.7) 3 (14.3) 21 (100)
1998 16 (61.5) 10 (38.5) 26 (100)
1999 35 (50.7) 34 (49.3) 69 (100)
Source: Department of Health and Children
AIDS :  Since recording began in 1982 and up until December 31st 1999,
there have been 691 AIDS cases reported in Ireland, and 349 AIDS related
deaths (see Table 3.3, Appendix 2 In 1999 there were 41 new AIDS related
cases recorded. Intravenous drug users continue to represent one of the main
risk categories recorded in this data source. In 1999, intravenous drug users
accounted for 39% of new AIDS cases, and 41% of the year’s AIDS related
deaths.
Special Studies
A number of special studies have been carried out which have explored the
prevalence of HIV among drug users in a range of study locations mainly in
treatment settings. The studies include drug users located in: the community,
drug treatment centres, needle exchange programmes and prisons. A
summary of the research findings on the prevalence of HIV infection among
drug users is presented in Table 3.3c below.
One of the first studies of drug use in Dublin began in 1985 when O’Kelly et al.
(1996) identified a cohort of known intravenous drug users in an inner city
area. The prevalence of HIV infection among this group was monitored over
the next decade. In 1991, 57.3% of the total cohort (N=82) were known to be
HIV positive, by 1994, 64.6% of the cohort had tested positive for HIV. In total,
18 of those who had tested positive by 1994 had died. O’Kelly et al. (1996)
argue that the high prevalence rate of HIV among this cohort reflect the
context in which their intravenous drug use developed. It was argued that “the
uncontrolled use of injected drugs and the sharing of scarce equipment were
commonplace at the time; the true impact of these practices is now clear in
terms of the spread of HIV infection among the young people who lived there”
(O’Kelly et al. 1996, p. 114). Another study carried out with a cohort who had
begun injecting during the same period found similar rates of HIV prevalence.
Williams et al. (1990) found that of a cohort of sixty-nine individuals on a
methadone maintenance programme 70% were HIV positive.
These high prevalence rates of HIV were not found in studies subsequent to
those of O’Kelly et al. (1996) and Williams et al. (1990). Johnson et al. (1994)
found that in 1991, 14.8% of a sample recruited from a needle exchange
programme were HIV positive. The Dorman et al. (1997) study, which was
carried out in 1992 in the context of a World Health Organisation multi-
national research initiative, found that 8.4% of a sample of 180 injecting drug
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users, recruited from both in and out of treatment, were HIV positive. In
contrast, the Smyth et al. (1998) study of a drug treatment sample tested
between 1992 and 1997 found a prevalence rate for HIV of only 1.2%. This is
low in contrast to an estimated 8% prevalence rate (based on laboratory
reports) among injectors attending Eastern Health Board methadone clinics in
1997 (Joe Barry, cited in Allwright et al. 1999:2).
More recently, two studies have been carried out which report on HIV
prevalence among the Irish prison population (Allwright et al. 1999; Long et al.
2000). Included in the data are the prevalence rates for those prisoners who
have a history of injecting drug use. It was found that 5.8% of committal
prisoners5 (Long et al. 2000) and 3.5% of general prisoners (Allwright et al.
1999) with a history of injecting drug use were HIV positive. Among those
prisoners who reported no history of injecting drug use the infection rates
were 0.5% among the committal population (Long et al. 2000) and 0.9% within
the general prison population (Allwright et al. 1999). In an environment where
injecting drug use is on-going in the absence of any provision for clean
injecting equipment, the risk for the spread of infection within this population is
high.
Table 3.3c.  Ireland 1991-1999.  Summary of research findings on the prevalence of HIV
infection among particular cohorts of drug users
Author Study
period
Sample Source Self Report/
Test
Serum/
Saliva
Sample
size tested
% infected of
those tested
Long et al
(2000)
1999 Committal
prisoners
N=593
Test Saliva IDUs6
(n=173)
IDUs
5.8%
Allwright et al
(1999)
1998 Irish Prison
Population
N= 1178
Test Saliva IDUs
(n=509)
IDUs
3.5%
Smyth et al
(1998)
1992-
1997
Drug treatment
centre
N=735
Test Serum IDUs
(n=600)
IDUs
1.2%
Dorman et al
(1997)
1992 Drug treatment
centre & non-
treatment IDUs
N=185
Test Serum
and saliva
IDUs
(n=180)
IDUs
8.4%
O’Kelly et al
(1996)
1984-
1995
IDUs in
community
N=82
Test Serum IDUs
(n=66)
IDUs
65%
Johnson et al
(1994)
1991 Needle
exchange
N=106
Test Saliva IDUs
(n=81)
IDUs
14.8%
In summary, injecting drug use continues to be one of the main risk categories
to which HIV positive cases are attributed each year. Despite the rates of new
HIV positive cases attributed to injecting drug use plateauing in the early and
mid 1990s, recent figures suggest that there is an upward trend in the number
of new HIV positive cases among Irish drug users. The information available
on those who are testing positive for HIV remains limited. Analysis of the
                                                
5 Committal prisoners are prisoners who have been admitted to the prison within the preceding 48
hours, accused or guilty of a new crime, excluding those on temporary release or transferred from
another prison. The committal population includes individuals entering on remand, following sentence,
committed as a result of a bench warrant and non-nationals without valid documentation (Long et al.
2000: p.2).
6 IDUs: Injecting drug users
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figures highlights the need for more information, in particular of a socio-
demographic and behavioural nature, to facilitate comprehensive
epidemiological analysis of the trends.
b) Hepatitis B and C
There is very little information in Ireland on the prevalence and incidence of
hepatitis B among both the general population and the injecting drug using
population. While data are collected on the number of positive tests carried
out for hepatitis B by the Virus Reference Laboratory, no behavioural data is
collected and therefore those infected through drug use cannot be identified.
Information on prevalence rates is therefore confined to a small number of
special studies that have been carried out in the field.
The Smyth et al. (1998) study of drug users located within a treatment setting
found that only 1% were infected with Hepatitis B. However, more recent
research carried out in the prison setting found significantly higher prevalence
rates among injecting drug users. Allwright et al. (1999) and Long et al. (2000)
found 18.5% and 17.9% prevalence rates for hepatitis B, respectively. While
these figures suggest that hepatitis B may be prevalent among the injecting
drug user population, the lack of data prohibits any in-depth epidemiological
analysis of the situation in Ireland.
Table 3.3d.  Ireland 1992-1999.   Summary of research findings on the prevalence of
Hepatitis B infection among particular cohorts of drug users
Author Study
period
Sample Source Self Report/
Test
Serum/
Saliva
Sample size
tested
% infected of
those tested
Long et al
(2000)
1999 Committal
prisoners
N=593
Test Saliva IDUs
(n=173)
IDUs 17.9%
Allwright et al
(1999)
1998 Irish Prison
Population
N= 1178
Test Saliva IDUs
(n=509)
IDUs
18.5%
Smyth et al
(1998)
1992-
1997
Drug treatment
centre
N=735
Test Serum IDUs
N=729
IDUs
1%
In Ireland, there are no routine data collected on hepatitis C. However, there
have been a number of special studies carried out among samples of drug
users in a variety of study settings (see table 3.3e).
The first study of hepatitis C infection among injecting drug users was carried
out between August 1992 and August 1993 by Smyth et al. (1995). The study
sample was identified through a treatment centre where all new attenders and
re-attenders who presented during the study period and who reported a
history of injecting drug use were encouraged to take part. In total, 272
injecting drug users took part and a prevalence rate of 84% for infection with
hepatitis C was found. Among those injectors who had been injecting for
between six months and two years inclusive the prevalence rate was 70%.
Among those with a longer injecting history, i.e. an injecting history of longer
than two years, the prevalence rate was 95%. Furthermore, there was a
significant difference between genders in terms of infection. 156 of the 194
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males (80%) tested positive, whereas 73 of the 78 females (94%) were
positive.
Further studies were carried out by Smyth et al. (1998, 1999a), which
examined the prevalence of hepatitis C among in-treatment populations.
Consecutive new attenders at a treatment service who attended between July
1993 and December 1996 were approached to take part in the study. In all, a
sample of 353 injecting drug users who reported an injecting history of less
than 25 months were recruited. Overall, a prevalence rate of 52.1% was
recorded within this sample. In an extension of this study cohort, Smyth et al.
(1998) later found that of 733 consecutive new attenders between September
1992 and September 1997 at the same treatment centre, 61.8% were
hepatitis C positive.
In two prison studies, which have been discussed in previous sections, the
prevalence of hepatitis C among prisoners was explored (Long et al. 2000;
Allwright et al. 1999). The prevalence of hepatitis C was found to be high
within this population. Allwright et al. (1999) found that among 509 prisoners
with a history of injecting drug use, 81.3% tested positive for hepatitis C. In
contrast, 3.7% of those prisoners who did not report a history of injecting drug
use had tested positive for hepatitis C. A follow-up study of the committal
prisoner population (Long et al. 2000) found that of 173 prisoners with a
history of injecting drug use, 71.7% were hepatitis C positive. Only 1.4% of
those prisoners who reported that they had no history of injecting drug use
tested positive for hepatitis C.
While it is not possible from the available data to analyse infection trends over
time, it would appear from the studies available that hepatitis C infection has
been prevalent among Irish injecting drug users over the past decade.
Anecdotal evidence suggests that the relative ease with which hepatitis C can
be spread through injecting drug use, and a lack of knowledge among users
about hepatitis C and the associated risks, have all contributed to its spread.
In summary, the prevalence rate for hepatitis C has been found to be
consistently high within the drug using population over the past decade.
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Table 3.3e.  Irealnd 1992-1999.   Summary of research findings on the prevalence of
Hepatitis C infection among particular cohorts of drug users
Author Testing
period
Sample
Source
Self
Report/
Test
Serum/
Saliva
Sample size
tested
% infected
of those
tested
Long et al
(2000)
1999 Committal
prisoners
N=593
Test Serum IDUs (n=173)
Non IDUs
(n=420)
IDUs 71.7%
Non IDUs
1.4%
Allwright et
al (1999)
1998 Irish Prison
Population
N= 1178
Test Serum IDUs
(n=509)
Non IDUs
(n=669)
IDUs
81.3%
Non IDUs
3.7%
Smyth et al
(1999a)
1993-
1996
Drug treatment
centre
N=353
Test Serum IDUs
N=353
IDUs
52.1%
Smyth et al
(1999b)
1997 Drug treatment
centre
N=84
Self-
report
n/a IDUs
N=84
IDUs
89%
Smyth et al
(1998)
1992-
1997
Drug treatment
centre
N=735
Test Serum IDUs
N=733
IDUs
61.8%
Smyth et al
(1995)
1992-
1993
Drug treatment
centre
N=272
Test Serum IDUs
(n=272)
IDUs
  84%
In summary, the most comprehensive data available on drug related infectious
diseases in Ireland are for HIV. While the number of new positive tested cases
for HIV, which were attributable to injecting drug use, appeared to stabilise in
the mid-1990s, figures for 1999 show an increase in the number of cases. For
both hepatitis B and C, analysis is dependent solely on data from special
studies. Despite the absence of comprehensive data it appears from the
evidence available that hepatitis C continues to be highly prevalent among
Irish injecting drug users. Overall, it would appear from the data that are
available that drug related infectious diseases continue to be an issue of
concern in relation to Irish injecting drug users. Furthermore, this highlights
the need for more comprehensive data collection in the area of all drug related
infectious diseases in order to monitor changes in the trends over time.
c) Other drug related infectious diseases
Data have not been collected on other drug-related infectious diseases in
Ireland. Anecdotal evidence suggests however that tuberculosis may be
increasing in prevalence among Irish drug users.
Chronic drug effects:  The most obvious consequences of HIV and hepatitis
B and C are the impact these diseases have on the individual’s health. There
are no data available on the number of drug users who develop chronic
hepatitis C or require care for hepatitis B infection. The only routine data
collected on the health consequences of drug related infectious diseases are
those on AIDS related cases and deaths. Since recording began in 1982 and
up until December 31st 1999, there have been 691 AIDS cases reported in
Ireland, and 349 AIDS related deaths. In 1999 there were 41 new drug-related
AIDS cases recorded. Intravenous drug users continue to represent one of the
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main risk categories recorded in this data source. In 1999, intravenous drug
users accounted for 39% of new AIDS cases, and 41% of the year’s AIDS
deaths.
Table 3.3f.  Ireland 1997-1999. AIDS cases and deaths by risk category
1997 1998 1999Risk Category
Cases Deaths Cases Deaths Cases Deaths
Intravenous Drug Use
Related7
10 1 12 8 16 7
Homo/ Bisexual 12 3 13 9 13 5
Haemophiliacs/
Heterosexuals/ Others
8 2 14 4 11 5
Undetermined 2 1 2 0 1 0
Total 32 7 41 21 41 17
Source: Department of Health and Children/ Virus Reference Laboratory
3.4 Other drug-related morbidity – Mary O’Brien
a) Non-fatal drug emergencies
Information on non-fatal drug emergencies is not available in Ireland.
b) Psychiatric co-morbidity
National policy on the treatment of alcohol and drug misuse (Department of
Health 1984) stipulates that the emphasis in the management of alcohol and
drug-related problems be on community-based intervention, rather than on
specialist inpatient treatment. Despite the general policy of providing
treatment for problem drug use at non-residential services in the community,
drug-related admissions to psychiatric inpatient hospitals are continuing to rise
(see Appendix 2, Table 3.4).  The proportion of drug-related admissions – with
a primary or secondary diagnosis - increased from 2.2% in 1995 to 3.6% in
1999 for all admissions (National Psychiatric Inpatient Reporting System
[NPIRS], personal communication).  For first admissions (admission for the
first time ever) the proportion increased from 2.4% to 5.0% in the same
period.  This is in contrast to the general trend of a decrease in overall
admissions to psychiatric hospitals.
The rates (per 100,000 population) increased from 16.2 in 1995 to 24.6 in
1999 for all admissions, and in the case of first admissions the rate doubled
between 1995 and 1999 from 4.7 to 9.8 per 100,000 population.  Admission
rates for ‘drug dependence’ to inpatient psychiatric hospitals vary according to
geographic location (see Table 3.4a). This is not necessarily an indication of
morbidity but may perhaps be linked to drug treatment provision in different
areas and/or more willingness in certain areas to admit people with drug
problems to psychiatric hospitals.
                                                
7 Includes categories ‘intravenous drug users’, ‘homo-bisexual/intravenous drug users’ and ‘babies
born to intravenous drug users’.
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Table 3.4a.   Ireland 1997-1999.  First Admissions to Inpatient Psychiatric Hospitals.
Drug dependence diagnosis. Rates per 100,000 population aged 16 years and over.
Health Board Area 1997 1998 1999
Eastern 10.9 13.4 13.4
Midland 10.1 8.0 17.4
Mid-Western 10.6 10.2 13.2
North-Eastern 6.3 6.8 8.6
North-Western 6.5 6.5 2.6
South-Eastern 7.1 8.0 8.7
Southern 6.6 6.1 6.1
Western 5.4 6.5 7.7
Total 8.7 9.6 10.6
Source: National Psychiatric Inpatient Reporting System, Mental Health Division, The Health Research Board.
The NPIRS data from 1997 to 1999 did not show any noteworthy psychiatric
co-morbidity (NPIRS, personal communication).  Close family ties and good
family supports could be a factor in preventing people with psychiatric
disorders from becoming involved in problematic drug use.
In an attempt to draw attention to concerns of the Irish Council of Attention
Deficit Disorder Support Groups (INCADDS) a submission was made on their
behalf to the National Drugs Strategy Review which took place during 2000.
The submission was made as a result of concern that attention deficit
hyperactivity disorder (ADHD) may be a significant risk factor for involvement
in substance misuse; and that people with ADHD are more likely to self
medicate.  The aim was to highlight the need to identify drug users who suffer
from ADHD and ensure the provision of appropriate treatment programmes for
their care and management.
c) Other important health consequences
The Medical Bureau of Road Safety, Department of Forensic Medicine,
National University of Ireland, Dublin, in collaboration with the Garda
Siochana (police) has undertaken a study to determine current trends in
driving under the influence of drugs in Ireland.  A survey being carried out in
the year 2000 will investigate the presence of amphetamines,
benzodiazepines, cannabis, cocaine, opiates and methadone in blood and
urine samples taken by the Gardai under the Road Traffic Act, 1994.  One
thousand samples will be randomly selected and another 1,000 from those
who are under the legal alcohol limit for driving.  Preliminary results (see
Table 3.4b) from 338 samples (under the legal alcohol limit) showed that
cannabis was most frequently found (34%), followed by benzodiazepines
(25%).  Cocaine was the drug least commonly found at 4% of the sample
(Moane et al. 2000).  These results indicate that there has been a significant
increase in driving under the influence of drugs since 1987, when a similar
study was carried out and 14.6% of samples (under the legal alcohol limit)
tested were found positive for drugs.  The current preliminary study found that
the percentage had risen to 37%.  The results of this survey will identify the
types of drugs being taken and their combination with other drugs, including
alcohol.
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Table 3.4b.   Drugs Driving in Ireland 2000.  Preliminary Study of Prevalence of Driving under
the Influence of Drugs - for sample under legal alcohol limit. Type of Drug.  Percentages
Type of Drug Percentages
Cannabis 34
Benzodiazepines 25
Amphetamines 16
Opiates 14
Methadone 7
Cocaine 4
Source: Moane et al. 2000
4. Social and Legal Correlates and Consequences
4.1 Social problems – Paula Mayock
a) Social exclusion
For several years, professionals working in disadvantaged communities and in
the field of drug treatment have been aware that the development of long-term
and damaging drug careers is most often associated with social
marginalization and exclusion (McCarthy and McCarthy 1995; Loughran
1996).  Research in Ireland has, over the past two decades, consistently
demonstrated a link between concentrations of drug use and various
indicators of poverty and social exclusion, such as unemployment, poor
housing, one-parent families and low educational attainment (Dean et al.
1983; O’Kelly et al. 1988; McKeown et al. 1993; O’Higgins and O’Brien 1995;
Coveney et al. 1999).  In 1996, Irish Government drug policy recognised the
link between poverty and concentrations of serious drug problems in the First
Ministerial Task Force on Measures to Reduce the Demand for Drugs.  As
Butler (1991) has commented, the role of setting, that is the impact of
environmental or contextual factors in the development of drug-related
problems, was acknowledged for the first time.  The Irish National Drugs
Strategy, which aims to provide an integrated response to the problems posed
by drug misuse, can be characterised as supporting general initiatives to
tackle social exclusion and specific initiatives targeted at drug related
problems.
The mid-1990s in Ireland witnessed increased attention to the plight of
families, parents and children living in neighbourhoods with high
concentrations of drug use and related illegal activity.  In 1996, community
members engaged in direct action by marching on the homes of suspected
drug dealers with the intention of intimidating them.  Media attention to the
activities of resident anti-drug and vigilante groups increased substantially
during this time, raising public awareness of drug-related activities as well as
the link between drug use and crime. The murder of journalist Veronica
Guerin in 1996, resulting in public outrage and heightened intolerance of drug-
related activities, forced the drugs issue to the top of the political agenda
(Memery and Kerrins 2000).  In December 1996, the Government introduced
the Housing (Miscellaneous Provision) Bill which was enacted in July, 1997.
According to Section (1), (a) and (b) of the 1997 Act, anti-social behaviour
includes either or both of the following :
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(a) the manufacture, production, preparation, importation, exportation, sale supply,
possession for the purposes of sale or supply, or distribution of a controlled drug
(within the meaning of the Misuse of Drugs Act, 1997 and 1984),
(b) any behaviour which causes or is likely to cause and significant or persistent
danger, injury, damage, loss or fear to any person living, working or otherwise lawfully
in or in the vicinity of a house provided by a housing authority under the Housing
Acts, 1966 to 1997, or a housing estate in which the house is situated and, without
prejudice to the foregoing, includes violence, threats, intimidation, coercion,
harassment or serious obstruction of any person.
This legislation, which gave powers to local authorities to evict tenants on
grounds of anti-social behaviour, was and remains strongly criticised by
several sectors involved in the care and rehabilitation of drug users, and is
equally strongly supported by certain community activists.  According to the
Merchants Quay Project, a voluntary service which provides a range of
services to drug users seeking help, the Housing Act 1997 has contributed to
an increase in homeless drug users in Dublin (Memery and Kerrins 2000).
The Merchants Quay Project has noted an increase of young drug users
sleeping rough in its recently published annual report.  They claim that “both
homelessness and lack of experience of drug use make these drug users a
particularly vulnerable group in terms of risk of infection and general health
and well being” (Merchants Quay Project, 2000: 1).
Research evidence across a range of studies suggests that the Housing Act
1997 has impacted negatively on drug users. The Costello and Howley (2000)
qualitative study of fifteen homeless drug users found that several of their
respondents perceived the 1997 Act as leading to their further exclusion in
gaining access to independent housing.  The respondents’ perception that
they are discriminated against by local authority and resident committees
because of their drug use was reported as creating a considerable barrier to
their seeking accommodation.  Similarly, Woods (2000), reporting on a study
of female drug users’ experience of parenting, found that respondents
described the Housing Act 1997 as “anti-woman” and “anti-family”.
Respondents recounted several cases where drug users have been delivered
the ultimatum to either access treatment or leave their communities.
The Cox and Lawless (1999) study of homeless drug users in Dublin city
highlights the extreme vulnerability of this group, among whom they found low
levels of educational attainment, high unemployment and histories of serving
prison sentences.  Fifty-six percent of the study’s respondents reported that
their drug use had escalated as a result of being out of home.  This group of
homeless drug users was found to engage in very high levels of risk
behaviour, with 66% of clients injecting in public places, 49% reporting sharing
injecting equipment and a further 24% stating that they recently borrowed
used injecting equipment.  This highly marginalised group meet further
exclusion at some of the homeless services due to a policy of non-acceptance
of active drug use in most direct access accommodation, such as hostels or
shelters.  Costello and Howley (2000) note the numerous negative
consequences of excluding drug users from accommodation services for
homeless people, including increased likelihood of sharing needles, lack of
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safe places to store and dispose of needles, lack of access to clean injecting
equipment, and the lack of a clean safe environment in which to inject.
The impact of the Housing (Miscellaneous Provision) Act 1997 has been
recently assessed by Memery and Kerrins (2000).  This report documents an
increase in evictions related to anti-social behaviour by Dublin Corporation
since the introduction of the Housing Act, 1997.  These authors conclude :
Instead of working to resolve the wider and complex drug issues for these
communities and address the needs of drug users directly, a very blunt piece of
legislation was put in place with the emphasis on excluding those involved with
drugs from local authority housing. (ibid.: 29).
b) Public nuisance, community problems
The links between local authority rental tenure and various forms of
disadvantage are well-documented in Ireland (Nolan et al. 1998).  Less
attention has been given to the investigation of the impact of social and
environmental conditions on areas characterised by extreme deprivation,
despite the susceptibility of such communities to a range of social problems,
including drug misuse.  However, one recent study of living conditions in
seven local authority estates in urban areas throughout Ireland (Fahey 1999),
highlights a range of social order problems in the study’s estates.  O’Higgins
(1999) notes that the nature of social order problems experienced in the
seven estates varied.  At one end of the scale, social problems consisted of
relatively minor “nuisance behaviour”, while at the other, a number of estates
endured more serious problems, ranging from illegal drug use and dealing to
intimidation and harassment.  This study found that the use of heroin and
other “hard” drugs was confined mainly to Dublin estates, and was particularly
acute in one large local authority flat complex located in Dublin’s south inner
city.  The profound negative effects of concentrations of drug problems
emerged strongly from the reports of children living in the estate, and
interviewed for the purpose of the research.  Children in focus groups
recounted routine encounters with drug users and made casual reference to
the presence of drugs paraphernalia on the stairs, on balconies and in the
stairwells.  Coupled with this, parents expressed extreme anxiety about the
negative consequences of high level of exposure to drugs for their children.
Drug use and activities related to the distribution of illegal drugs were
considered to be among the most enduring problems on the estate, and one
which impacted negatively on the quality of life of a high proportion of
residents.
In another study of a local authority estate, Corcoran (1998) similarly reported
that all aspects of the drug problem, including drug-taking in public areas and
the sale and distribution of drugs, were perceived as the biggest problem.
Both Corcoran (1998) and O’Higgins (1999) note that the activities
surrounding the distribution of drugs draw a steady stream of non-residents
onto estates.  This among other factors, exacerbates the “palpable sense of
tension” (Corcoran, 1998: 21) in the area.  There was a widespread belief
among residents that the drug situation was out of the control of both
residents and the Gardai (McAuliffe and Fahey 1999).  Reporting on research
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carried out in another large inner-city flat complex with a long history of social
problems, Morley (1998) also highlighted the perceived negative impact of
drug problems on the quality of life in the community.  The socio-economic
profile of this estate revealed in the research - high rates of long-term
unemployment, low educational attainment levels and high rates of early
school leaving - is again indicative of a community struggling with the issues
of social exclusion and marginalisation.  This estate also hosted a large
number of problem opiate users.
The management of social order problems on local authority estates has
involved, inter alia, evictions of problem tenants, particularly those individuals
associated with drug dealing and related activities.  Fahey (1999) notes that
while the use of exclusionary strategies has resulted in some improvements in
social order in a number of estates, they can lead to further social problems
which ultimately exacerbate social exclusion.
4.1 Drug offences and drug-related crime – Mary O’Brien
a) ‘Arrests’ for use/possession/traffic and trends
The use per se of drugs, excluding opium, is not a criminal offence in Ireland.
Possession and trafficking/dealing/supplying are illegal activities under the
Misuse of Drugs Acts, 1977 and 1984 (MDA).  In 1999 prosecutions under
Section 3 of the Misuse of Drugs Acts (possession offences) made up 68% of
the total prosecuted; 28% were prosecuted under Section 15 of the Misuse of
Drugs Acts (drug-related trafficking offences) (Table 4.2a below).  A
breakdown by region shows that most offences (38%) were in the Dublin
Metropolitan area (N=2719), followed by 25% in the Southern region
(N=1770).  The proportion of possession offences was almost the same in
these two areas (Dublin 29%, N=1437; Southern 29%, N=1394).  Over half
(56%, N=1097) of trafficking (supply/dealing) offences were in Dublin.
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Table 4.2a.  Ireland 1999.  Drug law offences by type of drug and region.
Numbers and percentages.
Region/Offence Type Possession
(Section3
MDA)
Supply/Dealing
(Section15
MDA)
Obstruction
(Section 21
MDA)
Other
offences
Total
Eastern 616 258 0 0 874
Dublin metropolis 1437 1097 127 58 2719
Northern 215 56 0 4 275
South Eastern 534 103 11 4 652
Southern 1394 341 14 21 1770
Western 687 116 12 32 847
Total 4883
68%
1971
28%
164
2%
119
2%
7137
100%
Source: Annual Report of An Garda Siochána 1999
With regard to the type of drug involved more than half (59%) were cannabis
offences and of these slightly more were in the southern region than in Dublin
(Table 4.2b).  Ecstasy accounted for 14% of drug law offences and the
majority of these were in the southern region.  The vast majority of heroin
offences (852 out of a total of 887, 96%) were detected in the Dublin region.
Table 4.2b.  Ireland 1999.  Drug law offences by type of offence and region.  Numbers
and percentages.
Region/Drug
Type
Cannabis Heroin LSD Ecstasy Amphetamine Cocaine Other Total
Eastern 543 19 3 200 83 9 17 874
Dublin
metropolis
1208 852 2 211 70 126 250 2719
Northern 187 0 1 60 16 4 7 275
South
Eastern
437 1 11 81 92 6 24 652
Southern 1227 12 5 368 108 10 40 1770
Western 583 3 4 103 95 14 45 847
Total 4185
59%
887
12%
26
0%
1023
14%
464
7%
169
2%
383
5%
7137
100%
Source: Annual Report of An Garda Siochána 1999
Trends over the five-year period between 1995 and 1999 show an increase in
the number of drug charges, from 4146 in 1995 to 7137 in 1999 (Table 4.2c).
There was a particularly sharp rise in cannabis offences in 1999.  In 1998
cannabis offences (N=2190) made up 39% of total drug law offences, this
increased to (N=4185) 59% in 1999.  Heroin offences have been steadily
increasing over the five-year period.  Amphetamine offences increased more
than three-fold from 138 in 1995 to 464 in 1999.  The most dramatic jump in
1999 was in relation to ecstasy offences which had been relatively stable in
the preceding four years.  This may have been as a result of a combination of
an increased number of large-scale dance music events, and more intensive
police activity at such events and in general.
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Table 4.2c.  Ireland 1995-1999.  Drug law offences by type of drug.  Numbers.
Type of Drug 1995 1996 1997 1998 1999
Cannabis 2600 1834 2671 2190 4185
Heroin 296 432 564 789 887
Other opiates 0 0 6 0 0
Cocaine 30 42 97 88 169
Amphetamine 138 152 239 273 464
LSD 70 24 39 13 26
Ecstasy 645 340 475 439 1023
Other offences 385 454 65 1839 383
Total 4146 3278 4156 5631 7137
Source: Annual Reports of An Garda Siochána 1990-1999
b) Convictions and court sentences for drug offences
Currently in Ireland no data are available on convictions or court sentences for
drug offences.
c) Drug-related crime
A study to examine the association between drug use and crime in Dublin
Metropolitan Area was carried out by the Garda Research Unit (Keogh 1997).
The ‘population’ (N=4,105) was drawn from police records and from (police)
local knowledge.  It included all those who had come in contact with the
Gardai through being arrested, charged or suspected of criminal activity
between August 1995 and September 1996.  The inclusion criterion was
‘individuals involved in hard drug use’; opiates, stimulants, hypnotics and
hallucinogens were included in the definition of ‘hard drugs’.  During the study
period 19,046 serious crimes were detected and 7,757 individuals were
apprehended for these crimes: of these 3,365 (43%) were identified as known
hard drug users.  It was deduced that the drug users were responsible for
12,583 (66%) of the crimes.
A sample of (n=351) of these agreed to be interviewed to provide more
detailed information. Over a third (37%) had left school before the official
school leaving age of 15; and 84% were unemployed.  While three-quarters of
the respondents had at some time sought treatment for problem drug use and
most had received it, a number (n=81) had never sought treatment of any
kind.  A majority said they had a poor understanding of the effects of drug use.
It was found that 51% had been involved in crime before their involvement
with drugs; 48% said family members were involved in crime.
The authors of the National Crime Forum Report (1998: 74) stated that they
were ‘deeply concerned with the impact of drug abuse on crime and the
response of the criminal justice system to that issue’. The authors were
impressed by suggestions to keep otherwise law-abiding young people out of
the criminal justice system – that young experimental users of cannabis and
ecstasy should be diverted to the Juvenile Diversion Programme.  (The aim of
this programme, which was established by the Garda Siochana, is crime
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prevention and to provide an alternative for juvenile offenders.  Rather than
being dealt with under criminal law, they enter the programme and thus are
diverted from the formal criminal justice system). The case for the
decriminalisation of certain drugs was presented to the Forum which agreed
that the issue was important and required more careful study.  Those against
decriminalisation argued that public opinion was opposed to such a change.
A general population survey (Bryan et al. 2000) to examine drug-related
knowledge, attitudes and beliefs, could be interpreted to support this view –
66 percent agreed that cannabis should be against the law.  Results from the
same study found that drug-related crime is considered to be a major problem
in Ireland by 94 percent (n=998) of those interviewed, and three-quarters of
the sample felt that the drug problem was out of control.
In 1998 a study was conducted by the Garda Research Unit to explore the
links between alcohol/drug use and crime (Millar et al. 1998).  Gardai at 27
stations throughout the country (12 in Dublin, 15 in the other 5 Garda
divisional regions) were asked for their ‘informed opinion’ (ibid.:2) as to
whether alcohol or drugs were involved in offences where a person was
‘arrested, charged, summonsed, or diverted under the Juvenile Diversion
Programme’ (ibid.:1).  Offences under the Misuse of Drugs Acts and the
Liquor Licensing Acts were excluded.   A total of 4,334 offences (no indication
is given as to whether these refer to individuals or incidents) were noted
during the study period (March-May 1998).  Forty-two percent of cases were
considered to be related to alcohol consumption, 17 percent to drugs and 4
percent to alcohol and drugs (drugs were implicated in 913 cases).  Alcohol
was most likely to be associated with public order offences, while drugs were
most often linked to robberies.  In Dublin heroin was the drug most likely to be
involved (83 percent of cases), while outside of Dublin cannabis (37 percent)
and ecstasy (26 percent) were the drugs most commonly cited (see Table
4.2d).
Table 4.2d.  Ireland 1998.  Juvenile Diversion Programme. Drug-related crime by drug.
Percentages.
Main drug
involved
Dublin Other areas
Opiates 83.1 20.1
Cannabis 13.5 37.4
Ecstasy 0.9 25.9
Amphetamines 0.9 1.1
Barbiturates 0.6 0.6
Cocaine 0.2 1.1
Hallucinogens 0.2 0.0
Other 0.6 13.8
Valid n 534 174
Missing n 136 69
Total n 670 243
Source: Garda Research Report No. 7/98
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4.2 Social and economic costs of drug consumption - Paula Mayock
a) Studies and estimates of healthcare costs, other social costs
Studies to estimate the healthcare or other social costs of drug consumption
have not been carried out in Ireland.  Nor are estimates available on the
economic costs to society from drug use.  Accepting that the “social costs”
incurred by drug use can be defined and interpreted variously, and that no
research has been undertaken in Ireland with the specific aim of estimating
such costs, a number of research findings can be drawn upon to illustrate
evidence of significant costs to individuals, families and communities as a
result of drug use.
As might be expected, this evidence arises primarily from research on a range
of social problems associated mainly with disadvantaged communities.
Numerous researchers have documented the perceived negative impact of
high levels of drugs misuse on communities where drug use is concentrated
(O’Higgins 1999; Corcoran 1998; Morley 1998).  Residents of estates where
drug use is concentrated consistently draw attention to the destructive effect
of drug use and drug trafficking on community life.  Furthermore, they are
acutely aware of the negative way in which their community is perceived by
outsiders.  Mayock (2000), in a qualitative study of drug use by young people
in a Dublin inner-city community noted that respondents made constant
reference to the area’s drug problem.  Furthermore, these young people
expressed resentment of outside representations of their neighbourhood.
They were particularly critical of the negative effects of disparaging media
reports of drug problems in their community, which they felt exaggerated the
issue.  Many clearly felt stigmatised by virtue of living in a locality where drug
use and associated activities are concentrated.
There is relatively little research available pertaining to the consequences of
drug problems for individual families.  For example, there is no available
estimate of the number of individuals affected by familial drug use.  However,
the issue of how children are affected by drug misuse has emerged as an
issue of critical concern.  Hogan (1997), in an exploratory study of the social
and psychological needs of children of drug using parents, found that the
majority of children whose parent(s) were heroin users were experiencing
difficulties at school.  Key workers interviewed for the purpose of the research
expressed concern about the quality and consistency of care-giving by drug
using parents.
b) Estimates of total consumption/demand/expenditure on drugs
In Ireland, there are no estimates of consumption nor demand nor expenditure
on drugs available.
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5. Drug Markets   - Mary O’Brien
5.1 Availability and supply
a) Availability of different drugs, trends and possible reasons
The ESPAD 1995 nationwide school survey of 15-16 year-old post-primary
school pupils (Hibell et al. 1997) found that ecstasy was perceived as very
easy to obtain in Ireland – 54% said that they could get it ‘very easy’ or ‘fairly
easy’.  Amphetamines were also reported to be easy to obtain – by one-third
of the respondents.
Seizures may, with caution. be taken as an indirect indication of the
availability of illicit drugs.  However, since the number of seizures and the
amounts of illicit drugs seized can be affected by factors such as the
resources committed to detection, changes in the quality of intelligence on
illicit drugs trafficking etc., they can not be used as a reliable indicator of
trends in relation to the amount of drugs available on the market.  The fact
also, that not all drugs seized in Ireland are destined for the Irish market, but
are in transit elsewhere, complicates the issue even further (Garda Siochána,
personal communication).
In Ireland there was a sizeable increase in the quantity of drugs seized in
1995 over previous years.  This can be partly attributed to the setting up of the
Garda National Drugs Unit and the Customs National Drugs Team in 1995.  In
that year there were two major seizures of cannabis, and one seizure of
ecstasy contained 40,000 tablets.  Measuring the availability of drugs is a very
difficult task given the illicit nature of the activity.  Special studies would need
to be undertaken in order to explore the issues involved.
b) Sources of supply and trafficking patterns within Ireland
The sources of supply vary according to the type of drug.  Cannabis comes
mainly from Morocco, while some smaller seizures are known to have
originated in Pakistan, Afghanistan and Lebanon (Garda Siochána, personal
communication).  Recently, some cannabis seizures were known to have
originated in South Africa.  Heroin seized in Ireland is thought to come from
Asia, mainly Afghanistan, Pakistan, India and Laos.  Cocaine traffic is
believed to originate in South America.  The main place of origin for ecstasy
seized in Ireland is the Netherlands and to a lesser extent Belgium (Garda
Siochána, personal communication).  .
Police report that most of the trafficking in cannabis to Ireland takes place
between Morocco and the south coast of Ireland.  It is transported in
articulated trucks using cross-channel ferries, and on sea-going yachts.  The
south-west of Ireland is a major trans-shipment point.  The bulk of heroin
seizures are transported to Ireland through the UK and some through the
Netherlands.  Individual drug couriers travelling by air, bring smaller amounts
from Europe.
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The police believe that most of the drugs seized in Ireland in recent years are
for the home market.  In the case of very large shipments it is speculated that
Ireland with its long coastline isolated in many areas, is used as an access
point for transit to the UK and Europe.  The police also believe that the
distribution of drugs within the country is organised by networks of criminal
gangs.  In some cases these gangs involve members of the same family.
Sale patterns at street level in Dublin differ from area to area, with price and
purity of drugs varying according to supply and demand factors.  No research
studies have been conducted in this area as yet in Ireland.
5.2 Seizures
Trends in quantities and numbers of seizures
In Ireland it is not possible as yet to distinguish between police and customs
seizures in relation to the quantities and numbers of drugs seized.  All
seizures, by both police and customs, are included in published Annual
Reports of An Garda Siochána (police).  Police and customs authorities
increasingly work on a collaborative basis and following approaches (by HRB)
to both organisations there is a willingness to provide separate information on
seizures in the future.
Between 1995 and 1999 the number of seizures of all drugs, except for LSD,
increased (Table 5.2 below).
Table 5.2.   Ireland 1995-1999. Quantity (kgs) and number of seizures of illicit drugs.
1995 1996 1997 1998 1999
Type of Drug N* Q** N* Q** N* Q** N* Q** N* Q**
Cannabis 3205 15606.5 3449 1935.4 4102 1282.7 4513 2201.7 4538 2577.3
Heroin 209 6.4 664 10.8 599 8.2 884 38.3 767 17
Cocaine 42 21.8 93 642 157 11 151 333.2 213 85.6
Amphetamines 89 1.5 217 7.6 475 102.9 680 45 467 13.4
Ecstasy*** 571 123699 534 23012 423 20434 509 609301 1074 229101
LSD 62 819 42 5901 48 1851 19 5901 29 577
Benzodiazepines na 152 7146 219 4942 181 2885 175 15393
Other drugs 0 93 159 93 55
Total number
seizures
4178 5244 6182 7030 7318
* N=Number of seizures
** Q=Quantity seized in kilograms; number of tablets in the case of ecstasy and benzodiazepines, and number of
doses in the case of LSD.
*** Ecstasy includes MDMA, MDEA, MDA, ephedrine
Source: Annual Reports of Garda Siochána
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The number of seizures of all drugs has increased from 4178 in 1995 to 7318
in 1999. There are more seizures of cannabis than any other drug: the
number increased from 3205 in 1995 to 4538 in 1999.  In fact, over the ten-
year period 1990 to 1999, cannabis accounts for most of the drugs seized
(see Figure 5.2a, Appendix 2).  During the same period the number of heroin
seizures more than tripled (from 209 to 767).  Cocaine increased five-fold
(from 42 to 213), as did amphetamine (from 89 to 467).  The number of
ecstasy seizures increased quite considerably from 509 in 1995 to 1074 in
1999.  It should be noted that ‘ecstasy’ can include various substances such
as MDMA, MDEA, MDA, ephedrine or ketamine.
The quantity of different types of drugs seized fluctuated from year to year.
Apart from the very large seizure in 1995 the quantities of cannabis have been
increasing each year.  There was a very large seizure of illicit
benzodiazepines (15,393 tablets/capsules) in 1999.  The majority of these
(13,389) were diazepam and one seizure alone that year constituted 7,800
diazepam.  All benzodiazepines are controlled under Section 15 of the Misuse
of Drugs Acts - it is illegal to supply or deal them other than by prescription.
However, in the case of flunitrazipam (Rohypnol) and temazepam they are
controlled under both Section 15 and Section 3 of the Misuse of Drugs Acts -
it is illegal to supply or possess them other than by prescription.  Seized
quantities of other drugs have tended to fluctuate in the same period – but in
general quantities are increasing (Figure 5.2b, Appendix 2).
5.3 Price, purity
It is not possible from the information available to distinguish between the
price of drugs at street level and trafficking level.  The Gardai collect
information on the street prices of drugs (EMCDDA Standard Table 16,
Appendix 2).  The data available up to now do not show any change in price
over the past five years.  However, this does not match with anecdotal
evidence, which suggests that the prices fluctuate according to the market
forces of supply and demand.  For example, the price of heroin increases
when supply is limited.  No information is currently available on prices at
trafficking level.
Drug seizures by the police are analysed at the Forensic Science Laboratory
of the Department of Justice, Equality and Law Reform, to ascertain purity
levels of heroin, cocaine and amphetamine.  Cannabis purity is not analysed.
Between 1995 and 1999 the purity levels of heroin decreased and in 1999 a
minimum purity level of 0.25% was recorded.  Purity levels of amphetamine
seizures have also decreased somewhat.  Cocaine purity levels have
fluctuated in the five-year period but the trend is downward (Table 5.3).
Table 5.3.  Ireland 1995-1999.  Purity of seized drugs.  Average percentages
Type of Drug 1995 1996 1997 1998 1999
Heroin 45 49 46 35 33
Cocaine 47 62 54 38 41
Amphetamine 4.7 9.8 3.5 6 3
Source:  Forensic Science Laboratory, Department of Justice, Equality and law Reform
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6. Trends per Drug  - Mary O’Brien
Cannabis
§ Cannabis remains the most widely available and the most commonly used
drug in Ireland.  Use is more experimental than habitual (see Section 2.2).
§ Around 20% of those aged between 18-64 years have tried cannabis at
least once (see Section 2.2).
§ Nine percent of those aged 18-64 have used cannabis in the past 12
months; 5% in the past month (see Section 2.2).
§ Cannabis use is most prevalent among young people between 18-24
years; around a third have tried it at least once.  A quarter of this age
group used it in the past 12 months; and 15% in the past month (see
Section 2.2).
§ The relatively high prevalence rate among 15-16 year olds found in the
ESPAD 1995 study has not been sustained in subsequent research (see
Section 2.2).
§ The proportion of all contacts presenting for treatment for problem
cannabis use has increased slightly from 15% in 1995 (the first year for
which national data are available) to 17% in 1999.
§ Of all the illicit drugs, cannabis features most frequently in prosecution and
seizure data.  Cannabis offences account for 59% of drug law offences.
The number of prosecutions increased from 2600 in 1995 to 4185 in 1999.
The number of cannabis seizures over the past five years has increased
from 3205 in 1995 to 4538 in 1999.  However, quantities of cannabis
seized tend to fluctuate (Figures 5.2a and 5.2b at Appendix 2).
§ Preliminary results from the study to determine current trends in driving
under the influence of drugs found that cannabis was the drug most
frequently found (34%) (Moane et al. 2000).
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Synthetic drugs
§ After cannabis, although much less prevalent, amphetamines and ecstasy
are the second most commonly used drugs in the general population.
§ Amphetamine use is more common than ecstasy in general population
studies.  Around 3% of those aged between 18-64 had used
amphetamines in the past year (see Section 2.2).  However, the picture
among school pupils is quite different.  Recent use of amphetamine,
ecstasy or LSD is preceded by solvent misuse (see Table 2.2e at Section
2.2).
§ Among school pupils of all ages, recent prevalence rates of amphetamine,
ecstasy and LSD use are quite similar.
§ The proportion presenting for treatment (for the first time) for ecstasy use
has decreased, from 11% in 1995 to 9% in 1999 (EMCDDA Table 4 at
Appendix 2).
§ Treatment for amphetamine use is quite low but has increased a little; from
0.4% in 1995 to 2% in 1999.
§ After cannabis, ecstasy is the drug which features next in prosecutions and
seizures data.  Up to 1998, the trend in ecstasy offences was fairly stable
but in 1999 the number of offences increased considerably (Table 4.2c at
Section 4.2).
§ Preliminary results from the study to determine current trends in driving
under the influence of drugs found that amphetamine was found in 16% of
cases (Moane et al. 2000).
Heroin/opiates
§ Heroin dependence is still mainly concentrated in and around the Dublin
area, although this seems to be changing with diffusion to urban areas
throughout the country.  The ‘visible’ users have serious health and social
problems.  Unlike treated heroin users in other EU countries, they are not
an ageing population: around 80% of all contacts presenting for treatment
are between 15 and 29 years of age; up to 90% of those presenting for
treatment for the first time are aged between 15 and 29.  Nor are there, as
yet, indications of serious psychiatric problems among treated drug users.
§ Heroin is the least used drug in Ireland but it is the most problematic with
serious health and social consequences.
§ The trend some years ago (among treated heroin users) towards smoking
rather than injecting heroin now seems to be changing. Smoking was the
preferred route for people starting to use heroin, at least initially.  However,
latest trends show that heroin is more likely to be injected.  It seems that
people who originally preferred to smoke heroin are now no longer
reluctant to inject (O’Brien et al. 2000).
§ Heroin offences constitute 12% of total drug law offences.  The number of
heroin seizures is increasing, the quantities seized fluctuates.
§ Preliminary results from the study to determine current trends in driving
under the influence of drugs found opiates in 14% and methadone in 7% of
cases (Moane et al. 2000).
Cocaine/crack
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§ Cocaine is used by about 2% of the general population in Ireland.
§ Treatment demand for problem cocaine use has always been very low:
between 1%-2%.  Apart from addiction counselling, there are no specific
treatments for problem cocaine users in Ireland right now.  Of all those
presenting for treatment for the first time in 1999 with multiple drug
problems (64%), 7% were seeking treatment for problem cocaine use.
§ The number of cocaine seizures is increasing.
§ A small-scale (N=10) qualitative study of recreational cocaine users found
that cocaine is more easily available in Ireland than previously, and that
more people are perceived to be using it.  It is used in private social
settings, such as home-based parties, rather than in public settings
(Mayock, forthcoming).
§ Preliminary results from a study to determine current trends in driving
under the influence of drugs found that cocaine was present in 4% of
cases (Moane et al. 2000).
Multiple use
§ In 1999, 64% of clients presenting for treatment for the first time were
using two or more drugs.  Cannabis was the most frequently cited (26%)
secondary drug of misuse followed by ecstasy (21%); benzodiazepines
(10%); amphetamines (9%); cocaine (7%); and methadone (7%) (National
Drug Treatment Reporting System).
§ A review of drug treatment services in the ERHA areas (Farrell 2000)
found high rates of benzodiazepine use among those attending treatment
suggesting a major problem of polydrug use.
§ A study on drug-related death in 1999 found that benzodiazepine was the
drug most commonly identified (in 75 cases), and was mainly in
combination with other drugs.  The most common combination of drugs
was opiates and benzodiazepines (Keating et al. 1999).
§ Benzodiazepines are now widely prescribed and need to be regulated
(Quigley, presentation to European Society for Social Drug Research
(ESSD) 11th Annual Conference, Trinity College Dublin, September 2000).
A Committee has recently been established by the Minister for Health and
Children to examine the nature and extent of benzodiazepine prescribing
in Ireland.  This Committee will examine current trends and make
recommendations on good prescribing practices, paying particular
attention to the management of drug users.
§ Preliminary results from a study to determine current trends in driving
under the influence of drugs found quite a high prevalence of
benzodiazepines - 25% of cases (Moane et al. 2000).
7. Conclusions
7.1 Consistency between indicators
A graphic analysis of the consistency between different indicators is presented
in Figures 7.1a and 7.1b (at Appendix 2) using data of four indicators of drug
misuse - treatment; drug-related death; prosecutions for drug offences;
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seizures of illicit drugs, from 1990 to 1999.  The data used in the graph are the
relative levels of each indicator compared with 1990 (index year 1990=100).
All these indicators show an upward trend.  Broadly speaking they present a
picture of increasing activity in the demand for and the supply of illicit drugs.
Other indicators such as general population surveys do not present as clear a
picture.  Methodologies for estimating local and national prevalence rates are
at the development stage and cannot be examined for trends.  The collection
of comparable information on drug-related infectious diseases is also at the
initial stages.
With regard to possible relationships between indicators, for example
treatment and prosecutions, apart from some isolated periods (between 1995
and 1997 when treatment increased and prosecutions decreased), the Irish
data provide no conclusive evidence that there is an inverse correlation
between them.  All the indicators presented show a fairly consistent increase
over several years.
7.2 Implications for policy and interventions
a) Possible hypotheses and reasons for main trends and new developments
in drug use
With regard to law enforcement statistics, increased resources, for example
the establishment of the Garda National Drug Unit in 1995, is likely to have
improved detection rates nationwide (see Sections 4.2 and 5.2).  The most
obvious increase – in drug-related deaths – appears to be substantially
attributable to more accurate recording procedures, though undoubtedly there
has also been a real increase in drug-related deaths.  Equally, the increase in
treatment demand could be partially attributed to an improvement in the
provision of drug treatment services.  The system now includes drug users
who would previously not have had access to treatment. As with drug-related
deaths, allowing for improvements in data collection procedures or institutional
changes, it is strongly indicated that there has been a rise in drug use in
Ireland.
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b) Relevance to policy issues or interventions for policy makers and
professionals
With regard to policy issues more in-depth qualitative research studies are
needed in order to understand more about injecting drug users, and thus help
towards making prevention strategies more effective.
Data from different indicators over several years show high levels of social
deprivation among problem drug users.  Economically, Ireland is relatively
better off than in previous times but not all its people have access to the
means of benefiting from the economic boom.  While the Irish economy
continues to grow certain sectors of society are excluded from participating in
the benefits of the so-called ‘Celtic tiger’.  Lack of material and cultural capital
such as having a job, having a decent place to live, access to education,
having good skills, even having expectations, prevents people from availing of
the current opportunities.  This is not just confined to so-called marginalised
urban areas.  Key policy areas which require attention in this context are;
economic and fiscal policy, housing policy, education policy, employment
policy, and the operation of the criminal justice system.  New policies and
strategies in the context of the National Development Plan and Local Drugs
Task Forces (see Parts 1 & 3 of this report) aim at addressing the drug
problem in the broader socio-economic context and will help towards the
alleviation of such adverse social conditions.
7.3 Methodological limitations and data quality
Methodological limitations, evaluation of data quality, new information needs
and priorities for future work
Ø General population surveys to study the extent of drug use in Ireland vary
in objectives, methodologies, focus of data collection, questionnaire
design, age groups studied etc..  Comparisons are therefore tentative and
must be viewed with these variations borne in mind.  If meaningful
interpretations and comparisons are to be made a priority for future work
should be that prevalence surveys are carried out using comparable
methodologies.  Information on recent and annual use should be available
as well as lifetime experience of drug use.  Surveys should be comparable
nationally as well in the wider European sense where possible.  It is also
important that these surveys be replicated at frequent interval if trends
over time are to be available.
Ø More work needs to be carried out on the evaluation of data quality.
Ø More in-depth qualitative research studies are needed to understand more
about injecting drug users, and thus help towards making prevention
strategies more effective.
Ø Interest in the availability of drugs has been growing.  However, measuring
this is a very difficult task given the illicit nature of the activity.  Special
studies would need to be undertaken in order to explore the issues
involved.
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Ø In Ireland, there are no estimates of consumption or demand or
expenditure on drugs available.  Nor are there any estimates of healthcare
or other social costs available.  This is an area that will need examination.
78
References
Allwright, S., Barry, J., Bradley, F., Long, J., Thornton, L. (1999). Hepatitis B,
hepatitis C and HIV in Irish prisoners: Prevalence and risk. Government
Publications, Dublin.
Andraghetti, R., Goldberg, D., Smith, A., O’Flanagan, D., Lieftucht, A., and
Gill, N. (2000).  Update: Illness among Injecting Drug Users in Scotland,
Ireland and England.  EPI-INSIGHT, 1, 4, September 2000.
Butler, S. (1991) Drug Problems and Drug Policies in Ireland : A Quarter of a
Century Reviewed.  Administration, 39, 210-233.
Cassin, S., Geoghegan, T. and Cox, G. (1998). Young Injectors: A
Comparative Analysis of Risk Behaviour. Irish Journal of Medical Science 167
(4) 234-237.
Corcoran, M. (1998) Making Fatima a Better Place to Live .  Report prepared
for Fatima Groups United.
Costello, L. & Howley, D. (2000) Working Towards Inclusion : A feasibility
study on the provision of accommodation for people sleeping rough and using
drugs in Dublin city.  Dublin Simon Community and Merchant’s Quay Project.
Unpublished Report.
Coveney, E., Murphy-Lawless,J., Redmond.D., and S.Sheridan (1999).
Prevalence, Profiles and Policy. A case study of drug use in north inner city
Dublin. Dublin: North Inner City Drugs Task Force.
Dean, G., Bradshaw, J., & Lavelle, P. (1983) Drug misuse in Ireland, 1982-
1983.  Investigation in a north central Dublin area and in Galway, Sligo and
Cork.  Dublin : The Medico-Social Research Board.
Department of Health (1984). The Psychiatric Services – Planning for the
Future. Dublin: The Stationery Office.
Department of Health (1996). National Task Force on Suicide – Interim
Report.  Dublin: The Stationery Office.
Department of Health & Children (1998).  Report of the National Task Force
on Suicide.  Dublin: The Stationery Office.
Dorman, A., Keenan, E., Schuttler, C., Merry, J., O’Connor, J. (1997). HIV risk
behaviour in Irish intravenous drug users. Irish Journal of Medicine 166 (4)
235-238.
79
Fahey, T. (Ed) (1999) Social Housing in Ireland : A Study of Success, Failure
and Lessons Learned.  The Katherine Howard Foundation and Combat
Poverty Agency.
Geoghegan, T., O’Shea, M. and Cox, G. (1999). Gender differences in
characteristics of drug users presenting to a Dublin syringe exchange.  Irish
Journal Psychological Medicine, 16 (4), 131-135.
Hogan, D. (1997).  The Social and Psychological Needs of Children of Drug
Users : Report on exploratory study.  Dublin : The Children’s Research
Centre.
Hibell, B., Andersson, B., Bjarnason, T., Kokkevi, A., Morgan, M. and Narusk,
A (1997). The 1995 ESPAD Report. Alcohol and Other Drug Use among
Students in 26 European Countries.  Stockholm: The Swedish Council for
Alcohol and other Drugs (CAN) and Council of Europe, Pompidou Group.
Johnson, Z., O’Connor, M., Pomeroy, L., Johnson, H., Barry, J., Scully, M.,
Fitzpatrick, E. (1994). Prevalence of HIV and associated risk behaviour in
attendees at a Dublin needle exchange. Addiction 89 603-607.
Keating, C., Ramsbottom, V. and Harbison, J. (1999). An analysis of drug-
related deaths in Dublin city and county in 1997.  Unpublished.
Kiernan, R. (1995) Report on substance use among adolescents in the
Western Health Board. Galway: Western Health Board.
Long, J., Allwright, S., Barry, J., Reaper-Reynolds, S., Thronton, L., Bradley,
F. (2000). Hepatitis B, hepatitis C and HIV in Irish prisoners, part II:
Prevalence and risk in committal prisoners 1999. Dublin: Government
Publications.
Loughran, H. (1996) Interview with Fergus McCabe.  Irish Social Worker, 14,
3-4.
McAuliffe, R. & Fahey, T. (1999) Responses to Social Order Problems. In T.
Fahey (Ed) Social Housing in Ireland : A Study of Success, Failure and
Lessons Learned.  The Katherine Howard Foundation and Combat Poverty
Agency.
McCarthy, D., & McCarthy, P. (1995) Dealing with the Nightmare : Drug Use
and Intervention Strategies in South Inner-City Dublin.  Community Response
and Combat Poverty Agency.
McKeown, K., Fitzgerald, G., & Deegan, A. (1993) The Merchants’ Quay
Project : A drugs/HIV service in the inner city of Dublin 1989-1992.  Dublin :
Keiran McKeown Limited, Social and Economic Research Consultants.
Mayock, P. (2000) “Choosers or Losers?” A Study of Drug Use, Young People
and the Inner-City.  Trinity College Dublin : The Children’s Research Centre.
80
Memery, C. & Kerrins, L. (2000) Estate Management and Anti-Social
Behaviour in Dublin.  A Study of the Impact of the Housing (Miscellaneous
Provisions) Act 1997.  Dublin: Threshold.
Merchant’s Quay Project (2000) Annual Report 1999.  Dublin: The Merchants’
Quay Project.
Moane, S., Leavy, C.P., Cusack, D.A. (2000).  Drugs Driving in Ireland – A
Preliminary Study of the Prevalence of Driving under the Influence of Drugs
on Irish Roads.  Dublin: Medical Bureau of Road Safety, Department of
Forensic Medicine, University College Dublin.
Moran, R., O’Brien, M., Duff, P. (1997). Treated drug misuse in Ireland.
National Report 1996.  Dublin: The Health Research Board.
Morley, C. (1998) Consultation Process on the Future of St. Michael’s Estate.
Research, Education and Development.
Mullen, L. and Barry, J. (1999). Needle exchange in the Eastern Health Board
Region: An analysis of first attenders 1990-1997.  Dublin: Eastern Health
Board.
National AIDS Strategy Committee (2000). AIDS Strategy 2000. Government
Publications, Dublin.
Nic Gabhainn, S. and Walsh, F. (2000).  Drug prevention: Perspectives on
Family and Community interventions in Dolan, P. Canavan, J. and Pinkerton,
J. (eds) Family Support: Direction from Diversity.  London: Jessica Kingsley.
O’Brien, M., Moran, R., Kelleher, T. and Cahill, P. (2000).  National Drug
treatment Reporting Syste. Statistical Bulletin 1997 and 1998.  Dublin: The
Health research Board.
O’Gorman, A. (1999). No room for complacency: Families, communities and
HIV. Cairde, Dublin.
O’Higgins, K. (1999) Social Order Problems.  In T. Fahey (Ed) Social Housing
in Ireland: A Study of Success, Failure and Lessons Learned.  The Katherine
Howard Foundation and Combat Poverty Agency.
O’Higgins, K., and O’Brien, M. (1995) Treated Drug Misuse in the Greater
Dublin Area: Report for 1994.  Dublin: Health Research Board.
O’Kelly, F., Bury, G. (1996). An analysis of the effects of HIV infection in a
cohort of intravenous drug users. Irish Medical Journal 89 (3) 112-114.
O’Kelly, R., Bury, G., Cullen, B., and Dean, G. (1988) The rise and fall of
heroin use in an inner city area of Dublin.  Irish Medical Journal, 157(2), 35-
38.
81
O’Neill, M. and O’Connor, A.M. (1999). Drug-using women working in
prostitution. Dublin: The Women’s Health Project, Eastern Health Board.
Nolan, B., Whelan, C.T., & Williams, J. (1998) Where are Poor Households?
Dublin: Oak Tree Press in association with Combat Povery Agency.
Rhatigan, A. and Shelley, E. (1999). Health behaviours of school pupils in the
Eastern Health Board. Dublin: Eastern Health Board.
Smyth, B., Keenan, E., O’Connor, J. (1998). Bloodborne viral infection in Irish
injecting drug users. Addiction 93 (11) 1649-1656.
Smyth, B., McMahon, J., O’Connor, J. and Ryan, J. (1999). The use of
primary care services by opiate-dependent injecting drug users in the era of
‘shared care’.  European Journal of General Practice, 5, 143-148.
Smyth, B., Keenan, E., O’Connor, J. (1999a). Evaluation of the impact of
Dublin’s expanded harm reduction programme on prevalence of hepatitis C
among short-term injecting drug users. Journal of Epidemiology and
Community Health 53 (7) 434-435.
Smyth, R., Keenan, E., Dorman, A., O’Connor, J. (1995). Hepatitis C infection
among injecting drug users attending the National Drug Treatment Centre.
Irish Journal of Medical Science 164 (6) 267-268.
Smyth, B., McMahon, J., O’Connor, J., Ryan, J. (1999b). Knowledge
regarding hepatitis C among injecting drug users. Drugs: education,
prevention and policy 6 (2) 257-264.
Smyth, B. O’Brien, M. and Barry, J. (2000).  Trends in treated opiate misuse in
Dublin: the emergence of chasing the dragon.  Addiction, 95,8,1217-1223.
Williams, H., Mullan, E., O’Connor, J., Kinsella, A. (1990). Risk behaviour for
HIV transmission in attenders on methadone maintenance. Irish Journal of
Medical Science 159 (5) 141-144.
Woods, M. (2000) Women, Drug Use and Parenting in Dublin : The Views of
Professional Workers in the Drug Treatment and Social Work Fields.  In A.
Springer & A. Uhl (Eds) Illicit Drugs: Patterns of Use - Patterns of Response.
Proceedings on the 10th Annual ESSD Conference on Drug Use and Drug
Policy in Europe.  Innsbruchm : Studienverlag.  September, 1999.
82
Part 2 – Epidemiological Situation
Appendix 1
Table 2.  Ireland.  Census of Population 1996.
Age group Male Female Total
0-4 years 128740 121654 250394
5-9 years 145335 137608 282943
10-14 years 167377 158710 326087
15-19 years 173950 165586 339536
20-24 years 149143 144211 293354
25-29 years 129363 129682 259045
30-34 years 127735 133194 260929
35-39 years 126140 129536 255676
40-44 years 120064 120377 240441
45-49 years 113816 111584 225400
50-54 years 94818 91829 186647
55-59 years 77809 75998 153807
60-64 years 68690 69256 137946
65-69 years 60256 66553 126809
70-74 years 50124 62418 112542
75-79 years 35228 48869 84097
80-84 years 21074 34697 55771
85 years & over 10570 24093 34663
Total 1800232 1825855 3626087
Source: Central Statistics Office.
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Table 2.2.   Ireland.    Estimated migration classified by country of destination/origin, 1995-2000.
Emigrants ImmigrantsYear
ending
April
UK Rest of
EU
USA Rest of
World
Total UK Rest of
EU
USA Rest of
world
Total
Net
migration
000’s
1995 13.3 5.1 8.2 6.6 33.1 15.6 6.3 3.8 5.5 31.2 -1.9
1996 14.1 5.1 5.2 6.8 31.2 17.6 7.2 6.4 8.0 39.2 8.0
1997* 12.9 4.1 4.1 7.9 29.0 20.0 8.1 6.6 9.3 44.0 15.0
1998* 8.5 4.3 4.3 4.1 21.2 21.1 8.7 4.9 9.3 44.0 22.8
1999* 10.2 4.5 5.4 8.9 29.0 21.6 10.0 5.7 10.2 47.5 18.5
2000* 6.3 4.3 3.2 8.5 22.3 16.4 9.8 4.6 11.5 42.3 20.0
* Preliminary
Source: Central Statistics Office
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Table 3.2.    Ireland 1990-1999.  Drug-Related Deaths** from Drug Dependence and Opiate Poisoning.  Numbers
and percentages.
1990 1991 1992 1993 1994 1995 1996 1997* 1998* 1999*
Ireland
(All ages)
N
%
7
100
8
100
14
100
18
100
19
100
43
100
53
100
55
100
99
100
80
100
Dublin
(All ages)
N
%
6
86
8
100
14
100
16
89
17
89
39
86
43
81
49
89
76
77
66
83
Gender % M
% F
86
14
100
0
79
21
89
11
95
5
86
14
83
17
87
13
76
24
74
24
Under 30 years old N
%
7
100
4
50
8
61
8
44
11
58
22
51
30
57
34
62
53
54
35
44
15-49 years old N
%
7
100
7
88
14
100
16
89
19
100
39
91
50
94
52
96
90
91
70
88
Drug dependence
(ICD-9 Code 304)
(All ages)
N
%
4
57
5
63
13
93
13
72
15
79
38
88
42
79
43
78
90
91
75
94
Source: Central Statistics Office
* provisional data
** For the purpose of this report a drug-related death is defined as one where the underlying or external cause
of death was due to drug dependence (ICD-9 Code 304) or opiate poisoning (ICD-9 Code 965.0).
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Table 3.3.   Ireland 1982-1999.  AIDS cases and deaths by risk category.
Risk
category
1982 – 1992 1993 1994 1995 1996 1997 1998 1999
Cases Deaths Cases Deaths Cases Deaths Cases Deaths Cases Deaths Cases Deaths Cases Deaths Cases Deaths
Intravenous
Drug Use
Related
8
142 61 43 21 22 27 25 27 34 17 10 1 12 8 16 7
Homo/Bisexual 109 45 13 14 27 11 16 11 34 16 12 3 13 9 13 5
Haemophiliacs/
Heterosexuals/
Others 52 27 12 9 18 6 13 8 11 1 8 2 14 4
11 5
Undetermined 5 3 0 0 0 0 1 0 0 0 2 1 2 0 1 0
Total 308 136 68 44 67 44 55 46 79 34 32 7 41 21 41 17
Source: Department of Health / Virus Reference Laboratory
                                                
8 Includes categories ‘intravenous drug users’, ‘homo-bisexual/intravenous drug users’ and ‘babies born to intravenous drug users’.
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Table 3.4   Ireland 1994-1999.  All and First Admissions to Inpatient Psychiatric Hospitals.  All Ages.  Numbers,
percentages and rates.
1995 1996 1997 1998 1999
Admissions All First All First All First All First All First
Drug-related
admissions (N)
580 172 678 263 691 280 846 308 893 354
Admissions for all
disorders (N)
26440 7246 26656 7130 26069 7049 25295 7137 25118 7147
Drug-related (%)
(primary or
secondary
diagnosis)
2.2 2.4 2.5 3.7 2.7 4.0 3.3 4.3 3.6 5.0
Rate per 100,000 16.2 4.7 18.7 7.2 19.1 7.7 23.3 8.5 24.6 9.8
Source: National Psychiatric Inpatient Reporting System (NPIRS), Mental Health Division, Health Research Board
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Figure 5.2a Ireland 1990-1999. Quantity of Drug Seizures(kgs)
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Source: Annual Reports of An Garda Siochana
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Figure 5.2b  Ireland 1990-1999. Quantity of Drug Seizures other than cannabis 
(kgs)
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Figure 7.1a  Ireland 1990-1999.  Indicators of Drug Misuse.  Index year 1990=100.
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Figure 7.1b  Ireland 1990-1999.  Indicators of Drug Misuse.  Index 1990=100.
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EMCDDA Standard Tables
STANDARD TABLE  01a:  BASIC RESULTS AND METHODOLOGY OF POPULATION SURVEYS ON DRUG USE
      NOTES:     Include information on national (or relevant regional) surveys on drug use conducted during the last five years
                          Here only summarised results are requested. In Table (PO-SUR-A) results are requested broken down by five years age groups.
                          Age groups presented are partly due to maintainment of consistency with other EMCDDA indicators and other International Organizations
COUNTRY    Ireland All adults Young adults Broad age groups
DRUGS LIFETIME  PREVALENCE (%)
(important: see "drug definitions" 15-64 15-34 15-24 25-34 35-44 45-54 55-64
in the Methodology box) M F T M F T M F T M F T M F T M F T M F T
1. any illegal drugs 11.0 6.3 8.5 18.3 9.5 13.4 23.2 12.9 17.9 13.6 7.1 9.8 7.2 4.1 5.5 4.7 3.4 4.1 2.8 2.6 2.7
2. cannabis 23.1 16.5 19.9 36.7 24.6 30.0 37.9 29.1 33.4 35.5 21.6 27.4 21.3 14.6 17.6 12.0 5.1 8.8 3.1 1.0 2.1
3. opiates (total)
4. heroin
5. other opiates (specify)
5. cocaine (total, including crack)
8. amphetamines
9. ecstasy
10. hallucinogens (total)
11. LSD 
12. other hallucinogens (specify)
13. hypnotics and sedatives (total)
14. benzodiacepines
15. other medic. (specify)
16. solvents
17. steroids
18. other (specify)
M = Male / F = Female / T= Total
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COUNTRY All adults Young adults Broad age groups
DRUGS LAST 12 MONTHS PREVALENCE (%)
(important: see "drug definitions" 15-64 15-34 15-24 25-34 35-44 45-54
in the Methodology box) M F T M F T M F T M F T M F T M F T M F T
1. any illegal drugs
2. cannabis 11.9 7.3 9.4 22.9 13.4 17.7 30.3 21.9 26.0 15.7 7.5 10.9 4.5 2.2 3.2 1.9 1.4 1.7 0.5 0.5 0.5
3. opiates (total) 0.4 0.1 0.2 0.8 0.2 0.5 0.7 0.4 0.5 0.9 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
4. heroin 0.5 0.2 0.3 1.1 0.3 0.7 0.9 0.6 0.8 1.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
5. other opiates (specify) 0.2 0.0 0.1 0.5 0.2 0.3 0.5 0.2 0.3 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
5. cocaine (total, including crack) 1.9 0.8 1.3 4.1 1.5 2.6 4.9 2.1 3.4 3.3 1.1 2.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0
8. amphetamines 3.7 1.5 2.6 8.2 3.1 5.4 11.7 6.1 8.8 4.9 1.0 2.6 0.5 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0
9. ecstasy 3.0 1.8 2.4 6.5 3.6 4.9 9.6 6.7 8.1 3.7 1.4 2.4 0.3 0.1 0.2 0.5 0.3 0.4 0.0 0.0 0.0
10. hallucinogens (total) 2.1 0.4 1.4 4.6 1.4 2.8 7.6 2.4 4.9 1.9 0.8 1.2 0.2 0.4 0.3 0.3 0.0 0.1 0.0 0.0 0.0
11. LSD 2.0 0.9 1.4 4.3 1.8 2.9 6.3 3.1 5.1 1.5 0.9 1.1 0.2 0.3 0.2 0.3 0.0 0.1 0.0 0.0 0.0
12. other hallucinogens (specify) 2.3 0.6 1.4 5.0 1.1 2.8 8.0 1.6 4.7 2.3 0.7 1.3 0.2 0.4 0.3 0.3 0.0 0.1 0.0 0.0 0.0
13. hypnotics and sedatives (total) 1.3 1.2 1.2 1.8 1.1 1.4 2.7 1.6 2.1 1.0 0.7 0.8 0.5 0.8 0.7 1.2 2.2 1.7 1.1 1.2 1.1
14. benzodiacepines
15. other medic. (specify)
16. solvents 0.5 0.2 0.3 1.2 0.4 0.8 1.8 1.0 1.4 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
17. steroids
18. other (specify)
M = Male / F = Female / T= Total
55-64
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COUNTRY All adults Young adults Broad age groups
DRUGS LAST 30 DAYS  PREVALENCE (%)
(important: see "drug definitions" 15-34 15-24 25-34 35-44 45-54
in the Methodology box) M F T M F T M F T M F T M F T M F T M F
1. any illegal drugs
2. cannabis 7.2 3.2 5.1 14.1 6.0 9.7 20.7 10.0 15.3 7.8 3.1 5.1 2.2 0.7 1.3 1.6 0.7 1.2 0.5 0.5
3. opiates (total)
4. heroin
5. other opiates (specify)
5. cocaine (total, including crack)
8. amphetamines
9. ecstasy
10. hallucinogens (total)
11. LSD 
12. other hallucinogens (specify)
13. hypnotics and sedatives (total)
14. benzodiacepines
15. other medic. (specify)
16. solvents
17. steroids
18. other (specify)
M = Male / F = Female / T= Total
15-64 55-64
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TABLE   TAB 01a:
METHODOLOGY
REFERENCE: SLAN (Survey of Lifestyle, Attitides and Nutrition). Dept. Health Promotion, NUI, Galway. Drug section of survey not published
year
single/repeated study
contex (health/crime/drugs only…)
area covered
age range
data collection procedure
sample size
sampling frame
sampling procedures proportionate random sample based on Health Board population size, and urban/rural breakdown.
oversampled groups
weighting procedures
response rate 15-69  (M,F,T) 15-34 (M,F,T)
Remarks
DRUGS DEFINITIONS Provide a detailed description of what is included in each drug category
1. any illegal drugs tranquilisers or sedatives, amphetamine, LSD, cocaine, heroin, ecstasy, solvents, magic mushrooms
2. cannabis marijuana or cannabis
3. opiates (total)
4. heroin heroin 
5. other opiates (specify)
5. cocaine (total, including crack) cocaine (coke, crack)
8. amphetamines amphetamines
9. ecstasy ecstasy (E, XTC)
10. hallucinogens (total) LSD and magic mushrooms
11. LSD LSD (acid, trips)
12. other hallucinogens (specify) magic mushrooms (pucal, mushies)
13. hypnotics and sedatives (total) tranquilisers or sedatives without prescription (barbs, downers, jellies)
14. benzodiacepines
15. other medic. (specify)
16. sovents solvents (e.g. glue, gas)
17. steroids
18. other (specify)
1998
to be repeated, four years
health and lifestyle behaviours
national, Republic of Ireland
18+ years
none
Total n=6539, 62.2%
postal, self-administered questionnaire
10,415
Electoral register
none
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STANDARD TABLE  01b:  BASIC RESULTS AND METHODOLOGY OF POPULATION SURVEYS ON DRUG USE
      NOTES:     Include information on national (or relevant regional) surveys on drug use conducted during the last five years
                          Here only summarised results are requested. In Table (PO-SUR-A) results are requested broken down by five years age groups.
                          Age groups presented are partly due to maintainment of consistency with other EMCDDA indicators and other International Organizations
COUNTRY    Ireland All adults Young adults Broad age groups
DRUGS LIFETIME  PREVALENCE (%)
(important: see "drug definitions" 15-64** 15-34** 15-24** 25-34 35-44 45-54 55-64
in the Methodology box) M F T M F T M F T M F T M F T M F T M F T
1. any illegal drugs
2. cannabis 17.5 10.9 14.2 28.7 23.3 26.2 32.3 32.3 32.3 23.6 16.0 19.6 12.9 5.4 9.0 9.2 4.9 6.7 4.7 0.0 2.6
3. opiates (total)
4. heroin
5. other opiates (specify)
5. cocaine (total, including crack)
8. amphetamines
9. ecstasy
10. hallucinogens (total)
11. LSD 
12. other hallucinogens (specify)
13. hypnotics and sedatives (total)
14. benzodiacepines
15. other medic. (specify)
16. solvents
17. steroids
18. other (specify)
M = Male / F = Female / T= Total
** minimum age is 18 years
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COUNTRY All adults Young adults Broad age groups
DRUGS LAST 12 MONTHS PREVALENCE (%)   not collected
(important: see "drug definitions" 15-64** 15-34** 15-24** 25-34 35-44 45-54
in the Methodology box) M F T M F T M F T M F T M F T M F T M F T
1. any illegal drugs
2. cannabis
3. opiates (total)
4. heroin
5. other opiates (specify)
5. cocaine (total, including crack)
8. amphetamines
9. ecstasy
10. hallucinogens (total)
11. LSD 
12. other hallucinogens (specify)
13. hypnotics and sedatives (total)
14. benzodiacepines
15. other medic. (specify)
16. solvents
17. steroids
18. other (specify)
M = Male / F = Female / T= Total
COUNTRY All adults Young adults Broad age groups
DRUGS LAST 30 DAYS  PREVALENCE (%)   not collected
(important: see "drug definitions" 15-34** 15-24** 25-34 35-44 45-54
in the Methodology box) M F T M F T M F T M F T M F T M F T M F T
1. any illegal drugs
2. cannabis
3. opiates (total)
4. heroin
5. other opiates (specify)
5. cocaine (total, including crack)
8. amphetamines
9. ecstasy
10. hallucinogens (total)
11. LSD 
12. other hallucinogens (specify)
13. hypnotics and sedatives (total)
14. benzodiacepines
15. other medic. (specify)
16. solvents
17. steroids
18. other (specify)
M = Male / F = Female / T= Total
55-64
15-64** 55-64
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TABLE   TAB 01b:
METHODOLOGY
REFERENCE: Bryan,A., Moran,R., Farrell,E. and O'Brien,M. (2000) Drug-Related Knowledge, Attitudes and Beliefs in Ireland. 
year 1998
single/repeated study ad hoc (to be repeated)
contex (health/crime/drugs only…) general social omnibus survey
area covered Ireland
age range 18 years and over
data collection procedure questionnaire, face-to-face interview 
sample size 1000
sampling frame Electoral Register
sampling procedures two-stage proportionate to size random sampling design
oversampled groups none
weighting procedures none
response rate 18+ (Total) 64.5
Remarks
DRUGS DEFINITIONS Provide a detailed description of what is included in each drug category
1. any illegal drugs not collected
2. cannabis cannabis 
3. opiates (total) not collected
4. heroin not collected
5. other opiates (specify) not collected
5. cocaine (total, including crack) not collected
8. amphetamines not collected
9. ecstasy not collected
10. hallucinogens (total) not collected
11. LSD not collected
12. other hallucinogens (specify) not collected
13. hypnotics and sedatives (total) not collected
14. benzodiacepines not collected
15. other medic. (specify) not collected
16. sovents not collected
17. steroids not collected
18. other (specify) not collected
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STANDARD TABLE  02a :  METHODOLOGY AND RESULTS OF S C H O O L  S U R V E Y S  O N  D R U G  U S E
NOTES: a) Include information on national (or relevant regional) surveys on drug use conducted during the last five years
b) A year by year estimate is asked due to the sharp increase of drug experience with age. 15-16 group is used to maintain
 potential comparabililty with previous years and other international projects
COUNTRY   Ireland Total sample blank cells = information not available
DRUGS LIFETIME PREVALENCE(%)
(important: see "drug definitions" (9-18) 13__ 14 15_16
in the Methodology box) M F T M F T M F T M F T M F T
1. any illegal drugs 22.3 15.3 18.1 10.9 5.7 8.0 19.5 13.2 16.2 32.0 23.0 27.5 33.2 32.5 32.8
2. cannabis 16.2 8.7 12.3 4.9 1.5 3.0 12.0 4.1 8.0 27.0 16.1 21.7 28.7 28.5 28.5
3. opiates (total)
4. heroin 2.4 0.3 1.3 2.1 0.2 1.0 1.8 0.3 1.0 2.8 0.3 1.8 3.8 0.4 2.2
5. other opiates (specify)
5. cocaine (total, including crack) 2.9 1.7 2.3 3.2 1.8 2.4 2.4 1.6 2.0 3.0 1.5 2.2 4.8 2.1 3.5
8. amphetamines 3.9 1.3 2.6 1.9 0.3 1.0 2.4 0.7 1.5 6.1 2.2 4.2 8.0 5.3 6.6
9. ecstasy 3.3 0.6 2.1 2.3 0.2 1.2 2.4 0.2 1.3 4.3 1.3 2.8 6.8 4.3 5.7
10. hallucinogens (total) 6.8 2.0 4.4 3.8 0.5 2.0 5.2 1.6 3.4 10.3 3.3 6.9 10.0 4.9 7.5
11. LSD 3.6 0.9 2.3 2.0 0.3 1.1 2.6 0.4 1.5 5.1 1.7 3.4 8.4 2.5 5.5
12. other hallucinogens (specify) 5.6 1.8 3.6 3.4 0.4 1.7 4.2 1.5 2.8 8.3 2.6 5.5 7.7 3.5 5.7
13. hypnotics and sedatives (total) 3.2 2.4 2.8 2.2 0.7 1.4 2.4 3.0 2.7 4.5 3.2 3.9 4.2 3.2 3.7
14. benzodiacepines
15. other medic. (specify)
16. solvents 11.5 8.3 9.9 5.9 2.9 4.3 12.4 9.2 10.7 14.5 11.4 13.0 14.4 13.7 14.2
17. steroids
13. other
11_ 12 17_18
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COUNTRY  Ireland Total sample blank cells = information not available
D R U G S  LAST 12 MONTHS PREVALENCE (%)
(important: see "drug definitions" ( 9 - 1 8 )  13_14 1 5 _ 1 6 1 7 _ 1 8
in the Methodology box) M F T M F T M F T M F T M F T
1. any illegal drugs
2. cannabis 14.1 6.7 10.3 3.9 1.0 2.3 10.1 3.1 6.5 23.8 12.7 18.3 25.8 22.4 24.0
3. opiates (total)
4. heroin
5. other opiates (specify)
5. cocaine (total, including crack)
8. amphetamines
9. ecstasy
10. hallucinogens (total)
11. LSD 
12. other hallucinogens (specify)
13. hypnotics and sedatives (total)
14. benzodiacepines
15. other medic. (specify)
16. solvents
17. steroids
13. other
1 1 _ 1 2
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COUNTRY Ireland Total sample blank cells = information not available
DRUGS LAST 30 DAYS PREVALENCE (%)
(important: see "drug definitions"  (9-18)* 11_12 13_14 15_16 17_18
in the Methodology box) M F T M F T M F T M F T M F T
1. any illegal drugs 12.8 7.4 10.0 6.9 3.4 5.0 11.9 6.8 9.3 18.0 10.8 14.4 15.0 13.4 14.3
2. cannabis 8.9 3.1 5.9 2.3 0.5 1.3 7.1 1.5 4.3 15.3 5.7 10.5 11.6 10.4 11.0
3. opiates (total)
4. heroin 1.8 0.1 0.9 1.7 0.1 0.8 1.4 0.2 0.8 1.9 0.1 1.0 3.4 0.4 2.0
5. other opiates (specify)
5. cocaine (total, including crack) 2.2 1.2 1.7 2.3 1.6 1.9 2.1 0.2 1.6 2.1 0.9 1.5 2.7 0.7 1.8
8. amphetamines 2.5 0.6 1.6 1.3 0.2 0.7 1.6 0.2 0.9 3.8 0.9 2.4 5.7 3.9 4.9
9. ecstasy 2.2 0.5 1.3 1.2 0.1 0.6 1.8 0.1 0.9 3.1 0.6 1.9 4.2 2.9 3.7
10. hallucinogens (total) 3.5 0.9 2.2 2.4 0.2 1.2 2.8 0.8 1.8 4.6 1.4 3.0 6.1 2.2 4.2
11. LSD 2.2 0.3 1.3 1.3 0.1 0.8 1.7 0.2 0.9 2.7 0.5 1.7 5.3 1.8 3.7
12. other hallucinogens (specify) 2.8 0.6 1.7 2.2 0.1 1.1 2.3 0.7 1.4 3.7 1.1 2.3 3.0 0.7 2.0
13. hypnotics and sedatives (total) 1.8 1.1 1.4 1.2 0.4 0.8 1.4 1.4 1.4 2.2 1.5 1.9 2.7 1.1 2.1
14. benzodiacepines
15. other medic. (specify)
16. solvents 8.0 3.7 4.8 4.5 1.6 2.9 6.7 4.6 5.7 6.7 0.5 5.9 5.3 2.5 4.1
17. steroids
13. other
* 9-18 included here
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METHODOLOGY  Standard Table 2a
REFERENCE: Irish Health Behaviours in Schools Survey, Dept. Health Promotion, NUI Galway. Not yet published.  
year 1998
single/repeated study Single, to be repeated in 2002
contex (health/crime/drugs only…) Health behaviours and perceptions
area covered National: Republic of Ireland - 26 counties
type of school All 
age range 9-18 included here
data coll procedure self-completed questionnaire
sample size 8497
sampling frame School, primary and post-primary from Department of Education & Science lists
sampling procedures Two-stage random sample, within Health Board regions and classrooms
oversampled groups none
weighting procedures none applied here
absents of school at the time of survey 6% in primary schools, 14% in post-primary schools
response rate (M,F,T) 92% of primary schools, 86% of post-primary schools.  Total, including absentees = 73%. Gender breakdown not available.
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DRUGS DEFINITIONS Provide a detailed description of what is included in each drug category
1. any illegal drugs tranquilisers or sedatives, amphetamine, LSD, cocaine, heroin, ecstasy, solvents, magic mushrooms
2. cannabis marijuana (grass, pot) or cannabis (hash, hash oil)
3. opiates (total)
4. heroin heroin (smack, skag)
5. other opiates (specify)
5. cocaine (total, including crack) cocaine (coke, crack)
8. amphetamines amphetamines (speed, whizz)
9. ecstasy ecstasy (E, XTC)
10. hallucinogens (total) LSD and magic mushrooms
11. LSD LSD (acid, trips)
12. other hallucinogens (specify) magic mushrooms (pucal, mushies)
13. hypnotics and sedatives (total) tranquilisers or sedatives without prescription (barbs, downers, jellies)
14. benzodiacepines
15. other medic. (specify)
16. solvents solvents (e.g. glue, gas)
17. steroids
18. other (specify)
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STANDARD TABLE  02b :
METHODOLOGY AND RESULTS OF SCHOOL SURVEYS ON
DRUG USE
NOTES: a) Include information on national (or relevant regional) surveys on drug use conducted during the last five years
b) A year by year estimate is asked due to the sharp increase of drug experience with age. 15-16 group is used to
maintain
 potential comparabililty with previous years and other international projects
COUNTRY   Ireland Total sample    blank cells=information not available     
DRUGS        LIFETIME PREVALENCE(%)     
(important: see "drug definitions" (10-18)* 11_ 12   na
13__ 14
na
15_16
na 17_18   na
in the Methodology box) M F T M F T M F T M F T M F T
1. any illegal drugs                
2. cannabis 25.9 14.5 20.5             
3. opiates (total)                
4. heroin 1.9 0.4 1.1             
5. other opiates (specify)                
5. cocaine (total, including crack) 2.8 1.2 2.0             
8. amphetamines 6.3 2.8 4.6             
9. ecstasy 4.6 1.6 3.1             
10. hallucinogens (total)                
11. LSD 4.8 1.7 3.3             
12. other hallucinogens (specify) 7.4 2.5 5.1             
13. hypnotics and sedatives (total) 3.7 3.0 3.3             
14. benzodiacepines                
15. other medic. (specify)                
16. solvents 15.1 9.9 12.6             
17. steroids                
13. other                  
* age group (10-18)
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COUNTRY Total sample    blank cells=information not available     
DRUGS        LAST 12 MONTHS PREVALENCE (%)  not available
(important: see "drug definitions"  e.g. (12-18)  11_12  13_14   15_16   17_18  
in the Methodology box) M F T M F T M F T M F T M F T
1. any illegal drugs                
2. cannabis                
3. opiates (total)                
4. heroin                
5. other opiates (specify)                
5. cocaine (total, including crack)                
8. amphetamines                
9. ecstasy                
10. hallucinogens (total)                
11. LSD                
12. other hallucinogens (specify)                
13. hypnotics and sedatives (total)                
14. benzodiacepines                
15. other medic. (specify)                
16. solvents                
17. steroids                
13. other                  
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COUNTRY Total sample    blank cells=information not available   
DRUGS        LAST 30 DAYS PREVALENCE (%)    
(important: see "drug definitions"  (10-18) *   
11_12
na   
13_14
na   
15_16
na   
17_18
na  
in the Methodology box) M F T M F T M F T M F T M F T
1. any illegal drugs                
2. cannabis 14.4 6.2 10.5             
3. opiates (total)                
4. Heroin** 1.3 0.5 0.9             
5. other opiates (specify)                
5. cocaine (total, including
crack)** 2.1 0.8 1.5             
8. Amphetamines** 4.5 2.0 3.4             
9. Ecstasy** 4.2 1.4 2.9             
10. hallucinogens (total)                
11. LSD** 2.7 1.2 2.0             
12. other hallucinogens
(specify)** 4.7 1.5 3.2             
13. hypnotics and sedatives
(total)** 2.0 1.9 1.9             
14. benzodiacepines                
15. other medic. (specify)                
16. Solvents** 8.7 5.3 7.1             
17. steroids                
13. other                  
**post-primary schools only
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METHODOLOGY
REFERENCE:   
Rhatigan,A., & Shelley, E. (1999) Health behaviours of school pupils in the Eastern Health Board.
Dublin: Eastern Health Board.
year   1998            
single/repeated study single            
contex (health/crime/drugs only…) health            
area covered Local:  Eastern Health Board area      
type of school Primary and post-primary schools      
age range 10-18 year olds          
data coll procedure
self-administered questionnaire (based on WHO Health Behaviour in school-aged children
questionnaire)  
sample size 6081             
sampling frame Schools list          
sampling procedures
A random sample of schools stratified by county and by school type
(the latter in the case of post-primary schools only)  
oversampled groups none            
weighting procedures none            
absents of school at the time of survey pupils: absent (n=674); refused (n=24); parental consent not given (n=264)  
response rate (M,F,T)   T=78.2%. Gender not reported       
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DRUGS DEFINITIONS
Provide a detailed description of what is included in each drug
category   
1. any illegal drugs not reported          
2. cannabis cannabis or marijuana           
3. opiates (total) not reported              
4. heroin heroin, smack, skag            
5. other opiates (specify) not reported              
5. cocaine (total, including crack) cocaine, coke, crack            
8. amphetamines amphetamine, speed, whizz          
9. ecstasy ecstasy, E, XTC             
10. hallucinogens (total) not reported              
11. LSD
LSD, acid,
trips              
12. other hallucinogens (specify) magic mushrooms, pucai, mushies         
13. hypnotics and sedatives (total)
tranquilisers, sedatives, barbs, downers, jellies, (without a doctors
prescription)  
14. benzodiacepines not reported separately           
15. other medic. (specify) not reported              
16. solvents
solvents, glue,
gas             
17. steroids not reported              
18. other (specify)
drugs by injection with a
needle          
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S T A N D A R D  T A B L E  0 4 :   E V O L U T I O N  O F  T R E A T M E N T  D E M A N D S    ( A )   A L L  T R E A T M E N T S
COUNTRY    Ireland 1995-1999. Dublin 1990-1994
CHARACTERISTICS 1990* 1991* 1992* 1993* 1994* 1995 1996 1997 1998 1999
Nr. of ALL treatment cases/demands 1575 1722 1931 2043 2250 3609 3924 3879 5081 4277
Sex distr. Male (%) / Female (%) 76/24 78/22 78/22 78/22 81/19 80/20 73/27 70/30 71/29 70/30
Mean age (years) 25 25.3 24.7 23.7 22.8 22.6 22.8 23.6 24.3 24.6
Age distribution         <15 1 1.7 2 1.2 2.1 1.3 1 0.8 0.7 0.7
15-19 17.6 15.7 20.1 26.4 33.4 35.8 34 28.6 23.9 21
 (%) 20-24 32.2 28.8 31.2 34.4 33.3 35.7 36.4 35.6 35.8 36.9
25-29 29.4 31.6 25.2 21.2 17.1 14.6 14.7 18.4 20.6 22
30-34 12.9 14.2 14.6 10.7 9.8 7.2 8.7 10.3 10.6 10.8
35-39 4.7 5.5 5 3.9 3 3 3.2 4.1 5.3 5.6
40-44 1.5 1.5 1.3 1.7 0.8 1.4 1.3 1.2 1.8 1.7
45-49 0.2 0.8 0.3 0.2 0.4 0.5 0.7 0.7 0.8 0.7
50-54 0.2 0.1 0.2 0 0.1 0.3 0.1 0.1 0.3 0.4
55-59 0.1 0 0.1 0 0 0.1 0.1 0.1 0.1 0.1
60-64 0.1 0.1 0 0 0 0.1 0 0.1 0.1 0.1
>=65 0 0 0 0 0.1 0 0.1 0 0
Number of cases with missing inform on age 36 33 13 10 15 19 10 15 18 20
Currently injecting any drug (%) 53.1 50.4 51.8 50.8 46 32.4 31.8 38.1 36.7 34.4
Ever injected any drug but not currently (%) 24.2 23.1 17.4 17.1 18.1 16.5 16 18.8 23.5 24.9
Ever injected any drug (%) 78.4 75.8 70 68.9 64.7 50.5 48.8 58.7 63.4 61.7
IV route of ad. main drug (%) 66.3 59.9 56.8 57.8 55.3 39.4 36.9 45.3 48.7 48.8
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Main/primary drug  (%)  --  (% IV use)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)
  Opiates (total) 78.2(84) 75.1(79) 72.8(77) 77.3(75) 80.5(69) 72.1(55) 76.9(48) 77.2(59) 78.8(62) 73.3(66)
       Heroin 34.6(88) 34.9(85) 35.0(78) 49.3 (76) 59.0(69) 62.1(54) 71.3(49) 69.0(64) 70.8(67) 68.6(69)
       Methadone (any) 1.7(16) 3.5(5) 4.7(3) 5.2 (1) 4.8(12) 3.4(0) 2.9(0) 6.4(5) 5.6(4) 3.1(11)
       other opiates 41.8(83) 36.7(81) 33.0(86) 22.8(89) 16.7(84) 6.6(89) 2.6(74) 1.8(57) 1.7(69) 1.7(51)
  Cocaine (total) 0.7(18) 0.4(0) 0.5(30) 0.3(0) 0.4(13) 0.5(6) 0.6(9) 1.0(11) 1.6(11) 1.2(14)
     Cocaine ClH 0.7(18) 0.4(0) 0.5(33) 0.3(0) 0.3(17) 0.5(6) 0.6(9) 0.9(11) 1.5(11) 1.1(15)
     Crack 0 0 0.1(0) 0 0.1(0) 0 0 0 0 0
Stimulants (total) 0.3(0) 0.8(8) 3.3(2) 5.1(2) 3.3(1) 8.0(0) 6.5(0) 7.1(0) 4.9(0) 6.4(2)
      Amphetamines 0.3(0) 0.5(13) 0.5(0.0) 0.6(17) 0.5(9) 0.4(7) 0.4(7) 1.3(0) 1.4(2) 1.4(10)
      MDMA and derivates 0 0.3(0) 2.8(2) 4.4(0) 2.8(0) 7.4(0) 6.0(0) 5.8(0) 3.6(0) 4.9(0)
      other stimulants 0 0 0 0 0 0.2(0) 0.1(0) 0 0 0
Hypnot. and sedat. (total) 3.8(7) 5.2(0) 3.7(11) 2.8(0) 1.6(6) 2.3(1) 1.5(2) 1.7(3) 2.1(2) 1.4(0)
      Barbiturates 0 0.3(0) 0 0.1(0) 0 0.1(33) 0 0 0 0
      Benzodiacepines 3.6(7) 4.7(0) 3.5(12) 2.2(0) 1.5(6) 1.8(0) 0.9(3) 1.3(2) 1.8(2) 1.1(0)
      others 0.1(0) 0.2(0) 0.3(0) 0.6(0) 0.1(0) 0.4(0) 0.6(0) 0.4(7) 0.3(0) 0.2(0)
Hallucinogens (total) 0.3(20) 0.8(8) 1.4(4) 2.1(2) 1.8(0) 1.4(0) 0.4(6) 0.6(0) 0.3(0) 0.2(0)
      LSD 0.3(20) 0.7(8) 1.4(4) 2.1(2) 1.4(0) 1.1(0) 0.4(6) 0.6(0) 0.3(0) 0.2(0)
      others 0 0.1(0) 0 0 0.3(0) 0.3(0) 0 0 0 0
Volatile inhalants (total) 2.4(0) 2.5(0) 2.5(0) 0.9(0) 0.9(0) 0.7(0) 0.6(0) 0.6(0) 0.7(0) 0.6(0)
Cannabis (total) 13.4(1) 14.5(1) 15.3(1) 11.4(0) 11.5(0) 14.9(0) 13.4(0) 11.8(0) 12.1(0) 16.6(0)
Others substance (total) 0.8(8) 0.6(0) 0.5(11) 0.3(0) 0.1(0) 0.2(0) 0.1(0) 0 0.1(0) 0.3(0)
Nr. Inpatient / Residential  UNITS reporting 3 2 2 2 2 5 11 18 18 17
Nr. Outpatient / Nonresidential  UNITS repo. 8 9 10 10 11 13 31 45 76 75
Nr. Low treshold  UNITS reporting reporting 1 1 1 0 0 2 1 2 6 7
Nr. General Practitioners reporting 1 1 0 0 0 4 4 0 1 32
Nr. Treatment Unit in Prison UNITS reporting 3 2 2 1 1 2 1 0 0 2
Remarks on coverage changes (1) see footnotesee footnotesee footnotesee footnotesee footnotesee footnotesee footnotesee footnotesee footnotesee footnote
(1) residential, non-residential(very good coverage); GPs(1990-1998(poor coverage), 1999(good coverage), prisons(poor coverage).  The incorporation of GPs was greatly improved in 1999. 
* Dublin
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TABLE TAB 04: EVOLUTION OF TREATMENT DEMANDS  (B) FIRST TREATMENTS
COUNTRY Ireland 1995-1999. Dublin 1990-1994
CHARACTERISTICS 1990* 1991* 1992* 1993* 1994* 1995 1996 1997 1998 1999
Nr. of FIRST treatment cases/demands 624 450 668 859 1150 1870 2014 1465 1621 1636
Sex distr. Male (%) / Female (%) 75/25 81/19 79/21 80/20 83/17 80/20 73/27 72/28 74/26 73/27
Mean age (years) 22.8 21.9 21.5 21.1 20.6 21.1 21.3 22 22.1 22.7
Age distribution         <15 2.3 5.4 5.1 2.3 3.5 2.4 1.7 1.6 1.6 1.5
15-19 33.1 34.9 37 42.4 47.8 45.9 44.1 38.3 36.5 32.2
 (%) 20-24 33.6 34.2 35.8 36.6 32.8 33.7 34.8 36.5 36.2 38.2
25-29 17.5 14.4 12.8 11.9 9.3 10.7 11.3 14 15.8 16.3
30-34 7.8 7 53.7 4.2 5 4 4.5 5.3 5.4 6.4
35-39 3.6 2.3 2.7 1.8 1.2 1.7 2.2 2.7 2.6 3.2
40-44 1.6 0.5 0.5 0.4 0.3 0.9 0.8 1 0.9 1.3
45-49 0 0.9 0.3 0 0.1 0.3 0.5 0.3 0.4 0.3
50-54 0.2 0.2 0.2 0 0.1 0.3 0.1 0.1 0.4 0.3
55-59 0.2 0 0 0 0 0.1 0 0 0.1 0.1
60-64 0 0.2 0 0 0 0 0 0.1 0.1 0.2
>=65 0.2 0 0 0 0 0.1 0 0.1 0 0
Number of cases with missing inform on age 8 6 3 2 5 6 2 5 4 10
Currently injecting any drug (%) 38.7 31.3 31.7 38.8 36.8 19.8 20.9 24.6 22.8 22.7
Ever injected any drug but not currently (%) 17.7 11.9 9.5 11.4 15.4 10.9 10.8 11 12 15.2
Ever injected any drug (%) 58.9 44.2 41.7 50.8 52.5 32 32.1 36.8 37.2 39.3
IV route of ad. main drug (%) 48.3 36.2 33.9 44.1 46.7 23.8 24.3 29.3 28.8 30.6
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Main/primary drug  (%)  --  (% IV use)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)  dr. %  ( IV%)
  Opiates (total) 61.1(78) 49.0(73) 48.9(67) 64.0(69) 74.7(62) 60.5(39) 65.5(37) 61.2(48) 59.8(48) 55.4(55)
       Heroin 22.1(83) 24.0(74) 26.3(61) 46.2(67) 59.0(63) 54.5(38) 63.1(37) 58.6(49) 56.3(50) 53.2(56)
       Methadone (any) 1.2(29) 1.1(20) 1.4(0) 2.6(0) 3.7(12) 2.2(0) 1.3(0) 1.7(4) 2.5(3) 1.2(15)
       other opiates 37.6(77) 23.8(75) 21.2(79) 15.2(85) 12.0(77) 3.8(87) 1.2(48) 0.8(50) 1.0(50) 1.1(39)
  Cocaine (total) 1.0(0) 1.1(0) 0.6(50) 0.4(0) 0.3(0) 0.5(0) 0.8(6) 1.4(0) 2.0(0) 1.6(8)
     Cocaine ClH 1.0(0) 1.1(0) 0.6(50) 0.4(0) 0.3(0) 0.5(0) 0.8(7) 1.4(0) 1.9(0) 1.6(8)
     Crack 0 0 0 0 0 0 0.1(0) 0 0.1(0) 0
Stimulants (total) 0.5(0) 1.1(0) 5.9(3) 8.6(1) 4.1(0) 11.6(0) 10.4(1) 13.1(0) 9.6(0) 11.0(1)
      Amphetamines 0.5(0) 0.7(0) 0.2(0) 0.7(17) 0.5(0) 0.4(0) 0.6(8) 2.2(0) 2.3(0) 2.1(6)
      MDMA and derivates 0 0.5(0) 5.7(3) 7.9(0) 3.6(0) 11.0(0) 9.6(0) 10.8(0) 7.3(0) 8.8(0)
      other stimulants 0 0 0 0 0 0.2(0) 0.2(0) 0.1(0) 0.1(0) 0
Hypnot. and sedat. (total) 5.7(9) 5.5(0) 4.5(3) 2.6(0) 1.0(0) 1.8(0) 1.1(0) 1.7(0) 1.9(0) 1.0(0)
      Barbiturates 0 0.5(0) 0 0 0 0.1(0) 0 0 0 0
      Benzodiacepines 5.3(9) 4.8(0) 4.2(4) 2.0(0) 0.8(0) 1.1(0) 0.7(0) 1.3(0) 1.5(0) 0.8(0)
      others 0.3(0) 0.2(0) 0.3(0) 0.6(0) 0.2(0) 0.7(0) 0.5(0) 0.5(0) 0.4(0) 0.2(0)
Hallucinogens (total) 0.5(0) 1.8(0) 2.4(0) 3.6(0) 2.3(0) 1.9(0) 0.5(0) 0.8(0) 0.4(0) 0.2(0)
      LSD 0.5(0) 1.6(0) 2.4(0) 3.6(0) 1.7(0) 1.6(0) 0.5(0) 0.8(0) 0.4(0) 0.2(0)
      others 0 0.2(0) 0 0 0.5(0) 0.3(0) 0 0 0 0.1(0)
Volatile inhalants (total) 4.7(0) 6.6(0.0) 5.4(0) 1.6(0) 1.1(0) 1.0(0) 0.9(0) 0.8(0) 1.4(0) 1.2(0)
Cannabis (total) 25.4(0.7) 34.1(0.7) 30.9(1) 18.6(0) 16.3(1) 22.4(0) 20.7(0) 21.0(0) 24.7(0) 29.4(0)
Others substance (total) 1.2(0) 0.7(0) 1.4(11) 0.6(0) 0.3(0) 0.2(0) 0.1(0) 0 0.3(0) 0.2(0)
Nr. Inpatient / Residential  UNITS reporting 2 2 2 2 2 5 10 13 16 12
Nr. Outpatient / Nonresidential  UNITS repo. 8 7 9 10 11 13 29 40 72 69
Nr. Low treshold  UNITS reporting reporting 1 1 1 0 0 2 1 1 2 4
Nr. General Practitioners reporting 1 0 0 0 0 4 3 0 1 19
Nr. Treatment Unit in Prison UNITS reporting 3 2 1 1 1 2 1 0 0 2
Remarks on coverage changes (1)
(1) Incorporation of GPs greatly improved in 1999.
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method of data collection Standard questionnaire completed [hard copy] at treatment agencies and returned to HRB
(eventual changes over time) Changes have been made to original questionnaire to ensure compatibility with TDI standard
geographical coverage 1990-1995 Dublin only; 1995-1999 Ireland
(eventual changes over time)
FIRST TREATMENT
     Definition of case An individual who received treatment for the first time, i.e. had never previously been treated anywhere for problem drug use.
     Double-counting controled (Y/N°Double counting within centres is checked. Should be no double counting, as these are first time ever contacts. 
(eventual changes over time) From 2000 onwards, an anonymous attributor code will be used to avoid double counting
ALL TREATMENTS
     Definition of case Treatment contacts during a given year, excluding 'carryover clients' (those in continuous treatment since year(s) before).  
     Double-counting controled (Y/N°Double counting within centres checked; double counting between centres not possible up to now. 
(eventual changes over time) From 2000 onwards, an anonymous attributor code will be used to avoid double counting.
Remarks
Changes in coverage GPS and Prisons to be included in the NDTRS. Possibility of inclusion of Needle Exchange Programmes being investigated.
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STANDARD TABLE 16: PRICE*** IN EUROS AT STREET LEVEL OF SOME ILLEGAL SUBSTANCES
Please, fill in this table for each routine statistic or ad-hoc study reporting on price of illicit drugs
NAME OF THE SOURCE: Garda National Drugs Unit
COUNTRY: Ireland
YEAR
SIZE OF THE SAMPLE
Min. Max. Average Min. Max. Average Min. Max. Average Min. Max. Average Min. Max. Average
Cannabis resin (per gram) na na 13 na na 13 na na 13 na na 13 na na 13
Cannabis leaves (per gram) na na 3 na na 3 na na 3 na na 3 na na 3
Heroin brown (per gram) 100 300 190 100 300 190 100 300 190 100 300 190 100 300 190
Heroin white (per gram) na na na na na na na na na na na na na na na
Cocaine powder (per gram) na na 102 na na 102 na na 102 na na 102 na na 102
Crack (per rock) na na na na na na na na na na na na na na na
Amphetamines powder (per gram)10 13 12 10 13 12 10 13 12 10 13 12 10 13 12
'Ecstasy' (per tablet) 19 25 22 10 15 13 10 15 13 10 13 12 10 13 12
LSD (per dose) 10 15 13 10 15 13 10 15 13 10 15 13 10 15 13
na: not available
 
Type of study:
Geographical coverage: 
Sampling frame:
Sampling bias:
Price reported by:
Method of estimation: 
Source references:
Bibliographic references:
police intervention
law enforcement agency - police
user's report to police street workers
personal communication - police 
personal communication - police 
street work by police
N = not known
Methodological comments
N = not known N = not known N = not knownN = not known
1997
ad-hoc - estimations of street prices by police, from street work   
local (Dublin prices - number of sites covered not known)
1998 19991995 1996
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PART 3
DEMAND REDUCTION INTERVENTIONS
8. Strategies in Demand Reduction at National Level : Eimear Farrell
8.1 Major strategies and activities
As outlined in Part 1, the Government’s approach to drug policy is embedded in a
social inclusion framework which aims to combat poverty and exclusion. The
structural framework in relation to policies on reducing the demand for drugs is
similar to that for the general drug policy
The general objective of the Irish national drug policy is to maintain people in, or
restore people to, a drug-free lifestyle. However, it is acknowledged that this may
not be a viable option for many drug users in the short term.  Accordingly, a
pragmatic approach has been adopted which recognises the need for harm
reduction.  In Ireland, as in many countries, the initial introduction of harm
reduction strategies was motivated by the need to respond to the threat posed to
Irish society by HIV.  While a number of harm reduction initiatives have been
introduced including methadone maintenance, needle exchange, outreach and
low threshold programmes,  Kiely & Egan (2000) argue that ‘there is no strong
policy framework underpinning harm reduction in relation to illicit drug use in Irish
society which has meant that no legal framework has been built around the
strategy of harm reduction’ p.20.
The Government’s drug policy involves a range of responses, which address
both the causes and consequences of drug misuse as noted in Part 1.  The Irish
drug policy encompasses both general initiatives to tackle social exclusion and
specific initiatives designed to address the drug problem.  General initiatives
target issues  which are believed to contribute to the drug problem such as
unemployment and social deprivation. Such programmes provide scope for
agencies and communities affected by the drugs problem to avail of financial and
other resources to tackle problems implicated in drug misuse in their
communities. Two of  the most important specific initiatives introduced by the
Government to deal with the drug problem, are the Local Drug Task Force
structures and the Young People's Facilities and Services Fund.  These
initiatives are described briefly below (see part 4.12 for detailed description).
Local Drugs Task Forces
Local Drugs Task Forces were established to provide a strategic local response
by statutory, community and voluntary sectors, to the drugs problem in the areas
worst affected. Task forces have been set up in priority areas (12 Dublin, 1 Cork,
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1 Bray) where drug misuse is a serious problem. The Task Forces comprise
representatives from statutory bodies such as the Health Boards, Gardaí, Local
Authorities, FAS (employment) and the Vocational Education Committees as well
as from voluntary and community groups.
Young People’s Facilities and Services Fund (YPFSF)
This fund was established by the Government in 1998 to assist in the
development of preventative strategies in a targeted manner through the
development of youth facilities, including sport and recreation facilities and
services in disadvantaged areas, where a significant drug problem exists or has
the potential to develop. The aim of the fund is to attract "at risk"  young people in
disadvantaged areas into these facilities and activities, thereby diverting them
from the dangers of substance misuse.
Overall, the approach to the drug problem in Ireland could be described as an
integrated holistic intersectoral one which involves the co-ordination of drug
programmes and services at local level and which focuses on actions to deal with
the drug problem in communities where it is most severe.
In terms of financing the drug policy, the Government has overall responsibility
for the provision of financial support in the drugs area which is channelled
through the budgets of the relevant Government Departments, Regional Health
Boards, local government structures, the Local Drugs Task Forces and the
Young People’s Facilities and Services Fund (YPFSF) in the context of structures
set up under the National Development Plan 2000-2006 (see Part 1).
With regard to education and information provision in relation to drugs, at
Government level, the Departments of Health & Children and Education &
Science are responsible for education and information relating to drug misuse.
The Department of Health and Children operates mainly through its Health
Promotion Unit, the Regional Health Boards, and cooperates with the Community
and Voluntary Sectors etc.  The Department of Education and Science operates
mainly through the formal education system.  The two departments liaise closely
on a bilateral basis and are both represented on the National Drugs Strategy
Team and active in intersectoral structures set up to address the drugs issue [see
Part 1].  Both departments also support initiatives in the non-formal education
sector as does the Department of Tourism, Sport and Recreation.
The Department of Health and Children, through the Health Promotion Unit, is
responsible for the dissemination of information on drug misuse to the general
public and to at-risk groups. The Department and the Health Boards work closely
with the Community and Voluntary Sectors in providing prevention programmes,
and through outreach and harm reduction programmes aimed at current drug
users.
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The National Health Promotion Strategy produced by the Department of Health
and Children during 2000, outlines a number of objectives relating to drug
misuse. The principle aim of the strategy is to support models of best practice
which promote the non-use of drugs and minimise the harm caused by them. The
objectives include :
· to ensure each Health Board has in place a comprehensive drugs education
and prevention strategy
· to continue to support the implementation of existing drug related health
promotion programmes
· to work in partnership with relevant government departments (e.g.
Department of Education and Science) and other bodies to co-ordinate health
promotion activities
· to develop prevention and education programmes with particular emphasis on
schools, the youth sector and on interventions in areas where drug misuse is
most prevalent.
There has been a proliferation of local community based drug initiatives
particularly in relation to drug awareness over the last number of years, owing to
the increased availability of funding for projects to tackle the drug problem
through the Local Drug Task Forces, the Young People’s Facilities and Services
Fund and other more general social inclusion initiatives. A sample of these
initiatives will be presented in Section 9.1.4 – Community Programmes.
Currently, the National Drug Strategy is under review.  To date, a comprehensive
consultative process has taken place.  Public fora have been held throughout the
country and interested groups were asked to make submissions in relation to the
review. Consequently, there have been no major changes in drug policy during
2000 as policy makers await the results of the review. The Minister for State with
responsibility for the drugs area has promised that a revised strategy will be in
place by the end of 2000. This is likely to have implications for policy in the
demand reduction area.
8.2 Approaches and New Developments
· New and innovative approaches
There is an increased emphasis on rehabilitation in drug services in Ireland. This
is reflected in the service plans produced by the Eastern Regional Health
Authority, representing the three Health Board areas where the majority of drug
users reside. The ERHA have also devised a rehabilitation/re-integration
blueprint to guide the development of rehabilitation services and will be
appointing three rehabilitation co-ordinators to develop the rehabilitation aspect
of drug treatment.
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· Socio-cultural developments relevant to demand reduction
In Ireland, a holistic inter-sectoral approach (health, education, employment,
housing, estate management, policing etc.) has been adopted to address the
drug problem which has concentrated on tackling the problem in the communities
where it is most severe. This approach has focused on co-ordinating drug
services at local level and involving communities in the development and delivery
of locally based strategies.
A partnership approach has also prevailed in the drugs area in recent years, as
reflected by the LDTF structures which include representation from community,
voluntary and statutory agencies.
· Developments in public opinion
A survey of Knowledge, Attitudes and Beliefs towards illegal drugs & their
users/misusers in Ireland was published by the Drug Misuse Research Division,
of the Health Research Board during 2000. The survey on which the research
was based constituted a module of the 1998 Irish Social Omnibus Survey.  A
total of 1,000 adults 18 years and over, randomly selected from the 1997
Register of Electors for the Republic of Ireland, took part in the study. Data was
collected using face-to-face interviews between February and April 1998.  The
survey findings reveal that the general public in Ireland hold very negative
attitudes towards individuals addicted to drugs; believe that experimentation with
drugs is commonplace amongst young people; are supportive of drug prevention
education in primary schools and agree with present treatment policy/options.
The survey also revealed widespread public concern about the current drug
situation. A very high percentage of the sample perceived all illegal drugs to be
harmful to health while 56% agreed that alcohol abuse caused more problems in
society than drug abuse. Respondents were also asked about their levels of
knowledge of a range of illegal drugs. The study found that respondents had a
good general awareness of commonly used illegal drugs. However, their
perception of the general harmfulness of these substances indicates a lack of
accurate knowledge about the different effects associated with different types of
drugs.  Consequently, the study recommends that accurate non-sensationalist
information about the relative known risks associated with different types of drugs
be provided to all age groups.  Given the negative attitudes of the Irish general
public towards drug users, the study also emphasises the need to promote more
positive attitudes towards those who misuse drugs, particularly among older
people and those with less education. The report concludes that a positive
attitudinal climate is important to the social integration of problem drug users and
to their willingness to avail of treatment.
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· New research findings
A National Advisory Committee on Drugs has been established which has
identified a three year programme of research priorities in the drugs area.
The Drug Misuse Research Division is due to publish research findings in relation
to drug use amongst prisoners, the ERHA mobile clinic, and cocaine use in the
near future.
· Specific events during the reporting year
Young People and Drugs - EHB Conference
This two day conference organised by the EHB, was held in Dublin Castle on 17
and 18 of February 2000. A range of papers were presented focusing on current
trends of drug use among young people, current settings for drug use and
treatment and suitable responses to the problem.  Practitioners, administrators
and community groups addressed issues such as research, prevention,
education, treatment and rehabilitation. The need for early intervention and to
develop treatment programmes specifically for young people which adopt a life
skills approach and if possible involve parents was emphasised.
· Dissemination of information on demand reduction among
professionals (networks, Internet, etc.)
Drugnet Ireland
The Drug Misuse Research Division of the Health Research Board publish and
distribute the newsletter “Drugnet Ireland” twice yearly.  This magazine fulfils an
important role in the distribution of information, news and research among health
professionals and other interested parties involved in the drugs area in Ireland.
Its readership includes : community groups, policy makers, academics, treatment
providers and educationalists. The newsletter contains information on : ongoing
research in drug misuse, recently published materials and reviews, recent and
upcoming events, developments in the EU, local and world news and information
on research funding and fellowships.
EDDRA
EDDRA also plays a role in the demand reduction field by raising awareness of
types of demand reduction activities that are in place throughout the country.
During 2000, an EDDRA  brochure was developed and distributed with DrugNet
Ireland and at various seminars, workshops and conferences attended by
members of Drug Misuse Research Division. In addition a training session on
evaluation was conducted by the Drug Misuse Research Division with regional
drug co-ordinators et al. in attendance.
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Regional Drug Co-ordinator Meetings
Regional drug co-ordinators have been appointed in all the health board areas
with the exception of the ERHA.  Regional drug co-ordinator meetings are held
on a regular basis to discuss new developments in the drugs field in an Irish
context.
9.  Intervention Areas
9.1 Primary prevention
9.1.1 Infancy and Family
Infancy
The ERHA is in the process of employing three drug liaison midwifes to make
contact with substance misusing pregnant women and to liaise between the
obstetric hospitals and the drug treatment services. The midwives are
responsible for ensuring that the medical, psychological, obstetrical and social
needs of each woman have been accurately assessed and for preparing a
detailed clinical/psychological/social care plan for each women (EHB 1998). No
statistics or evaluation results are available. No information on specific training is
available.
Infancy and Family
The Lorien Project
The Lorien project, based in Tallaght, a large suburb of Dublin provides a range
of early year’s services to the children and siblings of drug users.  It also provides
support services for the families of drug users. The project, managed by
Barnardos (a large voluntary childcare charity) has three staff members and
provides a service for 60 families. No detailed statistics or evaluation results are
available. No information on specific training is available.
Family
The government has made available IR£2.4 million/Euro 3.05m each year for the
period 1998 to 2000 in order to set up family support projects for children and
families at risk within particular communities. Projects have been established in a
number of locations both urban and rural throughout the country including :
Dublin, Cork, Galway and Sligo (Department of Health and Children 2000).
The Springboard Initiative
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This initiative was established by the Department of Health and Children to assist
vulnerable children and their families in thirteen areas throughout the country.
Projects established under the initiative work intensively with children and their
families and provide necessary supports, in a co-ordinated manner to strengthen
the capacity of families. No statistics or evaluation results are available. No
information on specific training is available.
Fás le Chéile (Grow Together)
Fás le Chéile is a support programme for parents of primary school children
which was set up by the North Western Health Board area to train parents to act
as group leaders and to run courses for parents in conjunction with local primary
schools. The programme is aimed at mothers and fathers who have children in
primary schools and who are interested in meeting other parents for support and
information in relation to the healthy development of their family. It is based on
social learning theory and the emphasis is on group discussion and peer-led
facilitation. The overall purpose of the programme is to promote a positive
relationship between parents and their children. The substance misuse
component of the programme encourages dialogue amongst family members
about drugs, provides accurate information about drugs and alcohol, increases
awareness of the importance of self-esteem in preventing substance abuse and
builds parents confidence and skills in handling difficult situations. An evaluation
carried out in 1999 revealed that the parents were very satisfied with the
programme. Participants reported that their communications and listening skills
had improved with both their partners and their children. Participants also
experienced an increase in confidence in their own parenting skills and they felt
that the social learning approach was conducive to learning. No statistics on
participation are available.
Family communication and self esteem
The programme was developed in response to a need for parents to develop
skills to equip them to deal with the issue of the prevention of misuse of alcohol,
drugs and other substances. The programme focuses on the parents as the
primary educators and seeks to exploit the connection between prevention of
drug misuse and family communication. The programme has two main aspects:
parenting education and drug education. The emphasis of the programme is on:
empowering and enabling participants to help themselves, building up self-
esteem and developing interpersonal skills and resources.   An evaluation of the
programme indicated that both parents and tutors responded very positively to
the programme. Parents highlighted many learning outcomes and provided
concrete examples of how they have been putting into practice, new skills
learned. No statistics on programme participation are available.
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9.1.2 School programmes
The Department of Education and Science in collaboration with the Department
of Health and Children has developed specific substance abuse prevention
programmes for both primary and secondary school children.  The programmes
known respectively as 'On My Own Two Feet' and ‘Walk Tall’  place an emphasis
on self-esteem, feelings, influences, drug awareness and decision-making skills
to  help children withstand pressures to use drugs.
An outcome evaluation of ‘On My Own Two Feet’ found that compared to a
control group, students who participated in the programme had less positive
attitudes to drug/alcohol use, and stronger beliefs in the negative outcomes of
such use (Morgan et al. 1996).  A formative evaluation by Morgan (1998) found
that the ‘Walk Tall’ programme incorporates the approaches demonstrated to be
most effective in preventing substance abuse. The evaluation also indicated that
there was a very high rate of satisfaction with the programme among teachers
who participated in the programme.  No statistics on programme participation are
available for either programme.
It is planned that the new Social, Personal and Health Education (S.P.H.E.)
programme to be introduced in second level schools from September 2000, will
subsume “On my Own Two Feet” and that S.P.H.E. will become an integral part
of the curriculum for all junior cycle students. A National Co-ordinator has been
appointed for the implementation of the S.P.H.E. programme and ten Regional
Development Officers are being recruited.  The initiative is being supported by
the Departments of Education and Science and of Health and Children and the
regional Health Boards.  The Regional Development Officers currently being
recruited will work in partnership with Health Promotion personnel from the
Health Boards.  They will also collaborate with other statutory and voluntary
bodies to offer a co-ordinated support service.
The Healthy Schools Project
At the regional level, a school based programme known as the ‘The Healthy
Schools Project’ has been introduced.   This initiative was developed by the
North Eastern Health Board (NEHB) for schools in the NEHB catchment area.
The central objective of the programme is to encourage students to take
responsibility for their own health and behaviour. The programme places an
emphasis on the development of life skills including decision making,
assertiveness and self-esteem. An evaluation of the programme indicated that
there were significant differences between the pilot and the control group on
items relating to acceptance of responsibility, self-esteem, positive outcomes in
adulthood and attitudes to substance abuse (Morgan 1997). No statistics on
programme participation are available.
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Killinarden Drug Primary Prevention Group
A local based project, situated in one of the major urban areas in the Dublin
region, the Killinarden Drug Primary Prevention Group run a number of drug
education / self esteem programmes in schools in Killinarden. The project is run
by local parents and the programmes are delivered to children at both primary
and secondary level. This project has two part time staff and occasional
facilitators. No statistics or evaluation results are available.  No information on
specific training is available.
9.1.3 Youth programmes outside schools
Young People’s Facilities and Services Fund (YPFSF)
This fund was established by the Government in 1998 to assist in the
development of preventative strategies in a targeted manner through the
development of youth facilities, including sport and recreation facilities and
services in disadvantaged areas, where a significant drug problem exists or has
the potential to develop. The aim of the fund is to attract "at risk"  young people in
disadvantaged areas into these facilities and activities, thereby diverting them
from the dangers of substance misuse.
Copping On
The Copping On Programme, a national crime awareness programme targeted at
early school leavers and young people at risk, was established in 1996. The
programme aims to reduce the risk and incidence of offending behaviour among
young people and to decrease harmful and damaging behaviour such as bullying,
alcohol and drug use. There are two main strands to the programme. The first
strand involves providing training to professionals who work with early school
leavers and with young people at risk. The training focuses on creating a greater
awareness of the factors influencing offending behaviour, examination of
personal values and underlying principles and identifying effective responses to
the target group. The second strand of the programme consists of  training for
early school leavers and young people at risk. The course content focuses on
similar topics to the training for professionals, including communications,
relationships, drugs and alcohol, moral education, understanding the criminal
justice system.  At the end of the programme individuals are invited to provide
feedback through specially designed evaluations. A recent evaluation (Bowden
1998) concluded that both trainers and young participants reacted positively to
the programme. No statistics on programme participation are available.  No
information on specific training is available.
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National Youth Health Programme
The National Youth Health Programme is a partnership between the National
Youth Council of Ireland, the Health Promotion Unit of the Department of Health
and Children and the Youth Affairs Section of the Department of Education. The
aim of the programme is to provide broad based flexible youth health education
within the non-formal education sector. It assists youth workers, leaders and
volunteers working within the youth services and other community groups in
addressing the health needs of young people. The service provides training at an
organisational, regional and national level and gives advice and support to youth
and community organisations that are developing their own health education
programmes and initiatives.
The project has developed a Youth Work Support Pack dealing with the drugs
issue. The pack covers a number of issues and is divided into four sections; 1)
Youth work in a drug using society; 2) Youth work responses to drug use; 3)
Policy development and 4) Supporting information. No statistics or evaluation
results are available. No information on specific training is available.
Sound Decisions
This initiative established in the North Eastern Health Board region is targeted at
nightclub and disco staff and young people attending discos and nightclubs. One
of the main objectives of the project is to raise awareness of the dangers of drugs
among young people and nightclub staff.  It was also designed to increase the
competence of nightclub staff in dealing with drug related issues.  The
programme consists of training sessions to inform nightclub staff about the legal
implications relating to drug use, to enable them to recognise signs of drug use
and to respond effectively to drug related emergencies.  Promotional materials
such as pins, posters, leaflets, stickers and t-shirts are used to highlight for club-
goers the dangers associated with drugs. No statistics or evaluation results are
available. No information on specific training is available.
The Staying Alive Campaign – A Dublin Safer Dancing Initiative
This initiative introduced in 1997 in the Eastern Health Board area is designed to
provide training and support to night club staff in order to allow them to respond
more effectively to drug related situations in night clubs (Harding 2000). A similar
initiative has been organised in the South County Dublin area between the Dun
Laoghaire/Rathdown Local Drugs Task Force and the Eastern Health Board.
The first and second phase of this project involved the organisation of training
programmes for club owners/managers and door supervisors which focused on
increasing participants knowledge about drugs, exploring their attitudes towards
drugs and examining legal, health and safety issues. The third phase of this
project is designed to allow young club goers to obtain access to accurate
information about drugs.  This phase, currently in the pilot stage, will involve
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distributing information about drugs in the form of a small credit card sized
booklet known as the Vital Information Pack (VIP) through a number of venues
including third level colleges and clubs (Harding 2000).  Phases four and five of
the project have also been planned. In phase four, a one day conference will be
organised to gain support from the music/dance industry for the development of
acceptable policies in dance venues across the ERHA region.  Phase five will
involve standardising training for door supervisors where different training
elements will be provided in modular form. No statistics on programme
participation are available. No statistics or evaluation results are available. No
information on specific training is available.
Health Advice Café
Funding has been approved for the establishment of a health advice café in
Galway’s city centre.  Galway is located in the Western Health Board region.
However, no suitable premises for the project have yet been found. The main aim
of the café will be to offer young people direct access to health services and to
health information and advice.  The café will incorporate a range of drug
prevention and education strategies and provide information about available
treatment services.  It will also place an emphasis on ‘fun drug free activities’ to
illustrate to young people that it is possible to have a good time without using
drugs. No statistics or evaluation results are available. No information on specific
training is available.
9.1.4 Community programmes
There has been a proliferation of local community based drug initiatives
particularly in relation to drug awareness over the last few years, owing to the
increased availability of funding for projects to tackle the drug problem. The
initiatives organised by community groups include: drug awareness programmes,
family support groups and the development of strategies to reduce the demand
for drugs in local areas.  A few examples of the different types of initiatives that
are in place are presented here.
Southside Communities Drugs Initiative (Waterford)
The Waterford Community Based Drugs Initiative (CWCBDI) was established in
November 1999 and aims to :
· Increase the awareness or drug related issues
· Develop strategies for the reduction of demand for drugs
· Support local communities to respond to local needs relating to drug related
issues and to improve the quality of life of those affected by drug misuse.
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The project is currently involved in the following initiatives : determining what
local people think about drug related issues (needs analysis); providing drug
awareness programmes to youth  groups and schools; running parent support
groups and promoting the development of drug policies in various organisations.
CWCBDI adopts a multi-faceted approach to its work. Representatives from
statutory, community, and voluntary organisations are involved in the
management committee of the project. This means that local people are involved
in the management of the project and in making any major decisions relating to
the project.  It also ensures that the work is inclusive and consultative of local
needs and issues. No statistics or evaluation results are available. No information
on specific training is available.
Drug Questions - Local Answers
This community-based training programme produced by the Health Promotion
Unit of the Department of Health and Children is aimed at health/education
professionals, Gardaí (Police), community groups, doctors, youth workers etc.
The objective of the five unit, ten hour training course is to help participants cope
better with alcohol- and drug-related problems which they meet in their
work/lives. and to contribute to community based responses to the drugs
problem. The Health Promotion Unit of the Department of Health and Children, in
conjunction with the eight regional health boards has provided convenor training
programmes to demonstrate to instructors how to use the training materials
effectively. No statistics or evaluation results are available. No information on
specific training is available.
Crew Network
The Crew Network, based in the Eastern Health Board area, is a non-profit
making organisation dedicated to the care, rehabilitation, education and
occupational re-integration of those affected by substance misuse. The network
is engaged in a number of demand reduction activities including school-based
programmes and parent and community awareness nights.  It has developed a
community leadership and substance misuse awareness course accredited by
National University of Ireland, Maynooth.   The Crew network also provides a
family and counselling service. No statistics or evaluation results are available.
No information on specific training is available.
DAP - Crosscare
The Drug Awareness Programme (DAP) operated by a registered charity –
Crosscare, helps groups and communities in the Dublin area, to develop a
comprehensive approach to drug prevention. DAP provides a wide range of
services including needs assessment for local drug prevention, drug awareness
training and peer education programmes. DAP also provides a counselling,
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support and telephone helpline service. No statistics or evaluation results are
available. No information on specific training is available.
Community Addiction Response Programme (CARP)
CARP began as a partnership between the local community and a medical
practitioner in the West Dublin area of Tallaght, with the aim of providing a
methadone prescription service. The service has since expanded to include
various activities for those receiving methadone including artwork, homeopathy,
bowling and football. The overall purpose of the programme is to deliver a user-
friendly, client-centred service to opiate users of Killinarden so that they can re-
integrate themselves into the community. The programme is targeted at those
aged 16 and older who are problem drug users, although it will also cater for
younger drug addicts who present for treatment. While the programme is
primarily targeted at those with heroin addiction, it also offers a service for those
abusing other substances. CARP also aims to help families affected by drug use
and has established a support group for parents of drug users.
CARP has forged links with various vocational training programmes in the area to
allow clients in receipt of methadone maintenance to gain access to further
training. CARP also produces a newsletter, which is distributed to the local
community every quarter, and members of the organisation give talks on drugs to
local schools. An evaluation report (Bowden 1997) showed that participants
generally viewed the programme in positive terms and the programme allowed
participants to develop the ability to resist heroin. No statistics or information on
specific training are available.
Ballymun Youth Action Project
This project offers a range of services to individuals and families in the Ballymun
area of Dublin.  There are three main strands to the project 1) individual and
family services 2) education and training and 3) community work.  Advice,
referral, information, counselling and family support are offered under the
individual and family services aspect of the project.  The education and training
component consists of providing community education on drug abuse,
developing drug/alcohol awareness programmes targeted to meet the needs of
specific groups and delivering primary school programmes (See Section 10.4
Urrus/Ballymun Youth Action Project for more details). The community work
element of the project consists of liasing and networking with other groups and
agencies, contributing to policy development, empowering local people to
participate in responding at a local level and researching how community
development principles can be put into practice in relation to drug issues. No
statistics or evaluation results are available. No information on specific training is
available.
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Ballymun Community Action Programme
This project, which is run by a management committee of local people who live
and work in Ballymun, acts as a community resource centre and development
programme.  It aims to respond to the needs of local groups, initiate activity
where gaps in service provision may exist and to draw lessons from the
experience of local groups that can inform policy.  The project is actively involved
in influencing policy from a community perspective and in encouraging local
people to contribute positively to policy development in relation to the drug issue.
No statistics or evaluation results are available. No information on specific
training is available.
Adult Substance Misuse Education Programme
This programme developed by the Kilkenny Drugs Initiative (KDI) is designed to
help build the capacity of local communities to deal with the issue of substance
abuse in their local area so they can further facilitate and train other people in the
community. The programme is delivered to groups of between 6 and 12
participants and consists of between two and five sessions which are two hours
in duration and cover aspects of substance misuse such as effects of drugs,
signs and symptoms of drug use and drugs in a legal context. No statistics or
evaluation results are available. No information on specific training is available.
As part of their remit to involve communities in the development of locally based
strategies to reduce the demand for drugs, The Local Drugs Task Forces provide
financial support to community based programmes. The following are examples
of some of the types of projects that have  been evaluated under the Local Drug
Task Force evaluation initiative (See 10.2 Evaluation of LDTF funded projects for
further details).
Jobstown Assisting Drug Dependency (JADD)
Jobstown Assisting Drug Dependency (JADD) was established in 1996, by a group of
local people, in response to the growing problem of heroin abuse in Jobstown, a suburb
of Dublin city. JADD emerged from a series of local community meetings concerning the
drugs problem. The overall purpose of the programme is to support and help drug users
and their families and to help drug users re-integrate back into the community. The
project works with active drug misusers, drug misusers who are drug free and drug
misusers who are participating in methadone programmes. The majority of JADD clients
are male, early school leavers and unemployed. The clients are targeted through word
of mouth, contact with healthcare professionals and current clients. One of the main
services offered by JADD is methadone maintenance and gradual detoxification. JADD
also provides a counselling service, a drop-in centre, primary health care and after care.
The drop-in facility is opened five days a week. The counselling and drop-in services
are also available to family members. Clients can take part in education and training
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programmes such as drama, art, computer skills, literacy skills, creative writing, career
guidance, job searching and sport/fitness. JADD has a Family Support Group which
meets once a week for two hours. JADD also aims to inform and educate the local
community regarding drug addiction and drug related diseases and to network with
other local community groups. A recent evaluation (O’Rourke 2000) found that
participants generally viewed the programme in positive terms and that JADD had made
a significant contribution to the quality of life and provision of opportunities for many
people living within the Jobstown area. No statistics or information on specific training is
available.
Cabra Resource Centre
This project established in September 1999 was set up as a ‘drop in’ centre for
individuals and families within the community concerned about alcohol and
substance abuse issues.  The centre provides brief intervention counselling and
an information service and is equipped with a multi-media library.  It also acts as
a referral agency and organises family support groups. No statistics or evaluation
results are available. No information on specific training is available.
The Crinian Project
This project based in Dublin and funded by the City of Dublin Youth Services
Board, was established to cater for young drug users (15-18 years) who are
especially vulnerable and have few service or treatment opportunities.
Participants have usually left school at a very young age and have had frequent
involvement in illegal activities. The project  is holistic and places emphasis not
only on medical intervention but also on providing enabling-skills and drug-free
alternatives to the young clients. The project has two main components a day
programme and an after-hours component. The main services offered by the day
programme include :
· Individual and group therapy
· Medical services including detoxification and drug testing
· Youthwork
· Family support
The after-hours aspect of the programme which is designed to complement the
day programme in Crinian, involves evening activities, week-end events, literary
and education support and youth work training and networking. An evaluation
was carried out by Morgan 1997, however no statistics or evaluation results are
available. No information on specific training is available.
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9.1.5 Telephone help lines
EHB Helpline
A free telephone helpline was established by the Eastern Health Board during
1997 and is available five days per week from 10.00am to 5.00pm.   It was set up
to provide a confidential service offering information, support, guidance and
referral for those concerned with any aspect of drug misuse. No statistics or
evaluation results are available. No information on specific training is available.
Waterford Drug Helpline
This Helpline provides a telephone counselling and information service between
10am and 12am Monday to Friday and on two evenings a week from 8pm to
10pm.  The helpline has ten unpaid volunteers. The service was set up to
educate the general public and particularly parents and young people about drug
related issues and to provide a listening service to those effected by drug use.
The service aims to be easy to contact, confidential and non-judgmental. It also
provides factual information about drugs and their effects and gives out details of
drug related services in the region.  In 1999, a total of 1270 calls were received
by the helpline.   The majority of these calls related to cannabis/alcohol (31.3%),
ecstasy (30.9%) and amphetamines (24.2%) (Waterford Helpline, personal
communication 1999).   The Helpline is a member of the European Foundation of
Drug Helplines (PESAT). No evaluation results or information on specific training
is available.
Cork Helpline
The Southern Health Board also provides a helpline offering information on
prevention and service provision.  It is a charge-free service and operates
weekdays from 1-2 pm. No statistics or evaluation results are available. No
information on specific training is available.
9.1.6 Mass media campaigns
The Health Promotion Unit of Department of Health and Children disseminates
information on drugs and their effects on an on-going basis.
HYPER
A new bi-monthly magazine ‘HYPER’ was launched in Spring 1999 by the project
promoter – Soilse which is a rehabilitation programme in the EHB. HYPER which
is an acronym for Health, Youth, Promotion, Education and Rehabilitation acts as
a voice for young people affected by drugs.  HYPER is funded through EHB by
Youthstart and an EU Employment initiative for 18-20 year olds. It is produced by
six former drug users as part of a rehabilitation project and aims to bring young
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people a magazine which they can relate to and which critically addresses their
lifestyles without preaching or scare-mongering.  The magazine includes
interviews, book and theatre reviews, cartoons and articles that challenge
peoples’ attitudes towards drugs, young people and health. In July 1999, HYPER
won an award in the British based Total Publishing Awards competition for
design innovation.  The magazine was selected from over 400 entries.
9.1.7 Internet
No information available.
9. 3 Reduction of drug related harm
9.3.1 Outreach work
Each Health Board is developing its outreach capacity as part of the overall
service development in the drugs area.  Outreach workers provide needle
exchange, support for sex workers and referrals for methadone maintenance.
According to the EMCDDA Insights report, outreach workers in Ireland
emphasise the importance of a community presence which enables them to
‘intervene and fast-track individuals to treatment while concentrating on making
contact and increasing service accessibility’ p. 131 (EMCDDA 1999).
ERHA Outreach programme
This programme targets intravenous drug users, women in prostitution and gay
or bisexual men.  It aims to :
· Reach IDUs who are not in touch with services and provide them with
information on HIV and its prevention
· Encourage and facilitate referrals to drug-treatment agencies
· Provide information to community groups about HIV (EMCDDA 1999).
No statistics or evaluation results are available. No information on specific
training is available.
9.3.2 Low threshold services
The Mobile clinic
A  Mobile Clinic was established in the Eastern Health Board in 1996.   The
service is low-threshold and provides initial services to the more chaotic drug
user who is addicted to an opiate, is injecting and is incapable of stabilisation on
methadone maintenance.  A second mobile clinic was introduced in 2000, which
136
increased the number of areas where drug users can avail of this service. No
evaluation results are available. No information on specific training is available.
The Drug Misuse Research Division is currently carrying out a research study
which is assessing the needs of users of this service and their experience of this
and other drug treatment services.
9.3.3 Prevention of infectious diseases
Drug users who present for treatment at any of the statutory drug treatment
services are routinely offered HIV/Hepatitis C testing. Needle exchanges are
operational in only the Eastern Regional Health Authority which covers the
greater Dublin area where the vast majority of injecting drug users reside.
According to the report of the National AIDS Strategy Committee, recent HIV
statistics indicate that interventions with intravenous drug misusers are effective
in reducing transmission rates among this ‘at risk’ group (Department of Health
and Children 2000).  However, there was a major increase in the numbers of
drug users with HIV in 1999. The figure for 1999 was 69, compared to 26 and 21
for 1998 and 1997 respectively (Department of Health 2000).
 A nationwide routine linked antenatal HIV testing programme has been
established which can reduce perinatal transmission through the use of antenatal
treatment of HIV positive women with anti-retroviral drugs and careful
management at delivery (Department of Health 2000). No evaluation results are
available. Training for midwives and others involved in the programme was
provided in all health boards by a team including expert clinicians, a midwife and
a social worker.
Health Promotion Unit – Merchants Quay Project
The largest needle exchange in the country is operated by a voluntary agency –
Merchants Quay. The Health Promotion Unit within Merchants Quay operate the
needle exchange which is aimed at drug users who inject heroin and offers a
drop-in service which is open Monday to Friday, 2.00pm until 4.30pm. The Health
Promotion Unit offers a range of services to its clients. It provides a range of
needles and syringes, sterile water, filters, swabs, citric acid and condoms. The
Unit also acts as a source of referral to other drug treatment services and offers a
nursing service. This service provides clients with basic wound care, and deals
with other health issues such as scabies, athletes foot and any other conditions
that clients present. When appropriate, referrals are made to other services and
clients may also apply for a medical card. Encouraging clients to engage in
specialist contact such as having an HIV test and receiving the hepatitis B
vaccination is also considered an integral part of the Health Promotion Unit. A
recent evaluation (Cox and Lawless 2000), found that the Health Promotion Unit
had a positive impact on clients’ drug using behaviour. There was a reduction in
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the frequency of injecting and the incidence of sharing and an increase in
condom use reported by clients at the three month follow up visit. No evaluation
results are available. No information on specific training is available.
9.4 Treatment
9.4.1 Treatments and health care at National level
The Government Strategy to Prevent Drug Misuse (National Co-ordinating
Committee 1991) recognised that the treatment, care and management of drug
misuse does not lend itself to a 'one solution' approach. Consequently, a variety
of treatment options are provided including : counselling and support,
detoxification, treatment at therapeutic communities, needle exchange, and
methadone maintenance. In practice until recently there has been an emphasis
on provision of methadone maintenance for opiate misusers, more recently
rehabilitation measures as an aspect of treatment is increasingly being stressed.
Drug treatment services are provided through a network of treatment locations
and the policy is to provide treatment locally where possible (Department of
Health and Children 2000). Thus in addition, to some central treatment services,
a network of addiction centres and satellite clinics have been developed –
particularly in the ERHA areas. Primary provision is developing and involvement
of GPs, local pharmacies etc. in local delivery is being actively encouraged. In
some Health Board areas drug services are structured under health promotion or
public health while in others services are provided under the psychiatric services
umbrealla. There is not a consistent approach across health boards.
The treatment services aimed at drug users are organised at regional level and
local levels under the Health Boards and increasingly will involve more active
liaison with local government structures. The main funding is made available
through the Department of Health and Children to the Health Boards, and
through the Health Boards to voluntary and community agencies at present.
More involvement of local government structures is developing.
Financing
Two government departments fund initiatives in the drugs area – the department
of Health & Children and the Department of Tourism, Sport and Recreation.  The
Department of Tourism, Sport and Recreation had an annual budget of IR£35
million in 2000 for the drugs area.  No exact figures are available for Department
of Health and Children funding which is administered through a number of
different sections with the Department including: childcare, health promotion and
mental health.  However, an additional IR£7.75 million was made available to
community drugs services by the Department of Health and Children in 2000.
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In 1999, the EHB AIDS / Drug Service was allocated IR£17.5 million/Euro 22.2m
including capital development costs which represents 15% of the EHB’s budget
for health promotion, mental health, addiction and social development (Farrell et
al 2000).  The ERHA budget in 2000 was over IR£ 22 million.
Statistics and Evaluation results
National Drug Treatment Reporting System Statistics
The National Drug Treatment Reporting System (NDTRS) data for 1998 (the
latest year for which published data are available) indicate that there were 6043
recorded contacts with treatment services during 1998. Of these contacts, 1625
were receiving treatment for the first time.  For 71% of all cases, the main drug of
misuse was heroin. The vast majority of contacts (86%) were treated in the
Eastern Health Board area. Two-thirds (66%) of all contacts had injected at some
stage in their drug using careers. The gender breakdown of contacts indicated
that 70.2% of cases were male.  Almost three-fifths (58%) of those receiving
treatment were under the age of 25. Two-thirds (65%) of contacts were living with
their parents or other family members.  Interestingly, one-fifth of all cases
receiving treatment were in gainful employment an increase from 14% in 1997
(O’Brien, Moran, Kelleher & Cahill, 2000).
Review of the EHB Drugs and AIDS services
In 1999, a review of the EHB drugs and AIDS services was conducted (Farrell
2000).  The purpose of the review was to :
· To appraise the current drug policies and practices within the service
· To examine the development of the service since the last review conducted 5
years earlier
· To comment on the EHB service response in context of trends and practices
elsewhere.
One of the indicators of drug treatment centre performance that the report
examined was the results of urine tests for opiates, benzodiazepines and
tricyclics among five addiction clinics across the EHB area. These tests were
conducted over a four month period in 1999.  The results indicated that overall,
on aggregate, there was a 70% reduction in heroin use among those attending
treatment.  However, high rates of benzodiazepine use were found (65%
positive) which suggest a major problem of polydrug use among drug users in
treatment.  The authors indicated that the costs of urine screening in EHB clinics
are disproportionately high and needed to be reviewed. The review also found
that a number of satellite clinics informally reported rates of returning to work of
40% (Farrell 2000).
The report concluded that the EHB has succeeded in achieving a major
expansion in services over the last five years and that the rates of opiate use as
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indicated by urine testing suggests that clinics are operating to a very high
standard of performance on that particular parameter. The authors recommend
that an audit of  benzodiazepine prescribing processes be conducted within the
service as a matter of urgency. They also argue that the needle exchange
service needs to be expanded and that services should be broadened to include
briefer types of intervention.
Specific Training
General practitioners – GPs, are required to undergo specific training before they
are permitted to prescribe methadone since the introduction of the Methadone
Prescribing Protocol in 1998. The Irish College of General Practitioners provides
this training in conjunction with the relevant local health board. The training aims
to provide GPs with the knowledge, skills and attitudes required to manage
opiate misusers in general practice. There are two training levels that GPs can
complete. The level attained will dictate the nature of the contract the GPs will
have with the health board in terms of the substitution service he/she can provide
within their general practice.
Level 1: This level permits GPs to prescribe methadone only for clients that have
been stabilised on a methadone programme in a clinic setting. These stabilised
clients are referred to the GP from the health board treatment centres. GPs in
this group are limited to providing services for a maximum of 15 clients.
Level 2: This level of training permits GPs to initiate the treatment of opiate
dependent persons. Doctors must have worked for a minimum of one year in a
clinic based setting before they can undergo this training. A GP in this group may
treat up to 35 clients in his/her own practice but if in a practice with two or more
doctors may cater for a maximum of 50 clients.
In an effort to provide comprehensive national epidemiological information on
treated drug misuse, the Drug Misuse Research Division make an input to this
training relating to the completion of NDTRS forms. Individual training is also
provided by the Drug Misuse Research Division.
9.4.2 Substitution and maintenance programmes : Lucy Dillon
Organisation and delivery of substitution drugs:
(a) Criteria of admission
During the early 1990’s substitution services in Ireland were expanded and
became more widely available to the opiate using population. In accessing
maintenance programmes preference has always been given to pregnant women
and those who have AIDS or are HIV positive. However, in 1998 the Eastern
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Health Board produced an ‘Inventory of Policies’ which lays down criteria for
admission to substitution programmes. These are as follows:
§ Clients must meet physical, emotional and behavioural criteria for addiction as
set down by the International Classification of Diseases Version 10 [ICD-10]
§ Clients must be 18 years of age. Those between the ages of 18 and 20
require a more extensive investigation before being commenced on
methadone
§ Clients under the age of 18 will need their parents to attend and give parental
consent. There should be a history of at least one failed detoxification, usually
two or three preferably at inpatient level. However, where patients have a very
long history that can be verified, this condition may be waived
§ For admission to a maintenance programme a client must have an extensive
one-year history of intravenous drug use. For interim programmes a client
must have been using opiates for a minimum of two years and/or injecting for
one year
§ Clients must have gone through at least one previous detoxification attempt.
§ Special circumstances may dictate being accepted on a programme without
fulfilling all the above criteria. Such circumstances include being HIV positive,
being pregnant and being a partner of a client already on a programme.
Prior to the introduction of these guidelines, the criteria of admission onto
maintenance programmes were generally left to the discretion of an individual GP
or particular clinic. As such, there may have been extensive variation between
programmes in terms of the criteria used for admission.
(b) Mode of prescription
Legal Basis for Substitution
Prior to October 1998 there was no policy in relation to GPs prescribing
methadone. There is no data available on the extent to which GPs prescribed
methadone up until this point, as the provision of such a service was up to the
discretion of individual GPs. However, in the early 1990s there was a move away
from the centralised specialist model toward a more decentralised model of
service provision. This called for the involvement of community based GPs and
pharmacists in the prescribing and dispensing of methadone. Although some
individual GPs were already involved in providing this service, the aim was to
establish a structured and co-ordinated approach to the provision of services. An
Expert Group was set up to develop a suitable treatment protocol. In March 1993,
the Protocol for the Prescribing of Methadone was issued which set out
guidelines for GPs prescribing methadone within the general practice setting, and
for pharmacists in their dispensing of methadone. Guidelines set out in a review
of this protocol produced in 1997 were implemented in October 1998.
Consequently, the Misuse of Drugs (Supervision of Prescription and Supply of
Methadone) Regulations were published in 1998.
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The guidelines aim to create a more controlled environment for the prescribing
and dispensing of methadone. Under the Regulations the prescribing medical
practitioner must register each client in receipt of a methadone prescription on
the Central Treatment List.  The guidelines aim to restrict the number of clients
for whom individual GPs can prescribe methadone. While there is no specific
licence required by GPs in Ireland to provide substitution programmes, they are
required to undergo training and must be approved by the relevant health board.
Methadone itself is a licensed prescription drug controlled under Schedule 2 of
the Misuse of Drugs Regulations, 1988. Methadone is currently prescribed in two
service settings: clinic setting and GP setting. Furthermore, it is also dispensed
from community pharmacies.
Clinic Setting
Clinics have been developed specifically to meet the needs of drug users.
Expansion in the clinic services has been overwhelmingly in the area of
substitution programmes, including methadone detoxification, stabilisation and
maintenance. The number of clinic locations where methadone is prescribed has
grown from two in 1991 to four in 1994, to 45 in 1999 and 53 in 2000. Forty-nine
of the fifty-three clinics are based in the Eastern Regional Health Authority Area
where the large majority of opiate users reside.
Clinics fall in to one of two categories. First is the category referred to as
‘addiction centres’ where a range of services are available to clients, including
substitution programmes. The majority of the clients attending these clinics are
dispensed their methadone on-site on a daily basis, this means they consume
the methadone under the supervision of a member of staff. Supervised urine
samples are taken on a regular basis. When clients have demonstrated a certain
level of stability by providing opiate-negative samples over a period of time, they
may be dispensed ‘take home’ doses. This means less frequent attendance at
the clinic is required.
The second category of clinic is referred to as ‘satellite clinics’. These are clinics
based in communities identified as having a significant opiate using population.
These clinics provide methadone prescribing services, although it is not
dispensed on site. Rather, clients attend a designated community pharmacy
where their methadone is dispensed.
General Practice Setting
As mentioned above, in 1993 a protocol was published for the prescribing of
methadone in the GP setting. The basic premise outlined in the 1993 Protocol is
that GPs should take on responsibility for the care of opiate dependent people
once they have been stabilised in either an addiction centre or a satellite clinic.
GPs and clients should then have the continued support of that centre. A protocol
review committee was established which produced a report in 1997, the
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recommendations of which were implemented in October 1998. The main
changes this had on the organisation and delivery of methadone services in the
GP context were:
§ GPs had to register with the health board to enable them to prescribe
methadone
§ GPs were restricted in the number of drug users they could treat, depending
on their level of training
§ Only GPs having undergone specialised training could initiate the prescription
of methadone in the treatment of drug addiction. Other GPs could only treat
those already stabilised in a clinic setting
§ GPs were no longer allowed to prescribe methadone to patients in a private
capacity but had to provide the service free of charge to the patient
§ All patients in receipt of a methadone prescription had to be registered on a
Central Methadone Treatment List.
As with the number of clinics providing substitution services, the number of GPs
offering the service has increased dramatically over recent years. In 1996 there
were 58 GPs registered as prescribing methadone in their practice setting, this
grew to 97 in 1998, 143 in 1999 and in 2000 has grown to 158.
Community Pharmacists
As substitution programmes have become more decentralised the role of the
community pharmacist has become increasingly important. Pharmacies are
responsible for dispensing methadone to clients attending a GP based
substitution programme and those attending satellite clinics. Each client is
assigned to a particular pharmacy in the local community, from which his or her
methadone will be dispensed. Pharmacists are involved in dispensing take home
doses and also provide a supervised administration service. The Pharmaceutical
Association of Ireland recommends that pharmacists agree a written contract with
clients upon initiating these services. Contracts detail the pharmacy service and
the expected standards of behaviour of clients. The number of pharmacies
involved in dispensing methadone has increased significantly over recent years.
As of 2000 there were 207 pharmacists involved in dispensing methadone, one
hundred and fifty four of these were based in the Eastern Regional Health
Authority area (personal contact, Pharmaceutical Society of Ireland).
Specialised Prescription Forms
It is required that methadone be prescribed using specialised prescription forms.
These prescription forms must be correctly written and allow for a single supply
or supply on instalment. The prescription form must also indicate whether or not
the administration of the dose should be supervised by the pharmacist
(Department of Health 1997).
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(c) Objective (gradual detoxification, maintenance)
The objectives of substitution programmes vary depending on the type of
programme. While the ultimate aim of the services is to facilitate the individual to
return to a drug free lifestyle, a variety of programmes are available. While some
programmes aim to detoxify the individual on a short-term programme others
offer a longer term maintenance which is not subject to a specific time limit.
(d) Substitution drug/s, mode of application
The only substitution drug currently prescribed in Ireland is oral methadone. Prior
to 1996 the only form of methadone available in Ireland was Physeptone Linctus
(2mg methadone per 5mls of syrup). As part of a move in the reorganisation of
the methadone treatment services, the Health Boards decided to transfer patients
on to methadone mixture (5mg methadone per 5mls syrup). This change was first
implemented in treatment clinics and then in GP surgeries. This methadone
mixture is the only form currently available from treatment services.
The Pharmaceutical Society of Ireland has proposed that the use of non-opioid
alternatives to methadone for the management of addiction, such as Lofexidine,
be considered and this is currently being reviewed. Research projects under the
management of the consultant psychiatrist with responsibility for drug misuse are
also currently investigating the effectiveness of Loxexidine, LAAM and
Bufenorphine.
(e) Psycho-social counselling (requirements and practice)
Counselling is available on-site to those attending a clinic-based programme.
Interim programmes have counsellors available to clients on an ad hoc basis.
Access to counselling is provided where there are complex/acute issues
involved. Clients of maintenance programmes are allocated a full time counsellor.
While participation is recommended within the programme, it is ultimately
voluntary. In the GP setting clients can be referred to local counsellors if so
required. Attendance is also voluntary.  There is no data available on the level of
uptake of counselling services or the number of visits made per client from either
treatment setting.
(f) Drug testing
Both clinic and GP based programmes require clients to give regular supervised
urine samples that are tested for the presence of prohibited substances. In the
clinic settings, urine samples are taken on a twice-weekly basis during
stabilisation, and on at least a weekly basis once clients are stabilised. These
samples are all screened for opiates and methadone. On a monthly basis all
clients are screened for other substances such as benzodiazepines and cocaine.
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Where clients are identified as having a specific ‘problem’ with such substances
they are screened for them on at least a weekly basis. Where clients are
transferred to a GP based programme, urine screening is organised between the
Health Board and the GP, and carried out on a weekly basis. All samples are
currently sent to the Drug Treatment Centre for analysis.
(g) Diversion of substitution drugs
No research has been carried out to date in Ireland looking specifically at the
extent to which substitution drugs are diverted. However, the National Drug
Treatment Reporting System data show that of those who presented to drug
treatment services with problem drug use during 1998 (N=5076), 6.3% reported
‘street methadone’ as their main drug of misuse. This suggests that at the time,
methadone continued to be diverted from the treatment service environment.
However, it will be necessary to examine these figures as they become available
to asses the impact of the tighter regulations on methadone prescribing on the
diversion of methadone to the street market.
(h) Statistics (measure point)
At the end of July 2000 there were 4,851 clients receiving substitution treatment
in Ireland. Clients of both GP and clinic based programmes are all registered on
a Central Treatment List. As mentioned in previous sections, opiate use in Ireland
is overwhelmingly based in the Eastern Regional Health Authority Area, therefore
most substitution programme clients are resident there. As of July 2000 only 90
of a total of 4,851 clients registered on the Central Treatment List were receiving
substitution services outside the Eastern Regional Health Authority area. Data
gathered through the Central Treatment List is confidential and is not available
for epidemiological analysis.
(i) Specific research results
Most research carried out in Ireland with clients of substitution programmes has
focused on their identity as injecting drug users rather than their experiences of
substitution programmes. In addition this has been limited to sample populations
from one particular clinic (Smyth et al. 1998; Smyth et al. 1995; Dorman et al.
1997; Williams et al. 1997). Little research has been done looking at substitution
programmes per se.
A nation-wide general population survey on ‘Drug-Related Knowledge, Attitudes
and Beliefs in Ireland’ (Bryan et al. 2000) has been carried out by the Drug
Misuse Research Division of the Health Research Board. In this study one
thousand members of the public were asked about a range of drug-related
issues, including drug treatment services. In relation to substitution services
specifically, respondents were asked to what extent they agreed with the
following statement:
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‘Medically prescribed heroin substitutes [such as Methadone/physeptone]
should be available to drug addicts.’
Only 16.1% disagreed with this statement while 63.5% agreed and 20.3%
responded ‘don’t know’. These views appear to contradict the negative attitudes
expressed by communities in relation to the establishment of treatment centres in
their localities.
Evaluation results
No detailed evaluation of substitution service provision in Ireland has been
carried out to date.
9.5       After-care and re-integration : Eimear Farrell
There has been an increased focus on rehabilitation in recent years as indicated
by recent speeches of the Minister of State with special responsibility for the
drugs area, the service plans of ERHA and the development of a rehabilitation/re-
integration blueprint. However, as of yet, there are relatively few rehabilitation
programmes in place.   Both statutory and community agencies provide these
services.  Below are some examples of the types of rehabilitation programmes
available.
St. Francis Farm
Merchants Quay, a voluntary drug treatment project based in Dublin has
established an innovative drug free therapeutic training facility known as Francis
Farm in a rural area in the south-east of Ireland. The training facility offers a one-
year programme for former drug users, which involves both vocational and
educational training in a farm environment. Participants learn a wide range of
skills including animal care, horticultural techniques, catering and food
preparation, building and joinery, machine maintenance and literacy/numeracy
skills. Organic farming methods are used on the farm to mirror the chemical free
status of participants. The programme enables those with a low skill level to
discover new areas of ability that will help them to gain access to more formal
training on completion of the programme. No statistics or evaluation results are
available. No information on specific training is available.
Tallaght Rehabilitation Project
Tallaght Rehabilitation Project was initiated in early 1997 and began to deliver
services to drug users in the Tallaght area, one of the major Dublin suburbs, in
February 2000. The service provides education and training to former drug users
and drug users who have stabilised on methadone maintenance.  It is run by a
management team of statutory and community representatives.  The aim of the
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project is to facilitate drug users to re-integrate into their communities and into
mainstream employment, education and training. Participants attend the project
for four hours a day.  This is broken down into three hours of education and
training and one hour of social interaction and group work. Currently, 14
participants, nine women and five men are taking part in the programme. No
evaluation results are available. No information on specific training is available.
Soilse
Soilse, set up by Eastern Health Board in 1995, is a dedicated drug rehabilitation
programme specialising in insertion to employment, vocational training and
education.  Soilse aims to overcome the limitations of a psycho-therapeutic
approach to addiction by building goals and supporting participants in their desire
to re-socialise themselves personally, economically and culturally.  Soilse also
seeks to re-integrate former drug users into society through restoring
independence, self esteem and self direction. The programme is a non-
residential day drug rehabilitation model, balancing group therapy and
counselling (resistance training and normative education) with creativity and soft
vocation skills.  An evaluation of the project has indicated that that the
programme has been successful in enhancing participants self-esteem and in
facilitating their entry to employment and training. No statistics are available. No
information on specific training is available.
9.5.2 Employment
FÁS – the state training agency have forged links with the LDTFs and many
participants taking part in rehabilitation programmes are doing so under the
Community Employment Scheme which aims to facilitate the long-term
unemployed in returning to work. FÁS are also making a substantial number of
training slots available for drug addicts in treatment (Farrell 2000).
No statistics or evaluation results are available. No information on specific
training is available.
9.5.3 Housing
No specialised housing projects have been initiated in Ireland for drug users.
9.6 Interventions in the Criminal Justice System : Lucy Dillon
(a) Interventions
Medical (detoxification, drug substitution)
In Ireland any individual held in custody has the right to request to see a general
practitioner (Criminal Justice Act). Where a drug user wishes, he/she may
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request to see a general practitioner who will tend to them while they are being
held in custody and assess whether to provide the individual with medication, e.g.
methadone, to alleviate withdrawal symptoms. However, data is not currently
collected on either the number of people held in custody who avail of this service
or the proportion who do so as a consequence of their drug use.
Upon imprisonment there is a standard thirteen-day methadone detoxification
programme offered to prisoners who are found to test positive for opiates. This
service however is not available in all prisons around the country and tends to be
based in the Dublin prisons. In what has been the main committal prison in
Ireland up until recently (i.e. Mountjoy Prison, Dublin), there were an estimated
1,200-1,500 cases of prisoners receiving methadone detoxification per year
(Department of Justice, Equality and Law Reform, 1999). Prisoners who may
have been stable on a methadone maintenance programme in the community
are generally detoxified upon incarceration.
The following is the detoxification regime followed in Mountjoy Prison, Dublin.
This is a methadone based detoxification programme, in which Melleril1 (25mgs)
is also offered for the first seven nights during detoxification. In the context of
Mountjoy prison this programme has been described as being provided in an
“essentially unstructured and unsupervised fashion, with no follow-up or medium
to long term planning” (Department of Justice, Equality and Law Reform 1999).
The programme is the same for each prisoner, irrespective of the quantity of
opiates being used prior to imprisonment. The doses involved are as follows:
Day 1-2 25mls methadone mixture (green colour)
Day 3-4 20mls methadone mixture (green colour)
Day 5-8 15mls methadone mixture (green colour)
Day 9-11 10mls methadone mixture (green colour)
Day 12-13 5mls methadone mixture (green colour)
Melleril 25mgs each night on day 1-7 of this programme.
The provision of methadone maintenance within the Irish prison system remains
limited. Methadone maintenance is only available to prisoners who are HIV
positive or who have AIDS and, to a limited extent, to those who are on a
maintenance programme prior to imprisonment. Methadone maintenance only
commenced in Irish prisons in the case where a prisoner is HIV+. In a limited
number of prisons, including the country’s main male juvenile prison, a
methadone maintenance programme is available to those prisoners who are
coming from the community and are already on a methadone maintenance
programme. This is a recent development in service provision.
                                                
1 Melleril contains thioridazine which belongs to the phenothiazine class of drugs. Among other uses, it is
used to relieve tension and anxiety.
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Drug-free programmes
The Probation and Welfare Service provides a Drug Awareness Programme in a
number of Dublin based prisons. This is a four-week programme consisting of
one session per week. The principal aim is to educate participants about their
drug use and the associated risks. It is aimed at all prisoners with a history of
drug use, including those who have ceased their drug use and those who are
continuing to use within the prison setting. The programme is run regularly in a
couple of prisons but staffing shortages prevent it from being a more widespread
service.
A seven-week ‘Drug Detoxification and Rehabilitation Programme’ is run by
probation and welfare officers, and is based in the Medical Unit of Mountjoy
prison. The programme caters for nine male prisoners at a time. There is no
equivalent service available to female prisoners. To access the programme
prisoners are interviewed by probation and welfare officers and assessed for
suitability. Only prisoners with less than 26 months to serve or with a court
sentence review date less than 26 months away can apply for the programme.
Participation entails an initial methadone detoxification followed by an intensive
rehabilitation programme. A multi-disciplinary team that includes both medical
staff and counsellors from outside agencies delivers this programme. Participants
who remain drug free during the seven-week period are then transferred to a
designated drug free unit (the Training Unit). While workers from a therapeutic
community are involved in service provision for this particular programme, there
is no therapeutic community type programme available to drug users in the Irish
prison system. A similar programme with more of a focus on factors associated
with imminent release into the community is run over an eleven week period. This
is also based in Mountjoy Prison Dublin and will be discussed in the ‘Release’
section (below).
Self-help groups
Self-help groups within the Irish criminal justice system are based within the
prison setting. The only structured self help group available to prisoners which
specifically addresses the issue of drug use is Narcotics Anonymous (NA).
HIV/Hepatitis prevention (needles and syringe exchange)
Needle and syringe exchanges are not provided to drug users in the Irish prison
system. Furthermore, there is no structured access to cleaning materials for
injecting equipment.
As mentioned above the Probation and Welfare Service in Mountjoy prison
Dublin have developed a Drug Awareness Programme which is also run to some
extent in other prisons. This is a four-week programme consisting of one session
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per week. The principal aim is to educate participants about their drug use and
the associated risks. It is aimed at all prisoners with a history of drug use,
including those who have ceased their drug use and those who are continuing to
use within the prison setting. Included in this programme is a session on HIV and
Hepatitis.
(b) Drug testing
In the community, drug testing (urinalysis) is sometimes used by probation and
welfare officers as a condition of an offender’s Supervision Order.
Routine randomised drug testing is only carried out within the prison system in
the designated drug free area of the Training Unit in Mountjoy Prison. A drug free
environment is ensured by the requirement for all prisoners, irrespective of
whether they have a drug using history or not, to undergo random urinalysis.
Where a prisoner tests positive for a prohibited substance, he is moved either to
another prison or another area of Mountjoy.
Drug testing is also used to monitor those prisoners who are receiving
methadone on a maintenance basis in the prison setting.
(c) Release: referral to treatment, aftercare, probation
In Ireland there is no formal referral scheme for drug using prisoners to treatment
upon release. The need to develop a structured through-care programme from
the prison system to the community has been identified within the Irish criminal
justice system (Irish Prisons Service 2000). The Probation and Welfare Service
of the Department of Justice, Equality and Law Reform carry out group work
programmes in the prison setting. These aim to promote desired behavioural
changes in terms of risk behaviour and drug addiction, and to help prisoners
cope with imprisonment and to prepare them for life demands following release
from prison.
There are also a couple of specific projects underway which are targeted
specifically at dealing with the issues surrounding release:
As mentioned above, the Probation and Welfare Service of Mountjoy Prison run
an eleven week drug rehabilitation programme that focuses on factors associated
with imminent release into the community. The programme facilitates prisoners in
developing a Community Release Plan through contact with his probation and
welfare officer. After the initial eleven week period prisoners are released subject
to Temporary Release Rules. Prisoners then contact their probation and welfare
officer and link in with therapeutic, education, training and employment contacts
in the community.
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There is also a rehabilitation programme for ex-prisoners based in Cork
(southern Ireland), that has as its aim the integration of ex-prisoners back into
mainstream society and stop them re-offending. This is a collaborative project
managed by a partnership of voluntary and statutory bodies, part funded by the
Cork Drugs Task Force. Key roles in the development of the project have been
played by: the Probation and Welfare Service of the Department of Justice,
Equality and Law Reform, the Cork Prison’s Governor, the prison staff and the
Education Department in the prison. The project serves prison inmates, ex-
prisoners, those who are on probation and family members of prisoners. The
project provides a counselling and referral service to clients referred by the
Probation and Welfare Service. In addition the project provides a counselling
service within the prison and an ‘Addiction Education and Awareness
Programme’. Since it started, the project’s counsellor has had some form of
contact with 181 people.
The CONNECT project was established in Mountjoy under the European
DESMOS project which is supported by the European Social Fund under the
Integra Employment Initiative. The main objective of its work is ‘to encourage the
(re) integration of offenders in society through employment as a support.’ Each
country has developed its own national programme which has as its base the
guidelines on employment recommended by the Council of Europe, which have
at its core four aims:
§ Improving employability
§ Developing entrepreneurship
§ Encouraging adaptability of businesses and their employees
§ Strengthening the policies of equal opportunities for women and men.
In Mountjoy, the CONNECT project is an action-research project led by the
Department of Justice Equality and Law Reform and run by the National Training
and Development Institute. Initially the project carried out research to identify the
education and training gaps in programme provision in Mountjoy Prison and the
Training Unit. In response, the project has developed and implemented pilot
strategies and systems to fill the gaps identified and improve the employability of
offenders while in custody. Included in the pre-vocational training is training in job
seeking skills and work-related social skills. The process at the centre of the
project is described as the ‘transition from custody, through training, on to
reintegration in the community and more specifically, on to labour market
participation’. Each course caters for up to fourteen male prisoners.
(d) Statistics and evaluation results
There has been little evaluation carried out of programmes aimed at drug users
in the Irish criminal justice system. Crowley (1999) provided a medical review of
the seven-week Drug Detoxification and Rehabilitation Programme in Mountjoy
prison, Dublin. Up to February 1999, 187 prisoners had entered the programme,
173 completed the detox and 14 failed to complete the detox. While this implies a
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93% success rate, Crowley (1999) highlights the need for the success of this
intervention to be determined by the 6 and 12 month relapse figures. Overall it
was found that there was a twelve monthly relapse rate of 78%. Crowley argues
that while this may appear high, it compares favourably to outcome rates of other
inpatient detoxification programmes.
(e) Specific training
There is little specific training of those working within the Irish criminal justice
system in relation to drug use and the specific needs of drug users.
As part of their training, members of the Irish police force (An Garda Siochana)
receive instruction in the area of drug misuse. The programme includes training
in:
§ the enforcement of drug-related laws
§ the procedures for dealing with drug cases
§ health and safety issues.
As part of its proposals for the staff development the Steering Group on Prison
Based Drug Treatment Services (Irish Prisons Service 2000), it is proposed that
a special Prisons Service Training Officer be appointed. It is proposed that this
Training Officer would work in tandem with the Area Health Authority’s training
department of the Drugs/AIDS services. The Officer would have responsibility for
implementing a full training package for all staff within the prison who are working
with drug users. The proposed training would consist of two levels. The first level
would cover general education, basic skills training and awareness training of
drug problems for all prison staff in relevant institutions. The second level would
be more specific training for a core group of staff who would be working directly
with drug users, within prison treatment units.
There is an on-going review of the prison services which  includes an evaluation
of the prison drug service.
The Probation and Welfare Service have funded two places in one of the drug
treatment clinics – Ashling, thus there are 2 treatment places available to which
the probation and welfare service can refer people.
The Bridge Project : Eimear Farrell
The Bridge Project is a community-based programme for young adult offenders
that provides an alternative to custody.  It is supported by the Probation and
Welfare Service.  It aims to prevent re-offending by young adult offenders (aged
between 17 and 26) who would otherwise receive substantial custodial
sentences. The programme addresses the key factors that contribute to and are
associated with criminal behaviour such as drug addiction. The programme
consists of three phases.
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Phase 1: This phase involves a detailed assessment of each participant to
determine his/her strengths and weaknesses and prepares participants for the
second stage of the project which involves group work.  During this phase,
addictions and other personal and social problems are identified.
Phase 2: The second phase consists of a 17 week intensive group-based module
which focuses on participants offending behaviour and how it has affected them,
their families and the victims.  Contributing factors which can influence offending
behaviour such as alcohol, drug and gambling addictions, family relationship
problems, violence and anger management are also addressed.  During this
phase, education and training and work needs of participants are assessed.
Phase 3: In this phase, participants pursue personal goals in education, training
and employment. This phase continues until participants’ court orders are
completed.
An evaluation of the Bridge Project (Kelleher Associates 1998) has shown that
participants respond positively to the programme. No statistics are available. No
information on specific training is available.
Cork LDTF – Rehabilitation Programme for Ex-Prisoners
This project based in Cork, received funding to set up a rehabilitation programme
with the aim of integrating ex-prisoners back into mainstream society and stop
them re-offending.
The project is managed by a partnership of voluntary and statutory bodies but
has a specific management committee of four. The Probation Service of the
Department of Justice Equality and Law Reform has along with the Governor his
staff and the Head Teacher and the Education Department in the prison been the
primary animators in the development of this project. The project serves the
inmates of the prison who prior to detention resided in the Cork Drugs Task
Force area but also works with family members of prisoners and with ex-
prisoners and those who are on probation. An addiction counsellor has been
employed by the project to work with the above target group.
The project provides a counselling and referral service to clients referred by the
Probation and Welfare Service. The project also provides an individual
counselling service in Cork Prison and an Addiction Education and Awareness
Programme. The worker runs an Alcohol Management Course with the Intensive
Probation Scheme and also link in with the Auto Crime Diversion Unit. A working
alliance has been established with a number of related groups. Since the
project’s inception, 181 people have had some form of contact with the
counsellor. In addition to this number there is a current waiting list of fifteen.
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9.7 Specific targets and settings
Gender-specific issues
SAOL
The SAOL programme is an inner city rehabilitation and training project for a
small group of women in recovery or stabilised on methadone.  It offers women a
chance to acquire a range of skills including literacy and numeracy and other
social skills in order to give them a better opportunity to return to normal living.
The project operates on the basis of social justice, adult education and
community development principles. An evaluation of the project found that
women who participate in the programme report increased stability in their lives,
increased levels of self-esteem and gains in terms of educational and vocational
development (SAOL Project, 1996). No statistics or information on specific
training are available.
Women’s Health Project
This project was established in 1991 to target women working in prostitution in
Baggot St. Clinic of the EHB. The overall aims of the project are to prevent HIV
and improve the general health and well being of the women attending the
project. There are two main aspects of this service – 1) a drop in
medical/counselling service in an informal setting, which aims to promote
women’s health in a confidential way in an informal setting and 2) an outreach
service.  The project provides advice on safer sex and injecting, needle exchange
and offers a wide range of health services including cervical smears, STD
screening, contraception and HIV and Hepatitis testing and referral to other
services (O’ Neill & O’ Connor 1999). The project operates on a peer-support
basis where women involved in prostitution are involved in contacting other
female sex workers (EMCDDA 1999). Since May 1999, a harm reduction service
consisting of a low dose of methadone and needle exchange has been provided
on a nightly basis from the mobile clinic unit that operates daily throughout the
city.  A welfare service is also available once a month which provides advice on
welfare rights such as entitlements and housing. No statistics or evaluation
results are available. No information on specific training is available.
Star Women’s Rehabilitation Project
This project established in 1998, provides a 50 week adult education and training
course for 15 women drug users who have stabilised on methadone
maintenance.  It operates in the Ballymun area of Dublin city.  The programme
consists of 6 week modules covering a variety of issues including
communication, computers, team building, parenting, basic English and art
drama and drug issues.   Of the 1999 programme cohort, 9 of the 15 initial
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participants completed the programme.  Of the six that did not complete the
programme, four left to pursue further training or other positions. At the end of the
programme, nine of the fifteen initial cohort were either in training or community
employment, one was employed in the industrial sector, four were actively
seeking employment and two were not seeking work (Ballymun Local Drug Task
Force, personal communication 2000). During the course of the year, many of the
participants attained accredited training qualifications in areas such as word
processing, addiction studies, childcare and youth studies. No evaluation results
or information on specific training are available.
Children of drug users
Support is provided in some local areas by way of crèche, play-school and after-
school facilities for the children of drug users receiving treatment.  However, a
study by Moran (1999) indicates that current levels of crèche provision are
inadequate.  The study found that only 20% of drug treatment centres in the
Dublin area currently provide crèche facilities and that existing crèche facilities
are insufficient. The study found that lack of access to crèche facilities served as
a barrier to treatment uptake.
Lorien Project
(See Section 9.1.1 for details).
Parents of drug users
Family Communication and Self-Esteem programme
(See Section 9.1.1 for details).
Fás le Chéile
(See Section 9.1.1 for details).
Kilkenny Drugs Initiative (KDI) Family Support Group
This group, based in Kilkenny city in the south-east of Ireland, was set up for
parents and partners of substance misusers in Kilkenny city and county.  The
group meets once a week for two hours and offers an opportunity for people to
come together to chat, share information and talk about their experiences.  It also
offers the opportunity for personal healing through aromatherapy, meditation, and
the chance to engage in substance misuse education programmes. No statistics
or evaluation results are available. No information on specific training is available.
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Drug use at the workplace
No information available.
Ethnic minorities
Cork LDTF – Travellers Visibility Group
Funding was granted to conduct research on the experiences and attitudes of
young travellers and their families in relation to drug misuse. The task force is
developing focus groups amongst the young people and through these groups
they plan to assess drug experiences amongst the Traveller community.
The issue of drug use among ethnic minorities including an indigenous Irish
ethnic group known as ‘travellers’ is an emerging issue which requires further
attention.
Self-help groups
A variety of self-help groups are available through the drug treatment centres.
There are also a number of community based self help groups including
Narcotics Anonymous which is based on the 12 step AA philosophy and Nar-
Anon a support group for the families and friends of drug users based on similar
principles. No statistics or evaluation results are available. No information on
specific training is available.
Alternatives to prison and prosecution: Lucy Dillon
In Ireland, where drugs are involved in an offence, the police have no
discretionary powers to issue a caution [informal or formal] nor to impose an on-
the-spot fine. Therefore, officially, charges will be brought against any individual
found to have committed an offence against the Misuse of Drugs Act. An
exception is made in the case of a juvenile offender (under 18 years old) found in
possession of a small amount of drugs, where drug trafficking is not an issue. In
such a case, the Juvenile Diversion Programme is brought to bear. The Garda
Juvenile Diversion Programme was introduced in 1963 with the aim to divert
juvenile offenders from criminal activity. The Programme allows that if certain
criteria are met, a juvenile offender may be cautioned as an alternative to being
prosecuted. The programme operates on the basis of the common law principle
of police discretion (An Garda Siochana 1999). While this programme is
specifically aimed at juvenile offenders committing first offences, it can be
adapted/extended to include juveniles committing subsequent offences.  A
juvenile offender who is eligible for inclusion in the programme is dealt with by
way of a caution, as opposed to being prosecuted for a criminal offence.
Cautions may be either formal or informal. A Juvenile Liaison Officer [JLO]
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becomes involved with the offender and the family.  While an informal caution
may be given by the JLO, a formal caution must be given by the Garda
Superintendent of the district where the offender lives. There is no provision for a
similar system of cautioning for adults.
In terms of alternatives to prison there is a range of non-custodial options
available to sentence those who plead guilty or are found guilty through the
courts. The decision of the court in relation to the imposition of a custodial or non-
custodial sentence may be influenced by a Pre-Sanction Report where available.
This report is compiled by the Probation and Welfare Services and includes
information on factors such as addiction that may have contributed to the
individual’s offending. Pre-Sanction Reports are often not available, however a
judge may request that one be provided. The non-custodial options available in
the Irish criminal justice system were overviewed in a report on the Irish
Probation and Welfare Services (Expert Group on The Probation and Welfare
Services 1999) and include :
§ A suspended sentence*
§ Supervision during deferment of penalty*/ Intensive Supervised Probation:
This facility was designed to increase restraints on offenders in the
community. Offenders are required to report for frequent urine testing. The
type and levels of demand placed on offenders differ enormously by
jurisdiction
§ A Community Service Order: Community Service Order requires offenders to
perform unpaid work for between 40 and 240 hours. There is a perceived lack
of suitability of community service for offenders with addictions (Expert Group
on The Probation and Welfare Services 1999). This can be due to the
Probation Service’s inability to provide occupational insurance in the event of
an accident due to known disability in the offender i.e. addiction
§ A fine: A fine has statutory limits, fixed for a particular offence. The money
goes to Central Funds and if unpaid can be enforced by committal to prison
§ A Compensation Order: A Compensation Order has a specific statutory
format as laid out in the Criminal Justice Act, 1993 and is related to the wrong
done. The money goes to the victim as opposed to Central Funds
§ A fine and Compensation Order
§ Release under the Probation of Offenders Act, 1907: In this instance a
decision is made not to proceed to convict
§ Probation Order (Probation of Offenders Act, 1907): The purpose of a
probation order is to secure the rehabilitation of the offender, to protect the
public and to prevent the offender from committing further offences. This is
used for drug users by imposing conditions. Conditions may include
attendance for treatment and the provision of urine for analysis. This is the
preferred procedure in the District Court when dealing with drug users
§ Order of Recognisance (Misuse of Drugs Act, 1977, Section 28 as amended
by the Misuse of Drugs Act, 1984): This is an order requiring an offender to
                                                
* Both these options have no statutory basis but are widely used by the Courts
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undergo treatment for his/her drug condition in a residential centre or in the
community.
The ‘Order of Recognisance’ would appear to be an important non-custodial
option for drug users who offend in Ireland. However, in practice this Order is not
generally used by the courts. The necessary rules and regulations have not been
made. Furthermore, the provision of a statutory place of treatment has always
been problematic. The Expert Group on the Probation and Welfare Services has
recommended that the necessary Courts Rules and Regulations be updated by
the various Court Rules Committees to facilitate wider use of the ‘Order of
Recognisance’ (Expert Group on the Probation and Welfare Services 1999).
Furthermore, it is planned that a Drug Courts system will be introduced in Ireland
on a trial basis early in the year 2000. ‘The Working Group on a Courts
Commission’ was established by the Minister for Justice, Equality and Law
Reform to advise on the development of such a Drug Courts System. As
mentioned above, the legislative framework required for such a system is already
in place under the Misuse of Drugs Act, 1977 as amended by the Misuse of
Drugs Act, 1984.
‘Power of court to remand person convicted of offence to which
section 7 applies and to obtain a report and in certain cases to
arrange for the medical or other treatment or for the care of such
person.’
[Section 8, Misuse of Drugs Act, 1984]
While this legislative framework exists, little use of it has been made in relation to
a court arranging for the treatment of an individual. The Working Group’s report
however describes what it sees as a ‘quasi-drug courts system’ in operation in
some courts. In these instances a court may adjourn a case for a time, usually a
year, during which time the accused undergoes treatment while being monitored
by the Probation and Welfare Services. The accused enters into a bond that
requires him/her to follow the direction of the Probation and Welfare Services
over a certain period of time, usually at least one year. Where this bond is
broken, for example if the accused gives a urine sample that tests positive for
opiates, the Probation and Welfare Service and the Gardai can bring offenders
back to the court. The limitations to this process have been highlighted by the
Working Group. These include a lack of resources in the Probation Service.
In a second example, the report describes a sentencing structure adopted by one
particular judge residing in the Circuit Court. Upon a guilty plea the defendant is
either remanded on continuing bail or in custody. A Probation and Welfare Report
is then requested and the defendant is given the opportunity to address his/her
addiction by attending treatment and undergoing urinalysis. When the defendant
returns to court for sentencing the Probation and Welfare Report is taken into
account (Working Group on a Courts Commission 1998).
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Thus, while a ‘quasi-drug-court’ system may be in place in Ireland, this does not
function in a unified or structured manner, and does not have adequate
infrastructure. At the time of writing the application of such diversion activities
depend on individual judges and the availability of relevant support. The
implications of such activities therefore occurs in an ad hoc manner. A structured
drug court will be initiated on a pilot basis later in the year 2000 under the
jurisdiction of the District Court. This pilot programme will be subject to an
independent evaluation.
10. Quality Assurance
10.1 Quality assurance procedures
As outlined in 12.3 below, a culture of evaluation is developing in the drugs area
and is an integral aspect of programme development in some existing
programmes. For example, guidelines have been developed for the conduct of
evaluations in the context of the LDTFs [see 12.3].
Evaluation of Local Drug Task Force Funded Projects
Over 200 projects were funded through the Local Drug Task Forces during 1999
and 2000.  During April and May 2000, 133 of these projects were evaluated.
The evaluations were process orientated and centred on the development of
objectives and setting up of appropriate structures and processes to support the
achievement of these objectives rather than outcomes.
Of the projects evaluation, half were in the field of education and prevention,
about a third (36%) were treatment and rehabilitation projects, and the remainder
were in a combination of education/prevention and treatment/rehabilitation (7%),
research and information (3%) and supply control (3%).   Most of the projects
were based in either the voluntary/community sector (58%) or were a partnership
of voluntary and statutory agencies (22%), 6% were statutory agency projects
and the remaining 14% were classified as ‘other’ (National Drug Strategy Team,
personal communication).  On the basis of the evaluation reports produced, the
National Drug Strategy decided that 122 of the 133 projects would be
mainstreamed. This effectively means that these projects will receive statutory
funding on an on-going basis in line with agreed procedures.  A composite
evaluation report is currently being compiled, however, it was not available at the
time of writing.
10.2 Treatment and Prevention Evaluation
There is little evaluation carried out in the treatment services but this is changing
with a move towards evidence-based health care delivery.
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Review of EHB Drugs and AIDS Service
A review of the Eastern Health Board’s Drugs and AIDS services was conducted
during 1999 (Farrell et al. 2000). The review was designed to examine the
service development over the 5 years since the last review was undertaken, to
assess the current service provision and service mix and to make
recommendations about policy development and the evolution of policies in the
context of services and practices elsewhere. The report concluded that the
Eastern Health Board has achieved a major expansion in drug services over the
last five years and has developed innovative services. A number of
recommendations were made in the report. It was suggested that an audit of
benzodiazepeine use should be conducted and that the current needle exchange
facilities be expanded. The need to broaden the services available and consider
briefer types of intervention was also recommended (See Section 9.4.1 for further
details of the evaluation).
10.3 Research
A National Advisory Committee on Drugs comprising of experts from the research,
voluntary, community and statutory sectors was established during 2000 to co-
ordinate and commission research on drug problems. This advisory group have
identified a prioritised three year research programme.
The Drug Misuse Research Division has an active research programme and
currently 8 projects are underway [see www.hrb.ie].
An Addiction Research Centre has recently been established in Trinity College
Dublin.  This centre will be involved in research into drug addiction in the coming
years.
10.4 Training for professionals
There has been a major proliferation in the number of training courses in the
drugs area in Ireland in recent years [see Department of Tourism, Sport and
Recreation 1999. Directory of Training Courses in Drug Misuse].  The growth in
provision is partly in response to a growing demand for trained workers with
expertise in the drugs area, e.g. community and voluntary sectors, inter alia.
In August 1999, the Department of Tourism, Sport and Recreation commissioned
a study to compile a directory of existing courses and to identify gaps and
overlaps. The study identified a wide variety of training courses, ranging from
single sessions to courses lasting between one and three years.  The depth of
coverage of the issues varies considerably, according to the length of the course
and the level at which it is aimed.  There are also variations in the training
methods and in the underlying principles and approaches to the issues of drug
misuse.  The problem of drug misuse provokes different feelings, attitudes and
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beliefs, and these are reflected to some extent in the training courses listed in the
directory.  Some courses provide broad coverage of a variety of viewpoints, while
others are clearly based in the context of a particular perspective.
While there is a wide range of courses available, not all of these are available
throughout the country. In general, the Dublin area is best provided for, while the
range of training available elsewhere is more limited, although there are
indications that this is beginning to change.
The courses listed in the directory are divided into six categories, according to
course length and purpose.  The categories used are as follows:
A) Short courses aimed at providing basic information and/or raising awareness
of drug misuse among the general public
B) Short courses aimed at providing information, raising awareness and
developing skills among those whose paid or voluntary work brings them into
contact with drug misuse
C) Longer courses aimed at providing information, raising awareness and
developing skills among those whose paid or voluntary work brings them in
contact with drug misuse
D) Courses leading to professional qualifications in the field of drug misuse
E) In-service training for professionals and other vocational groups working in
the field of drug misuse or related areas
F) Courses in drug misuse aimed at young people.
The directory is very extensive (though it claims not to be exhaustive) and
includes almost 40 courses.  Therefore, in this section, only a selection of these
courses is described.  As the purpose of this section is to describe the types of
courses that are available for professionals, the courses described here are
examples of the type of courses offered under categories C and D listed above
which covers courses for both community members and voluntary workers and
courses that result in professional qualifications.  Within these categories, the
courses were chosen to represent examples of the type of programmes offered
by the three main education providers in this area, namely, community
organisations, voluntary agencies and the third level education sector. No
statistics or evaluation results are available for any of the programmes presented
here.
Examples of Category C Courses
DICE – Drugs Information and Community Education
This course is provided jointly by two community development projects based in
one Dublin suburb – namely the Project West Community Development Project
(CDP) and Finglas South CDP.  The course was developed as a local response
to drug addiction and leads to the award of a National University of Ireland  (NUI)
certificate.  The programme, which is 100 hours in duration, is designed for
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community members. It is designed to allow participants develop an awareness
and understanding of addiction and how it can impact on the community.
Urrus/Ballymun Youth Action Project
The Ballymun Youth Action Project, the first community response to drug misuse in
Ireland, was set up in 1981.  Urrus was established in 1996 to deal with all aspects
of training within the Ballymun Youth Action project. Urrus runs two courses in the
drugs area: a community addiction studies course and a course that provides
further training in community drugs work.
The community addiction studies course : This course consists of five units
(drugs and their effects; the process of addiction; intervention strategies;
community responses; and personal development) and is 100 hours in duration.
It aims to provide participants with knowledge about different drugs and their
effects, to raise awareness of the dynamics of addiction, to challenge attitudes
towards drugs, addiction and communities affected by addiction.  It also
examines community responses to drugs using the Ballymun Youth Action
Project as an example.  It is open to anyone with an interest in the drugs field
including; professionals, community and voluntary workers, community members,
young people, stabilised drug users and people in recovery. It is counted as one
module of a National Council for Vocational Assessment (NCVA) level 2
qualification.
Further Training in Community Drugs Work : This course is aimed at local people
who have completed the Community Addiction Studies course.  It is designed to
provide participants with the skills to deliver drug awareness programmes in their
own communities. It is counted as two modules of a National Council for
Vocational Assessment (NCVA) level 2 qualification.
IACC Training
The Irish Association of Addiction Counsellors has secured funding to provide
additional training in drug misuse treatment to ensure high standards are
maintained in the area.
Merchants Quay Project Drugs/HIV Service
The Merchants Quay project provides a number of courses in drugs and
addiction education including the following:
· Foundation level course in drug use and addiction
This course serves as an introduction to the broad issues associated with
drug use and addiction.  It is designed to prepare participants to interact with
drug users and the issues that they face.
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· Motivational interviewing and brief counselling skills course
This intensive three-day course is aimed at people working with drug users. It
is designed to teach participants motivational interviewing and brief
counselling/intervention skills.
· Certificate in drug counselling and intervention skills
This one-year part-time course validated by the University College Dublin
aims to provide participants with the skills to respond more effectively to the
issue of drug misuse.  The course consists of three modules: theories and
models of; 1) addiction, 2) intervention and brief therapy skills for working with
drug users and 3) policy and prevention. It is targeted at both paid and
voluntary workers who work in the area of drug misuse.
Examples Of Category D Courses
National Diploma/Degree in Community Drug Prevention Studies
The Waterford Institute of Technology, located in the South east of Ireland,
provides an introductory certificate, a diploma and a degree course in community
drug prevention. All courses are offered on a part-time basis.  The aim of the
courses is to provide accredited third level education that will qualify candidates
to work in the area of community drug prevention. The courses were developed
in conjunction with the South Eastern Health Board in response to a need for
skilled drug workers in the region.
National University of Ireland (N. U. I.) - Certificate in Addiction Studies
This course run by the Centre for Adult Education, N U I Maynooth, is aimed at
voluntary and community workers with experience or interest in the drugs area.  It
is designed to provide participants with the knowledge and skills necessary to
respond positively to addiction related issues. It focuses on current debates on
addiction and uses teaching methods based on the principles of adult education.
In 1999/2000, the course is also being provided at a number of locations in the
Dublin area and to Eastern Health Board staff.  The course is also being offered
in Clonmel (South Eastern Health Board).
Trinity College Dublin - TCD
The Department of Social Studies, in Trinity College, provides both a Diploma in
Addiction Studies and an M.Sc. in Drug and Alcohol Policy.
Diploma in Addiction Studies - TCD
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This one-year full-time course is aimed at people with experience in
the drugs field.  It is designed to allow participants to familiarise
themselves with the various treatment modalities and to develop an
understanding of evaluative research.   It examines the theoretical
and practical aspects of problem drug and alcohol use and analyses
public policy in relation to alcohol and drug problems. Participants are
also trained to be proficient in the use of at least one of the major
counselling approaches.
M.Sc. in Drug and Alcohol Policy - TCD
This part-time course conducted over a two-year period is aimed at those holding
management or policy-making positions in the alcohol and drugs field.   It is
designed to allow students to develop a broad critical understanding of how
society attempts to prevent or respond to problems associated with the use of
illicit and licit drugs. The course consists of six modules; 1) alcohol and drugs –
use and problem use, 2) national and international policy, 3) research and
evaluation, 4) research seminars, 5) therapeutic interventions into problem
alcohol/drug use and 6) service management.
11. Conclusions: future trends
A partnership approach has been adopted in the drugs area in Ireland with
voluntary, statutory and community sectors working together to tackle the drug
problem. This approach is reflected in the Local Drugs Task Force (LDTF)
structures and in the models of work adopted by the Health Boards. This model
appears to be working well and is likely to continue in the future.
Community based projects based in the areas designated to have the most
serious drug problems, have in recent years, been securing funding through the
Local Drugs Task Force structures. This trend is also likely to continue, as is the
recent approach of mainstreaming projects funded through the LDTFs following
evaluation.
The increase in the funding allocation for the Young People’s Facilities
and Services Fund (YPFSF) should result in a proliferation of projects
aimed at young people in disadvantaged areas over the coming years.
Two other major additional developments during 2000 are likely to have a major
influence in the drugs area; 1) The Review of the National Drug Strategy and 2)
the establishment of a National Advisory Committee on Drugs.
The findings of the National Drug Strategy Review will have a major impact in
shaping Irish drug policy in the coming years. The National Advisory Committee
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on Drugs will, inter alia, provide support for research which will help inform policy
in Ireland over the coming years.
There also appears to be an increased focus on rehabilitation in the drug
services and on increasing the options available to drug users in treatment,
particularly in relation to providing alternatives to methadone, which is likely to
continue for the foreseeable future.
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PART 4
KEY ISSUES
12. Drug Strategies in European Union Member States :
Rosalyn Moran
12.1 National policies and strategies
Since 1996, the Irish Government’s drugs strategy has been underpinned by the
findings, recommendations and policies established by the two reports of the
Ministerial Task Force on Measures to Reduce the Demand for Drugs.
De facto, national policies and strategies in recent years have been undergoing
considerable changes which involve an integrated, inter-agency response to the
drugs problem with involvement of local communities in policy making and
implementation [e.g. Integrated Services Process, Local Drug Task Forces  etc.].
More recently, greater regionalisation in the implementation of initiatives in the
drugs area is taking place within the framework of the new National Development
Plan 2000-2006 and related social partnership arrangements, which, inter alia,
prioritise social inclusion as an objective of national development. These and
related developments are likely to be reflected and, if so, formalised in the major
review of the National Drugs Strategy which is currently underway and which is
due for completion before the end of 2000 [see below].
At the micro level, a major objective of drug policy in Ireland is to maintain people
in, and restore misusers to, a drug free lifestyle.  In practice, it is acknowledged that
this is not an option for a number of citizens in the short term.  Accordingly, a
pragmatic approach is taken and the importance of the minimisation of risk i.e.
harm reduction is stressed in treatment and in a number of education and
rehabilitation programmes. The emphasis on harm reduction has grown with the
concern relating to the public health implications of the growth in AIDS/HIV and
hepatitis B and C infections.
The overall aim of the Irish Government’s Drug Strategy is to provide an
effective, integrated response to the problems posed by drug abuse and to work
in partnership with the communities most effected by the drugs problem in
tackling the issues raised.
Arising from this, the key objectives of Government policy are to :
· reduce the number of people turning to drugs in the first instance through
comprehensive education and prevention programmes
· provide appropriate treatment and aftercare for those who are dependent on
drugs
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· have appropriate mechanisms at national and local level aimed at reducing
the supply of illicit drugs and
· ensure that an appropriate level of accurate and timely information is
available to inform the response to the problem.
In line with these overall aims and objectives, four basic principles underpin the
Government’s strategy :
- it is recognised that an effective strategy must encompass a range of
responses which not only addresses its consequences, but also attacks its
causes
- the response to the drug problem must take account of the different levels of
drug misuse, which are being experienced around the country.  While illicit
drug use is a nation-wide phenomenon, [particularly the use of drugs such as
cannabis and ecstasy], heroin abuse – in view of its public health implications
and close association with crime – is currently seen as the most pressing
aspect of the problem.  A more targeted response is required, therefore, in the
areas experiencing the highest levels of heroin abuse
- the need for all agencies which have a role in responding to the drug problem to
work together so as to ensure that their individual contributions form part of an
overall coherent approach. There is a need to ensure that all programmes and
services which respond to the drug problem are delivered in a coherent,
integrated manner
- the need to tap the depth of experience and knowledge which community
groups and voluntary organisations can bring to a response to the drug
problem. It is recognised that there is considerable knowledge and experience
among communities in the areas experiencing the highest levels of use. These
communities, therefore, must have an opportunity to participate in the design
and delivery of the response to the problem in their areas  [Flood, 1999].
An interesting aspect of the Irish Government’s drugs strategy is a resourcing of the
development of sporting and recreational activities for young people at risk with a
view to promoting more healthy and productive behaviour.
As outlined in Part 1, Ireland’s drug policy is most appropriately viewed within the
framework of the Government’s response to social exclusion. A nexus of
agreements between the Government and the social partners has resulted in social
inclusion becoming a major aspect of the Irish National Development Plan 2000-
2006. Under this seven year Plan spending earmarked for social inclusion amounts
to Ir£19,077.7 million i.e. Euro 24,223.7m. The Plan involves greater devolution to
the regional and local levels, with the South-East region and Border-Midland West
regions receiving respectively allocations of Ir£112 and Ir£10 million [Euro 142.2m
& 12.7m] specifically to combat drug abuse.
The recently established County and City Development Boards – CDBs whose
primary function will be to draw up a comprehensive Strategy for Economic,
Social and Cultural Development [by Jan 2002] have a key role in co-ordinating
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local delivery of social inclusion measures. The CDB’s will operate on the
partnership principle with the Regional Assemblies and under the local
government umbrella with membership drawn from local development
organisations, social partners, local representation of State agencies and local
government itself [NDP – National Development Plan 2000]. A Director of
Community and Enterprise has been appointed by each CDB. All the relevant
programmes and projects, and their delivery mechanisms, covered by the NDP
will be expected to accord with this framework.
The Government’s social inclusion strategy involves a range of responses, which
addresses the causes and consequences of drug misuse. The Government’s
response can be characterised as supporting general initiatives to tackle social
exclusion and specific initiatives within the social inclusion framework but more
specifically targeted at drug related problems. The general initiatives are targeted at
issues seen as contributing to the drugs problem [e.g. unemployment, social
deprivation] [see DMRD (1999), National Report on Drug Issues 1999, Ireland;
internal report]. Such programmes provide scope for agencies and communities
affected by the drugs problem, to avail of financial and other resources to tackle the
broader problems associated with drug misuse in their communities.
The Government’s specific response to tackling the drugs problem is focused
around two major initiatives - the Local Drug Task Forces and Young People's
Facilities and Services Fund [see 12.2 below]. Both initiatives have been largely
focused on urban areas where the drug problem is most acute. These initiatives will
be described in section 12.2 below.
In addition to these two major initiatives which are largely focused in urban areas,
Government strategy has begun to address the drug problem on a nation-wide
basis in particular the use of recreational drugs, such as cannabis and ecstasy,
particularly among young people. Regional Drugs Co-ordinators have been
appointed to assist the Regional Health Boards in developing appropriate
programmes and services, mostly in relation to drug awareness, education and
prevention. A number of the Health Boards have set up Regional Co-ordinating
Committees in their areas, which work in partnership with other relevant agencies in
developing a co-ordinated response to the drug problem, having regard to the
needs of their particular regions.
The status of the national strategy on drugs in Ireland is characterised by
change and development at this time. The Government [informed by experience
with the implementation of the various policy initiatives at local level and by
international experience] have identified a need to examine the existing strategy
and initiatives. Two major initiatives have been put in place in this context. A
comprehensive review of the National Drugs Strategy is underway and is due to
report before the end of 2000, and a National Advisory Committee on Drugs has
been established.
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Review of the National Drugs Strategy
A comprehensive review of the National Drugs Strategy was initiated by the
Department of Tourism, Sport and Recreation in April 2000. A sub-group of the
Inter-Departmental Group on Drugs, which includes representatives of the State
Agencies and the National Drugs Strategy Team, are overseeing the
management of the review. They were assisted by independent consultants. It is
intended that the review will be completed and the new strategy in place before
the end of the year.
The objective of the review is to identify any gaps or deficiencies in the existing
strategy and to develop revised strategies and, if necessary new arrangements
through which to deliver them. The review will identify the latest available data on
the extent and nature of drug misuse in the country as a whole and it will also
attempt to identify any emerging trends and pinpoint the areas with the greatest
levels of drug misuse. To be as comprehensive as possible, the review will also
be looking at international trends, developments and best practice models
[DofTSR, Internal doc., No. 2].
The review has involved extensive consultations through invited submissions
[over 190 received], discussions with key players in the State, voluntary and
community sectors and through a series of 8 public regional consultative fora
[attendance 600 approx.] held throughout the country during June 2000. Over 30
agencies and organisations were invited to make detailed presentations to further
assist in the identification of any gaps or deficiencies in the current strategy.
These consultations will be underpinned with extensive research of international
examples of best practice, a review of various relevant evaluation reports and
other literature.
The Drug Misuse Research Division made a detailed written submission and
were one of the groups invited to make a presentation at the oral hearings.
While the results of the review will not be published until  the end of 2000/early
2001, on the basis of the Drug Misuse Research Division’s attendance at the
Public Fora held nationwide, and documents to hand [DofTSR, Internal
Document] the emerging issues include :
· the need for co-ordination between the various “players” – statutory and
voluntary/community – dealing with the drug problem on the ground
(especially in non-task force areas)
· the need to make substance misuse programmes compulsory in all schools,
particularly in Local Drug Task Force areas to heighten awareness
· the need for a continuum of care for drug users and for more “half-way”
houses for recovering drug users to ease the transition back to “normal” life
· the need for an awareness programme for parents to educate them on issues
around drug misuse and the various services that are available
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· the inclusion of alcohol in any new strategy – for many areas, under-age
drinking is seen as a big problem and a “gateway” drug
· the need for a major media campaign highlighting the dangers of drug use
· the need for increased treatment facilities
· the need for improved community policing particularly in areas of high drug
misuse
· the need for research findings into all aspects of drug misuse.
In addition, an address by the Minister of State for Local Development and with
special responsibility for the National Drugs Strategy, Mr. Eoin Ryan T.D. at the
European Cities Against Drugs [ECAD] conference on 28th April 2000 where he
outlined some of his policy priorities for tackling the drugs problem over the
coming years, is indicative of future directions -
1. Continuation of support for the Local Drugs Task Forces as a mechanism for
responding to the drug problem at local level.
2. Given the success of the Task Forces, it intended that the partnership
principles enshrined in them are expanded to the rest of the country.
3. Programmes to move people who are in treatment towards full rehabilitation
and re-integration into society will be supported. Such programmes will
address the education and training needs of drug users, to equip them with
the skills to access employment.
National Advisory Committee on Drugs
An Interim Advisory Committee on Drugs was established by the Cabinet
Committee on Social Inclusion in recognition of the importance of having
authoritative information and research findings available as a guide to policy. The
Group was chaired by the then Minister of State with special responsibility for
National Drugs Strategy, Chris Flood T.D.. The Group reported in February 2000
and, inter alia, made a number of recommendations regarding a structure and
composition for a National Advisory Committee and recommendations for a three
year programme of research and evaluation on the extent, nature, causes and
effects of drug misuse in Ireland.
The resultant National Advisory Committee on Drugs, NAC - was established in
July 2000. The Committee is being established on a non-statutory basis for 3
years and will have responsibility for research and information on drug misuse in
Ireland and for a 3 year prioritised work programme of research and evaluation.
The functions of the Committee are as follows :
· to advise the Cabinet Committee on Social Inclusion and through it, the
Government - based on the Committee’s analysis and interpretation of
research findings and information available to it - in relation to the prevalence,
prevention, treatment and consequences of problem drug use in Ireland
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· to review current information sets and research capacity in relation to the
prevalence, prevention, treatment and consequences of problem drug use in
Ireland and to make recommendations, as appropriate, on how deficits should
be addressed including how to maximise the use of information available from
the community and voluntary sector
· to oversee the delivery of a three year prioritised programme of research and
evaluation as recommended by the Interim Advisory Committee to meet the
gaps and priority needs identified by;
¨ using the capacity of relevant agencies engaged in information gathering
and research, both statutory and non-statutory to deliver on elements of
the programme
¨ liasing with these agencies with a view to maximising the resources
allocated to delivering the programme and avoiding duplication
¨ co-ordinating and advising on research projects in the light of the
prioritised programme;
¨ commissioning research projects, which cannot be met through existing
capacity
· to commission additional research at the request of the Government into drug
issues of relevance to policy
· to work closely with the Drug Misuse Research Division of the Health
Research Board on the establishment of a national information/research
database (in relation to the prevalence, prevention, treatment and
consequences of problem drug use) which is easily accessible
· to advise relevant agencies with a remit to promote greater public awareness
of the issues arising in relation to problem drug use and to promote and
encourage debate through the dissemination of its research findings.
The first meeting of the Committee took place in late September 2000. The head
of the Irish Focal Point has been nominated to serve on the Committee.
On foot of the report of the Interim Committee, the Drug Misuse Research
Division of the Health Research Board - HRB, has been nominated to establish a
National Documentation Centre. The Government has designated the HRB as a
central point to which all information on drug use in Ireland should be channelled.
[Press release : Minister of State, Eoin Ryan establishes NAC on Drugs, July
2000]. The Documentation Centre will include a drop-in access point or library
facility focusing on grey literature in the drugs area, development of an electronic
library and in collaboration with the EMCDDA a virtual library which will provide
access to a pan-European information network on drugs. In the long term it is
envisioned that this resource will be entirely electronically based. Related added
value activities envisioned include regular publication of a Register of Research
on Drug Misuse in Ireland and Annotated Bibliographies on Drug Misuse in
Ireland. An information and dissemination function will be an integral part of the
Centre.
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An overview of the Three Year Work Programme of the National Advisory
Committee on Drugs is presented in Box 12.1 [see next page].
Box 12.1 : Three Year Work Programme of National Advisory
Committee
Inventory of Research and Information :
· to compile a comprehensive inventory of existing research and information sets relating to the
prevalence, prevention, treatment/rehabilitation and consequences of problem drug use in
Ireland.
Improved co-ordination of research and data collection :
· to open communication channels with key agencies to ensure that the NAC is kept informed
of any new research being undertaken or new data being collected
· to establish a research network which will ensure better co-ordination and integration of
research projects among relevant agencies and maximise resources in the context of the
NAC’s programme of research.
Prevalence :
· to determine the size and nature of the drug problem in Ireland
· to determine the extent and nature of opiate use, poly-drug use and patterns of problem drug
use (experimental, occasional, regular non-medical use) particularly among young people
under 25
· to identify emerging trends and geographical spread
· to determine the extent and nature of problem use of prescription drugs
· to determine the prevalence of problem drug users not in contact with treatment services.
Prevention :
· to examine the effectiveness in terms of impact and outcomes of existing prevention models
and programmes, with particular regard to evaluation instruments developed at European
level
· to undertake comparative studies of different models with particular reference to those in
operation in Task Force areas
· to determine transferability of models among different target groups.
Treatment/Rehabilitation :
· to examine the effectiveness in terms of impact and outcomes of existing treatment and
rehabilitation models and programmes
· to undertake longitudinal studies of the effectiveness of existing treatment and rehabilitation
models
· to examine the context in which relapse occurs
· to examine the impact of the treatment setting.
Consequences :
· to examine the cost to society of the drug problem in terms of :
. drug related deaths
.the impact of drugs on the family and communities
.the relationship between drugs and crime
.the methods for tackling social nuisance related to drug misuse.
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12.2 Application of national strategies and policies
The ongoing review of the National Drugs Strategy underway may result in
changes to the existing and emerging mechanisms outlined below. The existing
institutional mechanisms involved in ensuring the implementation of the National
Drug Strategy, not surprisingly, overlap with the mechanisms in place to combat
social exclusion in general. Foremost here is the Cabinet Committee on Social
Inclusion – which gives political direction to the Government’s social inclusion
policies including the national drugs strategy. This Committee receives input from
the Inter-Departmental Group on National Drugs Strategy and the  National
Drugs Strategy Team.  The relevant Government Departments and agencies are
represented in these groups. In addition, two representatives, one from each of
the community and voluntary sectors, are represented on the National Drugs
Strategy Team which plays a central role in overseeing the implementation of
the Government’s Drug Strategy and at the operational level the work of the
Local Drugs Task Force, inter alia. The Team was established on the principles
outlined in the Strategic Management Initiative for addressing issues which cut
across the remit of a number of Government Departments and Agencies. The
Drugs Co-ordinating  Committees of the Regional Health Boards  operate at
the regional level. The Local Drugs Task Forces – 12 in Dublin, 1 in Cork and 1
in Bray - provide a strategic locally-based response by the statutory, community
and voluntary sectors to the drug problem in the areas worse effected. The
National Assessment Committee and Development Groups  established
under the YPFSF are also involved at the implementation level [see below].
Preliminary arrangements have been put in place to give expression to the recent
developments towards greater devolution to the regional level under the National
Development Plan 2000-2006 inter alia. Accordingly, the LDTFs and Area Based
Partnership Companies are due to work with the Directors of Community and
Enterprise and the City/County Development Boards - CDBs, when drawing
up their integrated local action plans. Arrangements for co-ordination of planning
and delivery of services are to be agreed with the CDBs.
 Local Drugs Task Force – LDTFs
 Purpose : The Local Drugs Task Forces were established  in 1997 with a three
fold purpose - to ensure effective co-ordination of drug programmes and services
at local level; to involve communities in the development and delivery of locally
based strategies to reduce the demand for drugs and to focus actions on tackling
the problem in the communities where it is at its most severe. It was hoped that
the establishment of the Task Forces would also help offset the feelings of
marginalisation and abandonment being felt by these communities.
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Functions : Fourteen LDTFs2 have been established in areas experiencing the
highest levels of drug misuse and, in particular, where heroin misuse is most
prevalent. In line with the aims of the Government strategy outlined above, the
LDTFs were mandated to prepare and oversee the implementation of action
plans which co-ordinate all relevant drug programmes in their areas and to
address any gaps in service. Over 200 separate measures, mainly community
based initiatives, were initially funded to complement and add value to existing
services and programmes under the themes of education, prevention, treatment,
aftercare, rehabilitation and reducing supply [DofTSR (1999). A Handbook - Local
Drugs Task Forces – A local response to the drug problem, Dublin].
 
 Composition : The Task Forces comprise representatives from statutory bodies
such as the Health Boards, Garda Siochana, Local Authorities, FAS (training and
employment agency), the Vocational Education Committees, Probation and
Welfare Service, Departments of Education and Science* and Social Community
and Family Affairs [under discussion at moment]* as well as from voluntary and
community groups. It is expected that representatives at a senior level from these
agencies be nominated to the Local Drug Task Forces – i.e. people who are in a
position to influence policy. In addition, organisations are required to view staff
participation in Task Force activities as core duties and to allocate the time
necessary for meaningful participation.
The formal composition of the Task Forces allows for broad representation and, in
addition, allows for representation of vocational groups/agencies through the sub-
committees and working groups of the Task Forces. Drug users can achieve
representation through the use of drug user fora. Some of these latter groups are
campaigning for more direct involvement. Task Forces are required to ensure that
appropriate procedures are in place to assist them with the regular review of
representation [see DofTSR (1999), LDTF Handbook, p16]. At this stage of the
development of LDTFs, formal and informal activists are calling for greater
networking and sharing of experiences between Task Forces.
 
Structure and Functioning : When the Task Forces were being established, an
independent chairperson was nominated to each Task Force by the Area
Partnership in whose area the Task Force operates. The Area Partnerships were
set up in 38 disadvantaged areas around the country [including all the LDTF
areas] under the Operational Programme for Local Urban and Rural
Development 1994-1999, to address the issue of long term unemployment,
particularly in the context of social inclusion. Subsequent chairperson vacancies
are filled through nomination by the Partnership, in consultation with the Task
                                                
2 The LDTF areas are: Ballyfermot, Ballymun, Blanchardstown, the Canal Communities, Clondalkin,
Dublin North Inner City; Dublin South Inner City, Dublin 12, Dun Laoghaire/Rathdown, Finglas-Cabra,
North Cork City, North East Dublin and Tallaght. Bray has recently been designated as an LDTF area.
· Not initially part of the LDTFs but added/being added, in view of the key role which initiatives
operating under their aegis play in responding to drug misuse.
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Force and the National Drug Strategy Team. The Area Partnerships also channel
funding to certain projects and administer the Task Force administrative budgets
[see DofTSR (1999). Handbook, p.30].
Supports : A range of supports have been put in place to assist the Local Drug
Task Forces in their work. Each Task Force has a full-time co-ordinator funded
by the relevant Health Board. The Community Sector is supported by Dublin
Citywide Drugs Crisis Campaign which acts as an umbrella group for the
community sector, trade unions and voluntary groups tackling the drugs problem.
Citywide facilitates training and regular meetings of the Task Force community
representatives. A similar support structure for the voluntary sector is under
consideration. Each LDTF has been requested to identify their training needs.
 Phases and Funding : Phase 1 of Local Drug Task Force Operation – From
January 1997 to October 1998 : The Task Forces prepared action plans for their
areas and  Ir£10 million/Euro 12.7m, was set aside to finance such plans. This
money funded over 200 separate projects - mostly community based and
designed to complement and add value to the drug programmes and services
already being provided or planned by the State Agencies. Although projects were
initially funded on a one year basis, they subsequently received interim funding,
pending their formal evaluation and a decision in relation to their ‘mainstreaming’
[see below].
 
 An evaluation of the Local Drug Task Forces was concluded in October 1998 which
focused on the processes and structures associated with the initiative. The
evaluation found that the Local Drug Task Forces had ‘achieved a considerable
degree of success in the short term since they were established and that their
very existence had provided a strong focus for tackling drug issues in the target
areas, often reducing the feeling of isolation felt by local communities and
preventing a potentially critical situation from developing further’ [PA Consulting
Group 1998].
 
 Phase 2 of Local Drug Task Force Operation - From October 1998 to date i.e.
October, 2000 : The National Drugs Strategy Team subsequently undertook a
detailed review of the operation of the Local Drugs Task Forces – taking account
of the findings and recommendations of the independent evaluator. In July 1999,
the Cabinet Committee on Social Inclusion agreed arrangements for the
continued operation of the Local Drugs Task Forces based on the
recommendations brought forward by the National Drug Strategy Team, on foot
of this review.
These arrangements included the continuation of the Local Drug Task Forces for
at least a further two years, new terms of reference and the addition of elected
public representatives and representatives from the Departments of Education &
Science and Social, Community & Family Affairs [under discussion at moment] to
the membership of the Task Forces, [in view of the key part which initiatives
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operating under the aegis of these Departments play in the response to the drug
problem].  They also included the putting in place of an evaluation framework
which would allow the LDTF initiative to be measured in terms of outcomes and
impacts [see details in Box 12.2 below]. A Handbook - Local Drugs Task Forces
– A local response to the drug problem, outlining the revised arrangements for
the operation of the Task Forces was published by DofTSR in late 1999 [referred
to in text as DofTSR (1999) Handbook.]
 
 Box 12.2
 Arrangements Adopted by the Cabinet Committee on Social Inclusion for the
Continued Operation of the Local Drug Task Forces – July 1999
 
· New Terms of Reference for the Local Drugs Task Force have been developed. Thus LDTF
are to :
· oversee and monitor the implementation of projects already approved under their existing
action plans
· ensure the evaluation of current projects, with a view to their mainstreaming by the relevant
statutory agencies
· in accordance with agreed guidelines, prepare updated action plans which:
· update the area profile and take into account changes in the drug problem since preparation
of the original plan and
· ensure that emerging strategic issues are identified and propose policies (actions) to
address such issues
· oversee the implementation of the local drugs strategy, in consultation with appropriate
voluntary and statutary agencies and community/resident groups
· ensure appropriate representation by the voluntary and community sectors on the LDTF
· identify any barriers to the efficient working of the LDTF
· develop networking arrangements for the exchange of information and experience with
other LDTFs and the dissemination of best practice
· identify the training needs of LDTF members and take the necessary steps to ensure those
needs are met through appropriate courses, training programmes etc.
· take account of and contribute to other initiatives aimed at tackling social disadvantage
under the aegis of the Cabinet Committee on Social Inclusion, including the Integrated
Services Process, the Young Peoples’ Facilities and Services Fund, the Local Development
Programme, the Community Development Programme, etc.
· provide such information, reports and proposals to the NDST, as may be requested from
time to time.
· Membership of the Local Drugs Task Force to be expanded to include representatives from
the Department of Education and Science and Department of Social Community and Family
Affairs and it is recommended that locally elected public representatives be given the option
of becoming members.
· Each Local Drug Task Force to be asked to prepare updated action plans, following specified
guidelines which stressed the need for a more strategic approach. The updated action plans
are to be structured in 3 parts, as follows – review of progress in implementing the existing
action plans; development of a revised strategy and development and prioritisation of specific
proposals to give effect to the revised strategy. The guidelines provided were very detailed
and further guidance in the form of information sessions was made available to Local Drug
Task Forces particularly with reference to compiling and disseminating examples of best
practice under the various themes to be addressed in the plans.
· Designation of Local Drug Task Force Areas – it was recommended that the focus should be
on those areas, where the drug problem is most acute.  The criteria to be used in determining
such areas should be drug treatment data from the Health Services; Garda crime statistics;
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data relating to school attendance/drop out and other relevant data on the levels of social and
economic disadvantage in the area. Using these criteria it was recommended that Bray to
added to the designated Task Force areas.
 
In agreeing these arrangements, the Cabinet Committee also allocated a further
£15 million/Euro 19.05m to the initiative over the period 2000 – 2001. This
funding will enable the Task Forces to update their plans, as well as address
issues which need to be tackled on a cross-Task Force basis. As indicated
above, the National Drugs Strategy Team have issued detailed guidelines to
assist the Task Forces in updating their plans.
Under the revised Drugs Strategy in the National Development Plan, the
allocations to combat drug abuse specifically through the LDTFs3 will be £122
million Irish pounds/Euro155m over the seven year period of the Plan. The
allocation under the Regional Programmes will be Ir£112 million/Euro142.2m, for
the SE Region and Ir£10 million/Euro12.7m for the BMW Region. [DofTSR,
Internal Doc. 10].
Achievements of LDTF
The LDTFs are an innovative response to a serious drug problem which
manifested itself most acutely in a number of deprived communities. Amongst the
achievements of the initiative has been the active and constructive community
response in areas where resources were few and the establishment of a broad
range of initiatives in the areas of treatment, rehabilitation, education, prevention
etc. which address local needs.
Mainstreaming of Local Drug Task Force projects has been instituted in order to
ensure the continuity of projects which are meeting their aims and objectives.
The National Drug Strategy Team has prepared a set of protocols to govern the
mainstreaming of such  projects. Fundamental to mainstreaming in this context,
is the transfer of budgetary responsibility from Government departments to
agencies / project promoters for specific pieces of work. The exchange to be
consolidated as a formal contract /agreement witnessed by the Local Drug Task
Force. Standards acceptable for Exchequer accounting purposes will apply.
These protocols will provide a platform on which project promoters and statutory
agencies can enter into an arrangement for the continuous operation of projects
on a mutually acceptable basis.
One hundred and forty Task Force projects were evaluated April-June, 2000 and
1224 of them were subsequently mainstreamed involving a number of
Government departments. PR Consultancy has coordinated a composite report
on the evaluation.  Mainstreaming will ensure ongoing funding. The process
copperfastens the role played by community and voluntary organisations in responding to drug misuse at a local level.
 
                                                
3 DofTSR vote
4 This includes the merging of a number of projects on foot of recommendations from the evaluators.
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 Documentation provided by the DofTSR indicate the following as amongst the
achievements of the LDTFs - 800 stabilised drug users are participating in
specially designed Community Employment projects developed by the Task
Forces, in conjunction with FAS, the national training agency. These projects,
supplemented with treatment and counselling, will assist drug users to improve
their employment potential [DofTSR, Internal Document, No.1]. The Task Forces
have also been involved in creating greater awareness about the issues around
drug misuse. Nearly 350 schools have undergone drug awareness programmes
in Task Force areas, with around 6,000 school children participating in these
programmes. In addition, 350 teachers have received training; over 300 youth
groups have run drug prevention initiatives; while training programmes have also
been delivered to 1,300 community workers, 1,200 parents and 1,300 young
people outside the school setting. These programmes are aimed not only at
creating greater awareness of the dangers of drug misuse among young people,
but also at educating communities about the needs of drug users, so that they
are in a better position to respond to these needs [personal communication,
DofTSR]. Evaluation of the LDTFs  will be ongoing.
 
 The Young People’s Facilities and Services Fund – YPFSF
 An innovative and interesting feature of policy in the drugs area in Ireland is a
focus on the potential of sport and recreation to engage young people
constructively and thereby discourage or divert them from involvement in drugs
and unhealthy life choices.
 
 Under an initiative separate but complementary to the Task Force initiative, the
Government set up the Young People’s Facilities and Services Fund (YPFSF).
The aim was to develop youth facilities, including sport and recreational facilities,
and services in disadvantaged areas where a significant drug problem exists or
has the potential to develop. The three-year Fund aims to attract young people in
those areas – at risk of becoming involved in problem drug use – into more
healthy and productive pursuits. The target group for this Fund is youth aged 10
to 21 years who traditionally have found themselves outside the scope of
mainstream youth activities because of their family background, their involvement
in crime or drug misuse or their lack of education.
 
 The primary focus of the YPFSF is on the LDTF areas and 6 urban areas of
Galway, Limerick, South Cork City, Waterford, Bray and Carlow, where a serious
drug problem exists or has the potential to develop.
 
A National Assessment Committee was established under the Young People’s
Facilities and Services Fund, to prepare guidelines for the development of
integrated plans in the target areas for the Fund; to assess the plans and to make
recommendations on funding to the Cabinet Committee on Social Inclusion. The
Committee oversees the implementation of the Fund. Membership of the
Committee comprises civil servants, representatives of state agencies and
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representatives of the community and voluntary sector, and the National Drugs
Strategy Team.
 Development Groups in the 13 Task Force areas and 6 Urban Areas outside
the Task Force areas were established to develop plans and strategies for the
YPFSF and to oversee their implementation in conjunction with the relevant VEC
and Local Authority. In the LDTF areas, the Development Groups comprise one
representative each from the LDTF, the VEC and the relevant local authority. In
the targeted urban areas, the local VEC has responsibility for the development
and delivery of the strategies in conjunction with relevant state agencies and the
community & voluntary sectors.
To ensure complimentarity with the LDTFs plans for the area, the LDTFs
nominated a representative to the Development Groups [who generally act as
chairperson]. The YPFSF  plans and implementation process reports are passed
to the LDTFs for their information and views before submission to the NAC -
National Assessment Committee [which evaluated them and recommended
funding to support their implementation]. The Development Groups are
responsible  for overseeing the effective implementation of the plans.
Under the devolution of structures outlined above, the LDTFs and Area Based
Partnership Companies are due to work with the Directors of Community and
Enterprise and the City/County Development Boards –CDBs, when drawing up
their integrated local action plans. Arrangements for co-ordination of planning
and delivery of services are to be agreed with the CDBs. It is likely that the
YPFSF will adopt similar procedures when their next funding is due i.e. 2002.
YPFSF outside the LDTF Areas : Recognising that the issue of problem drug
use is not confined to the urban areas, YPFSF funding has been allocated to a
number of nation-wide initiatives to inform and raise awareness of the dangers of
problem drug use, particularly through peer education, as can be seen below. Up
to Ir£7.2m/Euro 9.14m has been allocated under the YPFSF for the “Springboard
Initiative” [see below] which will see the establishment of 14 family support
projects aimed at children at risk in disadvantaged areas around the country.
YPFSF Budget5 : The Young People's Facilities and Services Fund was
established in 1998 with a Ir£30 million/Euro 38.1m  allocation over 3 years. This
has since been increased to Ir£37.4 6 million/Euro 47.5m. Of this amount, Ir£27.4
million/Euro 34.8m has been approved for support of over 295 projects in the
LDTF areas. The remaining Ir£10 million/Euro 12.7m [approx.] has been allocated
as follows :
                                                
5 Acknowledgements – Kathleen Stack, DofTSR and S. Falvey, DofE&S for supplying budgetary
information.
6 This funding is separate to LDTF and is in Department of Education and Science vote
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- Ir£7.2m/Euro 9.14m over 3 years 1998-2000 has been allocated to the
Springboard Initiative, which is administered by the Department of Health and
Children. Springboard funds 15 family support projects. The projects work
intensively with mainly 7-12 year olds (who are at risk of going into care or
getting into trouble) and their families
- Ir£2.3m/Euro 2.9m was allocated to other urban areas outside the Task Force
Areas for prevention work e.g. Waterford, Galway, South Cork City, Limerick,
Bray and Carlow
- Ir£0.5m/Euro 635,000 goes to voluntary organisations who have the capacity
to deliver drug prevention programmes at national or regional level; this is a
new initiative in 1999.
In terms of the new structures set up under the National Development Plan, the
breakdown of this money is as follows :
South and Eastern Region:      Ir£29.756m/Euro 37.782m
Border Midlands and Western Region: Ir£   0.450m/Euro .571m
Dept. of Health and Children: Ir£   7.200m/Euro 9.142m
Total: Ir£  37.406m/Euro 47,496m
The type of projects and initiatives approved as part of the plans and
strategies submitted to date include :
· capital projects such as building, renovating or fitting out community
centres, youth facilities and sports clubs so as to provide suitable
accommodation for programmes and services geared for the most “at risk”
young people in an area.  Access for the target group is an essential condition
of funding for capital projects
· a number of purpose-built youth centres which will provide a focal point for
youth activities in an area, particularly those areas such as Tallaght,
Ballymun, Clondalkin and Blanchardstown where there is a dearth of
dedicated youth facilities
· the appointment of youth and outreach workers to work on the ground with
the target group offering developmental activities and educational
programmes for young people who have traditionally found themselves
outside the scope of mainstream youth work due to family background,
involvement with crime or drug misuse or lack of education
· the appointment of sports workers to encourage greater involvement of the
target group in sports and recreational activities
· a wide variety of community-based prevention/education programmes,
including Early School Leaving Programmes, Sports and Recreational
Activities, Family Support Programmes, Art, Drama and Music Programmes,
Counselling and Transport Services
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· targeted interventions for particular groups such as youth work projects for
young travellers
· the appointment of national drugs education and training officers for youth
organisations catering for the target group who will deliver programmes
throughout the organisation
· a provision to meet the training needs arising from the Fund, particularly in
the area of drugs training for youth workers.
 Innovative Conditions, which can serve as a model for such projects, have been
applied to the draw down of funds under the YPFSF. These measures ensure that
the most deprived groups will have access to funded facilities and services and will
prevent ‘creaming’ or the admission of only the ‘more desirable clients’ which can
be a feature of some programmes. The conditions include inter alia - Clear focus on
target group; Mandatory access for the target group; Proof of the operation of
strategies to attract the target group into the facility/program; Integration with
existing or proposed initiatives in the area. Access for the target groups will be
enforced where possible through the involvement of the Local Authorities and/or the
VECs in the management structure. If this is not possible then it will be necessary
for projects to provide a satisfactory access programme showing how the target
group will be reached and quantifying the extent of access.
 
Main Results Achieved : A speech by Minister of State for Local Development
and with special responsibility for the National Drugs Strategy, Mr. Eoin Ryan,
T.D., at European Cities Against Drugs, Millennium Mayor’s Conference, held in
Cork, 28th April, 2000, overviewed achievement under the YPFSF. He stated
‘Through the Young People’s Facilities and Services fund, we are supporting the
building or refurbishment of nearly 50 youth facilities, 20 sports clubs and nearly
20 community centres in disadvantaged areas. Almost 80 youth and outreach
workers are being appointed to work with young people, offering them the type of
developmental activities and educational programmes which were previously
outside their reach, due to their family circumstances or their involvement with
drugs or crime. The Fund is also supporting a wide variety of programmes,
including early school leaving projects, family support programmes, art, drama
and music, counselling and transport services’.
12.3     Evaluation of national strategies
The policy frameworks underlying actions in the drugs area i.e. the National
Development Plan, National Anti-Poverty Strategy- NAPS and Programme for
Prosperity and Fairness - PPF are underpinned by a culture of evaluation and
accountability. Thus targets, review, evaluation, benchmarking, indicators and
indexation are core concepts and increasingly specific resources are being set
aside to develop the research capacity which can effectively deliver good quality
monitoring and evaluation [see Social Inclusion Strategy, Annual Report of the
Inter-Departmental Policy Committee 1999/2000]. Poverty and equality  proofing
are also to become an integral aspect of national and regional programme
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development. Thus the more general social inclusion initiatives in the drugs area
will be evaluated within this framework.  The specific mechanisms in place to
evaluate the LDTFs are outlined below.
Evaluation and the LDTF : The culture of evaluation ensures that evaluation is
seen as an intergral part of the planning exercises of the Local Drugs Task
Forces. The Phase 2 updated plans [see above] were required to specify the
proposed inputs and expected measurable outputs, outcomes and impacts in
relation to each proposal and how it integrated into the overall drugs strategy.
Thus, in addition to the evaluation of the overall process to measure its success
or otherwise, evaluation of individual projects takes place with a view to
mainstreaming those which are operating effectively [see above & DofTSR
(1999), Handbook, p45].
In the Handbook : Local Drugs Task Forces – A local response to the drug
problem, published by the DofTSR in 1999, the National Drug Strategy Team laid
out the mechanisms they have developed to facilitate the evaluation process [see
Box 12.3 below]. These guidelines state that the evaluation process must be
objective and transparent and must be carried out by individuals with a
recognised and proven track record, in accordance with agreed criteria.
Evaluation Criteria for Projects : Over 200 projects were approved for funding on
foot of the initial Task Force plans. There was a wide variation in range, type and
size of these projects. From a financial viewpoint, projects are divided into three
types: those costing over Ir£50,000/Euro 63,487 per annum; those costing
between Ir£10,000/Euro 12.700  and Ir£50,000/Euro 63.487m per annum; and
those costing less than Ir£10,000 per annum. The majority of projects were set
up with a view to being ongoing, but some were once-off.
Box 12.3  Mechanisms to Facilitate the Evaluation Process – LDTF
The following mechanism were put in place to facilitate the evaluation process :
· a steering group (comprising of the National Drugs Strategy Team and the Task Forces) was
set up to oversee and monitor the process
· a specially appointed Evaluation Co-ordinator devised terms of reference for the conduct of
the evaluation, along with appropriate performance indicators and these were approved by
the steering group and
· a panel of evaluators were formed. Task Forces were free to nominate persons or companies
to this panel, provided they met the criteria outlined above. Task Forces could then make
their selection of evaluators from the approved panel. In the event of there being excessive
demand for the services of particular evaluators, the steering group determined their
assignment.
Acknowledging the wide variability of projects (including the fact that they
address the drug problem under different themes, i.e. education/prevention,
treatment, rehabilitation and community policing/estate management), it was
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acknowledged that it would be difficult to devise an evaluation framework that
would equally suit all projects. It was recommended thus to develop a process
that could be applied in a flexible manner, depending on the type of project. It
was envisioned that more rigorous evaluations would take place with the more
expensive projects.
Guidelines as to how the evaluations were carried out, along with the ground
rules, were considered to be necessary and these were developed by the
steering group, in consultation with the Evaluation Co-ordinator, Local Drugs
Task Forces and project promoters as the process developed.
As reported above, 140 Task Force projects were evaluated in April-June 2000
and 122 of these were mainstreamed. PR Consultancy coordinated a composite
report on the evaluation. Arrangements are in train to evaluate a further 34
projects before end 2000.
Evaluation of YPFSF – An overall evaluation of the YPFSF will be
commissioned by the end of 2000. The evaluation will take into account good
practise in relation to  existing evaluation mechanisms e.g. mechanisms for the
LDTF and the mainstream youth service projects.
The culture of evaluation discussed above, is not as developed or formalised
within drug treatment environments. Thus few evaluations of treatment
programmes have been conducted to date. However, the National Advisory
Committee on Drugs three year research programme includes a number of
evaluation studies in the drugs area and Health Boards increasingly are adopting
evidence based approaches in their work and developing research and
evaluation capabilities.
The implementation of EDDRA in Ireland has helped promote a culture of
evaluation in the treatment context. Actors in the drugs area are aware that
inclusion of projects in the EDDRA database requires such projects to have built -
in evaluation as an integral feature. In addition, EDDRA training was made
available to all regional drug co-ordinators by the Drug Misuse Research Division
in collaboration with the EMCDDA which covered inter alia, the planning and
implementation of project evaluation.  This training was evaluated highly by
participants.
Conclusion – main changes and trends.
The main changes & likely directions in Irish drug policy, strategies,
implementation and evaluation 1999 – October 2000 can be summarised as
follows :
- a major review of National Drugs Strategy is underway
- continued adoption of an integrated, inter-agency response to the drugs
problem involving local communities
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- adoption of the promotion of social inclusion as one of the priorities of the
National Development Plan 2000-2006 and situation of drugs issue within this
context
- greater devolution of power to regional structures, with which existing
structures in the drugs area will co-operate
- roll-out of pilot extension of poverty proofing to local authorities
- Continued involvement of local communities in the development and
implementation of drugs policy
- increasing role of voluntary and community sectors
- continued development of a culture of evaluation and increased resources of
knowledge infrastructure to support same
- programme for Prosperity and Fairness  identifies  workplace initiatives
dealing with drug misuse as an issue requiring attention
- cross border activity and co-operation in the drugs area likely to increase.
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13. Cocaine and Base/Cocaine - Ireland : Paula Mayock
 
Introduction
In Ireland, the heroin epidemic of the 1980s, coupled with the public health crisis
of HIV transmission through unsafe injecting practices, resulted in a
concentration of attention on ‘high risk’ drug use categories, most notably heroin
and other intravenous drug use.  The major focus in the domains of drug policy,
treatment and research centred on the ‘threats’ posed by enduring patterns of
drug use, unsafe methods of drug administration and associated risk behaviours.
Heroin, being a dominant drug of misuse among individuals receiving treatment,
certainly, in the greater Dublin area (O’Brien, Moran, Kelleher and Cahill 2000),
has attracted by far the greatest level of interest and attention.  This situation is
by no means unique to Ireland.  As Egginton and Parker (2000), in a recent
publication have remarked, “so distinctive is the impact of this drug that heroin
has its own epidemiology”(p.7).  In practice, prevalence studies and other
empirical research focus on groups, such as opiate users or injectors, who are of
concern at a particular time (Frischer and Taylor 1999).  Put differently, attention
to particular forms of drug use is very much a function of the drug political
situation of any given jurisdiction (Cohen 1996).
Despite heroin’s prominence, publicity and official concern, the past decade has
witnessed increased recognition of the pervasiveness of drug use in society
generally.  Drug use, traditionally associated with social and economic
disadvantage, is increasingly recognised as a widespread social phenomenon
and is clearly no longer confined to marginalised communities.  Population and
school surveys point to a definite increase in the number of individuals reporting
lifetime use of a range of illicit substances (Grube and  Morgan 1986; Grube and
Morgan 1990; Hibell et al. 1997; Brinkley et al. 1999).  A recent population
survey, examining the lifestyle, attitudes and nutritional status of people aged 18-
55 years, revealed a lifetime prevalence rate of 17% for cannabis.  Last year
prevalence was estimated at 2% for amphetamines and ecstasy and 1% for
tranquillisers and LSD (Friel et al. 1999). Although cannabis remains by far the
most popular of the illicit drugs and the most likely to be used repeatedly across
time, available data suggests that other drugs, including amphetamine, ecstasy
and LSD are increasingly likely to be used, particularly among our adolescent
population.  It would appear that we are increasingly living amidst a drug
conscious society.
In Ireland, relatively little attention has focused on the use of individual drugs.  As
a result, little is known about the extent and nature of specific forms of drug
involvement.  Attention to the use of individual drugs, apart from heroin, has
concentrated almost exclusively on ecstasy.  Bisset (1997), reviewing available
data pertaining to the use of ecstasy in Ireland, concluded that the upward trend
in ecstasy use by young people was likely to continue.  Murphy, O’Mahony and
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O’Shea (1998) compared Irish and European drug policies relating to the use of
ecstasy.  This research also included a small-scale qualitative study of ecstasy
use by adults.  More recently, a more detailed examination of patterns and levels
of ecstasy use was undertaken in Northern Ireland (McElrath and McEvoy 2000).
Other drug use, including amphetamine, LSD and cocaine have received little or
no attention in an Irish context.
The purpose of the current paper is to examine cocaine use in Ireland.  This
research is timely in that it coincides with renewed attention, in a European
context, to suggestions of a possible increase in the availability and use of
cocaine.  Increases in cocaine use across Europe have been visible since the
late 1960s (Erickson et al. 1987). Studies have shown steady increases in
various indicators of cocaine use in the UK during the past 10-15 years (Marsden
et al. 1998).  A recent British review of law enforcement figures, treatment
statistics and other key prevalence indicators, reveals a steady and significant
upsurge in cocaine use from 1991-98, suggesting that the UK may be witnessing
the rapid spread of new cocaine use (Corkery 2000).
The primary aim here is to investigate levels and patterns of cocaine use in
Ireland.  The research was undertaken against a backcloth of anecdotal and
impressionistic evidence suggesting that cocaine is very much ‘around’, more
easily procured than previously and making a conspicuous breakthrough on the
drug scene.  Hence, the research sought to locate and analyse all available data
identified as potentially useful in an assessment of the extent and nature of
cocaine use.
The multiple existing data sources utilised in the research are described in detail
below.  However, as a starting point is it helpful to provide a brief description of
the pharmacological properties of cocaine and of the principal routes of cocaine
administration.
Pharmacological Dimensions of Cocaine and Modes of Use
Cocaine is a naturally occurring substance derived from the leaves of the coca
plant, Erythroxylon coca, a shrub that grows in the Andean area of South
America (Fischman and Foltin 1991).  It is an odourless, white crystalline powder
and is classified as a central nervous system stimulant.  Cocaine was first
extracted in 1855 and later became a popular stimulant and tonic.  Up until 1904
Coca-Cola contained small quantities of cocaine (ISDD 1996).
The most common from of ingesting cocaine is ‘snorting’ - the sniffing of fine
cocaine crystals via the nostrils.  By snorting, cocaine is being conveyed into the
bloodstream via the mucous membranes of the nose and throat in which it
dissolves.  Cocaine increases feelings of alertness and energy and produces
intense euphoria.  Negative effects include anxiety, levels of aggressiveness not
appropriate to the actual situation, sleeplessness, sweating, impotence and
190
heavy feelings in the limbs.  Very heavy users of cocaine may report strong
feelings of paranoia.
The smokable form of cocaine is known as free-base, rock or crack cocaine,
where the powder form is converted into cocaine base and smoked, usually
through a pipe.  This method of use produces a shorter but more intense high
than snorting the drug (Corrigan 1997).  The speed at which the crack cocaine
produces effects is far more rapid than in powder form and this, coupled with the
shorter duration of the euphoria, makes crack smoking a potentially highly
addictive substance.  However, neither tolerance nor heroin-like withdrawal
symptoms occur with repeated use of cocaine (ISDD 1996).  Users may develop
a strong psychological dependence on the physical and mental well being
afforded by the drug.
Finally, cocaine may be used intravenously, although this mode of ingestion is
less common and is viewed as dangerous by most cocaine users (Cohen 1987).
Intravenous injection results in an almost immediate high within 15 seconds of
injecting (Pinger et al. 1995).  Some drug users combine cocaine powder or
crack with heroin to produce a drug cocktail known as “speedballs”.
Prolonged heavy cocaine use is usually followed by a ‘crash’ if use is
discontinued.  This ‘crash’ is characterised by exhaustion, restless sleep
patterns, insomnia and depression (Erickson et al. 1987).  However, there is
considerable disagreement over what constitutes 'addiction' or 'dependence' in
the case of cocaine.  Furthermore, there is little consensus on who is susceptible
to or at greater 'risk' of cocaine dependence.  Waldorf et al. (1991), in a study of
'heavy' cocaine users (users who the authors claim qualify as the most serious
1% of the cocaine using population), found that even among this group, a large
number maintained a stable, although heavy pattern of use over several years
without increasing their cocaine intake.  They added that "it is exceptionally
difficult to predict which users will maintain control and which will become
compulsive" (p.102).
Other research has similarly concluded that many heavy cocaine users do not
become dependent (Erickson et al. 1987; Cohen 1989; Chitwood and
Morningstar 1985).  Hammersley and Ditton (1994), in a study of Scottish
cocaine users not known via their criminality or contact with drug services,
concluded that "cocaine can lead to protracted bouts of heavy or excessive use,
but many users can then stop or moderate use prior to encountering
problems"(p.68).
The accumulated research evidence on cocaine use across several jurisdictions
suggests that, among community samples of cocaine users (that is, users not in
contact with drug treatment services), even heavy users will not necessarily
develop symptoms normally associated with chronic drug dependence.
Reinarman (1994), summarising three studies of cocaine users (Warldof et al.
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1977; Murphy et al. 1989; Waldorf et al. 1991), concluded that addiction is not an
inevitable consequence of cocaine’s pharmacological action on human
physiology.  Rather, both cocaine dependence and controlled use of the drug are
contingent upon the social circumstance of the user and on the conditions under
which cocaine is taken.
On the other hand, Parker and Bottomley’s (1996) study of crack cocaine users,
many of whom were known to drug services, revealed only a minority of
controlled users.  Among this group, there appeared to be a complex pattern of
dependency on both cocaine and heroin, whereby users were “psychologically
hooked into rock cocaine but physically dependent on heroin” (p36).  Other
research indicates significant differences between treatment and non-treatment
cocaine users.  Chitwood and Morningstar (1985) found that users in treatment
were more likely than community samples to be heavy rather than light users of
cocaine, and to be unemployed and lacking in support networks of close friends.
Research Methodology
There are three research components in this analysis of cocaine use in Ireland.
The first examines existing, predominantly statistical, data sources in order to
identify emerging patterns and trends in cocaine and base/crack cocaine use.
Relevant data from several sources, all considered to be key indicators of drug
misuse, are presented.  The combined information from the data sources listed
below, covering a range of population segments, are presented and analysed.
· Drug Seizures / Arrests
· Drug Treatment Figures
· Surveys : School-based and General Population
· Drug-related Deaths
· Hospital Morbidity
· Ethnographic / Qualitative Studies
Since no detailed empirical investigations of cocaine use have been undertaken
to date in Ireland, two additional components were incorporated into the research
in order to generate a more comprehensive picture of current patterns of use and
to assess dominant perceptions of the scale of the ‘problem’.  The emphasis in
the first was on accessing ‘front line’ indicators, that is, individuals working in the
community and at street level who are well-positioned to detect current local
developments.  This is important since available figures may not accurately
reflect current drug trends due to the time-lag between the collection and the
processing and publication of relevant data.
Individual face-to-face and telephone interviews were conducted with a range of
informants including drug service providers, An Garda Siochana - the police,
youth workers, drug counsellors, general medical practitioners, hospital
personnel, night-club owners and a number of key informants considered to have
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experience of and insight into common and preferred drug-taking practices.  The
primary objective was to access the views, perspectives and concerns of
individuals who have direct knowledge and/or experience of cocaine users and of
the drug scene generally.  In this context, there was a specific focus on
uncovering information pertaining to the availability of cocaine, local drug
markets, trafficking/dealing/ distribution patterns, health consequences and the
negative repercussions of use.  In addition, interviews with drug service staff
addressed the issue of service provision, including the needs of cocaine users
and implications for treatment intervention and other drug services.
Finally, in view of the widespread recognition of recreational or non-problematic
forms of cocaine use in other jurisdictions (Erickson et al. 1987; Cohen 1989;
Greene et al. 1995; Hammersley and Ditton, 1995), it was decided to undertake a
small-scale qualitative study of adult cocaine users not in contact with drug
treatment agencies.  The primary aim of this exploratory research was to
examine respondents’ use of cocaine and other drugs.  The research also sought
to examine attitudes to cocaine and other drug use, to investigate perceptions of
the risks associated with cocaine compared to other drugs and to examine
dominant or preferred circumstances associated with the use of cocaine.  The
selection criteria and recruitment process are discussed in detail at a later stage
in this paper.
It is apparent from the description above that multiple sources were utilised in
order to build a fuller picture from partial data.  The orientation of the research is
therefore largely investigative, with each segment of data feeding into a
“detective” approach (Douglas 1976).  General principles of analytic induction
were applied to the examination of pre-existing data and to data collected
through face-to-face and telephone interviews.  This approach involved
establishing an initial description of the phenomenon and the continued
refinement of that analysis in light of further evidence collected throughout the
course of conducting fieldwork.  The strength of this method is its ability to
consider many alternatives and then progress dynamically as opposing or
corroborating evidence appears (Adler 1990).  Analytic induction was formulated
by Znaniecki (1934) and later refined by Lindensmith (1947) as a procedure for
verifying propositions on qualitative data in a study of opiate addiction.  It was
used by Becker (1963) in his classic study of marijuana users.  This research
orientation is particularly suited to gathering information in sensitive and ‘hidden’
areas of human behaviour (Stimson et al. 1999).
Research Findings
This paper is divided into three sections.  The presentation of research findings
draws first, on existing data sources and documents all available empirical
research relevant to cocaine use in Ireland.  The analysis then moves to present
data generated from individual face-to-face and telephone interviews with drug
services providers and other key informants.  Finally, the findings of an
exploratory study of social/recreational cocaine use among adults are presented.
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Component 1 : Existing Data Sources and Other Relevant Empirical
Research
In this section, the data pertaining to the use of cocaine (and other drugs) from
several key data categories are presented.  These include law enforcement and
supply statistics, purity levels, drug treatment figures, general population surveys,
school surveys, cocaine-related deaths, hospital morbidity and other relevant
research findings arising from ethnographic and qualitative studies.
· Law Enforcement and Supply Statistics
Questions pertaining to the accuracy of police statistics are the source of
considerable debate (Bottomley and Pease 1986; South 1995).  One of the main
difficulties with these figures is that they are not contextualised by reference, for
example, to specific overt and covert operations or ‘luck strikes’.  Differences in
drug seizures might also reflect variation in drug control strategies across time
(Korf 1992).  However, at a local level drug seizure figures provide a useful broad
indicator or sensor of drugs supply and demand (Parker, Bury and Egginton
1998).
Available statistics pertaining to seizure and offender data is provided in the
Annual Reports of An Garda Siochana.  Table 13.1 presents the figures for
seizures of cocaine made by Irish police and customs between 1990 and 1998.
Seizure figures for heroin, cannabis, MDMA (ecstasy) and LSD are presented for
comparative purposes.
t= tabs; g = grams; kg = kilograms.
Source : Annual Reports of An Garda Siochana, 1990-1998.
This table illustrates considerable variation in the quantity of cocaine seized by
police and customs between 1991 and 1998. The record amount seized was
Table 13.1 : Quantity of Cocaine and Other Drug Seizures , 1990-1998.
Year Quantity Quantity Quantity Quantity Quantity
Seized Seized Seized Seized Seized
(Cocaine) (Heroin) (Cannabis (MDMA) (LSD)
Resin)
1990     1.009 kg     .578 kg   114.76 kg   0       90 units
1991    .031 kg     .161 kg       1.10 kg 429t 3169 units
1992  9.850 kg     .794 kg   498.47 kg 271t+.225g 13431 units
1993    .348 kg   1.285 kg 4200.31 kg 744t 5522 units
1994    .046 kg   4.649 kg 1460.72 kg 28,671t 16,634 units
1995      21.800 kg   6.400 kg  15,529  kg 123,699t 819 units
1996    642.000 kg 10.800 kg    1,933  kg 19,244t 5,901 units
1997      11.020 kg     .821 kg           1247.88 kg 17,516t 1,851 units
1998    333.167 kg     .038 kg             2157.24 kg 604,827t 798 units
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642kg in 1996. The figures for cocaine seizures are low however, compared to
those for other drugs, including cannabis, heroin and ecstasy.  Internationally, it
is often estimated that approximately 10% of all drugs in circulation are
intercepted (Boekhoutvan Solinge 1998).
Table 13.2 illustrates the number of cocaine offences where proceedings
commenced between 1990-1998.  The figures for heroin, cannabis and ecstasy
are again included for comparative purposes.
  Source: Annual Reports of An Garda Siochana, 1990-1998.
The number of individuals charged with or prosecuted on cocaine-related drug
offences is small compared to heroin, cannabis and ecstasy.   However, the
figures generally do point to an increase in the number of offences where
proceedings commenced between the year 1990 and 1998.  Figures doubled
between 1994 and 1995 and increased three-fold again, producing record figures
for cocaine-related drug offences by 1997.  ‘Offender’ data do, therefore, suggest
that an increase of cocaine possession and supplying is occurring on the ground.
Drug product data is determined from analyses carried out by the Forensic
Science Laboratory of the Department of Justice, Equality and Law Reform.
These analyses are conducted on drugs seized by the Gardai.  Information
attained from this source indicates that the purity of cocaine has dropped over
the past three years from 62% in 1996 to 38% in 1998.  These figures however,
may not accurately reflect the purity level of cocaine at street-level, as no
empirical evidence on such a link is available.
· Drug Treatment Figures
Unlike heroin, no specific drug is used for the treatment of cocaine dependence
and there are no prescription figures that can be used as a proxy measure of
cocaine addiction.  Hence, data pertaining to individuals receiving treatment for
drug-related problems are an important indicator of the level and extent of
cocaine use among this group.
Table 13.2 : Number of drug offences by type of drug, 1990-1998.
Year Cocaine Heroin Cannabis MDMA
 Resin
1990       11       71      1,413        --
1991         7       45      2,354       45
1992       11       91      2,643       31
1993       15       81      2,895       66
1994       15     230      2,848     261
1995       30     296      2,209     645
1996       42     432      1,441     340
1997       97     564      2,096     475
1998       88     789      1,749     439
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The National Drug Treatment Reporting System, operated by the Drug Misuse
Research Division of the Health Research Board (HRB), reports data on
treatment provided by statutory and voluntary agencies countrywide.  It is the
primary national source of epidemiological information about drug misuse,
providing annual figures on the uptake of services as well as socio-demographic
data on clients receiving treatment.  The regularity of data collection makes it
possible to identify changing patterns and trends in the use of particular drugs
across time.  Between 1990 and 1994, data was collected in the Greater Dublin
area only, but was extended to cover the whole country in 1995 (O’Brien and
Moran 1997).  One of the main advantages of more recent available figures
pertaining to individual receiving treatment is that they are regionally sensitive.  It
should be remembered however, that the figures relate to those problem drug
users who present to services, and not to all those who have a drug problem, or
indeed all those who use drugs.
Health Research Board figures consistently indicate that opiates are the primary
drugs of misuse.  Four out of five individuals presenting for treatment in Dublin
during the period 1990-1996 reported opiates as their main drug of misuse
(O’Brien and Moran 1997).  In 1998, 55.7% of first treatment contacts reported
heroin as their main drug of misuse (O’Brien et al. 2000).
In this section the number of clients reporting cocaine as a drug of misuse within
treatment services will be examined.  It should be pointed out however, that
because the development of drug services in Ireland has been orientated toward
problem opiate use, cocaine users may not be attracted to these settings. Table
13,3 illustrates the number of individuals presenting with cocaine as a primary
and secondary drug of misuse during the period 1995-19987.
       Source: National Drug Treatment Reporting System, Health Research Board.
                                                
7 Thanks to Mary O’Brien of the Drug Misuse Research Division who provided these figures.
Table 13.3: Number of Individuals Presenting with Cocaine as Primary
and Secondary  Drug of Misuse, 1995-1998.
         Cocaine as Main Drug    Cocaine as Secondary Drug
    All Contacts    First Contacts All Contacts   First Contacts
1995 24 10          67 21
1996 25 17         121 50
1997 42 22         195 48
1998 88 32         291 60
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Here we find a clear and consistent increase in the number of all and first contact
clients presenting with cocaine as a drug of misuse during the period 1995-1998.
This increase is most dramatic among individuals reporting cocaine as a
secondary drug of misuse.  The figure for all persons who made contact with
drug treatment services reporting cocaine as a secondary drug of use shows an
increase of over 400% during the period 1995-1998.  Individuals presenting with
cocaine-related problems were more likely to be male than female.  Of the 42
who reported cocaine as a primary drug of misuse in 1997, 37 were male and 5
female.  The gender breakdown for 1998 is somewhat similar, with 73 males and
13 females reporting cocaine as a main drug.  For the year 1998, 72.5% of
clients presenting with cocaine as either a primary or secondary drug of misuse
were male (O’Brien et al. 2000).
It is important to consider the figures for cocaine misuse in the context of the
overall drug treatment figures.  Taking the 1998 figures as an example, out of a
total of 1,625 first contacts nationally, the majority (904 individuals, or 55.7% of
the total client group) reported heroin as their primary drug of misuse.  This figure
was followed by 24.8% reporting cannabis, 7.4% ecstasy, 2.5% methadone,
2.3% amphetamine and 2% reporting cocaine as their main drug of misuse
(O’Brien et al., 2000).  Hence, individuals reporting cocaine-related drug
problems constitute a relatively small proportion of the total number presenting
for the first time with drug-related difficulties.
Looking then at the regional breakdown of reported cocaine-related problems
among all contacts within each of the Health Board Regions during 1997 and
1998, we find that individuals reporting cocaine as either a primary or secondary
drug of misuse are concentrated within particular Health Board Regions.
Source : O’Brien et al., (2000).
Table 13.4: Residents of Health Board Areas Presenting with Cocaine as
Primary and Secondary Drug of Misuse within each Health Board
Region, 1997 and 1998. Numbers and Valid Percentages.
All Contacts, 1997 All Contacts, 1998
   Number (%)     Number (%)
  Cocaine as    Cocaine as   Cocaine as           Cocaine as
Primary Drug Secondary Drug Primary Drug      Secondary Drug
EHB      30 (.7%)    173 (4.2%)    58 (1.1%)            263 (5.2%)
SHB       3 (1.2%)        7 (2.7%)    12 (4%)               7 (2.3%)
NWHB            ----          ----        ----               1 (2.1%)
MHB            ----          ----        ----               1 (1%)
WHB            ----         1 (7.1%)        ----               1 (7.1%)
MWHB         4 (4.0%)         2 (2.0%)       3 (3.1%)               2 (2.1%)
NEHB         2 (2.2%)         4 (4.3%)       2 (1.6%)               1 (0.8%)
SEHB         3 (1.9%)         5 (3.2%)       9 (4.5%)               5 (2.5%)
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The highest number of contacts stating cocaine as a drug of misuse were
resident in the Eastern Health Board region.  This is hardly surprising given that
the majority of treated contacts countrywide occur within this same region.  The
Southern Health Board and South Eastern Health Board areas had the next
highest proportion of treated cocaine contacts in 1997 and 1998.
It is clear from the available figures that greater number of individuals than
previously are presenting with cocaine-related difficulties.  However, cocaine is
clearly more likely to be a secondary than a primary drug of misuse.  Individuals
are less likely to present with cocaine-related difficulties, compared to other drug
problems, most notably those related to the use of heroin, benzodiazepines,
cannabis and ecstasy.
· General Population, College and School-going Populations
In Ireland, there is an absence of data, collected at regular intervals, on drug use
among the general population and concerning specific groups, including young
adults and adolescents. Furthermore, because differing methodologies are
utilised in available surveys, it is difficult to compare drug prevalence rates
accurately across time.  This section will report on all available data pertaining to
cocaine use in adolescent, college-going and general populations.
Survey research in Ireland has concentrated primarily on studies of secondary
school students.  Grube and Morgan’s (1986) study of drug use by 13-16 year
olds in twenty-four randomly selected schools in the greater Dublin area found a
lifetime prevalence rate of 1.5% for cocaine, with 0.7% having used the drug
during the month prior to completing the questionnaire.  This figure is low
compared to 13.2% who had ever used cannabis and 12.9% who reported the
use of glue/solvents at some stage in their lifetime.  Grube and Morgan’s (1990)
follow-up study revealed an increase of 0.2% in the numbers reporting past
month use of cocaine.  A more recent survey of rates and patterns of substance
use among Dublin post-primary pupils did not report on the use of cocaine
(Brinkley et al. 1999).
The most recently published national study of drug use by adolescents, carried
out in 1995 as part of the European Schools Project on Alcohol and Drugs
(ESPAD), found that 2% of students aged 16 years reported lifetime experience
of cocaine (Hibell et al. 1997).
As with other drugs, including cannabis, ecstasy and amphetamine, regional
surveys suggest somewhat lower cocaine prevalence rates than those reported
in Dublin samples.  A survey of post-primary school students in the Mid-Western
Health Board Region found that 1.3% reported lifetime use of cocaine and 0.4%
were current users of the drug (Gleeson et al. 1998).  Jackson’s (1997) survey of
drug use in Cork and Kerry revealed a lifetime prevalence rate of 1% for cocaine.
A much smaller proportion (0.1%) reported current use of the drug.
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The figures above concur with findings related to school-going populations in the
UK (Barnard et al., 1996; Balding, 1998) and suggest that cocaine use is
relatively rare among adolescents, certainly compared to other drug use.
Available figures indicate only a slight increase in the number of Irish adolescents
reporting lifetime experience and use of cocaine during the past two decades.
Rather less is known about drug use among college students.  A recent survey of
drug exposure and alcohol consumption among 366 health service attendees at
a Dublin University, revealed cocaine lifetime prevalence rates of 7.1% for males
and 4.9% for females.  This compared to a lifetime prevalence rate of 50% for
cannabis, 16.5% for ecstasy and 10.5% for LSD (Denehan, forthcoming).
Few national surveys of drug use prevalence have been undertaken in Ireland.
In 1998, a survey jointly carried out by the Health Promotion Unit of the
Department of Health and Children and the Centre for Health Promotion Studies,
NUI Galway, examined the lifestyle, attitudes and nutritional status of people in
Ireland.  Cocaine use during the twelve months prior to the completion of the
questionnaire was reported by 1% of respondents (Friel et al. 1999.  This is
consistent with findings in the UK, where cocaine use remains at low levels of
around 1% or less of adult populations (Baker and Marsden 1994).
In summary, although surveys suggest that drug use is increasingly a feature of
youth culture (Hibell et al. 1997; Brinkley et al. 1999), cocaine use remains rare
among school-going adolescents and has shown little sign of an increase during
the past two decades.  Lifetime prevalence among the general population is
currently running at approximately 1%.
 
· Morbidity and Mortality
Both morbidity and mortality statistics are of limited value in the estimation of
drug use and drug problems in general (Garretsen and Toet, 1992).  However,
available data relating to morbidity and mortality are presented as an indicator of
the extent to which cocaine is implicated in death or illness.
Mortality statistics are based on death certificates which usually contain
information on socio-demographic variables and on the cause(s) of death.
Throughout the 1990s there has been a marked increase in the number of drug-
related deaths throughout Europe.  This upward trend appears to be more
pronounced in Ireland than in other European countries (EMCDDA 1999) but is
substantially due to improved data collection procedures, (in  particular since
1988, with the introduction of Form 104).  The numbers of deaths where drugs
were implicated, during the period 1990-1998, are presented on Table 13.5 and
suggest along with anecdotal evidence an increase in drug-related deaths during
the 1990s.
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    Source: Central Statistics Office.
A recent analysis of drug-related deaths investigated by the Dublin City and
County Coroners in 1998 and 1999 (Byrne 2000) reveals that cocaine was
implicated in six out of a total of 86 drug-related deaths in 1998 and six cases out
of 77 in 1999.  Only in one of the 1998 cases, however, was death attributed
directly to cocaine overdose.  Five of the six cases had two or more drugs
implicated in addition to cocaine.  Heroin was implicated in all six of the cocaine-
related deaths in 1999 and the quantity of heroin revealed in toxicology tests was
higher than that for cocaine (Byrne 2000).
Hospital psychiatric data are available from the National Psychiatric In-patient
Reporting System (NPIRS) which collects data on admissions and discharges
from public and private psychiatric hospitals and units countrywide.  It provides
information on gender, age, marital status, socio-economic status, legal status,
diagnosis and length of stay (O’Brien and Moran 1997).  The figures for
admissions to psychiatric hospitals with a diagnosis of cocaine use (ICD-10/F14)
during the period 1994-1998 are presented on Table13.6 8.
 Source: National Psychiatric In-Patient Reporting System, Health Research Board.
The Hospital In-Patient Enquiry (HIPE) Scheme is a system designed to collect
medical and administrative data regarding discharges from acute hospitals.
                                                
8 8 Thanks to Mental Health Division of the Health Research Board for providing these figures.
Table 13.5: Numbers of Drug-related Deaths in Ireland, 1990-1998.
All Ages Age 15-49 years.
1990 7 7
1991 8 7
1992 14 14
1993 18 16
1994 19 19
1995 43 39
1996 53 50
1997 55 52
1998 99 90
Table 13.6: Psychiatric Hospital Admissions with
Diagnosis of Cocaine Use (ICD 10/F14), 1994-1998.
1994 18
1995  7
1996  8
1997  5
1998  9
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Information from private hospitals is not included in this data base.  One difficulty
with these data is that each discharge record represents one episode of care.  As
a result, double-counting may occur where patients have been admitted to
hospital on more than one occasion with the same or different diagnoses.  It is
important to note, therefore, that these records provide a better indicator of
hospital activity than of the incidence of disease.  Data relating to principal and
secondary diagnoses of cocaine-related discharges is provided on Table 13.7
below.
Source: Hospital In-Patient Enquiry System, Economic and Social Research Institute.
The figures recorded for the diagnosis of cocaine dependence (ICD 304.2) have
remained relatively stable during the period 1995-1998.  Those for non-
dependent drug abuse (cocaine), on the other hand, have tended to rise slightly
in recent years, all be it from a low base.
Accepting that mortality and morbidity data are not reliable tools for estimating
drug use or drug problems, they can, in association with other data sources, help
to improve the interpretation of available information.  Cocaine is implicated in
relatively few deaths, certainly when compared to heroin. Admissions to
psychiatric hospitals with a diagnosis of cocaine use indicate no clear upward
trend since 1994.
· Qualitative and Ethnographic Research
The advantage of qualitative research in the drugs field is that it provides detailed
knowledge about types and levels of drug involvement as well as important
details pertaining to the lifestyles, attitudes and motives of drug users.  However,
only a small number of such studies have been conducted in an Irish context.
Mayock (1999, 2000) investigated drug use and non-use among a sample of 57
young people, aged between 15 and 19 years, including abstainers, drugtakers
and problem drugtakers, in an inner-city Dublin community.  In this study, very
few of the young people described as drugtakers (i.e. drug users who did not
consider their drug use to be problematic) reported the use of cocaine at any time
Table 13.7: HIPE Figures for Hospital Discharges with Principal and
Secondary  Cocaine-Related Diagnoses, 1994-1998.
1994 1995 1996 1997 1998
Cocaine Dependence     2    9    11    11    13
(ICD 304.2)
Non-Dependent Drug Abuse (Cocaine)   5   20     9    11    19
(ICD 305.6)
Accidental Poisoning (Cocaine)   0     5    4    10      4
(E855.2)
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and of those who did, it was generally a one-time experience.  Cocaine use was
far more prevalent among problem drugtakers (i.e. young people who considered
their drug use to be problematic).  All of the young people in this ‘problem
drugtaker’ category (n=18) reported heroin as their primary drug of misuse.  The
vast majority (87.5%) also reported lifetime use of cocaine and nearly 20%
reported cocaine use during the week prior to interview.  In general, cocaine use
occurred subsequent to heroin initiation and was frequently used in conjunction
with heroin and other drugs (mainly benzodiazepines).  Most reported the
intravenous use of heroin and cocaine, a drug cocktail known as ‘speedballs’.
The reports below provide some insight into the nature of this group's cocaine
involvement.
[When did you start using cocaine?]
Am, there was a big drought on and everyone was just, there was no heroin, so
everyone was taking coke.  I was taking tablets like for me sickness, I was going
round stupefied on tablets, d'ya know what I mean, and then the coke just ...
everyone just got strung out on coke.
                                             Female, 18.1 years.
[Did you use coke when you were on gear?]
Yeah, used to mix it.  Used to wash up the coke into the drugs, like cook the gear
into the works, bung the two of them into me together.  Then I would be gettin' a
buzz like off the coke and then when I'm coming down off the coke the gear
would bring me down nice.
                                 Male, 19.1 years.
McElrath and McEvoy’s (2000) qualitative study of ecstasy users in Northern
Ireland found that 43% of respondents had tried cocaine powder.  The mean age
of the sample (n=106) was 25 years (range 17 to 45 years).  However, only one
respondent had snorted cocaine once a month during the previous six months.
Cocaine use appeared to be more sporadic by this group.  This finding suggests
therefore, that cocaine is one of numerous drugs tried or used by young
recreational polydrug users.
· Conclusion
The question of how many people are using illicit drugs is notoriously difficult to
answer.  The dearth of regular prevalence studies at both national and local
levels, utilising uniform or comparable methodologies, compounds this problem.
However, the difficulties associated with establishing accurate and reliable drug
use prevalence figures is not just about the absence or paucity of relevant survey
data.  The illegality of drug use ensures that the activity is undertaken
inconspicuously and that many drug users remain hidden.  The best way, in the
present situation, to assess the extent of particular forms of drug use is to utilise
all available data from a wide range of sources.
202
Accepting that available sources such as survey and other empirical data can
produce, at best, imperfect approximations, there are a number of conclusions
that can be drawn form the data presented above. Extensive use of the drug, is
not apparent among the general trend of increased drug experimentation,
cocaine is far less likely to be used than cannabis, ecstasy, LSD and
amphetamine, certainly among school-going teenagers.  Among adult population
samples, use appears to be restricted to a minority.  The difficulty with these
findings however, is that they fail to uncover substantial knowledge about
individuals who do use cocaine.
At the other end of the drugs spectrum are individuals who develop drug
problems.  Unlike the two previously mentioned populations, many are known to
drugs services.  While heroin remains the primary drug of misuse among problem
drug users who present to services, available figures suggest that cocaine is
more likely than previously to be cited as a secondary drug of misuse.  Irish drug
treatment data indicate that cocaine is rarely clients' primary problem.  Yet, there
is evidence to suggest that the drug repertoires of long-term ‘problem’ drug users
have extended to include a larger and more diverse range of substances
including, among others, benzodiazepines and cocaine (Rooney et al. 1999).
However, while cocaine is clearly available and increasingly likely to be used, it is
clearly less endemic, compared to heroin, benzodiazapines, cannabis and
ecstasy.
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Component 2 : Views of Service providers and key informants
 As stated earlier, this component of the research was concerned with accessing
current perceptions of the extent and nature of the cocaine 'problem', from the
perspectives of individuals working, or in regular contact, with drug users.  The
value of this data relates to its potential to report on current and 'new'
developments on the ground.  Tables 13.8 and 13.9 provide a breakdown of the
number and range of individuals interviewed face-to-face and by telephone.
Table 13.8: Face-to-face Interviews                 Table 13.9: Telephone Interviews
Individual
Interviews
Number of
Interviews
Telephone
Interviews
Number of
Interviews
Drug Service Staff 5 Student Welfare
Service
2
Youth Worker 1 Youth Worker 2
Youth Work Co-
Ordinator
1 Project Worker
(Young People)
2
Key Informant 2 Drug Service Staff 2
Police 1 Liaison Midwife 1
Night-Club Owner 1 G.P. 3
Hospital Personnel 1 Police 1
Drug Counsellor 2 Hospital Personnel 1
General Practitioners
(G.P.)
1 Prison Staff 1
Total 15 Total 15
It is evident from the range of individuals contacted that efforts were made to
incorporate a cross-section of respondents, in terms of the nature of their
experience of drug users and the drug scene.  Table 13.10 summarises the
issues addressed in the case of each ‘subgroup’ of interviewee.  Separate
interview schedules were designed for the respective ‘subgroups’ of study
respondents where appropriate.
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Table 13.10: Issues Addressed During Face-to-Face and Telephone Interviews
INTERVIEWEES ISSUES ADDRESSED
Drug Service Staff
(6)
Numbers presenting with cocaine-related difficulties
(stable, increase, decrease) / evidence of crack
cocaine? / cocaine as a primary drug of misuse / the
treatment needs of cocaine users / implications for
treatment and service provision.
Key Informants* (2) Who is using cocaine (age group/background/SES)?
Availability, cost and purity?  Is cocaine more accessible
than previously?  In what kinds of settings is use taking
place?  Patterns of use (regular/recreational/occasional
etc.)?
Police (1) Drug seizures and arrests : have the figures for cocaine
changed dramatically in recent years / any indicators of
increased availability of cocaine on the streets? / if so,
how have the Gardai responded to this ‘new’
development?
Youth Workers
(within ‘high risk’
areas)
Is there evidence of increased use of cocaine among
adolescents / any evidence to suggest that cocaine is
easier to access and / or more affordable than
previously? What are the dominant perceptions of the
‘risks’ associated with cocaine use?  Are youth workers
adequately equipped to respond to current drug use
trends?
Night-Club Owners Which drugs are most visible/available on the
club/dance scene?  Any evidence of cocaine use? If so,
when did this come to your attention?  Is cocaine more
easily available then previously?  Cost and accessibility?
General
Practitioners
Numbers presenting with cocaine-related difficulties
(stable, increase, decrease) / evidence of crack cocaine
/ cocaine as a primary drug of misuse / the treatment
needs of cocaine users / implications for treatment and
service provision.
Hospital Personnel Any evidence of cocaine emerging as a drug of choice?
Accident and emergency admissions?  Paediatrics?
* Key informants are individuals who have experience of and contact with the drug scene and are
considered to have knowledge and insights that may contribute significantly to the data collected
from other sources.
Face-to-face interviews were tape-recorded and partial transcripts of this material
prepared.  Detailed notes were taken both during and after telephone interviews.
The major issues and themes arising from these data are documented in this
section.  The presentation of findings will concentrate on the key questions
outlined on Table 13.8 and on other issues raised by informants in the context of
the interviews.  For the purpose of clarity and structure, the findings are
205
presented under three broad headings : cocaine availability, the extent and
nature of cocaine use and implications for drug treatment and service provision.
· Cocaine Availability
Cocaine was believed, by the majority of respondents, to be more easily
available than previously.  Broadly speaking, the evidence revealed a definite
consensus on increased accessibility and use of cocaine.  A spokesperson from
the Garda National Drug Unit described the current situation vis-à-vis cocaine in
the following terms.
We are quite aware that cocaine is being used and offered for sale,
particularly in certain areas.  If we look at the statistics in relation to
cocaine for say 1998, that shows quite an amount of cocaine being seized.
We have 333 Kilos and 167 grams.  This is a huge amount.  Now some of
that of course, came from major seizures.  But, coke has become more
popular.  I would have no hesitation saying yes, it is more prevalent.  
                        (Garda)
Several respondents involved in the delivery of drug treatment indicated that they
had become aware of an increase in the supply of cocaine within the areas
where they work, particularly during the past year.
You hear about it more and it's almost becoming a substitute drug for
heroin.  With the availability of methadone now people's need for heroin
isn't so great.                       (Drug Counsellor)
Similarly, many professionals working with young people in communities where
drug use is concentrated stated that they were conscious of a discernible shift
towards increased cocaine availability.
There is a strong sense that it's out there alright.  I've no concrete evidence from
the group we work with but a very strong sense that it's out there and available.  
                        (Youth Work Co-Ordinator)
My impression is that during the past year or year and a half there has been a lot
of selling going on and a good bit of use.  Yeah, it's definitely amongst problem
drug users and I think that you'd probably find a good number of urines testing
positive for cocaine.             (Youth Worker)
Other respondents drew attention to a decrease in the street price of cocaine and
felt that this served as a further indicator of the changed nature of availability and
use of the drug.
It would seem now at the moment that a half a gram can be as low as £25.  A
number of years ago it was £300 a gram.  Now it is down to between £60 and
£80 a gram.  One thing that is noticeable is that the price varies depending on
where you buy.                (Drugs Worker)
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Worthy of note also is that a number of individuals involved in the provision of
methadone treatment reported a conspicuous upsurge in the proportion of urine
samples revealing quantities of cocaine during the latter months of 1999 and the
early months of 2000.  Although this trend appears to have since abated, doubt
was expressed, in some cases, about the validity of the assumption that a
decrease in the percentage of urines revealing cocaine can be reliably viewed as
an indicator of a downward trend in cocaine use among clients receiving
treatment.
The prevalence rate (of cocaine in urines) would appear to be running at around
3% of the known drug users, the ones in treatment.  Again, I think that's probably
coloured by the fact that cocaine is short-lived in the system.  Drug users can
very easily get around the system and continue to use cocaine.  If say, somebody
is clear of every other drug and they're on weekly take-outs it's not a big deal for
them to make sure that they don't use two days before they come in to pick up
their methadone.  So how much of an indicator it is I don't know.  There certainly
was a peak in the three months of December, January and February but that
seems to have gone down again.  Now whether it is that it's been challenged and
drug users are altering their behaviour or whether they've just managed to work
the system, I don't know.
(Drugs Worker)
It is important to state that the perceived increase in cocaine availability and use
was associated with particular geographical locations in the Dublin area, which
will remain unidentified in this paper.  However, the most likely to be mentioned
were two specific areas associated with concentrations of known drug users.
This pattern was identified by a range of respondents including drug service
providers, general practitioners and the police.
From the point of view of gaining insight into individuals in the community who do
not identify themselves as drug users, a number of key informants with
knowledge of and contact with the ‘dance’ scene were interviewed.  These
respondents indicated that cocaine was currently more visible on the
club/dance/drug scene than previously.  It was also felt that this trend was
accompanied by increased acceptance of cocaine as a drug of choice.
I'm not into cocaine myself and I don't really hang out with people who are, ya
know, but I know of people who are.  I know it's become a usual thing for lots of
people. It's just a natural normal thing that they do.  There's definitely some
people who get more into it and prefer to do coke and there's also that thing
where it's seen as a slightly, you know, more prestigious.  Coke has always been
seen as a middle class drug; for people who have money essentially.  You can
link it directly in this country to the economic situation.  People have more money,
they're more affluent and cocaine is a more affluent drug.
(Key Informant #  1)
The majority of respondents stated that there was little evidence to suggest that
crack cocaine was available or was making a breakthrough on the drug scene.
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However, an interview with an ex-cocaine dealer and former crack cocaine addict
suggested some use of ‘home-made’ crack cocaine.  This respondent described
himself as 'in recovery' at the time of interview, having previously had a chronic
cocaine and heroin problem.  He stated that he was involved in the distribution of
cocaine, both within and outside of the Dublin area, for several years.
I went as far as South Dublin and out of Dublin to deal.  I would travel, yeah.  And
people would travel from everywhere ta me or else, if they couldn't make it I'd
make me way out ta them.  Inner-city, apartments as well, ya know, well-ta-do
people ... everywhere ... this would be sellin' cocaine.  On most occasions I
would have ta wash it up for them, turn it into crack for them like.  Very few would
actually just, very few people I actually dealt with were buying it ta snort, they
were buying crack.
[But people say that there's no crack around?]
I hear this, and I've said it to xxx (friend), and it actually makes me blood boil 'cos
there's a big problem out there like and it's like, look at heroin in the 80s.  It was
actually around before then but no, it's nothing, it's only a handful of people,
that’s what they said.  And look at it now!  And there's as much coke out there
now as heroin.  It's so easy to get, ya know.       (Key Informant #  2)
Overall, the data points to increased awareness of the presence of cocaine, its
availability on the street and of its potential to become a drug of choice for both
recreational and problematic drug users.
· The Nature and Extent of Cocaine Use
The identification of drug use patterns at local level is difficult to quantify and
requires specialist research (Parker et al. 1998).  Hence, the aim here is not to
advance evidence on the extent of cocaine use generally or among particular
sub-groups of the population.  Rather, the emphasis is on providing a description
of what is perceived to be occurring on the ground, based on the reports of
individuals who have regular contact with drug users.
One of the most noticeable features of informants’ reports was that despite the
belief that cocaine is easier to procure than previously, many felt that they had no
concrete evidence of cocaine’s emergence as a major issue, certainly compared
to heroin and other drugs.  In particular, participants felt unable to estimate the
extent of cocaine use in the communities where they worked.  There appeared to
be a number of important factors associated with this absence of clear evidence
or knowledge of cocaine’s ‘position’ as a drug of use.  First, respondents felt that
cocaine use was extremely hidden and consequently, unlikely to come to their
attention.  Secondly, according to a large number of interviewees, cocaine users
are unlikely to perceive their drug use as problematic and consequently, unlikely
to seek treatment or advice of any kind in relation to their cocaine use.
I’m not sure that this area is awash with cocaine but what I would have a sense
of is that the ones who are using cocaine are not in touch with services because
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they don’t really see themselves as having a problem.
                                    (Drugs Worker)
You see, young people wouldn’t seek treatment around that.  Young people do
come forward for treatment but it’s mostly for heroin.  They wouldn’t see their use
of cocaine as something they can get help for, or that they need help for.
(Youth Worker)
The picture that I’m getting is that the young people who start using coke don’t
see themselves as having a drug problem because they’re not on heroin.  So,
heroin is still the biggie in people’s perceptions and by taking coke you're
avoiding having a drug problem.
                     (Drug Counsellor)
A number of professionals working in the delivery of drug treatment at
community-level did however, report direct experience and evidence of cocaine
use and considered this development to be recent.  All stated that users were far
more likely to be smoking or injecting cocaine than using the drug intranasally.
Although most of the people who access this service have an opiate problem, I
have had contact with cocaine users.  One person I’m thinking of now started
using on holidays overseas and later developed a dependency.
                                 (Drug Counsellor)
I think it (cocaine) is a serious problem, it’s been a serious problem for quite a
while.  There’s a lot of it going around in the flats.  And we have an ongoing
struggle with people on treatment who might be doing fairly okay as regards the
heroin but dabbling or more than dabbling with cocaine. 
(Drug Service Co-Ordinator)
Two respondents made specific reference to cocaine use among women.  This is
particularly noteworthy in view of findings documented in a recent study of drug
using women working in prostitution in Dublin city (O’Neill and O’Connor 1999).
Of the 77 women interviewed, forty reported past month use of cocaine.
Following heroin and benzodiazepines, cocaine emerged as the next likely drug
to be used.
Most of the clients who report cocaine use to me are women.  And all of
them say that it’s very difficult to get off the drug, more difficult than heroin.
These women would also be working on the street and there seems to be
a link between the two.  (Drug Counsellor)
However, for respondents involved in the delivery of drug treatment, the
dominant focus is on heroin users.  There was general agreement however, that
cocaine was far more likely than previously to be a secondary drug of misuse.
Many respondents made reference to the practice of ‘speedballing’, one entailing
the simultaneous intravenous use of cocaine and heroin.  This practice was
described by one of the study’s key informants (a former heroin addict) in the
following terms:
209
What I did then was I made speedballs.  Ya know what a speedball is?  Ya put
your heroin on the spoon and cook it up, have your coke in the works, ya suck it
up.  The effects ya get from that!  You’re straight up in the air, like you head feels
like it’s goin’ to go ‘bump’.  It’s a great feelin’!  And then ya sorta come down then
nice and easy.  It’s the sorta feelin’ (pause), it’s unbelievable.  It’d frighten ya at
first ‘cos ya think you’ll die but this feelin’ ya get from it it’s, ya know, it takes all
the pain away and all this shit, that’s what it’s there for at the end of the day.
 (Key Informant #  2)
Several respondents acknowledged that ‘speedballing’ was a common practice
and a number drew attention to the health implications of injecting risk behaviour.
What we would find here is that most people are speedballing, they’re using a
combination of heroin and cocaine together.  So, in terms of harm reduction and
looking at issues around health, the same difficulties will arise if people are using
needles and injecting cocaine.  (Drugs Worker)
Furthermore, respondents consistently drew attention to dominant risk
perceptions and felt that cocaine was unlikely to be perceived by drug users to
carry the serious health risks associated with heroin use.  There is an implicit
danger here, if as perceived, cocaine is increasingly finding acceptance and is
more commonly in use.
I think the preference here (service) among drug users has been for the type of
effects that heroin gives.  Cocaine would not be seen by most of them as abuse.
It would be seen as recreational.  They don’t see it as such a problem.
                       (Drugs Worker)
Heroin, as I said before, has that dirty, filthy, low-life thing and all of that,
eventhough it hits all walks of life.  Cocaine is looked at, ‘ah, it’s alright, it’s only a
line a coke’.                                        (Key Informant)
I think that the dominant perception is that cocaine is primarily a recreational
drug, just as hash is understood as a recreational drug.  The effects aren’t as
dramatic or rapid.  And this is a problem too because I would certainly meet
people who have serious problems with cocaine.
                       (Drug Counsellor)
It is important to point out that not all of the respondents reported concern about
cocaine use among their client group.  This is important since it suggests that
different settings and services are more likely than others to attract cocaine
users.  A number of respondents stated clearly that opiates and benzodiazepines
remained their overwhelming concern.
We have heroin problems and all sorts of other problems, tablets and all that.
But from my point of view, and this is just an overview, we don’t get cocaine
coming up as a major issue.  And it seems to me that there’s a couple of angles
on that, if we generally accept that heroin is the drug of choice.  People will
dabble with cocaine, but that’s it they’ll dabble but they’ll revert to heroin.  So,
cocaine might be cheap on the streets, they might go for that for a while, it may
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become problematic with them but they quickly get out of it and back almost to
the safety of heroin, the known substance, the known area like.  
(Drugs Worker)
Finally, while concern was expressed, by the majority of respondents, about an
apparent increase in the availability and use of cocaine, the problem was not
considered, as yet, to have reached epidemic proportions or to merit being
viewed as ‘out of control’.  One informant, who previously worked with cocaine
and crack cocaine users in London, drew a clear line of distinction between the
situation in Dublin and that which prevailed in London a number of years ago,
particularly in terms of service needs and responses.
A serious crack problem developed and all of a sudden agencies were inundated
with these people and nobody could relate to them.  And we had to do a lot of
training to adjust to dealing with these people because it was totally different.
The way you’d approach a heroin user, you wouldn’t approach a crack user like
that.  But we’re not getting that here.
                         (Drugs Worker)
To summarise, cocaine use was judged to be far more widespread than
previously.  However, respondents found it difficult to estimate the scale or extent
of use among their client groups, or in the community at large.  While the majority
felt that the cocaine ‘problem’ was not comparable to that relating to heroin, they
identified cocaine use as an issue requiring attention also.
· Implications for Drug Treatment and Drug Service Provision
The question of whether the needs of cocaine users can be adequately met
within the context of existing treatment interventions was addressed with
interviewees engaged in the provision of services to drug users.  Considerable
variation emerged on what was viewed as an appropriate way to address the
issue of cocaine use within the context of existing services.  While some
respondents felt that specific tailor-made interventions were required to deal with
the needs of cocaine users, others believed that current services needed to
develop the knowledge and expertise required to deliver appropriate intervention
and counselling.  Some respondents stated that their agencies had already
begun to address the issue informally.
I would say that there is a need for separate interventions.  It’s a separate drug, a
separate addiction, one which can’t be treated like heroin.  If the two drugs are
lumped in together, then it follows that they’re going to be used together.  If
cocaine users are in a methadone clinic they’re bound to pick up the habits that
are all around them.             (Drugs Worker)
I do think it’s a different kind of problem and one of the reasons it’s different is
that there doesn’t seem to be the same physical withdrawal difficulties but there
is an enormous psychological withdrawal and psychological cravings.  So what
we’ve done here is supported the person as best we could, get them into
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counselling and we would also have treated them with acupuncture.
                        (Project Worker)
I think that as an agency we’ve already started to change our approach, even in
thinking what services can offer somebody who might have a dependency on
cocaine.  There’s no medical treatment so we have been looking at some level,
looking at ways that we can provide appropriately as a service. 
                         (Drug Counsellor)
More critical perhaps than the lack of agreement on appropriate interventions
was the fact that several interviewees who are involved in drug treatment delivery
felt ill-informed and ill-equipped to deal with the presenting behaviours and
problems of cocaine users. In addition, a number of respondents drew attention
to an absence of information on cocaine use and related risk behaviours at
community level.
They’ve (drug users) had more information, more education on heroin so maybe
the haven’t had enough information about cocaine.  Initially, they don’t have a
fear of cocaine because they would believe that it isn’t addictive.                               
(Drug Service Co-Ordinator)
Prevailing perceptions of the risks associated with cocaine use were considered
to be a compounding factor here.  One informant drew attention to the
importance of contextualising current perceptions of drug-related risk when
attempting to alter behaviour and beliefs about cocaine.
It’s largely a methadone culture and that’s the context I’m speaking in.  And
methadone is perceived as the solution to the problem.  And for people who are
seriously dependent on cocaine and want help, the belief is that methadone is
the solution for them as well and therefore, they want methadone treatment.
That’s the perception in the community.  So we would have had to be quite
strong in helping people to understand that it’s a totally different drug and that
there’s absolutely no point putting the person on methadone, that you’re actually
introducing them to opiates.  But this is all understandable in the context of a
strong heroin and methadone culture.                          
(Drugs Worker)
Most respondents agreed that there was a need for more information and training
on the effects of cocaine, the presenting behaviours of cocaine users and
appropriate treatment and intervention options.
· Conclusion
Using existing data systems, including available data on drug users, the previous
section of this paper found that opiates remain the primary drugs of misuse
among drug users who access treatment.  Despite this, there are subtle
indicators of a possible shift in the drugs landscape, with increased likelihood of
cocaine use among individuals whose main drug of misuse is heroin.
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The reports of drugs workers confirm this trend.  A large number of drugs
workers stated that clients are now more likely to present with cocaine-related
problems and the majority felt strongly that cocaine was more readily available
and accessible than previously.  The risk of ‘microdiffusion’, that is the dispersal
of drugs knowledge, practices and techniques, through established user
networks (Parker et al. 1998), may be substantial if, as indicated, cocaine is
making a breakthrough on the drug scene.  Further research is required to qualify
and quantify a possible spread of cocaine use among problem drug users.  In
particular, the nature of the relationship between heroin and cocaine use,
requires investigation.  Preferred routes of cocaine administration and related risk
behaviours need particular attention in this context.  Grund et al.’s (1991)
investigation of cocaine use in a sample of heroin addicts in Rotterdam found that
the mode of ingestion paralleled that of heroin: injecting drug users injected
cocaine-hydrochloride and heroin smokers smoked cocaine base.  The authors
documented the distribution of ‘gekookte coke’, otherwise known as ‘cooked’,
‘base’ or ‘rock’ cocaine, by a particular sub-population of drug users.  The
preparatory process is identical to that described by one of the current study’s
key informants, a former user and supplier of ‘homemade’ crack cocaine.
Well, basically all ya do is (pause) ya can add ammonia.  That's a lazy way ta do
it.  I call it the lazy man's way a doin' it.  Ya put your coke on the spoon, your
gram a coke or whatever ya have on the spoon, ya pour a dribble of ammonia
over it, light a flame underneath it.  It's like cookin' heroin.  It bubbles like fuck
and it goes inta sort of an oil and ya leave it cool or else ya can drain it off.  Ya
rinse it with cold water then, ya don't heat it up again, ya just rinse it with water
'cos if ya do that it'll just dissolve inta ... And then ya take it off.  And ya know a
hash pipe?  Like a seven-up bottle or something.  Instead of using tobacco ya
use the ash off the cigarette.  It has ta be fresh ash.  So like you'd have one
ashtray for cigarettes, for puttin' out your cigarette.  You'd have cigarettes burning
everywhere but ya wouldn't put the cork out on it 'cos ya want the ash.  Ya just
break bits a lump off it and whatever and (inhales) ya smoke it and ya get your
couple a seconds hit.
   (Key Informant #  2)
At present, there is no way of establishing how widespread the practice of
‘cooking’ cocaine may be, or of the prevalence of this technique among drug
users.  However, problem opiate users are far more likely to be using injecting or
smoking techniques than to be snorting cocaine (Grund et al. 1991).  Research is
required to explore dominant and preferred patterns of cocaine use among both
treatment and community samples of heroin users.
Finally, the treatment needs of individuals engaged in the co-abuse of opiates
and other substances requires attention.  Rooney et al. (1999), comparing Irish
drug users who are dependent on opiates and benzodiazepines with drug users
who are not dependent on benzodiazepines, found that the former group tended
to take more drugs in general.  Thirty five percent [35.3%] of those dependent on
opiates and benzodiazepines used cocaine compared to 13.8% of the opiate
users not dependent on benzodiazepines.
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While drugs workers and service providers in the current study expressed
concern about increased availability and use of cocaine among their client
groups, it also seems clear that some services are more likely than others to be
currently treating clients who report the use of cocaine.  Consequently, the lack of
consensus on appropriate treatment and intervention responses to cocaine use is
not altogether surprising.  More critical perhaps, is the fact that drugs workers felt
that they lacked adequate knowledge and understanding of cocaine use among
their client groups, including information on dominant user practices and the
effects, risks and health consequences associated with the co-abuse of heroin
and cocaine.
Component 3 : Exploratory Study of Social/Recreational Cocaine Use
Population surveys in Ireland identify few cocaine users.  However, anecdotal
evidence suggests that cocaine is easily available and its use more widespread
than previously.  In this exploratory study of social/recreational cocaine use, the
research challenge was to locate and gain the co-operation of a small number of
adult cocaine users in the community, who are not currently attending, and who
have at no stage contacted, a drug treatment centre.  In other words, the
emphasis was on accessing individuals who do not identify themselves as having
a drug problem.  The principal aim was to ‘capture’ users not normally accessible
through treatment or other institutional settings and to examine patterns of use
and attitudes to cocaine.
· Study Parameters, Research Instruments and the Recruitment Process
The study’s selection criteria, in terms of past and current cocaine use, was
deliberately broad.  No strict or binding guidelines pertaining to precise levels of
drug intake were applied at the outset of the selection procedure due to the
absence of prior empirical research on cocaine use in an Irish context.  However,
to qualify for participation in the study, respondents must have used cocaine at
least five times during their lifetime, preferably, at least once during the past year.
Other criteria for entry to the study, in addition to some experience with cocaine,
were that participants must be 21 years or over and must have been employed
for at least six of the twelve months prior to interview.
The purpose of the research was not to ascertain how many people use cocaine,
but rather to gain some insight into reported patterns of cocaine use among a
small group of social users.  Hence, the central concern was not one of
generalisability but one of access.  In this context, the guiding principle, in the
words of McCracken (1988), was “less is more” (p. 17).  McCracken (1988), who
describes the key characteristics of the long interview, recommends working
longer and with greater care with a small number of people, and suggests that
eight respondents is sufficient for many research projects.
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The research aimed to generate knowledge and insight into cocaine use by
adults, a phenomenon not previously researched in an Irish context.  Ten adult
cocaine users were interviewed individually.  The issues addressed in the context
of individual interviews included past and current cocaine use, other drug use,
typical cocaine-using contexts, availability, cost and quality of cocaine, the
benefits of cocaine use, perceptions of risks associated with use and the appeal
of cocaine.  Study respondents were accessed initially via the researcher’s
personal contacts with potential participants. This gradually facilitated access to
other individuals through ‘snowballing’, whereby, additional respondents were
recruited through the recommendations of individuals previously interviewed.
This technique is well-known in the drugs research field and is particularly suited
to investigations of illicit and hidden activities (Biernacki and Waldorf 1981;
Power 1989).
Attempts were made to access a variety of user networks.  The recruitment task
proved more difficult than originally anticipated, particularly during the early
stages of establishing contact with cocaine users.  Prospective participants were
sceptical about the intentions of the research and understandably reluctant to
divulge details about their drug use.  They invariably asked questions about the
purpose of the study and about the publication of study findings.  The challenges
to recruitment were overcome by gradually extending access routes and by
providing assurances of anonymity and confidentiality.  The recommendations of
key informants – individuals who had contact with cocaine users - greatly
facilitated this process.  The time invested in the selection of participants resulted
in six user networks across the sample.  All interviews were tape recorded.
Choice as to the time and place of the interview rested with the participant.
Interviews took place in a variety of settings including the researcher’s office
(n=1) or home (n=1), a public venue (n=3) or at the home of the respondent
(n=5).
Biographical details and drug history were recorded for each respondent using a
pre-coded structured questionnaire.  This included details of each respondent’s
age, gender, education, employment, household situation and current income.
Lifetime drug use, past month, past week drug use, as well as future drug
intentions were recorded for each individual participant.
All respondents were resident in Dublin city.  The study does not claim to be
representative of social/recreational cocaine users generally.  Rather, it is
illustrative of a ‘mode’ of cocaine involvement among adults who do not consider
their drug use to be problematic.  The primary objective of the investigation was
to gain insight into patterns of cocaine use among groups not associated with
problematic drug consumption.  The question of how users first came into contact
with cocaine, how their use progressed from the time of initial use, what they
perceived as the positive and negative effects of the drug, and how they
regulated their intake of the drug were key issues addressed during in-depth
interviews. Importantly, the research examined respondents’ use of a range of
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mood-altering substances, so that cocaine was not examined in isolation of other
drug use.
The protection of informants’ identities was a priority throughout the research.
No names, addresses or contact numbers were recorded on pre-coded
questionnaires.  In addition, all identifiers (place names, birth place, current area
of residence etc.) were removed from transcript material and fictitious names
substituted in all cases for the purpose of reporting the study findings.
· Data Analysis
Full transcripts of nine of the ten individual in-depth interviews were prepared.  A
partial transcript was prepared for one interview due to poor conditions at the
interview site, resulting in a high level of background noise.  This partial transcript
was reinforced by notetaking both during and after the interview.  The findings
presented here are based on a thematic analysis of all transcript material.
Boyatzis (1998) describes thematic analysis as a “process for encoding
qualitative information”(p.4) and clarifies the meaning and use of themes for
analytic purposes.
A theme is a pattern found in the information that at a minimum describes and
organises the possible observations and at a maximum interprets aspects of the
phenomenon.   (Boyatzis 1998, p.4).
In other words, a theme is not merely a ‘fact’ or set of facts extracted from the
data but a pattern that presents itself throughout a data set.  Themes provide a
useful interpretative structure for understanding the phenomenon of interest.  The
data was coded manually in accordance with the research aims.  Ancillary codes
were added as the fieldwork process advanced.  In this way, the analysis
incorporated both predefined categories and those that emerged directly from
respondents’ accounts of their cocaine use.
Interpretation of the results has to be qualified by a number of study limitations.
First, the research is based solely on self-reports of frequency and quantity of
drug consumption of a small number of informants, all of whom were resident in
Dublin city at the time of interview.  Second, the sample was opportunistic or one
of convenience. Accordingly, it would be inappropriate to generalise the findings
to cocaine-using adults generally.
A number of techniques were employed throughout the data collection and
analysis phases of the research to ensure valid and reliable findings.  The
safeguards concerning confidentiality and anonymity help to validate the
responses.  Moreover, the questioning and data collection techniques employed
meant that the consistency of cocaine and other drug use reported by
participants could be checked.  All respondents were asked about their drug use
(lifetime use, past year and past month use) on two separate occasions during
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the interview.  This data was also recorded on a questionnaire.  One hundred
percent consistency was found in respondents’ reports in practically all cases.
The presentation of research findings focuses first, on the socio-demographic
characteristics of study respondents.  Baseline data on cocaine and other drug
use is then presented.  The analysis moves then to present a more detailed
description of respondents’ use of cocaine, including the circumstances and
locations associated with use, the appeal of cocaine, negative effects and the
perceived benefits of cocaine use and risk perceptions.  The issues of availability,
price and purity are also examined.
· Socio-Demographic Characteristics
Eight males and two females were interviewed.  The average age of the research
participants was 27.3 years (range 25-29 years).  Nine of the ten interviewees
were born in Ireland.  One was born in the UK but has been residing in Ireland for
several years.
The educational attainment for the sample was high.  All had completed their
Leaving Certificate or equivalent and all attended a third level educational
institution.  Eight of the ten participants graduated with a third-level Degree or
Diploma.  Eight were employed full-time and two part-time at the time of
interview.  All had experienced periods of unemployment ranging from 2 months
to 6 years.  It is significant however, that in most cases, stated periods of
unemployment coincided with time spent travelling abroad and extended for only
one to two years.  Two participants declined to state their current gross annual
income.  Of the eight who did, annual incomes ranged from £10,000 to £30,000.
Seven of the ten respondents were earning in excess of £20,000 per annum and
five had a gross annual income of between £25,000 and £30,000.
Finally, all respondents resided in Dublin city.  All were single and over half (n=6)
lived with a partner.  Three participants lived with friends and one with their child.
All participants resided in a rented private sector house or apartment.
· Cocaine Use
This section provides baseline data on the participants’ reported cocaine use.
The average age of cocaine initiation use was 21.2 years.  Half (n=5) reported
first use of cocaine between the age of 20 and 23 years.  On average,
respondents had a cocaine ‘career’ of 6.5 years since initiation.  Eight of the ten
respondents had used cocaine at least once during the month preceding the
interview.  The most popular mode of cocaine ingestion was ‘snorting’, or
intranasal use of the drug.  Two respondents reported having ingested the drug
orally on a number of occasions and a third stated that he had smoked cocaine in
a ‘joint’.  Apart from this, none of the participants reported smoking cocaine at
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any stage.  In fact, they were unfamiliar with this practice and did not regard this
mode of administration as a future drug option.
Cocaine typologies have been devised by several researchers, based on
participants’ reported frequency and intensity of use (Hammersley and Ditton
1994; Waldorf et al. 1991; Ditton et al. 1996).  Typologies will not be presented
here due to the small sample size.  However, it is helpful to summarise general
patterns of cocaine use for the sample.  The majority did not engage in
subsequent use of cocaine for some time (sometimes 2-3 years) following first
use of the drug.  Overall patterns of cocaine use varied considerably across the
sample.  Although a number (n=4) reported bingeing on cocaine, the duration of
such ‘bouts’ of use were short.  The majority (n=6) had not used cocaine for more
that two concurrent days.  Monthly use was the most frequently reported current
pattern of use and daily cocaine use of the drug was not the norm for this group
of users.  Nine of the ten respondents intended to use cocaine in the future.  The
remaining participant stated that she may well use cocaine at some time but had
no definite plans to do so in the immediate future.
· Other Drug Use
Practically all participants were experienced users of a range of illegal drugs.
Table 13.11 presents the figures for lifetime, past month, and past week use of
cocaine and other drugs.  Drug intentions are also included on this table.  Alcohol
and tobacco, being licit drugs, are referred to independently.  Six of the ten
participants were current smokers and all consumed alcohol on a regular (2-3
times weekly) basis.
 Table 13.11 : Lifetime, Recent and Future Use of Cocaine and Other Drugs
(n=10)
Drug
Lifetime
Use
Past Month
Use
Past Week
Use
Future Drug
Use*
Cannabis 10 10 8 10
Ecstasy 10 7 4 7
LSD 10 1 1 2
Amphetamine 10 0 0 1
Cocaine 10 8 4 9
Heroin 3 0 0 0
Methadone 2 0 0 0
Psilocybin 9 0 0 3
Glue/Solvents 2 0 0 0
Tranquillisers 3 0 0 0
Other 6 0 0 0
    * Respondents were asked to state which drugs they intended to use in the future.
The average age of drug initiation for the sample was 15.8 years (range 13-19
years).  Five respondents were 17 years or over at the time of first drug use.  The
table above indicates that respondents had tried or used a range of substances.
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All reported lifetime use of cannabis, ecstasy, LSD and amphetamine.  Nine had
used psilocybin (magic mushrooms).  Three respondents reported lifetime use of
heroin, two had used methadone, two tranquillisers and two solvents or inhalants.
Lifetime use of other substances not listed included opium (n=2) , mescaline
(n=2) and crystal meths (n=2).
Cannabis was by far the most commonly stated first drug used.  LSD and
psilocybin (magic mushrooms) were frequently stated as second drugs used
(n=7).  Seven of the eight respondents were regular cannabis users (weekly or
fortnightly users) and a significant number (n=6) reported past month use of
ecstasy.  A large number reported concurrent drug use, that is the use of two or
more substances within a couple of hours of each other.  The most popular drug
cocktails were alcohol and cocaine; alcohol and cannabis; ecstasy and cannabis;
cocaine, ecstasy and cannabis and ecstasy and cocaine.  Cannabis was
considered to be compatible with most drugs and was frequently smoked
subsequent to the ingestion of another substances.  Nearly half of the
respondents (n=4) reported daily or near-daily use of cannabis.
Nine respondents intended to use cannabis and cocaine at some stage in the
future and a large number expected to use ecstasy (n=7).  Considerably fewer
intended to use LSD (n=2), psilocybin (n=2) or amphetamine (n=1).
· First Use of Cocaine
Respondents were asked to describe the circumstances surrounding their initial
use of cocaine.  Use was invariably initiated in the company of friends in a social
setting where alcohol and/or other drugs were being consumed.  The majority
stated that they had contemplated cocaine use in advance of first
experimentation.  However, while most stated that they intended to try cocaine at
some stage, first use usually occurred incidentally.  For this reason, first cocaine
experiences were often free.
With friends at a party under the influence of another drug which was Ecstasy.  I
hadn’t planned it as such but I had expressed an interest in taking it before that
night anyway.  I was up and ready for it but I hadn't planned it.
I was with some other musicians and they had it.  It’s a social drug and they were
sharing it. At that time I was only starting to dabble with that kind of stuff.
Someone asked me did I want some so I tried it.
For a smaller number of participants (n=3), first cocaine use was involved some
advance planning.
I got it through friends.  I asked to get it.  I got it for a party.  And I was in my early
20s at the time, about twenty-two.
A the time of initiation, most shared approximately one gram of cocaine with two
or three friends, the typical intake being “two or three lines” or “a few lines”.
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Informants usually reported drinking alcohol and/or using one other drug - either
cannabis or ecstasy - at the time of initial cocaine use.  The majority reported first
cocaine experiences in positive terms.
It was amazing.  Down there (abroad) anytime I got it, it was absolutely amazing.
I could really see the attraction in it ... it was weird being so high but so clear.  I
suppose it was a very confident buzz I got out of it.
I thoroughly enjoyed it, yes it was good.  It has similarities to other stimulants as
such but I would certainly differentiate between that and ecstasy or speed.
Only one respondent stated that he was not impressed with the drug at the time
of first use and asserted that he “didn’t really see what the attraction was”.  Most
agreed that subsequent cocaine experiences were superior to first or early use
episodes.  A process of learning to recognise and appreciate cocaine effects
clearly accompanied the initial stages of use.
I remember being able to deal with it and just kind of recognise the buzz and
again it was probably just a learning thing going on.
There is not a huge kick off it (cocaine) which is why I think you don’t know what
to expect at first and maybe after the second time you probably .... you can tell
people ‘that was crap’ and they say ‘well, did you not feel this’ ... and then you
say, ‘well maybe I did’.  And then the next time you have probably talked yourself
into the buzz, what you are supposed to feel.
At the time of first use, practically all respondents had previously experimented
with and used a range of stimulant and hallucinogenic drugs.  In fact, cocaine
was commonly listed as a fifth or sixth drug ever used by the majority of
respondents.  On average, there was a five and a half year time lapse between
first drug use and first cocaine use.  Hence, the majority were ‘experienced’ drug-
takers at the time they first tried cocaine.  None expressed any doubt, scepticism
or anxiety about the prospect of using cocaine when describing the
circumstances surrounding first use of the drug.  Hence, although cocaine
initiation occurred later in respondents’ drug ‘careers’, it was not an unexpected
or unanticipated event.
· Using Cocaine
All respondents were asked explicit questions about the frequency and quantity
of cocaine use generally, and in particular, during two specific periods: use during
the 2-3 year period subsequent to initial use and cocaine consumption during the
two years preceding the interview.  Hence, early and current use of the drug were
examined in detail in order to construct a picture of typical patterns of cocaine
use across time, amongst this group.  Given the substantial drug history of
respondents prior to first cocaine use, coupled with frequent reports of the using
cocaine in association with alcohol and other substances, cocaine use is
examined here with reference to respondents’ use of other substances. This
220
section will describe participants’ cocaine use, in terms of the frequency,
intensity, intake and duration of use.  The circumstances surrounding use is an
important component of this analysis.
As stated earlier, there was a considerable time-lapse between first and more
regular use of cocaine.  Hence, while cocaine initiation took place, on average, at
the age of twenty-one years, more consistent use of the drug did not emerge for
quite some time.  Use of the drug was sporadic initially, and appeared to be
dictated largely by economic factors: cocaine was expensive and most
respondents had not yet secured their first job.  Availability was an additional
factor that appeared to deter regular use at this stage.
In those days I was a student and I had fuck all money anyway, you know.  And a
lot of the time when you’re in that scenario, you probably get in with somebody
and get to know somebody who has a contact somewhere else.  Or, they might
be dealing themselves or be able to get it irregularly or cheaply.  And coke wasn’t
on of those kinds of drugs that you could get easily.  And when you got it, it was
never cheap.
When I was 21, £80 or £70 for a wrap of coke plus your drinking, plus geting into
a club .. I just couldn’t do it.  £150 out of your pocket for a night, I just couldn’t do
it ... and  I wouldn’t have had it myself because I wouldn’t really have known the
people that you would get it from, so it would have been a real hit and miss thing
which will change as you go along because you will find out people who sell it.
Consequently, early use of cocaine was intermittent and viewed largely as a
'treat', or an extravagant drug for special occasions.  At this stage, other drugs
were more likely than cocaine to be in use largely because they were more
economical and easier to procure.
I'd say it was more sporadic (for several years after first use), you know.  If it was
available and if I had the money in my pocket I'd get it.  But if there was other
stuff available I wouldn't bother.  I'd go the cheap route because number one it's
(other drugs) cheaper and number two, it'll go further.
There were huge gaps between when I would take it, so it would be months
between taking it.  It could be two or three months before a similar party or
circumstance would come up.  But it was always party generated, you know,
because of the nature of it.
It is significant that among this group of informants in their mid- to late-twenties,
most only started to use cocaine more regularly during the past three years or
less.  Current frequency of use varied across the group.  The largest number
(n=7) reported monthly use of cocaine.  One stated that he had used cocaine
approximately eight times during the past year.  For two others, use was less
regular and less deliberate: some respondents did not secure a regular personal
supply of the drug and described their current use as occasional.
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It is very rarely an arranged thing.  It would be a case of somebody saying 'I have
two grams of  coke, does anyone want to go in on it?'.  That is probably the
extent of my cocaine use at the moment.  I wouldn't be a huge fan, I don't really
see the value in it, shall we say.
A final participant reported having reduced her cocaine intake from former more
regular and intense consumption levels, including two 'bouts' of use when she
used cocaine several times weekly.
Given that regular cocaine use was quite a recent development for the majority of
participants, it is important to examine how interviewees described this drug
transition.  As stated previously, all respondents reported a sizeable repertoire of
drugs prior to cocaine initiation.  Practically all had gone through a short phase of
LSD use and a sustained phase of ecstasy use, ranging from several months to
two years.  While ecstasy was described in positive terms, the majority drew
attention to the negative effects of regular, heavy use and indicated a definite
shift from this particular phase of drug use.  Most stated that while they currently
used ecstasy on occasions, they had quit regular weekend use of the drug.
I have really gone off ecstasy just with mood swings during the week from it and
there was a time when I would probably have said I preferred ecstasy.  At the
moment if I was to go out I would probably say no to an E and seek coke as a lot
lighter.  I don’t feel as bad the next day so I would probably do a bit of coke.
I haven't done any (E) for a long time.  It is so physically draining for me to take,
you know, you take an E and for a couple of days you are just not really as sharp
as you normally should be.  You are not really on the ball.  It takes an awful lot
out of you.  I haven't’ taken acid in a couple of years either and that’s the same, it
knocks you for six.
Many perceived cocaine to be a lighter and more manageably drug.  First,
cocaine did not induce powerful physical effects during times of use, certainly
compared to ecstasy.  Second, it did not produce profound negative side-effects
during the days following use. Both factors emerged as primary motives for a
reduction of ecstasy (and LSD) intake on one hand, and increased cocaine use,
on the other.
I know if it is a line or two of coke I still find I can go about my daily routine.  If it
take ecstasy I know I won’t feel the best the next day but Es are a funny thing.
Sometimes you take one and you find that you can be in a pub atmosphere,
enjoy a pint or two and its not too heavy.  And then sometimes you take another
and whatever is in it, you’re just gone.
In comparison to ecstasy, physically with ecstasy it is hard to get up the next day
and get through it, you know, you have black rings under your eyes.  Usually on
ecstasy you’re higher than you are on cocaine, even if it is really good cocaine.
And then mentally with ecstasy, you know sometimes you have to have a couple
of days to recover from the night out as such.  Coke does not have that effect,
not on me anyway.  It is far easier to just go out and have a good time with some
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coke and get up the next day and either go to work or just get through the day
and not be in a hassle.
Respondents’ preferred circumstances of cocaine use varied but most favoured a
relaxed setting in the company of friends.  Respondents regularly drew attention
to the circumstances of use and considered the setting to be a strong
determinant of positive drug experiences.
Sometimes the buzz with coke is a bit better than others because of purity I
suppose.  But it is 90% circumstances.  I am not saying that circumstances
completely override the quality of coke at the end of the day, you know, if you are
a relatively seasoned user.  But at the end of the day when I look back at nights
when I have taken coke or taken some other drug it is usually the circumstances
and the company that I keep and whether I am enjoying myself, and my current
state of mind.  They are usually the predominant factors in how good the night
was, you know.
A majority preferred to use cocaine in private social, rather than public, settings.
Situations in which people wished to communicate and enjoy the company of
friends were most frequently mentioned as those where cocaine use occurred.
Less frequent, but visible also, were situations in which people wanted to dance.
I prefer to use coke in a house.  Yes, with a few friends in the house.  I have used
it in clubs before but you wouldn’t be using there often because you can’t use it
openly, you know.
It would be mostly at home or in the pub you might slip into the jacks and have a
quickie in the coke sense.  But generally it would be in a house situation.  It is not
really conducive to doing in a public place in that there is a little bit of preparation
and that involved.  You have to get it out into a line and it is not the ready-made
package that our friend ecstasy is.
I’d be inclined to use cocaine in quieter more laid back circumstances ... say
there was a weekend of music somewhere, a festival or something like that.  I’d
make up my mind, like I’d go for coke or for a few tablets as well, you know.
Taken on its own (cocaine) you are elated and you are aware of yourself but you
are aware of yourself as being full of confidence and you feel really sexy and
especially say, if you are dancing or you are in a club.
Most participants reported using cocaine in a social setting at night-time (either at
home or out).  However, a small number had also used cocaine during the day
on occasions, although this was by no means a preferred or usual practice.
The last time I took coke was two weeks ago.  It was in the middle of the day and
I was sitting in.  I was away for a week and I was sitting in the house drinking
cups of coffee and smoking joints.  And we decided it was time to hit the town so
it was about mid-afternoon, something like that.  And I had a line, went out,
spend the whole day buzzing around and would have had maybe two or three
more lines that night.
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From the reports of participants it could be inferred that cocaine use is strongly
related to lifestyles where going out, social gatherings and socialising are
dominant.  For the most part, cocaine use was confined to weekends and holiday
times, when there was sufficient time to ‘recover’ and fewer potential negative
repercussions from use or over-indulgence.  Cocaine use was strongly linked
with alcohol consumption. A number of respondents commented on the
compatibility of alcohol and cocaine.  In fact, cocaine was rarely, if ever,
consumed alone.  Although descriptions of use varied, cocaine using scenarios
invariably involved the use of other mood altering substances including cannabis,
alcohol and less frequently, ecstasy.
It is a drug you tend to mix as well, primarily with alcohol now, the two, for
whatever reason seem to combine.  Now medically they could be the worst thing
for you, I don’t know, but from a results or effects point of view they mix well and
you tend to drink more and you tend to sit around and you would be in
considerably better form, not really sure why, considerably better form.
Coke and alcohol are a very crucial mix for a night.  If you are doing coke you
have to have some booze so I would say that that goes hand in hand with the
amount of booze you are going to go through.
Hash may or may not come into it as well.  If we’re out drinking and are back in
someone’s house we might have a smoke or not.  I actually like mixing ecstasy
with a bit of coke too, you know it’s good fun.  You get a good energy and
physical (pause), an energetic rush from the ecstasy both mentally and physically
and taking it with a bit of coke also maintains the same kind of rush that you
would have got from ecstasy.  So it is almost prolonging the effect that  you get
from ecstasy.  They are both stimulants so they are both doing the same kind of
thing but ecstasy makes you more amorous and friendly to others and you would
be less likely to talk about yourself.
Current frequency of use was strongly linked with economic factors.  Individuals
with more disposable income were far more likely to use monthly or weekly.  One
respondent stated that cocaine was simply not economical and that he could not
afford to buy the drug regularly.  Compared to other drugs, cocaine's short-lived
effects relative to its high cost rendered other drug choices more cost-effective.
For the same money, if you want to compare them as regards what the user gets
out of it, you get a much better night or a much better hit of six Es which is the
equivalent (cost wise) as a gram of coke.  It think it (cocaine) is very expensive
and prohibitively expensive which is probably a good thing because if it got any
cheaper, it would become a lot more popular very quickly because I have noticed
an increase in its popularity in the last year, year and a half.
On a scale of drugs that I'd take, it would probably be the least common drug that
I'd use.  Um, because for value for money, it's the worst.  Because you could
actually buy a gram and consume the whole gram in one night.  So that eighty
224
quid, gone, whack.  Whereas you could get a good quality ecstasy tablet for a
tenner that would last you the whole night.  So, it's down the list for me anyway.
Other respondents, by contrast, stated that their current income permitted more
regular use of cocaine than in the past.
Well, at first it was never really something that I went out of my way to go off and
take and then when I had a bit more disposable income and I was growing tired
of other drugs that I had taken, ecstasy really, then I started doing it a bit more.
As a young adult I couldn’t really afford it whereas now I can afford it so there is
that sort of thing.
One respondent attributed his increased cocaine consumption during the past
year to a heavy workload, resulting in more stress and fatigue.
It (cocaine intake) has probably increased a little this year.  I don’t know why
really?  Probably work because I am working a hell of a lot more and so, I would
have two nights off.  And I kind of go for it big, kind of a more intense night out.
And that is probably one of the reasons for it.  Plus, in the last few months... it
gives you that sort of a pick up.  Because at the moment I have changed job so I
am working more hours and am more tired.
The study’s regular users of cocaine generally restricted use to weekends, when
their intake of the drug ranged between one and two grams per session.  Most
reported periods of abstinence ranging from one month to several months.  While
a number of informants stated that there were times when they had exceeded
their usual intake, bingeing on cocaine was not a common practice.  Cocaine was
rarely used on more than two consecutive days.
I suppose in the past I may have taken a load of coke and not slept, had a meal
or something like that and then started a session again if there was a particular
reason to be on a party buzz.  And then I may have done it two nights in a row,
sometimes I suppose three but I have never gone on a complete weekender
without any sleep.
I've never actually taken coke for more than like two days or something like that.
I've never gone on a binge of coke.
One respondent did report two separate phases of intense and regular cocaine
use.  On both occasions, the individual had easy access to the drug and did not
have to pay a high price for a 'good' supply.
I have gone on coke sprees.  I remember one in particular and it was really, really
good.  About three years ago it was with my boyfriends friend.  He had loads of it
and it was pure and when I think about that, it is interesting because now that I
remember it, it was great because there wasn't any comedown.  I think I have
particularly bad comedowns because of what it is mixed with.  But he was giving
us the good stuff.
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To summarise, while frequency of cocaine use varied across the ten persons
interviewed, it was possible to identify a number of distinct patterns of use.  The
largest group of cocaine users (n=5) had previously used a range of other
stimulants (ecstasy and amphetamine) and hallucinogenic drugs and had
significantly curbed their intake of these substances.  While all reported that they
enjoyed past drug experiences, the cumulative negative effects of ecstasy use, in
particular, were considered to be too costly.  In this context, cocaine had
increasingly emerged as a drug of choice.  This shift also appeared to coincide
with significant lifestyle changes.  In particular, respondents reported increased
career commitments.  Importantly, this group of mid-to relatively high-earners had
more disposable income than previously.  Cocaine was considered to be a
'cleaner' drug and use did not impinge on routine responsibilities which centred
largely on work.  Most engaged in weekend cocaine use, with use frequency
varying between one and four times monthly.
Four additional participants described a pattern of less regular cocaine use.  This
groups’ drug preferences did not focus as strongly on cocaine and they reported
more regular use of other drugs.  While cocaine-using occasions were
sometimes planned, most occurred by chance.  For this group, cocaine was not a
primary drug of use and was more likely to be incorporated into a polydrug
repertoire and used intermittently.  Finally, one participant, a former regular
cocaine user, had not used cocaine for several months.
In general terms, the broad picture emerging for the study participants is one of
illicit polydrug use.  It would appear that cocaine has become a more regular and
valued feature of this groups’ polydrug ‘careers’.  While regularity of cocaine use
varied across the sample, use frequency appeared to be determined by a
number of interacting factors including past drug experiences, current income
and user drug preferences.
· Availability, Purity and Price
Respondents were asked to comment on current availability and ease of cocaine
accessibility.  Across the sample, there was general consensus that cocaine is
more easily available and more commonly used than previously.
It is far more freely available now, you would see more and more types of people
doing it and there are bars and clubs in town where a lot of people would use it ...
it would have had that tag of being a more exclusive drug years ago because it
wasn't freely available and used more for an occasion.  But now a lot more
people I know do it every weekend.
It's a lot easier to get it now really, but that's probably down to my own circle of
acquaintances as well.  Yeah, if I want it I can get it.
Coupled with increased availability, there was a strong belief in cocaine’s
acceptance as a drug of choice.
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There is a large acceptance, people that I know and people's parents do it the
odd time, do a line, and it is fine by them.
There is a big difference now, sure even if you look at toilets in a club, it is
nothing to see two males go in and out of a cubicle together and the likelihood is
that they are both going in to do a line but nobody bats and eyelid.  I think years
ago whereby we were told how bad drugs were, people would readily stand up
and go 'listen'.  That is not on nowadays.  There just doesn't seem to be that
anymore.  Nobody is going to turn around and be disgusted that you are doing
something like that.
Strong differences emerged however, in the perceived reliability of personal
access routes to cocaine, particularly in relation to expectations regarding the
quality and purity of available supplies.  Regular cocaine users had sought out
and located one or more reliable supplier of the drug and felt self-assured about
the quality of cocaine they purchased.
I find availability okay.  I wouldn't buy it off somebody I didn't know, and you are
still taking a bit of a gamble with somebody you know with what you are getting,
you are still not getting extremely good quality but I would have no problems, if I
got muck in cocaine, giving it back to the person (supplier) as well.  I wouldn't pay
that amount for something that's not acceptable at all.
Others, who did not have a regular dealer, relied on friends to secure a supply of
cocaine.  It appeared that those who socialised in user circuits were able to
access cocaine easily.
If I wanted it (cocaine) I would have to talk to a particular friend ... and he would
talk to the guy who deals it for him.  I don't have a dealer so if I heard there was
something going on at the weekend and people getting stuff I could ring up and
just say put me down for a wrap or whatever.
Less committed and regular users of the drug, on the other hand, had to go to
greater lengths to procure "good" cocaine and a number did not have a reliable
dealer.
I have a regular supplier for years and I wouldn't be a heavy coke user.  So
anytime I go to get coke, it's more of a hassle for me to go and get it because I
have to go out of my way to get it because he doesn't supply it.
The quality varies from very poor to very good.  Again, there is no trend to that
either, its totally pot luck.  I am sure there are people, and again this is my
experience because I don't know many people or one person, to be honest, who
sells the stuff.  If you knew more people that sold it, the chances are you would
probably be able to get it more regularly and get good stuff.
Respondents' reports indicate that the current street price of cocaine varies
between £50 and £80 per gram.  The majority stated that the quality and purity of
supplies vary enormously depending on the source and availability of the drug.
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Most respondents had used cocaine out of Ireland at some stage and frequently
mentioned the inferior quality of cocaine here, certainly compared to that which
they had sampled abroad.
The way you kind of socially create sources for obtaining coke, well after a while
you do notice that one person gives you coke and it may not be as good as the
next person.  And sometimes after a few years or after a while of taking it you
can actually take some lines of coke and you can actually see what it is cut with,
you can taste it or you can see it.  It is just something that you develop over the
course of time and the purity in Dublin anyway is not always the best.
It is pricey, but as well as that you see it is hard to tell because in Ireland it is
hard to get good cocaine.  You can get it but it is few and far between, it is a bit of
a gamble when you go to buy because you don't know if its going to be good.
But if you have a regular source and you know what is good then you are fine.
And you will find that there are times when you will get really good stuff all the
time and then other times you are getting crap, you know.
In general, the evidence suggests that cocaine is readily accessible to individuals
who are motivated to use the drug and have established contact with a reliable
supplier.  Less frequent users, while having easy access to cannabis and ecstasy
via their regular dealers, had inferior access routes to illicit cocaine supply
systems.  They were not motivated to seek out a more reliable cocaine supply
route and allowed situational factors to determine the quality of the cocaine they
consumed.  At the buyer level then, it would appear that cocaine, albeit of
variable quality, is relatively easily available to individuals who opt to use the
drug.
· Perceived Attractive and Unattractive Aspects of Cocaine
All psychoactive substances have appealing and unattractive attributes and
cocaine is no exception in this regard.  All of the respondents were well-versed
on the drug-induced outcomes of a variety of substances, they distinguished
clearly between the effects of individual drugs and had preferences for specific
drugs or drug combinations, depending on the circumstances or settings
associated with use.  In this section, the perceived appealing and negative
aspects of cocaine will be examined.  Reference is made to the perceived
advantages of other drugs in instances where this has a bearing on respondents'
attitude to cocaine.
The data revealed three major cocaine attractions.  They are not discussed here
in hierarchical order, as it was difficult to determine individual advantages which
prevailed over others in terms of their significance.  Rather, all three merged as
components of a psychoactive ‘hit’ which was perceived to be gratifying,
beneficial and enjoyable.  Cocaine's appeal focused on three central themes -
pleasure, control and lifestyle.
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Cocaine simply made partying better, according to the majority of respondents.
The psychoactive 'hit' produced feelings of exhilaration, confidence and
psychological pleasure, thus enhancing social occasions in which the drug was in
use.
Taken on its own you are elated and you are really aware of everything and you
are aware of yourself but you are aware of yourself as being full of confidence.
It boosts the night by about five fold.  If you are out and you are having a great
laugh it seems to add that little bit extra to the night.  The banter is a bit quicker
as it goes on ... It is just like a mood enhancer.
With coke you can have a little stash of it and you can stay up all night.  It is just
that it breaks down all those barriers and you are just babbling away having a
good time, socialising with people.
Closely linked to the social and psychological pleasures described by
respondents was that cocaine provided an immediate injection of energy and
enthusiasm and made the night last longer.
If I was taking uppers - speed, cocaine, something like that - it would be to
promote my energy levels for the evening or elongate it so you can go with the
craic for longer.
Two respondents drew attention to the enhancement of sexual experiences
following cocaine use.
Coke is more of an indoor drug and if you are with someone that you are quite
into a relationship with it is good as well.  You can lock yourself in and have a
gramme of coke and have a really good night sexually as well as mentally.
As with other drugs, the pleasure factor was high on respondents’ list of priorities
when rating cocaine as a drug experience.  The physical and psychological
pleasures cited by participants in the current study are very similar to those
documented by Ditton et al. (1996) in their sample of cocaine users in Scotland.
A second key advantage of cocaine over other drugs, according to many
informants, was that unlike other drugs, cocaine permitted the user to retain a
high level of 'control' during times of use.  Discretion was closely associated with
control : cocaine did not demand much preparation and users felt able to conceal
the fact that they had taken the drug.  In addition, cocaine consumption facilitated
and enhanced communication with others, rather than hampering it.  At the same
time, the rapid onset of cocaine-induced effects following consumption, coupled
the short duration of these effects allowed the user to maintain charge over
his/her disposition and behaviour.
Its immediately effective and it's convenient to carry around and its convenient to
take, relatively.  Like, there's no work, you don't have to prepare anything, you
know.  And you get an immediate kick out of it.
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You can control it insofar as it only lasts ten minutes and then you can take some
more of it if you want it.  Whereas ecstasy, you take it and you are out of it for at
least two hours.
It is the most social because you can sit there and you can converse with
everyone and you don't look like you are out of it.  It's a good drug like that.
It doesn't stop me thinking and I don't do anything stupid, you know what I mean.
You can get into a taxi and talk to the taxi man and you know what you're doing.
Critically, cocaine use, according to several respondents, did not result in the
negative after-effects associated with ecstasy and other drug use.  Half of the
respondents (n=5) reported several undesirable side-effects following a
sustained period of regular ecstasy use.  Cocaine, on the other hand, did not give
rise to feelings of physical or psychological exhaustion, or feelings of being
'wrecked', during the days following use.  It would appear that many of the
respondents felt more ‘control’ over their physical condition following cocaine use
than they experienced with other drugs.
If you do acid or ecstasy the next day you are feeling a bit rough physically, a
couple of days later you may be feeling a bit depressed or even the day after
doing it you are lacking in energy and lacking in lustre in general.  The
advantages of cocaine for the user would be that in comparison to other drugs,
the next day you are grand. Well, you might have a bit of a head on you but
nothing that a shower and a fry wouldn't pretty much cure.
I have really gone off ecstasy just with mood swings during the week from it.  And
there was a time, I think, when I probably would have preferred ecstasy but at the
moment if I was to go out I would probably say no to ecstasy and see coke as a
lot lighter.  I don't feel as bad the next day so I would probably do a bit of coke.
Maybe I'm getting old!  I'm not really able for it anymore and the high just isn't
worth it, the low now outweighs the high.
Respondents' need to function clearly, in the context of holding down a job which
they valued, was closely linked with cocaine's appeal and the perceived absence
of serious and costly after-effects.  Cocaine use did not encroach on the user's
ability to carry out work-related responsibilities efficiently.  Hence, it allowed the
user to maintain a lifestyle where work played a central role.
I like the fact that you can go out and have a really good night, have a blast and
then the next day you can carry on and you can function properly and go to work
and do your job.  You don’t want to just go in and be useless for the day because
one day lost is bad really.
Despite cocaine's notoriety as the 'champagne of drugs', few respondents overtly
referred to cocaine's traditional association with the rich and famous.  However,
subtle references were made to cocaine's glamorous image and its acceptability
within particular social circles.
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I think in tems of image it is definitely viewed as, it is almost always viewed as
glamorous.  Of all of them (other drugs) it is probably associated with rock and
film stars.  So, I think it has a very glamorous image.
Initially, especially, it was that kind of feeling, maybe a little bit of superiority in a
sense because you had it (cocaine) and it can become part of your evening.  And
yet other people aren’t doing it and it kind of sets you on a different level to some
people and that is some of the attraction of it.
Relatively few negative aspects of cocaine use were mentioned by respondents,
certainly compared to its positive attributes.  Cost emerged as the dominant
disadvantage of cocaine use.  For a considerable number, this was a key factor
deterring regular use.  In addition to cost, cocaine's unpredictability, in terms of
the quality and purity of supplies, meant there was a significant risk of getting a
'bad deal'.  Other drugs were more reliable and considered to be better value in
terms of the nature and duration of the resulting psychoactive 'hit'.
My experience of cocaine is that it's very much potluck and that could mean £60
or £70 down the tubes ... it's too expensive, it really is like.
In terms of how cocaine rates here, I wouldn't rate it that highly at all because I'd
have, I know I can get much better quality stuff that would give me a similar buzz,
or better, for cheaper.
Four of the ten respondents described cocaine as a “greedy drug”.  When asked
to elaborate on this statement, some drew attention to the user's desire to
recreate the original 'high'.  Others described scenarios where they had noticed
people (friends and acquaintances) behaving in a self-indulgent way during
sessions of use.
It is physical and it is mental.  What happens when you are taking it is, with the
first few lines that is when you feel you are most high.  And then usually after that
you are trying to recreate that high and what happens is that the process is
(pause) ... anyway you want to recreate that buzz that you originally got and that
may take a bit more than you originally took, if you follow me.  And therein lies
one aspect of the greed.
It is strange to see people with it (cocaine), it is a very greedy drug.  I have never
found it that way and maybe because I see everyone else being so greedy I tend
not to be.  And they slip off  (for an extra line).  I hate to be like that.  I suppose I
have been disappointed in a few people, in their behaviour on it.
I have been at parties where, lets say, two or three or four people bought a gram
of coke each.  It is down on the mirror and it is there and you all set out having a
nice line.  And the next minute everyone is watching everyone else in case they
nip in and get a line ahead of them.  So it can speed things up ... because you
don’t want to miss a line.
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When respondents were asked if they had experienced negative side-effects
following cocaine use, a number (n=3) stated that they had, at times,
experienced irritability and agitation.
On one or two occasions there when I did too much of it I was lying there with my
heart pounding and then I must say it was a bit scary.
I think that the more you take of coke, the more irritable you become.  In a
physical sense, like you'll actually get quite nervous as you go.  So, there are
some side effect with the use of the drug that would say, prey on your nervous
system.  I don't know?  I've found that, you know.  If I  took four lines in one night,
I'd probably start feeling very kind of, what's the word I'm looking for? Not
nervous.  Edgy, yeah.  For me anyway, if I took more than four lines of coke in a
night I'd be feeling fairly edgy.
One respondent stated that while on a positive note, cocaine induces strong
feelings of self-confidence, this can, at times, prompt an aggressive attitude on
the part of the user.
It gives you that kind of feeling that you have a stronger presence and you hold
better eye contact.  You are very direct about what you are saying but at the
same time that can roll on to being quite aggressive.  And I have had nights out
where I have had arguments about the most ridiculous things but I was right!
And then you go home and think, ‘Jesus Christ, what was I talking about?’.
However, negative effects, including irritability and arrogance or aggression were
attributed largely to having exceeded normal cocaine intake levels on particular
occasions and only qualified as minor and uncommon irritations.
A small number of less regular users claimed that they had observed negative
behaviour in others who used the drug regularly.  These respondents considered
cocaine to be an individualistic and egotistical drug that all too often, encouraged
self-indulgent and assuming behaviour.  Others referred to mood swings and
depression among regular users.
I am talking about people I know and people who would use it as their drug of
choice and not just on weekends, but on a regular basis.  And it has changed
them hugely.  Like, you know, mood swings, vicious mood swings, and basically
just depressed when they are not high on coke.  And it makes for a sad life.
To summarise, cocaine was regarded as superior to other drugs for a variety of
reasons.  Users' subjective experiences suggests that cocaine was viewed
positively by the majority.  From the vantage point of the user, attractive features
of cocaine included its energising effects, the ability to maintain control while
intoxicated and the sociability of the drug.  Cocaine was perceived to be a 'clean'
drug, one which did not carry the negative image or undesirable after-effects of
other stimulant drugs.  Perhaps surprisingly, in view of cocaine's apparent allure,
only two respondents described cocaine as their 'favourite' drug.  Cannabis was
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by far the most popular drug across the sample (n=6).  Two respondents stated
that their preferred drug was ecstasy, in tablet or powder form.
· Risk Perceptions and Self-Regulation of Cocaine Intake
Respondents were asked to express their views on the risks associated with
cocaine and other drug use.  In general, respondents had no reservations about
using cocaine, provided they felt relatively self-assured about the source of the
drug.  Most stated that they would avoid buying cocaine from a stranger in social
settings such as nightclubs.  However, concerns about getting bad value for
money tended to be higher on respondents’ risk agenda, than anxieties about the
presence of contaminants.  Hence, one of the biggest 'risks' with cocaine was the
gamble of getting a ‘bad deal’.  Other drugs were considered to be far more
reliable in this respect.
Cocaine isn't dodgey.  You would probably be more likely to get a bad E that
makes you ill for whatever reason.  You will get bad coke but it is poor quality as
opposed to anything else.  When it's cut sometimes you can taste the glucose.  E
is probably more dangerous in that sense.
One interviewee compared cocaine to legal substances when expressing his
view on the risk of getting substandard cocaine.
I don't wonder what's in a cocktail at a bar because it's so readily available and
acceptable.  With cocaine it doesn't come into my head either to be honest.
The overwhelming view was that cocaine was a 'safe' drug.
I think it's probably one of the safest drugs.  You can't, of all the drugs that you
can take, if you take acid there is a small chance that you will have a bad trip.
But I think that cocaine is the safest drug.  The effects are short-lived.  There will
only be ill-effects if you are doing it all the time but that won't happen easily
because of the price of it.
When asked about the addictive potential of cocaine and other drugs, several
respondents placed a great deal of emphasis on the individual's relationship with
any given substances (including alcohol).  The general belief was that the
pharmacological properties of the substance played a secondary role in the
development of drug-related problems, certainly compared to other factors.  This
group of cocaine users did not believe that their own behaviour around drugs was
comparable to the behaviour, personal or social conditions they associated with
individuals who experience drug problems.
I'd say it depends on your personality or your state of mind.  But I could easily
imagine if you're in a scenario whereby you have an altered state of being, by
being on a drug and your life is a piece of shit, well, you'll obviously going to get
back to where you were last night as soon as possible.  Now that depends on
probably, your state of mind, your education, your ignorance of drugs.  All of that,
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all those levels - your social circumstances, the amount of friends you have
around you.  If you feel lonely and you feel down, you know, you just more than
likely want to get off your head.  I could easily see somebody getting addicted to
any drug.  But specifically to cocaine?  I don't know?  I think if it was me I'd want
to be seriously fucked in the head to get addicted to cocaine.
I can see why people can get addicted and having said that I could never see
myself becoming an addict to coke.  About a year and a half ago I kicked
cigarettes and I think that is about as addictive as anything you can get.
Many pointed out that their use of cocaine and other drugs took place in social
settings where friendship and other social relationships were more important than
the use, per se, of any drug.  Respondents distinguished clearly between drug
use and drug abuse and did not equate their own cocaine use with dangerous or
addictive patterns of drug consumption.  Again, ‘control’ emerged as an
organising construct in the discourse and respondents’ invariably pointed out that
they, and not the drug, maintained ‘charge’ in most situations where drugs were
in use.
I enjoy the fact that I have a fairly stable and happy atmosphere in my head and I
am confident that I can do it (cocaine).  And if I ever felt that being threatened
then there'd be no argument there.  If it retarded my sense of drive or whatever,
that'd be it.
I like to have control and I know how much I can handle.  Yeah, I’ve overdone it
at times but at the end of the day, drugs aren’t important enough to me to let
things get out of hand.
Several respondents recognised situations and emotional states that were not
apt for cocaine use.  For example, most respondents restricted use to the
company of friends and a number stated that they did not use the drug when
socialising with their parents and/or other family members.  While most admitted
that there were times when they went ‘overboard’, cocaine use was generally
confined to times when it was least likely to impact on work and other
responsibilities.  Respondents’ also made reference to the importance of the
individual’s emotional or psychological state at the time of use.
If I had to work the following day I wouldn’t take it.  If I was hungry I wouldn’t want
to suppress my appetite for a while because I would want to have a meal.  I
would say that if I had a lot on my mind, if I was stressed or if there was an awful
lot going on at work and in my life in general and I didn’t want to deal with a
hangover .... because at the end of the day if I go off and do some coke I am
going to have a pretty bad alcohol hangover too because I tend to do the two
together.  And you think you’re superman regarding alcohol intake so if my head
doesn’t feel right at the time then I wouldn’t be taking it.  Usually for me, if I had a
lot going on in general I would avoid it for that reason.  And then you are either in
the mood or you’re not, it’s like anything, you know.
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The quotes above illustrate the range of informal social controls that are
practised when people consume drugs.  Other respondents drew attention to how
they regulate their intake of cocaine during the course of a night out.
I would take cocaine more during the early part of an evening and then just let it
peter out.  What I don’t like is coming in at three o’ clock in the morning and
sitting there wide awake and not being able to sleep.  So, for myself I would have
the bulk at the beginning of the early part of the evening and then later in the
evening have one or two lines just for a perk.  And then when I get home, I am
home to actually sleep.
While the level of ‘control’ exercised by respondents varied across the sample, all
mentioned conditions which were more or less apt for cocaine use.  Overall, it
would appear that respondents’ perceived the risks associated with cocaine use
to be minimal, in terms of the drug’s potential to cause physical and/or
psychological harm.  Interestingly, two respondents expressed concern about the
legal risks associated with the posession and use of controlled substances.
The illegality of it is a huge worry because other than the fact that I use drugs for
recreation, I am a 100% law abiding citizen.  I pay my taxes etc.  So, it is very
hard to keep reminding yourself that you are actually a criminal.  But you do, you
actually have to remind yourself on occasion.  Even though you are a really nice
bloke, you are actually a criminal and if you get caught you coud well end up
inside ... and the repercussions could be huge from a legal, family, work point of
view.  Huge repercussions.
The majority, however, felt that it was relatively easy to conceal their use of
cocaine and that the chances of getting ‘caught’ were small or negligible.
I would never worry about being stopped because I can’t really see what
provocation there would be for the police to stop me.
I know it’s a class A drug but I usually wouldn’t worry.  I wouldn’t want to get
caught but I usually wouldn’t worry much so long as I am not carrying too much.
To summarise, cocaine was viewed as a relatively innocuous substance and
users did not consider that it had any dramatic ill-effects on their health or well-
being.  Many felt that cocaine was ‘safer’ than other drugs.  None expressed
concern about any short- or long-term health implications associated with their
personal use of the drug.
· Summary and Conclusion
Respondents in the current study described themselves as social/recreational
drug users.  Across the ten people interviewed, use was relatively modest and
none could be considered to be current heavy users of cocaine.  Cocaine was
clearly integrated into social events; it was shared in social settings, sometimes
in small intimate groups and other times in larger gatherings.  Cocaine was
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thought to facilitate communication and to induce feelings of self-confidence. The
stimulating properties of the drug were mentioned frequently in conjunction with a
‘controlled’ high.  This dynamic was important, particularly to more regular users,
who did not wish cocaine to interfere with their normal activities or with their
physical and psychological well-being.
Almost all respondents reported the concurrent use of alcohol and other drugs
during cocaine-using events.  In fact, the vast majority had extensive drug
repertoires and cocaine was just one of several drugs they had used over a time-
span of approximately five years since first cocaine use.  Most respondents had
gone through a phase of regular weekend ecstasy use.  While the pleasure factor
associated with ecstasy was rated highly, all had reduced their intake of the drug
during the past 2-3 years, due to the significant negative repercussions
experienced as a consequence of sustained use of the drug.  For this group,
cocaine was perceived to be 'lighter' and 'cleaner' and did not interfere with the
user's desired level of functioning and well-being.
Relatively few disadvantages of cocaine were mentioned by respondents.
However, most drew attention to the high cost of cocaine and to the poor quality
of available supplies.  Others commented on their observations of friends and
acquaintances during sessions of cocaine use and felt that cocaine consumption
sometimes produced undesirable self-indulgent behaviour, including arrogance
and greed.  Few respondents reported significant negative physical or
psychological side-effects following cocaine use.
The majority of respondents expected to find themselves in social settings where
cocaine was available and practically all intended to use cocaine at some time in
the future.  The street price of cocaine varied between £50 and £80 per gram,
according to respondents. Noticeable differences emerged in the quality and
reliability of respondents’ contact and association with local cocaine distribution
networks.  Respondents who socialised regularly in users circuits were more
likely to have reliable access routes to cocaine.
Respondents reported using informal control mechanisms similar to those
documented by Decorte’s  (1999) in a sample of cocaine and crack cocaine
users in Belgium.  In the current study, respondents prioritised work, friendships
and their partners, and did not wish to jeopardise these relationships.
Specifically, they did not allow cocaine (or other drug) use to impinge on their
performance at work.  Reference was made to a range of circumstances under
which the drug was not used, including during work, in the company of parents
and other family members.  Respondents also considered their own emotional
and physical well-being prior to using cocaine.  Cohen (1989) similarly reports a
range of control techniques and behaviours utilised by 'non-deviant' cocaine
users.
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None of the study’s respondents reported 'problems' as a result of their cocaine
use and none considered their current intake to be worrying or damaging,
certainly in the short-term.  The majority considered the addictive potential of
cocaine to be low, certainly from a personal viewpoint.  Indeed, it is claimed that
in many circumstances, cocaine is enticing rather than addictive (Hammersley
and Ditton 1994).  Drug dependence is, of course, strongly mediated by the
circumstances, disposition and views of the user (Zinberg 1984).  The cocaine
users here did not fear addiction.  Neither did they believe that they were
susceptible to developing a dependent relationship with cocaine, due largely to a
belief in their ability to ‘control’ their intake of the drug.
Cocaine Use in Ireland : Discussion and Conclusion
The drug scene in Ireland has undergone dramatic change during the past
decade and has become increasingly diverse by age, drugs of choice, availability
and price.  National and local surveys of youthful populations indicate a clear
upward trend in the range of drugs used, suggesting that recreational drug use
has become a more obvious feature of adolescent lifestyles.  At the other end of
the drugs spectrum, long-term opiate users, many of whom are known to drug
services, appear to have extended their repertoire from heroin and methadone to
polydrug patterns.  Benzodiazepines have been identified as a primary
supplement to opiate users drug intake (Rooney et al. 1999).  The propensity of
cocaine, particularly in its injectable and smokable form, to appeal to this
endemic group of heavy users is an issue of critical concern.
This research has attempted to build up a picture of cocaine use nationally using
available indicators of drug use/misuse and the perceptions of key informants
and drugs workers.  The research did not set out to estimate the prevalence of
cocaine use.  Rather it aimed to provide information on the nature and possible
extent of cocaine use, with specific reference to particular sub-groups, namely
recreational drug users and problem drug users who seek treatment.  A multi-
method approach, using several indicators, was judged to be the most effective
means of analysing the current cocaine situation.
The findings suggest increased availability of cocaine.  Law enforcement
statistics point to an upward trend in the availability of cocaine.  In addition, the
study has repeatedly noted the ease with which users can obtain cocaine.
Population and school surveys suggest that cocaine is used by small numbers
experimentally or intermittently.  However, the exploratory study of 10 cocaine
users provides evidence of individuals who use cocaine regularly for recreational
purposes.  Reference was made by most study respondents to the visibility of
cocaine on the club/dance scene, a development which was regarded as recent.
While there is no systematic evidence of widespread cocaine use, the broad
picture uncovered is one of increased likelihood of cocaine use among certain
groups of recreational drug users.  The extent, nature and frequency of cocaine
use among such groups, however, remains unclear.
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Coupled with a possible expansion of cocaine use within the recreational drug
scene, are signs of increased cocaine use among opiate users who come from
the more deprived urban areas, particularly within Dublin City.  While cocaine has
clearly been ‘around’ for some time, supply and availability appear to be stronger
than previously.  The reports of a diverse range of study participants confirms
that this development is recent, certainly, no more than three years old.
Available reports and impressions strongly suggest that cocaine use has become
a more conspicuous and accepted drug option.
It is important to state that the nature of cocaine use is likely to be diverse and
that role and function of cocaine within the drug repertoires of social/recreational
cocaine users is likely to differ substantially from that of ‘seasoned’, heavy and
problematic opiate drug users. Whereas members of the former group
interviewed do not perceive their drug use to be problematic, treatment data
indicate that the latter group tend to report cocaine as a secondary, rather than a
primary drug of misuse.  In addition, routes of administration are likely to vary
between the two groups.  Social users interviewed for the purpose of this
research ingested cocaine intranasally or orally.  None had been exposed to
crack cocaine and did not consider using cocaine in this form.
Available statistical indicators, coupled with the reports of drugs workers, suggest
that cocaine use is currently becoming more apparent than previously among
clients in treatment for heroin misuse.  However, as stated earlier, there is
currently little knowledge or understanding of preferred patterns of cocaine use,
or of dominant routes of cocaine administration among problem drug users.  This
information is essential if cocaine’s role in the drug repertoires of opiate users is
to be fully understood.  Furthermore, an understanding of smoking versus
injecting cocaine rituals would greatly enhance knowledge and awareness of the
possible range of health risks associated with cocaine use.
It would be premature to conclude, on the basis of the current study, that cocaine
is a major ‘drug issue’, or that there is a high risk of a spread to neighbourhoods
which already host a disproportionate number of heroin users.  Further research
and monitoring of drug trends at local level is required to confirm or alternatively,
discount the proposition that cocaine is an expanding ‘problem’.  Despite this, the
heroin epidemic has taught us that particular communities are susceptible to drug
outbreaks. If cocaine continues to be easily available and gains acceptance
among drug users, it may have the potential to find its way into communities that
traditionally attract drug problems.  In this sense, the current research might be
appropriately viewed as an ‘early warning sign’ (Parker et al. 1998) of cocaine’s
emergence, thus, signifying the opportunity to monitor the situation and ‘get
ahead’.  In this context, a cautious response to possible signs of increased
cocaine use is more appropriate than either outright rejection of the possibility, on
the one hand, or hysteria and over-reaction, on the other.
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14.  Infectious Diseases : Lucy Dillon
As in other European countries, the advent of HIV/AIDS and the connection
made between its spread and injecting drug use, can be seen to have played a
key role in influencing the development of drug related policy and services in
Ireland (Butler 1991; O’Gorman 1998). Prior to the early 1990s, abstinence was
seen as the most acceptable goal for Irish drug treatment programmes. However,
the early 1990s saw a move toward more harm reduction strategies and the
expansion of substitution and needle exchange programmes within Irish drug
treatment services. A 1991 report produced by the Government Strategy to
Prevent Drug Misuse confirmed both the shift in treatment philosophy from one
based solely on abstinence to one that included a harm reduction strategy, and
the central role the advent of HIV had played in this policy shift:
“Insofar as HIV infection is concerned, of the 1049 cases identified, 582 (or 57%)
are drug misuse related.....It is clear from the foregoing that the prevention of
transmission of HIV virus in this country must include strategies developed to
deal with the drug misuse problem. …..These strategies must be community
based, client orientated and, given the serious nature of the problem, of
necessity, innovative. They must include emphasis on outreach programmes
involving counselling, methadone maintenance and needle exchange. Advice on
risk reduction services generally must form an essential part of any such
strategies to minimise the spread of the disease, [HIV/AIDS].”
(Government Strategy to Prevent Drug Misuse 1991, p 7)
Furthermore, while the two reports (October 1996 & May 1997) produced by the
Ministerial Task Force to Reduce the  Demand for Drugs continued to reiterate the
ultimate aim of all treatment programmes as abstinence, harm minimisation
strategies specifically aimed at preventing the spread of HIV (i.e. substitution and
needle exchange programmes) became a central feature of drug treatment
services. The second report of the Task Force argued that it had developed “a
strong philosophy of harm reduction and treatment of the consequences of drug
abuse - stabilisation, methadone maintenance, detoxification, rehabilitation and
re-integration” (Ministerial Task Force to Reduce the Demand for Drugs 1997,p7)
While HIV/AIDS may be seen as the drug related infectious disease that was at
the centre of drug policy development in Ireland, other diseases, in particular
hepatitis C, are attracting an increasing amount of attention from those working in
the area. The following sections of the report will address three key issues on
drug related infectious diseases in the Irish context. The topics covered will be:
14.1 Prevalence of HIV, HBV and HCV among drug users
14.2 Determinants and consequences
14.3 New developments and uptake of prevention, harm reduction and care
 14.1 Prevalence of HCV, HBV and HIV among drug users
Epidemiological analysis of drug related infectious diseases in Ireland is
somewhat restricted by a lack of data. The gap in information is particularly acute
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in relation to hepatitis B and C. The following sections will examine the data that
are available in relation to each of the relevant drug related infectious diseases:
§ HIV
§ Hepatitis B
§ Hepatitis C
14.1 HIV
The majority of data collected on drug related infectious diseases are related to
HIV. There are two main sources of data that will be discussed below: first, the
routine data on HIV positive tests that are reported by the Department of Health
and Children; and second, the special studies which have been carried out which
have estimated the prevalence of HIV among particular cohorts of drug users.
Routine data on HIV testing
In Ireland, the Department of Health and Children, in collaboration with the Virus
Reference Laboratory, produces statistics on HIV positive tests which are
published every six months. The figures relating to HIV tests are broken down
according to risk category. There are a number of risk categories identified in
relation to HIV infection including injecting drug use, homosexual sex and
haemophiliac contact. Therefore, it is possible to get a breakdown of the number
of positive HIV cases attributable to injecting drug use in a given year. However,
there are a number of limitations to this data source that should be noted:
Ø It is limited to the tested population. Nothing can be inferred for those drug
users who have not been tested.
Ø It is not possible to identify non-injecting drug users within the data set.
Ø No socio-demographic data is collected on those who are tested.
Ø There is only a limited geographical breakdown available.
Ø A gender breakdown has only been made available since 1997.
Ø Both risk behaviours (e.g. injecting drug use) and test locations (e.g. prison)
are used as categories. This makes the data somewhat unclear. For example,
it is not known through what risk activity those tested in the prison setting
became infected with HIV.
Despite these limitations, this data source provides the best information with
which to examine the epidemiological profile of HIV in Ireland over the past
decade and a half.
The cumulative figures for the positive cases of HIV from the start of data
collection in 1982 up until 1985, show that just over 60% (n=221) of all positive
cases (N=363) were attributed to injecting drug use (see table 14.1).  Since 1985,
injecting drug use has continued to be one of the main risk categories,
accounting for 41.6% of the cumulative number of positive cases up until
December 31st1999 (see table 14.1). Since data has been collected, injecting
drug use has continued to be one of the main risk categories for infection. Two
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possible explanations have been given by O’Gorman (1999) for the high
proportion of intravenous drug users in the known HIV positive population. She
argues that the culture of injecting drug use that existed among drug users in
Ireland during the 1980s, at a time when both information on safe injecting
practices and access to clean injecting equipment were limited9, resulted in the
rapid transmission of HIV among the injecting population. Secondly, she argues,
the injecting drug using population may be more likely to have been tested for
HIV through their contact with drug treatment services than those individuals who
may be at risk of infection through other routes e.g. heterosexual sex (O’Gorman
1999, p. 6).
Table 14.1: Ireland 1985-1999. HIV positive cases by risk category. Numbers and
percentages
Year IVDUs n
(%)
Homosexual
Sex
n (%)
Heterosexual Sex/
Risk unspecified
n (%)
Other
n (%)
Total
n (%)
1985* 221 (60.9) 39 (10.7) 0 103 (28.4) 363 (100.0)
1986 112 (66.3) 11 (6.5) 21 (12.5) 25 (14.8) 169 (100.0)
1987 72 (49.7) 21 (14.5) 26 (17.9) 26 (17.9) 145 (100.0)
1988 58 (50.4) 17 (14.8) 20 (17.4) 20 (17.4) 115 (100.0)
1989 57 (49.1) 33 (28.5) 0 26 (22.4) 116 (100.0)
1990 50 (45.1) 25 (22.5) 24 (21.6) 12 (10.8) 111 (100.0)
1991 34 (36.9) 27 (29.4) 25 (27.2) 6 (6.5) 92 (100.0)
1992 82 (40.8) 58 (28.9) 50 (24.9) 11 (5.5) 201 (100.1)
1993 52 (38.0) 48 (35.0) 21 (15.3) 16 (11.7) 137 (100.0)
1994 20 (23.5) 31(36.5) 22 (25.9) 12 (14.1) 85 (100.0)
1995 19 (20.9) 33 (36.3) 30 (33.0) 9 (9.9) 91 (100.1)
1996 20 (18.9) 41 (38.7) 27 (25.5) 18 (17.0) 106 (100.1)
1997 21 (17.7) 37 (31.1) 40 (33.6) 21 (17.7) 119 (100.1)
1998 26 (19.1) 37 (27.2) 47 (34.6) 26 (19.1) 136 (100.0)
1999 69 (33.0) 40 (19.1) 59 (28.2) 41 (19.6) 209 (99.9)
Total 913 (41.6) 498 (22.7) 412 (18.8) 372 (17.0) 2195 (100.1)
 Source: Department of Health and Children
The proportion of positive cases attributed to the intravenous drug user category
generally decreased from 1992 through to 1998. In 1994, for the first time,
intravenous drug use accounted for less new positive cases than the
‘homosexual sex’ or ‘heterosexual sex/ risk unspecified’ categories (see table
14.1). In fact, the proportion of positive HIV tests attributed to intravenous drug
use fell from 49.7% in 1989, to a low of 17.6% in 1997 (see table 14.1). It is
suggested that the reduction both proportionately and in absolute numbers over
this period may be attributed, at least in part, to the expansion of services aimed
at reducing the spread of HIV among injecting drug users, i.e. substitution and
needle exchange programmes. In an analysis of the trends up until 1998 the
National AIDS Strategy Committee has commented that:
                                                
9 The first needle exchange programme in Dublin was established in 1989.
* Cumulative figures
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 “Epidemiological surveillance of HIV would indicate that in recent years the
overall incidence of HIV among intravenous drug users is reducing. While we
must be wary of drawing major conclusions from short term changes in infection
patterns service providers are optimistic that this trend is as a result of the
intervention through a combination of substitution therapy with methadone and
needle exchange services.”
(National AIDS Strategy Committee 2000, p. 63)
Despite the apparent reduction in the proportion of positive cases attributed to
injecting drug use and the actual number of positive tests, figures from 1999
show a substantial increase in the number of positive cases. Between 1998 and
1999 the total number of new cases of HIV increased from 136 to 209.
Furthermore, the number of new positive cases attributed to injecting drug use
increased from 26 of the total new cases (n=136) in 1998 to 69 of the new cases
(n=209) in 1999. Therefore, proportionately, injecting drug use as a risk category
increased from accounting for 19% of new HIV positive cases within this data
source in 1998, to 33% in 1999. This is the highest annual proportion of new
positive cases attributed to injecting drug use since 1993.
Anecdotal evidence suggests a couple of explanations for the increase in the
number of positive cases being attributed to injecting drug use during 1999.
Firstly, leading on from the Protocol for the Prescribing of Methadone issued in
1993, guidelines were developed for GPs prescribing methadone within the
general practice setting and for pharmacists in their dispensing of methadone.
Following the completion and evaluation of a pilot programme, in January 1998
the Report of the Methadone Treatment Services Review Group made a number
of recommendations on tightening control on both the prescribing and dispensing
of methadone, in accordance with the 1993 protocol. Consequently, the Misuse
of Drugs (Supervision of Prescription and Supply of Methadone) Regulations,
1998. The regulations aim to create a more controlled environment for the
prescribing and dispensing of methadone. Within this context, all those who were
receiving methadone in Ireland were integrated into a structured programme.
Furthermore, drug users were integrated into a structured programme setting
where there is an active policy of carrying out virology in relation to HIV and
hepatitis. It is suggested therefore, that this may have resulted in an increase in
the number of injecting drug users being tested for HIV and, in turn, an increase
in the number of positive cases being attributed to injecting drug use during 1999.
Secondly, it has also been suggested anecdotally that perceptions may be
beginning to change among the drug using population in relation to HIV. It is
argued that the availability of new treatment (HAART) and the visibility of
individuals in the community for whom treatment has been effective, has
encouraged people to come forward for testing so that they can avail of treatment
if necessary.
Prisoners:  As mentioned above, within the Department of Health and Children’s
reporting system on HIV positive tests, those who are tested in prison are
categorised according to the testing location, i.e. prison. While the proportion of
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positive cases from the testing location category of prison which are attributable
to injecting drug use is not known, anecdotal evidence suggests that most of
those being tested have a history of injecting drug use. Since 1989, a total of 39
new positive cases have been attributed to ‘prisoners’, 13 of whom tested
positive in 1999. The use of both risk categories and testing locations in the
Department of Health and Children’s reporting system does not allow for any
conclusions to be drawn as to the significance of these figures in relation to the
injecting drug using population. It is important that the risk category of these
cases be clarified.
Gender: While there are no socio-demographic data collected on those who are
tested for HIV from the Department of Health and Children’s Data source, the
gender of the individual being tested has been reported since 1997. An
examination of the figures by gender suggests a possible change in the profile of
those who are testing positive for HIV in Ireland (see table 14.2). In 1997,
females only accounted for 3 of the 21 new positive cases attributed to injecting
drug use. In 1998 this had increased to 10 of the 26 positive cases among
injecting drug users, and in 1999 it had increased further to account for 34 of the
69 positive cases. Speaking in percentage terms, women have increased from
representing 14.3% of the positive tests among injecting drug users in 1997, to
38.5% in 1998 and finally 49.3% in 1999. Due to the lack of information on
gender prior to 1997, it is not possible to explore trends over a more extended
period of time. Anecdotal evidence suggests that these figures may reflect a real
increase in the number of women injecting drug users who are becoming infected
with HIV. However, it is also suggested that these women may be becoming
infected through their sexual behaviour rather than their injecting drug use. Once
identified as an injecting drug user however, their infection will tend to be
attributed to their injecting drug using behaviour. Anecdotal evidence also
suggests that a growing number of women may be attending for testing in order
to be able to minimise the risk of infection to their baby were they to become
pregnant.
Table 14.2 Ireland 1997-1999. HIV seropositive intravenous drug users by gender. Numbers
and percentages.
Year Male
n (%)
Female
n (%)
Total
n (%)
1997 18 (85.7) 3 (14.3) 21 (100)
1998 16 (61.5) 10 (38.5) 26 (100)
1999 35 (50.7) 34 (49.3) 69 (100)
Source: Department of Health and Children
Special Studies
A number of special studies have been carried out which have explored the
prevalence of HIV among cohorts of drug users in a range of study locations. The
studies include drug users located in: the community, drug treatment centres,
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needle exchange programmes and prisons. A summary of the research findings
on the prevalence of HIV infection among particular cohorts of drug users is
presented in Table 14.3 below.
One of the first studies of drug use in Dublin began in 1985 when O’Kelly et al.
(1996) identified a cohort of known intravenous drug users in an inner city area.
The prevalence of HIV infection among this group was monitored over the next
decade. In 1991, 57.3% of the total cohort (N=82) were known to be HIV positive,
by 1994, 64.6% of the cohort had tested positive for HIV. In total, 18 of those who
had tested positive by 1994 had died. O’Kelly et al. (1996) argue that the high
prevalence rate of HIV among this cohort reflect the context in which their
intravenous drug use developed. It was argued that “the uncontrolled use of
injected drugs and the sharing of scarce equipment were commonplace at the
time; the true impact of these practices is now clear in terms of the spread of HIV
infection among the young people who lived there” (O’Kelly et al. 1996, p. 114).
Another study carried out with a cohort who had begun injecting during the same
period found similar rates of HIV prevalence. Williams et al. (1990) found that of a
cohort of sixty-nine individuals on a methadone maintenance programme 70%
were HIV positive.
These high prevalence rates of HIV were not found in studies subsequent to
those of O’Kelly et al. (1996) and Williams et al. (1990). Johnson et al. (1994)
found that in 1991, 14.8% of a sample recruited from a needle exchange
programme were HIV positive. The Dorman et al. (1997) study, which was
carried out in 1992 in the context of a World Health Organisation multi-national
research initiative, found that 8.4% of a sample of 180 injecting drug users,
recruited from both in and out of treatment, were HIV positive. In contrast, the
Smyth et al. (1998) study of a drug treatment sample tested between 1992 and
1997 found a prevalence rate for HIV of only 1.2%. This is low in contrast to an
estimated 8% prevalence rate (based on laboratory reports) among injectors
attending Eastern Health Board methadone clinics in 1997 (Joe Barry, cited in
Allwright et al. 1999, p. 2).
More recently, two studies have been carried out which report on HIV prevalence
among the Irish prison population (Allwright et al. 1999; Long et al. 2000).
Included in the data are the prevalence rates for those prisoners who have a
history of injecting drug use. It was found that 5.8% of committal prisoners10
(Long et al. 2000) and 3.5% of general prisoners (Allwright et al. 1999) with a
history of injecting drug use were HIV positive. Among those prisoners who
reported no history of injecting drug use the infection rates were 0.5% among the
committal population (Long et al. 2000) and 0.9% within the general prison
population (Allwright et al. 1999). In an environment where injecting drug use is
                                                
10 Committal prisoners are prisoners who have been admitted to the prison within the preceding 48 hours,
accused or guilty of a new crime, excluding those on temporary release or transferred from another prison.
The committal population includes individuals entering on remand, following sentence, committed as a result
of a bench warrant and non-nationals without valid documentation (Long et al. 2000: p.2).
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on-going in the absence of any provision for clean injecting equipment, the risk
for the spread of infection within this population is high.
Table 14.3 Ireland 1994-1999 : Summary of research findings on the prevalence of HIV
infection among particular cohorts of drug users
Author Study
period
Sample
Source
Self Report/
Test
Serum/
Saliva
Sample
size tested
% infected of
those tested
Long et al
(2000)
1999 Committal
prisoners
N=593
Test Saliva IDUs 11
(n=173)
IDUs
5.8%
Allwright et al
(1999)
1998 Irish Prison
Population
N= 1178
Test Saliva IDUs
(n=509)
IDUs
3.5%
Smyth et al
(1998)
1992-
1997
Drug treatment
centre
N=735
Test Serum IDUs
(n=600)
IDUs
1.2%
Dorman et al
(1997)
1992 Drug treatment
centre & non-
treatment IDUs
N=185
Test Serum
and
saliva
IDUs
(n=180)
IDUs
8.4%
O’Kelly et al
(1996)
1984-
1995
IDUs in
community
N=82
Test Serum IDUs
(n=66)
IDUs
65%
Johnson et al
(1994)
1991 Needle
exchange
N=106
Test Saliva IDUs
(n=81)
IDUs
14.8%
In summary, injecting drug use continues to be one of the main risk categories to
which HIV positive cases are attributed each year. Despite the rates of new HIV
positive cases attributed to injecting drug use plateauing in the early and mid
1990s, recent figures suggest that there is an upward trend in the number of new
HIV positive cases among Irish drug users. The information available on those
who are testing positive for HIV remains limited. Analysis of the figures highlights
the need for more information, in particular of a socio-demographic and
behavioural nature, to facilitate comprehensive epidemiological analysis of the
trends.
14.2 Hepatitis B
There is very little information in Ireland on the prevalence and incidence of
hepatitis B among both the general population and the injecting drug using
population. While data are collected on the number of positive tests carried out
for hepatitis B by the Virus Reference Laboratory, no behavioural data is
collected and therefore those infected through drug use cannot be identified.
Information on prevalence rates is therefore confined to a small number of
special studies that have been carried out in the field.
                                                
11 IDUs: Injecting drug users
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The Smyth et al. (1998) study of drug users located within a treatment setting
found that only 1% were infected with Hepatitis B. However, more recent
research carried out in the prison setting found significantly higher prevalence
rates among injecting drug users. Allwright et al. (1999) and Long et al. (2000)
found 18.5% and 17.9% prevalence rates for hepatitis B, respectively. While
these figures suggest that hepatitis B may be prevalent among the injecting drug
user population, the lack of data prohibits any in-depth epidemiological analysis
of the situation Ireland.
Table 14.4 Ireland 1998-2000 : Summary of research findings on the prevalence of Hepatitis
B infection among particular cohorts of drug users
Author Study
period
Sample
Source
Self Report/
Test
Serum/
Saliva
Sample
size tested
% infected
of those
tested
Long et al
(2000)
1999 Committal
prisoners
N=593
Test Saliva IDUs
(n=173)
IDUs
17.9%
Allwright et al
(1999)
1998 Irish Prison
Population
N= 1178
Test Saliva IDUs
(n=509)
IDUs
18.5%
Smyth et al
(1998)
1992-
1997
Drug treatment
centre
N=735
Test Serum IDUs
N=729
IDUs
1%
14.3 Hepatitis C
In Ireland, there is no routine data collection in the area of hepatitis C. However,
there have been a number of special studies carried out among samples of drug
users in a variety of study settings (see table 14.5).
The first study of hepatitis C infection among injecting drug users was carried out
between August 1992 and August 1993 by Smyth et al. (1995). The study sample
was identified through a treatment centre where all new attenders and re-
attenders who presented during the study period and who reported a history of
injecting drug use were encouraged to take part. In total, 272 injecting drug users
took part and a prevalence rate of 84% for infection with hepatitis C was found.
Among those injectors who had been injecting for between six months and two
years inclusive the prevalence rate was 70%. Among those with a longer
injecting history, i.e. an injecting history of longer than two years, the prevalence
rate was 95%. Furthermore, there was a significant difference between genders
in terms of infection. 156 of the 194 males (80%) tested positive, whereas 73 of
the 78 females (94%) were positive.
Further studies were carried out by Smyth et al. (1998, 1999a), which examined
the prevalence of hepatitis C among in-treatment populations. Consecutive new
attenders at a treatment service who attended between July 1993 and December
1996 were approached to take part in the study. In all, a sample of 353 injecting
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drug users who reported an injecting history of less than 25 months were
recruited. Overall, a prevalence rate of 52.1% was recorded within this sample. In
an extension of this study cohort, Smyth et al. (1998) later found that of 733
consecutive new attenders between September 1992 and September 1997 at the
same treatment centre, 61.8% were hepatitis C positive.
In two prison studies, which have been discussed in previous sections, the
prevalence of hepatitis C among prisoners was explored (Long et al. 2000;
Allwright et al. 1999). The prevalence of hepatitis C was found to be high within
this population. Allwright et al. (1999) found that among 509 prisoners with a
history of injecting drug use, 81.3% tested positive for hepatitis C. In contrast,
only 3.7% of those prisoners who did not report a history of injecting drug use
had tested positive for hepatitis C. A follow-up study of the committal prisoner
population (Long et al. 2000) found that of 173 prisoners with a history of
injecting drug use, 71.7% were hepatitis C positive. Only 1.4% of those prisoners
who reported that they had no history of injecting drug use tested positive for
hepatitis C.
Table 14.5 Ireland 1995-2000 : Summary of research findings on the prevalence of Hepatitis
C infection among particular cohorts of drug users
Author Testing
period
Sample
Source
Self Report/
Test
Serum/
Saliva
Sample
size tested
% infected
of those
tested
Long et al
(2000)
1999 Committal
prisoners
N=593
Test Serum IDUs
(n=173)
Non IDUs
(n=420)
IDUs 71.7%
Non IDUs
1.4%
Allwright et al
(1999)
1998 Irish Prison
Population
N= 1178
Test Serum IDUs
(n=509)
Non IDUs
(n=669)
IDUs
81.3%
Non IDUs
3.7%
Smyth et al
(1999a)
1993-
1996
Drug treatment
centre
N=353
Test Serum IDUs
N=353
IDUs
52.1%
Smyth et al
(1999b)
1997 Drug treatment
centre
N=84
Self-report n/a IDUs
N=84
IDUs
89%
Smyth et al
(1998)
1992-
1997
Drug treatment
centre
N=735
Test Serum IDUs
N=733
IDUs
61.8%
Smyth et al
(1995)
1992-
1993
Drug treatment
centre
N=272
Test Serum IDUs
(n=272)
IDUs
84%
While it is not possible from the available data to analyse infection trends over
time, it would appear from the studies available that hepatitis C infection has
been prevalent among Irish injecting drug users over the past decade. Anecdotal
evidence suggests that the relative ease with which hepatitis C can be spread
through injecting drug use, and a lack of knowledge among users about hepatitis
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C and the associated risks, have all contributed to its spread. In summary, the
prevalence rate for hepatitis C has been found to be consistently high within the
drug using population over the past decade.
Summary
In summary, the most comprehensive data available on drug related infectious
diseases in Ireland are for HIV. While the number of new positive tested cases
for HIV, which were attributable to injecting drug use, appeared to stabilise in the
mid 1990s, figures for 1999 show an increase in the number of cases. For both
hepatitis B and C, analysis is dependent solely on data from special studies.
Despite the absence of comprehensive data it appears from the evidence
available that hepatitis C continues to be highly prevalent among Irish injecting
drug users. Overall, it would appear from the data that is available that drug
related infectious diseases continue to be an issue of concern in relation to Irish
injecting drug users. Furthermore, this highlights the need for more
comprehensive data collection in the area of all drug related infectious diseases
in order to monitor changes in the trends over time.
14.4  Determinants and consequences
This section will address some of the determinants and consequences of drug
related infectious diseases in the Irish context. It will examine the research that
has been carried out which looks at the risk behaviours engaged in by Irish drug
users, both in relation to their injecting drug use and their sexual behaviour.
Furthermore, it will explore the data available on both the health-related
consequences and the wider social consequences of drug-related infectious
diseases.
§ Risk behaviours
Injecting risk behaviour
Once the link between the spread of HIV and injecting drug use was established
in the mid 1980s, the risk behaviours engaged in by the injecting drug using
population became a focus of research. In the Irish context, studies on the
injecting risk behaviour of drug users have spanned the last decade. During this
period the provision of harm reduction strategies has expanded from being
available through a small number of programmes which were accessible to a
small number of drug users, to more widespread availability to a significant
number of programmes which cater for a significant number of drug users. This
section will describe the findings of research related to the risk behaviours of the
general injecting population and then those findings relating to three sub-groups
of particular interest: young injectors, female injectors and injecting drug users in
prison.
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General injecting drug users: Research carried out by Johnson et al. (1994) in
1991 among a sample of attendees at a Dublin needle exchange, found that
52.6% of respondents reported that they had not shared equipment during the
preceding 28 days, while over 34.2% had shared with two or more other people.
A study carried out a year later, in 1992 (Dorman et al. 1997), among a sample
(N=185) of injecting drug users both in and out of treatment, found that 55.7% of
the sample had shared and 61.6% had lent injecting equipment in the previous
six months.
Despite the expansion of harm reduction strategies since the two studies
described above (Johnson et al. 1994; Dorman et al. 1997) were carried out,
more recent research has found that Irish drug users continue to engage in risky
injecting behaviour. In a study of those attending a needle exchange programme
Cox et al. (2000) found that 59% of the sample who had a history of injecting
drug use (N=1323), reported sharing injecting equipment at some stage in their
injecting drug using career. Furthermore, 29% of these respondents reported
sharing recently (i.e. in the previous four weeks). Among the 29% who reported
sharing recently, 17% had lent their injecting equipment, 50% had borrowed it
and 33% had done both. Data from the National Drug Treatment Reporting
System operated by the Drug Misuse Research Division of the Health Research
Board offers further evidence that Irish drug users continue to engage in injecting
risk behaviours. In 1998, 575 of first treatment contacts (N=1625) reported that
they had ever injected a drug, 45.6% of who reported that they had ever shared
injecting equipment. Furthermore, 352 of this sample reported that they were
currently injecting (i.e. within the last month), 32% (n=118) of who reported that
they were currently sharing injecting equipment (i.e. within the last month).
Young injectors: In a study specifically aimed at exploring the risk behaviours
engaged in by a sample of young injectors (n=485), i.e. those under the age of
twenty-five, Cassin et al. (1998) found a significant proportion regularly engaged
in injecting risk behaviours. Compared with a cohort of older injectors (n=285),
i.e. those over the age of 25, who were attending the same service, younger
clients were found to be significantly more likely to have reported both lending
and borrowing used needles and syringes in the 4 weeks prior to first contact with
the syringe exchange programme. Furthermore, 64.3% of the younger cohort
reported that they had shared injecting paraphernalia (i.e. spoons and filters) in
the four weeks prior to contacting the service, compared to only 43.8% of the
older cohort.
Female injectors: Female drug users have also been looked at specifically in
the literature in relation to their injecting risk behaviours. Cox et al. (2000) found
that among a cohort of needle exchange clients, women (n=304) were
significantly more likely than men (n=1000) to report sharing injecting equipment
with their sexual partner and to share injecting paraphernalia with other injecting
drug users. While 53% of men reported that they had shared injecting
paraphernalia, 63% of females reported that they did so. The gender difference
was more acute in relation to sharing injecting equipment with a sexual partner,
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13% of men compared to 37% of women reported that they did so. However, this
was directly related to the fact that 68% of women reported that they had a
sexual partner who was an injecting drug user, compared to just 24% of men.
Cox et al. (2000) argue that the greater personal involvement of women with
other drug users has consequences in terms of health related problems and risk
behaviour. The social opportunities created by living in close proximity with other
injecting drug users creates an environment in which risk behaviour flourishes
(Cox et al. 2000).
Injecting drug users in prison: To date, Irish prisoners do not have access to
clean injecting equipment and only a very limited number have access to a
methadone maintenance programme within the prison setting. This implies that
where injecting drug use occurs in the prison, it may be particularly risky in
relation to the spread of drug related infectious diseases. O’Mahony’s (1997)
study in a Dublin prison found that 42% (n=45) of a sample of 108 prisoners had
used heroin while in prison serving their current sentence. Thirty-seven of these
forty-five had engaged in intravenous use. One sixth of those reporting a history
of drug use had tested positive for HIV, while a quarter had never been tested. In
addition, half of these drug users said that they had tested positive for at least
one form of hepatitis. O’Mahony described as ‘alarming’ (O’Mahony 1997, p. 107)
the finding that of those who reported having tested positive for HIV, sixty percent
had engaged in needle sharing since being notified of their positive status. An
earlier study based on data gathered between 1987 and 1991, found that during
this period, 168 known HIV positive prisoners had spent time in Mountjoy. A
study of a sub-sample of these HIV positive individuals, selected on a random
basis, found that ninety four percent had engaged in drug use within the prison,
suggesting a potential spread of HIV to uninfected prisoners (Murphy et al. 1992).
A more recent study of HIV and hepatitis B/C prevalence among prisoners found
that users share injecting equipment within the prison setting (Allwright et al.
1999).  As may be expected in an environment where there is no formal access
to injecting equipment, it was found that injecting drug users were more likely to
share injecting equipment while in prison than when they were in the community.
Fifty-eight per cent of injecting drug users reported that they had shared all
injecting equipment (i.e. needles, syringes, filters, spoons) while in prison,
compared to 37% who reported sharing in the month prior to being incarcerated.
Furthermore, of those injecting drug users who had shared injecting equipment
inside the prison, 89.1% had tested positive for hepatitis C.
Sexual risk behaviour
In 1985 Irish family planning legislation was amended to allow for the sale of
condoms to people over the age of eighteen without a prescription from a range
of named outlets. The sale of condoms was not deregulated in Ireland until 1993,
when the law was changed to make condoms available for sale through outlets
other than pharmacies. This change in the law was principally in response to
public health concerns in relation to HIV/AIDS, and the law referred to condoms
as infection preventers rather than pregnancy preventers (Prendiville et al. 1993).
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Condoms are now available for sale from a wide range of sources, including
vending machines. Furthermore, condoms are distributed freely to groups
considered to be at high risk of infection, including injecting drug users. Despite
the wide availability of condoms, research carried out among drug users
suggests that they continue to engage in sexual risk behaviours which may
facilitate the spread of HIV and other infectious diseases.
A study of first attenders at the Eastern Regional Health Authority needle
exchange programmes from 1990-1997 found that only 55% of first time
attenders (N=5152) reported using a condom during sexual encounters in the
previous year (Mullen 1998). A study of drug using women working in prostitution
(N=77) (O’Neill et al. 1999), 83% of whom reported injecting drugs in the
previous month, found that while 92% ‘always’ used condoms with clients for
vaginal sex, only 15% ‘always’ used condoms with their partners for vaginal sex.
Furthermore, while none reported ‘never’ using condoms with clients for vaginal
sex, 52% reported that they ‘never’ used condoms with partners for vaginal sex.
There were similar findings in research carried out with a cohort of clients
attending a syringe exchange programme (N=1,309). It was found that 25% of
those who reported having no regular sexual partner reported ‘never’ using
condoms, whereas 41% of clients who reported having a regular sexual partner
(N=865) reported ‘never’ using condoms. It has been argued that the reluctance
to use condoms within long-term or steady sexual relationships can be
particularly problematic, this has been argued both in the context of the drug
using population (Cox et al. 2000) and the general population (Mahon et al.
1998).
Summary
In summary, this section highlights the extent to which Irish drug users continue
to engage in behaviours conducive to the spread of drug related infectious
diseases, both through their injecting drug use and their sexual activity. Despite
the expansion of harm reduction strategies since the early 1990s, Irish drug
users continue to engage in these risk behaviours. The findings of studies carried
out in the early 1990s in relation to risk behaviours may be explained by a lack of
appropriate service provision and a lack of knowledge among both service
providers and users of the risks involved in sharing. However, the more recent
study findings show that these patterns of risk behaviour continue to exist despite
the presence of appropriate services. Section 14.3 will present the research
findings which consider whether the introduction of harm reduction strategies
have had an impact on infecting drug users’ risk behaviours.
Consequences
The consequences of drug related infectious diseases have not received
significant attention in the Irish literature. The following sections will discuss these
256
consequences in two parts, first the health related consequences and second,
the wider social consequences.
Health related consequences: The most obvious consequences of HIV and
hepatitis B and C are the impact these diseases have on the individual’s health.
There are no data available on the number of drug users who develop chronic
hepatitis C or require care for hepatitis B infection. The only data collected on the
health consequences of drug related infectious diseases are those on AIDS
related cases and deaths. Since recording began in 1982 and up until December
31st 1999, there have been 691 AIDS cases reported in Ireland, and 349 AIDS
related deaths (see Table 3.3, Appendix 3). In 1999 there were 41 new AIDS
related cases recorded. Intravenous drug users continue to represent one of the
main risk categories recorded in this data source. In 1999, intravenous drug
users accounted for 39% of new AIDS cases, and 41% of the year’s AIDS related
deaths.
Another area of concern is the extent to which HIV/AIDS is passed on from
mother to baby. From January 1986 to December 1999, a total of 172 HIV
positive cases were attributed to the category ‘children at risk’, representing
7.84% of the total HIV positive cases reported over the period (Department of
Health and Children). However, this category does not indicate the route of
infection and it is therefore not known to what extent HIV among these children is
attributable to maternal injecting drug use. However, the statistics collected on
AIDS cases and deaths indicate where a child’s infection is attributable to
maternal drug use. In total, from 1982 to 1999 14 children born to drug users
were recorded as AIDS cases, this represents 2% of the total 691 cases
recorded up to December 31st 1999. Furthermore, there were 8 AIDS related
deaths among children of injecting drug users recorded in the same time period,
which accounts for 2.3% of the total 349 deaths recorded up to December 31st
1999.
Summary
In summary, little is known about the health related consequences of drug related
infectious diseases in Ireland. While there have been improvements in treatment
procedures, particularly in the area of HIV, coping with the impact of the high
prevalence rates of hepatitis C infection will present a particular challenge to
service providers.
Wider consequences: The close link between social deprivation and
problematic drug use in Ireland, has meant that those who are affected by drug
related infectious diseases are generally from areas characterised by high levels
of social deprivation. Individuals who may be considered socially excluded may
therefore suffer further exclusion as a result of being affected by a drug-related
infectious disease. In this context, it is important that the wider social
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consequences of drug-related infectious diseases be considered. However, little
research has been carried out in this field, either on individuals infected, their
families or the community at large. As part of a wider study on heroin use in
Dublin’s inner city, McCarthy et al. (1997) surveyed 26 opiate users and 18
families in which there was a drug using member. Among both groups drug-
related infectious diseases were raised as an issue of concern. A number of
respondents reported that they had to cope with either their own or a family
member’s infection and its effects. Particularly acute were the concerns
expressed of individuals within families where another member was HIV positive.
Twenty-eight of the respondents from the family cohort reported that they had a
family member who was HIV positive or living with AIDS. One mother reported
that four of her children had died from AIDS-related illness between 1989 and
1995 (McCarthy et al. 1997; p. 58). It was also found however, that none of the
respondents who lived with a person who was infected with HIV had availed of
any formal support services for themselves in relation to HIV/AIDS issues.
O’Gorman (1999) carried out a qualitative study of the experiences of both
people directly infected by HIV and also those whose lives have been affected by
HIV, i.e. the parents, partners, children and siblings of people who are HIV
positive. In total, members of 19 families participated in the study, 26 adults and
7 children who had been diagnosed HIV positive, and a further 29 adults and 54
children who were affected by HIV/AIDS. This study highlights the complex
nature of the problems faced by both those infected and those affected by
HIV/AIDS. The problems identified included the trauma involved in being
diagnosed, informing other family members (e.g. partners, children) who may be
at risk of infection, caring for a child who is HIV positive when the parent is also
HIV positive, complying with treatment regimes and coping with an AIDS-related
death. O’Gorman (1999) argues that in the absence of adequate public
information campaigns, HIV and AIDS continue to be widely viewed within Irish
society with “prejudice, fear and ignorance” (O’Gorman 1999, p. 55).
Consequently, those infected with the disease and their families have to live with
the added strain of coping with the stigma and secrecy that surrounds HIV.
Summary
In summary, as in other European countries the consequences of drug related
diseases in Ireland are multifaceted. While they encompass consequences on
the health and general well-being of the infected individual, they also impact on
the infected individual’s family and wider community. The wider social
consequences of drug related infectious diseases have been largely neglected in
the Irish context and are in need of further attention.
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14.5 New developments and uptake of prevention/harm reduction, care
As mentioned in previous sections, harm reduction strategies play a key role in
the provision of services for drug users in Ireland. Both needle exchange
programmes and those based on substitution treatment were expanded in an
attempt to curb the spread of HIV among injecting drug users. More recently
there has been an increased focus on the role these services play in preventing
the spread of other drug-related infectious diseases, i.e. hepatitis B and C. This
section of the report will give an overview of the harm reduction services
available to Irish injecting drug users, which aim to prevent the spread of drug
related infectious diseases among this population. Furthermore, it will give a brief
overview of those services which provide care for those already infected. The
following areas of service  provision will be addressed:
§ Harm reduction programmes
§ Testing and treatment
§ Hepatitis B vaccination
§ Harm Reduction Programmes
A number of harm reduction strategies have been developed which specifically
aim to prevent the spread of HIV and other drug-related infectious diseases
among injecting drug users in Ireland. However, the impact of these programmes
on infection rates among injecting drug users are unclear. Smyth et al. (1999a)
attempted to explore the impact these programmes had on the spread of
hepatitis C by carrying out tests for hepatitis C among a cohort of drug users. The
cohort included those who had begun their injecting drug use both before and
after the expansion of harm reduction programmes in Ireland. Smyth et al.
(1999a) argue that the findings suggest that those injecting drug users who
began their injecting drug use after the introduction of harm reduction strategies,
demonstrated a reduced risk of HCV infection. However, Smyth et al. (1999a)
emphasise that it was not possible to control for other factors that may explain
the decline in the HCV infection rate, such as a possible reduction in overall
injecting frequency among more recent injectors.
In this section three specific harm reduction services will be briefly overviewed,
and any research findings in relation to the impact they may have had on the
spread of drug related infectious diseases presented. The services that will be
covered in this section are:
§ Information and education programmes
§ Needle exchange programmes
§ Substitution programmes
Information and education programmes: Information on drug related infectious
diseases is made available to drug users through a number of sources. Leaflets
containing information on what these diseases are and how they are spread are
available to drug users from a number of locations, including drug treatment
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centres, health centres, drop in centres and voluntary organisations. An
information booklet dealing specifically with hepatitis C has recently been
produced which is directly aimed at informing drug users and their families about
the disease (Keating 2000). Furthermore, there have been a limited number of
education programmes aimed at informing drug users directly about drug-related
infectious diseases and the associated risks. In 1996 the Health Promotion Unit
of the Department of Health and Children produced guidelines for effective
HIV/AIDS education (Department of Health 1996). An example of an education
programme aimed directly at drug users was established by the Probation and
Welfare Service in Mountjoy Prison Dublin. This Drug Awareness Programme is
a four-week programme consisting of one session per week. The principal aim is
to educate participants about their drug use and the associated risks. It is aimed
at all prisoners with a history of drug use, including those who have ceased their
drug use and those who are continuing to use within the prison setting. Included
in this programme is a session on HIV and Hepatitis.
While education and dissemination of information about drug-related infectious
diseases and the associated risks have been an important component in
Ireland’s prevention strategy, the effectiveness of information dissemination and
the impact of such information on risk behaviour is unclear.
Prior to the development of the Probation and Welfare Service’s Drug Awareness
Programme an award winning booklet and video containing information for
prisoners on HIV discrimination, infection and prevention were produced and
were supposedly available to all prisoners. However, a study carried out based
on focus group interviews with prisoners and former prisoners, found that HIV
positive individuals in the focus groups had seen neither of these materials
(O’Brien et al. 1997). Furthermore, as will be discussed in more detail below,
Smyth et al. (1999b) found that even where injecting drug users may be
attending a treatment service and have regular contact with health professionals,
this does not necessarily result in the drug user developing a better
understanding of hepatitis C and the related risk behaviours. Bourke (1998) also
found that within a cohort (N=66) of young injecting heroin users (aged 15-22)
attending services “whilst most understood the significance of sharing needles
few were aware that sharing barrels, spoons and filters put them at risk” (Bourke
1998, p. 4).
It would appear from the evidence available that information is not always passed
on to injecting drug users in an effective manner. Despite the existence of
education and information materials as part of the prevention strategy in the area
of drug-related infectious diseases, it would appear that there is a need for this
information and education to be delivered in a more effective manner.
Needle exchange programmes: The first needle exchange programme in
Ireland was established in 1989. Since then the service has been expanded to
include approximately 12 sites. All of these sites are located in the Health Board
260
of the Eastern Regional Health Authority12 [ERHA], which includes Dublin City
and surrounding areas. Three types of programmes exist:
Ø The Merchant’s Quay Project is a voluntary organisation which, among other
services, provides a needle exchange programme.
Ø There is a mobile clinic which provides low threshold services to drug users
including a needle exchange and a low dosage methadone programme. This
clinic services four areas in Dublin city and the surrounding suburbs on a
Monday to Friday basis.
Ø The remaining programmes are all in statutory services run by the ERHA.
These are located in health centres and drug treatment centres around the
city.
A one-for-one exchange of needles is aimed for by all needle exchange services.
However, there is flexibility in order to ensure the service is client-friendly. The
mean number of needles given out to injecting drug users at first attendance at
ERHA exchange programmes is 4.0 (Mullen et al. 1998). Overall, the ERHA
programmes estimate that approximately 60-70% of needles are returned to its
exchange programmes. For ‘first time’ clients at the Merchant’s Quay Project the
number of syringes and needles given is normally two barrels and six needles (or
six microfines) (Cox et al. 2000). In 1998, a total of 16,509 syringes were
dispensed by the Merchant’s Quay Project through its exchange programme
(Cox et al. 2000).
While there has been an expansion in the number of needle exchange
programmes available to Irish drug users, a need for further expansion has been
identified. An external review of drug services in the Eastern Health Board has
described needle exchange provision in Dublin as “patchy and not very
comprehensive” (Farrell et al. 2000: 13). While it is recognised that community
resistance may impact on the expansion of these services, it was argued that
there needed to be a wider geographical distribution of these services.
Pharmacies have been suggested as a potential source for clean injecting
equipment for injecting drug users.
While there are no restrictions on pharmacies in relation to selling injecting
equipment in Ireland, in practice anecdotal evidence suggests that this rarely
happens. Currently there is no central policy or programme under which
pharmacists provide needles to injecting drug users. The Pharmaceutical Society
of Ireland has stated that they support “the principle of needle and syringe
exchange. Its members are ready and willing to provide such a service as part of
a comprehensive national needle and syringe exchange network” (McDermott
1999).
In an evaluation of the Merchant’s Quay Project’s syringe exchange programme,
it was found that it had a positive impact on reducing the incidence of injecting
risk behaviours among clients. Clients were questioned about their risk behaviour
                                                
12 Formerly the Eastern Health Board [EHB]
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when they first attended the service and then again after three months. Within
this period it was found that there was a 76% reduction in the numbers reporting
lending injecting equipment and a 71% reduction in the numbers reporting
borrowing injecting equipment (Cox et al. 2000: 69).
Substitution programmes: As described in section 9.4.2 of this report,
substitution programmes currently account for the majority of treatment
programmes available to injecting drug users in Ireland. At the end of August
2000 there were 4,813 clients receiving substitution treatment in Ireland. The
service is provided in a range of settings including addiction centres, satellite
clinics and from general practitioners in their own surgery. It is assumed that by
providing a substitute opiate (i.e. methadone) and monitoring illicit drug use
through urinalysis, participation on a substitution programme will reduce the illicit
opiate intake of a client and, in turn, their injecting drug use. However, a
secondary function of substitution programmes in relation to preventing the
spread of drug related infectious diseases is the dissemination of information to
clients about HIV and hepatitis and associated risk behaviour.
Williams et al. (1990) carried out a study with 69 clients of a methadone
maintenance treatment programme to investigate the extent of ‘at-risk’ behaviour
for HIV transmission among those known to be sero-positive, and to measure the
degree of positive change in their risk behaviour. It is important to note that this
study was carried out in 1988, prior to the introduction of needle exchange
programmes by the health board. Of those who were HIV positive (n=48), 63%
admitted that they had continued to share injecting equipment since getting a
positive test result. However, when comparing their reported pre-test activities
the findings were deemed to be encouraging. Prior to being tested 98% reported
that they had shared injecting equipment, compared to 63% after testing.
More recently, in 1997 Smyth et al. (1999b) carried out a study of knowledge
regarding hepatitis C among a sample of injecting drug users (N=84) in a
treatment setting in Dublin. Included in the sample were individuals who were on
a methadone maintenance programme and those who were on a short-term
detoxification programme. Their basic hypothesis was that those injecting drug
users with increased contact with medical services would demonstrate better
understanding of hepatitis C and associated risk behaviours, i.e. a ‘dose-
response’ type effect. This hypothesis was not confirmed. Seventy-three of the
sample recognised the four main infection routes, i.e. injecting drug use, sex,
transfusion and vertical. However, only 44% recognised activities with no
recognised risk, i.e. injecting without sharing, smoking heroin and kissing. Smyth
et al. (1999b) expressed concern about the finding that substantial minorities
believe that there is a risk of exposure even when not sharing injecting
paraphernalia. They argued that perceived personal vulnerability to infections
such as hepatitis C is likely to be a factor in leading individuals to avoid practising
unsafe injecting behaviour. Where this vulnerability is diminished by false beliefs
about already having been exposed to infection when actually engaging in ‘safe’
practices, then the preparedness to share injecting equipment may well increase.
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Summary
In summary, while section 14.2 of this report showed that a significant proportion
of Irish injecting drug users continue to engage in injecting risk behaviours, it
would appear from this section that harm reduction strategies have had some
positive impact on injecting drug users risk behaviours. While there is a need to
improve on how some services are delivered, the findings would suggest that
infection rates would be higher in the absence of the current harm reduction
strategies.
§ Testing and Treatment
Testing: Testing for hepatitis and HIV is offered to all those entering treatment
and is encouraged by low threshold services such as needle exchange
programmes. In these settings clients are given test results and may be offered
referral to treatment where appropriate. The actual proportion of injecting drug
users who have been tested for either heaptitis or HIV remains unknown. A study
of HIV and hepatitis B/C prevalence among the prison population (Allwright et al.
1999) found that of 509 prisoners with a history of injecting drug use, 59.3%
reported that they had been tested for hepatitis C, 49.6% for hepatitis B and 65%
for HIV. In the Cox et al. (2000) study of needle exchange attenders, 49%
reported that they had been tested for HIV. It has also been found that young
injecting drug users (below the age of 25) are significantly less likely to have
been tested for either HIV or hepatitis than the older cohort (Cassin 1998). While
the specific nature of these study populations needs to be considered, these
figures would suggest that a significant proportion of drug users have not been
tested for the various drug-related infectious diseases.
Treatment: The provision of treatment for those infected with both HIV and
hepatitis C is a key aspect of drug related infectious diseases. Treatment
programmes for both HIV and hepatitis C are available free of charge in Ireland.
While it is not essential for drug users to be referred by drug treatment clinics for
HIV and hepatitis C treatment, this is the route generally followed.
Highly Active Anti-Retroviral Treatment (HAART) is available free of charge to
drug users through referral to genito-urinary medicine (GUM) and infectious
disease clinics in Ireland. There are four clinics that provide HAART, three of
which are based in Dublin, the fourth in southern Ireland in Cork. The selection of
patients for HAART is based on medical criteria as set out by international
recommendations, and the motivation of the individual to undergo the treatment.
A drug user generally has to be stable on a substitution programme before
he/she will be accepted on to a HAART programme. This is due to problems of
compliance with the treatment regime and concerns about the risks of prescribing
HAART to those who are continuing to engage in illicit drug use.
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Treatment for hepatitis C is also available to drug users where its provision is
deemed appropriate. Guidelines have been developed for selecting suitable
candidates for hepatitis C treatment. It is generally agreed among service
providers that a potential client should be ‘drug stable’ (i.e. free from street
opiates and injecting drug use) for a minimum of a year prior to starting treatment
and that they should not be drinking alcohol (Keating 2000). As with HAART, it is
argued that an individual needs to be drug stable in order to maximise the
chances of compliance with the treatment regime involved for hepatitis C.
Therefore, while a person with a history of injecting drug use may access
treatment for hepatitis C, an active injecting drug user may not.
§ Hepatitis B vaccination
Hepatitis B vaccination is available free of charge to all injecting drug users
through the drug services and, where the individual is entitled to free medical
care, through their general practitioner. However, anecdotal evidence suggests
there is a lack of knowledge among drug users about hepatitis B in general, and
the availability of a vaccination. Furthermore, anecdotal evidence suggests that
not all service providers are offering drug users the hepatitis B vaccination. While
the total proportion of injecting drug users who are vaccinated against hepatitis B
is not known, special studies have found that a relatively low proportion report
having received a vaccination. A study of those clients attending the Merchant’s
Quay Project found that only 19% of clients reported having been vaccinated for
hepatitis B (Cox et al. 2000). Furthermore, a study of HIV and hepatitis B/C
prevalence among committal prisoners (Long et al., 2000) found that of 175
prisoners with a history of injecting drug use, only 23% (n=41) reported that they
had been fully vaccinated for hepatitis B. There is also a need to ensure that drug
users who begin a course of the hepatitis B vaccination complete the three
injections. In their study of HIV and hepatitis B/C prevalence among the prison
population Allwright et al. (1999) found that while 300 respondents reported that
they had been vaccinated against hepatitis B, only 184 had completed the three
doses.
Conclusion
In conclusion, there appears to be on-going evidence that a significant proportion
of Irish drug users may be infected with at least one drug related infectious
disease. However, analysis of the situation remains restricted in the absence of
comprehensive routine data collection in the field. It would also appear that while
harm reduction programmes have played a role in containing the spread of drug
related infectious diseases to some extent, a significant proportion of Irish
injecting drug users are continuing to engage in risky behaviours. It would appear
that there is a need for more comprehensive education and information
dissemination strategies targeted at drug users, and in particular young injectors.
Furthermore, there is a need for a more effective delivery of testing services and
in particular hepatitis B vaccination to drug users.
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ANNEX
Drug Monitoring System and Sources of Information – New
Developments
Information of this report was gathered with the co-operation of a wide range of
Government Departments, agencies, community and voluntary sector informants
etc. as acknowledged in the Forward to this report.
New developments in systems include
- National Drug Treatment Reporting System which is being extended currently
to include GPs and will be extended in the near future to include the Prison
Service.
- Drug co-ordinators in the Regional Health Boards plan to collect information
on Demand Reduction activities in their areas.
- Electronic treatment data capture at source is planned in the ERHA with the
development of the DIAS system. Other health boards are exploring the
development of electronic systems for drug treatment services.
Following the report of the Interim Advisory Committee on Drugs, the Drug
Misuse Research Division of the Health Research Board will develop a National
Documentation Centre. Collaboration with the Virtual Library project of the
EMCDDA is envisioned. The Document Centre will be a major information
resource in the national and European contexts.
